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Abstract 
Parasitic protozoa of the genus Leishmania possess a highly adaptable metabolic 
system which ensures their survival in two significantly contrasting in terms of 
metabolism hosts. A critical component of leishmanial metabolic machinery is the 
central carbon metabolism which encompasses a major fraction of metabolites and 
constitutively expressed enzymes whose localization, function, and manner of 
regulation in response to changes in nutrient levels in the different host niches, 
however, remain unclear. In a quest to elucidate how the Leishmania parasites 
overcome conditions with diminished levels of the primary nutrient D-glucose, a null-
mutant cell line that was deprived of the ability to acquire the hexose by genetic 
ablation of three related glucose transporters was created. As previously shown, the 
glucose transport deficiency in the null-mutant Leishmania mexicana (Δlmgt) is 
associated with reduced growth of the promastigote form in an axenic culture and the 
sand fly vector, no detectable utilization of the sugars D-glucose, D-fructose, D-
mannose, D-galactose, and D-ribose, reduced biosynthesis of sugar-containing 
glycoconjugates and virulence factors, increased sensitivity to nutrient starvation, 
elevated temperatures, and oxidative stress, and dramatically reduced levels of 
growth and parasitemia of the amastigote form in an axenic culture and 
macrophages. Considering all phenotypic characteristics observed previously, the 
main aims of this study were to determine whether the Δlmgt promastigotes use 
alternative carbon and energy sources, to investigate which pathways are altered as a 
result of possible utilization of alternative carbon sources, and to illustrate, as 
comprehensively as possible, the molecular events behind the changes in the central 
carbon metabolism in the Δlmgt promastigotes. For that purpose, a number of 
proteomic and metabolomic techniques were applied to identify and quantify 
modulations in protein and metabolite abundance in the Δlmgt promastigotes. The 
results revealed that the main energy and carbon sources for the Δlmgt promastigotes 
appear to be amino acids, with the tricarboxylic acid cycle playing a central role in 
amino acid catabolism. Furthermore, glycolysis/gluconeogenesis, pentose phosphate 
pathway, mannose metabolism, purine salvage pathway, and β-oxidation of fatty 
acids were also among the pathways affected by the glucose transporter incapacity of 
the Δlmgt promastigotes. Glycolysis/gluconeogenesis was shown to operate in a 
gluconeogenic mode and to be used for the synthesis of hexose phosphates. The 
oxidative phase of the pentose phosphate pathway and the glutathione metabolism 
were found to be down-regulated in the Δlmgt promastigotes, which is believed to be 
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the main reason behind the increased sensitivity of these parasites to oxidative stress. 
Mannose metabolism, which provides activated substrates for the synthesis of the 
variety of leishmanial secreted and membrane-bound glycoconjugates and the 
carbohydrate reserve material and virulence factor mannogen, was also down-
regulated and that finding corroborated with the previous observation of reduced 
glycoconjugate and mannogen synthesis in the Δlmgt promastigotes. Pyrimidine 
metabolism was not significantly modulated but the purine salvage pathway was 
down-regulated in the Δlmgt promastigotes. Nonetheless, the Δlmgt promastigotes 
appear to salvage ribose from nucleotide degradation and recycle it for the synthesis 
of new nucleotides. β-Oxidation of fatty acids was also decreased in the Δlmgt 
promastigotes, suggesting that lipids are not a major source of energy for these cells. 
Altogether, the data showed that the Δlmgt promastigotes i/ decrease high energy-
consuming processes such as DNA, RNA, and protein synthesis, ii/ rely heavily on 
amino acid catabolism via the tricarboxylic acid cycle for energy generation, iii/ use 
alternative carbon sources for the production of biosynthetic precursors, iv/ have 
reduced capabilities to synthesize key metabolites such as sugar phosphates and 
sugar-containing macromolecules, and v/ are characterised with impaired 
regeneration of the antioxidant defence system and decreased production of 
virulence factors which appear to determine the susceptibility of these organisms to 
oxidative stress.  
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CHAPTER I.   Introduction 
I.1.   Genus Leishmania 
Order Kinetoplastida represents a medically important group of protozoa that 
have been subjects of considerable scientific interest for many decades. Considered to 
have evolved and diverged from a single common ancestor quite early in the 
evolution of eukaryotes (Sogin et al., 1989; Stevens, 2008), the order comprises 
unicellular flagellated organisms possessing a number of unique features, including a 
presence of a kinetoplast (Jensen and Englund, 2012), glycosomes (Opperdoes and 
Borst, 1977), antigenic variation of surface glycoproteins (Bridgen et al., 1976), bent 
DNA helices (Marini et al., 1982), contracting telomeric deoxyribonucleic acid (DNA) 
repeats (Bernards et al., 1983), and highly complex forms of nuclear DNA 
transcription (Johnson et al., 1987), messenger ribonucleic acid (mRNA) trans-
splicing (Boothroyd and Cross, 1982; Walder et al., 1986) and mitochondrial RNA 
editing (Benne et al., 1986). From an ecological and medical perspective, 
Trypanosomatina, one of the two suborders belonging to the order, comprises nine 
genera of obligatory parasites infecting virtually all classes of vertebrates, as well as 
some invertebrates and plants (Wallace, 1966; Vickerman, 1994; Svobodova et al., 
2007; Vickerman, 2009). Of particular importance to humans are two of the genera, 
Trypanosoma and Leishmania. 
I.1.1.   Leishmaniasis     
The first scientifically significant information about Leishmania dates back to 
the beginning of 20th century when Leishman and Donovan described the species 
now known as Leishmania donovani. Subsequently, Ross classified the species in a 
separate genus, genus Leishmania (Ross, 1903). Currently, approximately 30 different 
species of Leishmania are known to exist. About 21 species infect humans (Shaw, 
1994) and cause the spectrum of clinical diseases collectively referred to as 
leishmaniasis. The disease occurs in three main forms: cutaneous, mucocutaneous, 
and visceral. Cutaneous leishmaniasis is caused mainly by L. major, L. tropica, and L. 
mexicana. It is the most common type of leishmaniasis and is characterised by 
localized open or closed skin lesions that can sometimes spread over the entire body 
and cause Diffused/Disseminated cutaneous leishmaniasis. Mucocutaneous 
leishmaniasis, caused by the L. braziliensis complex, leads to disfiguring destruction of 
the mucous membranes of the nose, mouth, and throat cavities. 
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Figure I-1. Areas at risk of infection with cutaneous and visceral leishmaniasis. 
Credit: WHO 
Visceral leishmaniasis, caused by L. donovani and L. infantum, results in anaemia, 
weight loss, swelling of the spleen and liver, and death if left untreated. Typical 
methods for detection of leishmaniasis include microbiological and molecular-based 
tests. Microscopic examination of stained tissues, from skin lesions or from bone 
marrow, is the classical way for detection of the Leishmania parasites. In vitro 
culturing and inoculation of animals are other conventional methods for parasite 
detection. Species determination can be achieved by isoenzyme, immunologic, and 
PCR analyses (Herwaldt, 1999).  
Successful vaccination is believed to be one of the main strategies for control of 
leishmaniasis. Many vaccines have been investigated on animals but none has proved 
effective in field tests (Kedzierski et al., 2006). In the first decades after the 
establishment of the genus Leishmania, whole killed organisms had been used as first 
generation vaccines for prophylactic purposes (Modabber, 2010). Some of the 
vaccines for prophylaxis, however, showed higher efficacy in treatment and were 
consequently used as therapeutic vaccines. As a first generation vaccines are used 
also live attenuated parasites. Contrary to leishmanization, which involves 
inoculation with live and virulent Leishmania, the live attenuated parasites are 
infectious but not pathogenic (Nagill and Kaur, 2011). The vaccinated with this type 
  CHAPTER I 
3 
 
of vaccine subject thus develops infection similar to the natural but asymptomatic. 
Reversion to virulence or reappearance of the infection in immune-suppressed 
subjects is still an existing concern with the live attenuated vaccines (Nagill and Kaur, 
2011). As second generation vaccines, which are usually comprised of a recombinant 
protein or poly-protein products of DNA cloning, have been tested a plethora of 
molecules, including gp63, gp46 (PSA-2), the Leishmania homologue for receptors of 
activated C kinase (LACK), hydrophilic acylated surface proteins (HASP), and a 
number of cysteine proteases (Kedzierski, 2011). The only second generation vaccine 
in clinical development is the LEISH_F1 + MPL_SE vaccine which is comprised of three 
recombinant LEISH_F1 antigens and adjuvant monophosphoryl lipid and squalene in 
stable emulsion (Modabber, 2010). Third generation anti-leishmanial vaccines, which 
consist of naked DNA, were developed as safer alternatives of the second generation 
vaccines. Due to a low immunogenicity, a number of strategies have been applied to 
increase the protective strength of the vaccines, including the use of a mixture of 
different conserved antigens (Rezvan and Moafi. 2015).    
Current treatment of leishmaniasis involves the use of a number of antileishmanial 
drugs which, however, are characterized with variable effectiveness and/or high 
toxicity, require long treatment, and lead to serious adverse effects. Nonetheless, 
rational combination of drugs can be used to overcome some of these disadvantages. 
Leading drugs in antileishmanial therapy include pentavalent antimonials, 
amphotericin B, miltefosine, paromomycin, and pentamidine (de Menezes et al., 
2015). Alternative treatment can also involve the use of controlled release systems 
such as the liposomal formulation of amphotericin B, AmBisome (de Menezes et al., 
2015) which specifically targeting patients with HIV-Leishmania co-infections. For 
many years, however, the ongoing strategy for the development of new treatment for 
leishmaniasis has been the investigation of the biology of Leishmania and their host 
with the main goal of identifying potential drug targets. 
I.1.2.   Leishmania life cycle 
Leishmania have a digenetic life-cycle that involves alternation between two 
distinct forms - an extracellular slender and motile promastigote form (Figure I-2, A) 
and an obligate intracellular rounded and non-motile amastigote form (Figure I-2, B), 
and transmission between two hosts - sand flies of the genera Phlebotomus and 
Lutzomyia (Killick-Kendrick, 1999) and mammalian macrophages (Herwaldt, 1999).   
  CHAPTER I 
4 
 
 
 
 
 
 
 
 
 
 
 
Figure I-2. Morphological forms of Leishmania. Scanning electron micrographs of promastigotes 
(A) and amastigotes (B) of Leishmania mexicana, WHO strain MNYC/ BZ/62/M379. 
Credit: Eva Gluenz 
The insect stage is initiated when a female sand fly acquires a blood meal from an 
infected mammalian host and ingests amastigote-containing macrophages (Figure I-
3). Ingested blood is transported to the gut of the fly, where it is enclosed in a type I 
peritrophic membrane (PM). Subsequently, the amastigotes differentiate into 
procyclic promastigotes, which start proliferating intensively and differentiate into 
nectomonad promastigotes. Nectomonads leave the PM-encased blood meal, attach 
themselves to the epithelial cells of the lumen and slowly start migrating towards the 
front part of the gut (Figure 3). While migrating, the nectomonads differentiate into 
leptomonad promastigotes, which multiply intensively and colonise the stomodeal 
valve of the fly. Present in the valve, in a matter of days, become two promastigote 
forms, haptomonads and metacyclics. The metacyclics migrate towards the proboscis 
of the insect and are inoculated into a mammalian host when the parasitized sandfly 
takes a further blood meal. In the mammal, the metacyclic promastigotes are quickly 
phagocytosed by macrophages and other mononuclear blood cells, where they 
differentiate into amastigotes. The amastigotes proliferate, rupture the infected 
macrophage and spread to other macrophages. When a sand fly takes a blood meal 
from the infected mammal, the cycle is continued (Figure 3) (Kamhawi, 2006; 
Dostalova and Volf, 2012). The life-cycle of Leishmania is therefore a series of 
complicated alterations between several morphological forms that represent 
adaptations to changes in the environmental conditions the parasites encounter in 
the two hosts. Each environment, whether a new host or a different compartment in 
the same host, is characterised by a certain number of stimuli that trigger specific 
morphological, physiological and biochemical changes in the parasites.  
A B A B 
  CHAPTER I 
5 
 
 
Figure I-3. Leishmania life cycle.  
Credit: Kramer, 2012 
Among the number of differences existing between the insect and mammalian host, 
temperature and pH are two well-known differentiation stimuli for Leishmania. The 
alimentary tract of the insect is characterised by pH ranging from acidic to slightly 
alkaline (Zilberstein and Shapira, 1994; Gontijo et al., 1998) and temperatures 
between 22°C and 28°C (Zilberstein and Shapira, 1994).The parasitophorous 
vacuoles of the mammalian macrophages, where the amastigotes develop, are 
characterised by acidic pH and temperatures between 31°C and 37°C (Zilberstein and 
Shapira, 1994). Thus, when transmitted from the fly’s alimentary track to the 
mammalian’s macrophages, the promastigotes experience elevated temperature and 
decreased pH. While a reduction in pH from neutral to acidic is necessary for the 
induction of metacyclogenesis in the Leishmania promastigotes (Bates and Tetly, 
1993), an increase in the temperature alone is enough to induce promastigote to 
amastigote differentiation in some species of Leishmania (Zilberstein and Shapira, 
1994; Saar et al., 1998). 
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I.1.3.   Nutrient availability in the Leishmania hosts 
I.1.3.1.   Nutrient availability in the insect vector 
Another critical adaptation affecting Leishmania propagation and infection is 
the spectrum of environmental niche-specific changes in the parasite metabolism 
resulting from the different nutrient availability in the two hosts. In the insect vector, 
the early promastigote forms are believed to utilize the nutrients in the PM-enclosed 
blood meal which contains mainly proteins, glucose, amino acids, fatty acids, 
phospholipids, vitamins and minerals. In addition to the blood, the flies take meals of 
honeydew excreted by insects of the families Aphidae and Coccidae and sap from a 
number of plants (Molyneux et al., 1991; Schlein and Jacobson, 1999). Since Aphidae 
and Coccidae also feed on plant sap, the sugar composition of the honeydew mirrors 
that of the sap to a certain extent. The honeydew, however, contains a broader 
spectrum of sugars ranging from phloem sugars (sucrose, maltose, glucose and 
fructose) to disaccharides (trehalose and trehalulose) and trisaccharides (melezitose 
and erlose) synthesized by the insects (Wackers, 2005). It is suggested that 
Leishmania utilize these sugars by secreting glycosidases and disaccharide splitting 
enzymes to pre-digest the di- and trisaccharides to monosaccharides before taking 
them up (Gontijo et al., 1996; Jacobson et al., 2001; Blum and Opperdoes, 1994). 
Known glycosidase activities exhibited by Leishmania include endoglucanase 
(cellulase), cellobiohydrolase (exo-glucanase), -amylase, -glucosidase, sucrase (-
D-fructofuranoside fructo-hydrolase), chitinase and N-acetyl--D-glucosaminidase 
activity (Table I-1) (Jacobson et al., 2001). The resulting monosaccharides, such as 
glucose, fructose and N-acetylglucosamine, are easily taken up by the Leishmania 
parasites (Rodriguez-Contreras et al., 2007; Nadered et al., 2010).  
Species Chitinase Cellulase α-Aamylase α-Glucosidase Sucrase 
Leishmania major + + + + + 
Leishmania donovani + + 0 + + 
Leishmania infantum +   + + 
Leishmania topica +  0 0 + 
Leishmania mexicana +    + 
Leishmania braziliensis + +  + + 
 
Table I-1. Glycosidase activities in Leishmania. + - enzyme activity; - low enzyme activity; 0 – no 
enzyme activity detected; blank space – not known. 
 
 
Credit: Jacobson et al., 2001 
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         Glycosidase Reaction  
Cellulase Cellulose + H2O <=> Cellulose + Cellobiose 
α-Amylase 
 
Starch <=> Maltodextrin + Maltose 
α-Glucosidase 
 
Maltose + H2O <=> 2 α -D-glucose 
Sucrase Sucrose + H2O <=> D-fructose + D-glucose 
Chitinase Chitin + H2O <=> N-Acetyl-D-glucosamine + Chitin 
 
           
            Table I-2. Reactions catalysed by the Leishmania glycosidases. 
 
In addition to sugars, the honeydew is believed to also contain relatively high levels of 
amino acids (Sandstrom and Moran, 2001; Crafts-Brandner, 2002). The most 
abundant amino acids in the honeydew are L-glutamine, L-glutamate, L-asparagine, L-
aspartate and L-serine (Byrne and Miller, 1990; Sandstrom and Moran, 2001; Crafts-
Brandner, 2002). L-Proline and L-glutamine, additionally, are found in considerable 
amounts in most insects’ hemolymph (Taylor, 1998). Characteristic amino acids, such 
as -alanine and taurine, can also be found in the hemolymph (Kanost, 2009). 
I.1.3.2.   Nutrient availability in the macrophages 
When transmitted to the mammalian host, the promastigote forms of 
Leishmania undergo receptor-mediated internalization by macrophages and develop 
into amastigote forms in the macrophage parasitophorous vacuoles (Ueno and 
Wilson, 2012). The latter are phagolysosome-like membrane structures characterised 
by highly acidic content rich in hydrolytic enzymes such as acid phosphatases, 
trimetaphosphatases A and B, β-glucuronidases, and cathepsins B, D, H and L 
(Antoine et al., 1998). The hydrolytic activity of the phagolysosome, together with the 
potential to fuse with other endosomal vesicles, may lead to generation within, and 
delivery to, the vacuole of a variety of low-molecular-weight metabolites and 
macromolecules, such as amino acids, peptides, sugars, lipids, nucleosides and 
phosphates resulting from the degradation of proteins, proteoglycans, glycoproteins, 
glycans, RNA and DNA (Burchmore and Barrett, 2001). It was shown that the uptake 
of metabolites such as D-glucose, L-proline, nucleosides, and polyamines by the 
amastigotes is optimal at acidic pH supporting the idea that the nutrient transport 
system of the amastigote forms is adapted to operate optimally in an acidic 
environment such as that of the parasitophorous vacuoles (Burchmore and Barrett, 
2001).   
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I.1.4.   Leishmania metabolism 
In addition to the nutrient preferences of Leishmania, important for our 
project are the metabolic specificities of these parasites which will be introduced 
herein. 
I.1.4.1.   Amino acid metabolism 
Amino acids are important nutrients for Leishmania promastigotes and 
amastigotes. Apart for protein synthesis, amino acids are required in osmoregulation, 
energy metabolism and differentiation. Despite their importance, Leishmania is not 
able to synthesize a number of proteinogenic amino acids. In particular, Leishmania 
lack the enzymes for de novo synthesis of the aromatic amino acids L-phenylalanine, 
L-tryptophan and L-tyrosine, the branched-chain amino acids L-isoleucine, L-leucine 
and L-valine, and L-arginine, L-histidine and L-lysine. The parasites therefore must 
acquire them from the host environment.  
Alanine (Ala). L-Alanine is the main constituent of the free amino acid pool in both 
promastigotes and amastigotes (Simon et al., 1983; Mallinson and Coombs, 1989). It 
can be taken up exogenously via transporter(s) (Inbar et al., 2013) or synthesized 
intracellularly from pyruvate (Pyr) by a cytosolic alanine aminotransferase, which 
catalyzes the reverse deamination of L-alanine to pyruvate as well (Figure I-4). L-
Alanine plays a key role in osmoregulation (Darling et al., 1990; Burrows and Blum, 
1991) and is one of the main end products of glucose metabolism in Leishmania 
(Darling et al., 1987).  
Aspartate (Asp) and asparagine (Asn). L-Aspartate is synthesized from oxaloacetate by 
a mitochondrial aspartate aminotransferase (Figure I-4). L-Asparagine can be 
converted to L-aspartate by a cytoplasmic L-asparagine I-like protein and L-aspartate 
can be converted to L-asparagine via an ammonia- and glutamine-dependent 
asparagine synthetase A (Manhas et al., 2014). Conversely, L-aspartate can be 
transaminated to oxaloacetate by a mitochondrial aspartate aminotransferase and fed 
into the tricarboxylic acid cycle (TCA cycle). Additionally, L-aspartate can also be 
converted to fumarate by adenylosuccinate synthase, adenylosuccinate lyase and 
adenosine 5’-monophosphate (AMP)-deaminase (Opperdoes and Michels, 2008). 
Arginine (Arg). The enzyme arginine succinate lyase, which is involved in the urea 
cycle, is absent in Leishmania (Berriman et al., 2005).  
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Figure I-4. Amino acid metabolism in trypanosomatids. Presented here are the pathways for 
amino acid biosynthesis in trypanosomatids. Indicated with question marks are the enzymes for which no 
unambiguous gene identification could be made. Abbreviations: AcAc - acetoacetate, AdoMet -  S-adenosyl-L-
methionine, B - biopterin, Cit - citrulline, DHF- dihydrofolate, HMGCoA - hydroxymethylglutaryl CoA, OAA - 
oxaloacetic acid, Orn - ornithine, PGA - phosphoglyceric acid, qH2B - quinoid form of dihydrobiopterin, THF - 
tetrahydrofolate. 
Credit: Opperdoes and Coombs, 2007 
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Thus, the parasites are not able to synthesize L-arginine and have to salvage it from 
the host milieu. The L-arginine, taken up by a high affinity, high specificity arginine 
permease designated AAP3 (Shaked-Mishan et al., 2006), can be used in protein 
synthesis, for energy storage, or for polyamine synthesis. In the glycosomes, which 
are membrane-bound peroxisome-like organelles compartmentalizing a variety of 
metabolic activities in trypanosomatids parasites (Parsons, 2004), L-arginine can be 
converted to phosphoarginine, a high-energy phosphagen (Colasante et al., 2006), or 
to L-ornithine (Figure I-4) (Roberts et al., 2004). L-Ornithine is involved in polyamine 
biosynthesis, important for cell growth and proliferation, and trypanothione 
synthesis, which has a key role in maintenance of redox homeostasis in Leishmania 
(Colotti and Ilari, 2010). Interestingly, the parasites are able to synthesize putrescine 
and spermidine via a cytosolic ornithine decarboxilase (ODC) and a spermidine 
synthase, respectively (Jiang et al., 1999), but lack the enzymes (except for 
agmatinase) for the synthesis of putrescine from L-arginine, of L-orthinine from L-
glutamate, and of spermine (Jiang et al., 1999; Roberts et al., 2004). Additionally, the 
parasites cannot convert spermine to spermidine or spermidine to putsrescine.   
Cysteine (Cys). L-Cysteine can be synthesized de novo from L-serine via a cysteine 
acetyltransferase and a cysteine synthase (CS) or from L-homocysteine through the 
reverse trans-sulfuration pathways involving cystathionine β-synthase and 
cystathione γ-lyase (CSE) (Williams et al., 2009). L-Cysteine can be converted to 
pyruvate (Figure I-4) or used for the synthesis of glutathione and proteins. Due to its 
ability to form disulfide bonds, L-cysteine plays a main role in protein folding and 
protein structure maintenance.  
Glutamate (Glu). L-Glutamate is another proteinogenic amino acid. It can be produced 
from α-ketoglutarate (2-oxoglutarate) by a mitochondrial nicotinamide adenine 
dinucleotide (NAD)-dependent or a putative cytosolic nicotinamide adenine 
dinucleotide phosphate (NADP)-dependent glutamate dehydrogenase (Figure I-4) 
(Mottram and Coombs, 1985), or by transamination reactions. L-Glutamate is also 
involved in pathways of nitrogen and redox metabolism. It can also be converted to L-
glutamine (Gln) via a glutamine synthetase (Figure I-4) (Opperdoes and Michels, 
2008). L-Glutamine is used in several biosynthetic pathways.  
Glycine (Gly). Glycine is a small amino acid. It can be reversibly oxido-decarboxylated 
to L-serine by serine hydroxymethyltransferase (SHMT) and tetrahydrofolate (THF)-
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dependent glycine cleavage system (GCS). L-Serine can then be converted to pyruvate 
by the serine/threonine dehydratase (STD) (Figure I-4) (Opperdoes and Coombs, 
2007; Muller and Papadopoulou, 2010). GCS, along with the serine hydroxymethyl-
transferase which converts L-threonine into L-serine, is part of the folic acid 
biosynthesis pathway whose operation leads to the formation of one-carbon units 
used for the biosynthesis of pyrimidines, purines and L-methionine (Muller and 
Papadopoulou, 2010).  
Leucine (Leu). L-Leucine is one of the branch-chain amino acids for which Leishmania 
parasites are auxotrophic. No leishmanial L-leucine transport system has been 
characterised to date. In the cytosol, L-leucine can be transaminated by a branched-
chain amino acid aminotransferase to 2-ketoisocaproate and further oxidized to 3-
hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) in the mitochondrion by a 
short/branched-chain acyl-CoA dehydrogenase, a carboxylase and a hydratase 
(Opperdoes and Michels, 2008). HMG-CoA is then directed to the isoprenoid synthetic 
pathway where it is incorporated into sterols (Figure I-4) (Ginger et al., 2000; Ginger 
et al., 2001).  
Lysine (Lys). Leishmania do not have the capacity to synthesize L-lysine de novo. They 
take it up from the host environment by a highly specific plasma membrane AAP7 
transporter (Inbar et al., 2012). Enzymes for L-lysine degradation are not present in 
Leishmania (Figure I-4) (Berriman et al., 2005). 
Methionine (Met). Leishmania take up L-methionine by a low specificity saturable, 
temperature- and energy-dependent transport system (Mukkada and Simon, 1977). 
Along with L-cysteine, L-methionine is one of the two sulphur-containing 
proteinogenic amino acids. L-Methionine residues, similar to cysteine residues, are 
easily oxidized to L-methionine sulfoxide which can then be reduced back to L-
methionine. This reversible oxidation of methionine was suggested to be a regulatory 
post-translational modification for protein activation and inactivation (Drazic and 
Winter, 2014). In addition to protein synthesis, in the Leishmania cytosol, L-
methionine can be converted to 2-oxobutanoate and transported to the 
mitochondrion where, through a series of reactions, can be degraded to succinyl-CoA, 
an intermediate of the TCA cycle. L-Methionine can also be converted to S-adenosyl-L-
methionine (AdoMet) by S-adenosylmethionine synthetase (Figure I-4). AdoMet can 
be further decarboxylated by S-adenosylmethionine decarboxylase and used for 
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polyamine synthesis (Colotti and Ilari, 2011), or it can be used as a methyl donor in 
various methylation reactions.   
Proline (Pro). As shown by Zilberstein and colleagues, Leishmania take up L-proline 
by at least three transport systems, two promastigote systems and one amastigote 
system (Mazareb et al., 1999). Further to protein synthesis, L-proline can be used as a 
source of energy by being oxidized by a mitochondrial ∆1-pyrroline-5-carboxylate 
dehydrogenase and a pyrroline-5-carboxylate synthetase to L-glutamate (Figure I-4) 
(Opperdoes and Michels, 2008).  The L-glutamate thus produced can be deaminated 
and fuelled into the TCA cycle. 
Serine (Ser). The first enzyme in the L-serine biosynthetic pathway, 3-phosphoglyce-
rate dehydrogenase, is present in the Leishmania genome (Figure I-4) (Opperdoes 
and Coombs, 2007). A BlastP search also detected a possible phosphoserine 
phosphatase homologue, which is the second enzyme in the L-serine biosynthesis. L-
Serine is implicated in protein synthesis but it is also an important precursor in 
phosphatidylserine and sphingolipid biosynthesis.  
Threonine (Thr). L-Threonine can also used as an energy source. It can be degraded to 
glycine and acetate with the concomitant production of adenosine 5’-triphosphate 
(ATP). L-Threonine can be converted to glycine in two ways. In the first, L-threonine 
is converted by SHMT in a THF-dependent manner to glycine. In the second, SHMT 
cuts the Cα-Cβ bond of L-threonine to generate glycine (Opperdoes and Coombs, 
2007; Muller and Papadopoulou, 2010). Alternatively, serine/threonine dehydratase 
(STD) can also convert L-threonine to 2-ketobutyrate which can be oxidized to 
succinyl-CoA. 
Tyrosine (Tyr). Leishmania have a putative phenylalanine-4-hydroxylase that can 
convert L-phenylalanine to L-tyrosine (Opperdoes and Michels, 2008). L-Tyrosine, in 
turn, is most likely converted to 4-hydroxyphenylpyruvate by an aminotransferase 
which is then probably reduced by an aromatic hydroxyacid dehydrogenase. Le Blanq 
and Lanham first showed that an aminotransferase able to transaminate L-aspartate, 
L-tyrosine, L-tryptophan and L-alanine operates in crude extracts of L. donovani, L. 
tropica and L. major (Le Blancq and Lanham, 1984). Later, a L. mexicana promastigote 
broad substrate specificity aminotransferase, that can transaminate L-aspartate, 
aromatic acids, L-leucine and L-methionine, was purified (Vernal et al., 1998) and the 
gene encoding it cloned and sequenced (Vernal et al., 2003). Expression in E. coli and 
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further characterisation showed that the enzyme is closely related to the Iα subfamily 
of aminotransferases. In 2014, Larraga and colleagues elucidated the crystal structure 
of L. infantum tyrosine aminotransferase and showed that the enzyme is cytoplasmic, 
belonging to the Iγ subfamily, involved in L-tyrosine metabolism and expressed at 
higher rate in amastigotes (Moreno et al., 2014a, b).  
I.1.4.2.   Carbohydrate metabolism 
As presented in I.1.3.1., it was shown that Leishmania secret glycosidases, 
disaccharide splitting enzymes and β-glucuronidases to digest the more complex 
sugars present in the insect gut to simple sugars which the parasites then take up via 
a number of transporters. Once internalized, the sugars can either be further 
hydrolysed, like sucrose which is broken-down to glucose and fructose by an 
intracellular sucrase (Singh and Mandal, 2011), or transported to the glycosomes 
where they are catabolized. Leishmania have several genes encoding sugar kinases 
that carry a glycosomal targeting signal. In addition to hexokinases, involved in 
glucose catabolism via the Embden-Meyerhof-Parnas glycolytic pathway, Leishmania 
have several other kinases, such as ribulokinase and xylulokinase, which indicates 
that other sugars can also be metabolized in the glycosomes (Opperdoes and Coombs, 
2007). 
Glycolysis. Glycosomes compartmentalize the first six to seven glycolytic enzymes, 
namely hexokinase, glucose 6-phosphate isomerase, phosphofructokinase, fructose 
1,6-bisphosphate aldolase, triosephosphate isomerase, glyceraldehyde 3-phosphate 
dehydrogenase and phosphoglycerate kinase (Hart and Opperdoes, 1984), that 
convert glucose to 3-phosphoglycerate. The last glycolytic steps occur in the cytosole 
and lead to the production of pyruvate, the end product of glycolysis (Figure I-5). The 
first stage of glycolysis is characterized by consumption of ATP and NAD+ while the 
last results in the generation of energy. The consumption of ATP and NAD+ in the 
glycosomes would result in imbalance in the energy and redox state of the organelle. 
The ATP and NAD+/NADH, however, is maintained by the glycosomal succinate 
fermentation in which phosphoenolpyruvate (PEP) is converted to succinate 
(Saunders et al., 2011). 
Pentose phosphate pathway. In addition to glycolysis, a portion of the D-glucose 
entering the glycosomes is diverted toward the PPP pathway and used for the 
synthesis of ribose 5-phosphate (R5P) and generation of NADPH (Maugeri et al., 
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2003). Generally, the pathway has two stages. In the oxidative stage, glucose 6-
phosphate (G6P) is oxidized to ribulose 5-phosphate (Ru5P) and CO2, with the 
simultaneous generation of NADPH (2 molecules of NADPH per molecule of G6P). In 
the non-oxidative stage, Ru5P is converted to the glycolytic intermediates 
glyceraldehyde 3-phosphate (GAP), fructose 6-phosphate (F6P), and G6P. The R5P 
produced during the PPP is used in nucleotide biosynthesis (Maugeri et al., 2003). 
Glycosomal succinate fermentation. Glycosomal succinate fermentation results in the 
two-step reduction of PEP to succinate, which is excreted by the Leishmania cells 
(Rainey and MacKenzie, 1991), and the generation of ATP and NAD+ (1 molecule of 
ATP and 2 molecules of NAD+ for each PEP molecule) (Figure I-5). The glycosomal 
succinate fermentation additionally leads to the generation of C4 dicarboxilyc acids 
which are used for anaplerotic reactions in the TCA cycle (Saunders et al., 2011). 
Tricarboxylic acid cycle (TCA cycle). The end product of glycolysis, pyruvate, can be 
transaminated to alanine by a cytosolic alanine aminotransferase, which can be 
subsequently excreted by the cells (Rainey and MacKenzie, 1991), or imported in the 
mitochondrion where it is converted to acetyl-CoA by mitochondrial 
acetate:succinate CoA transferase (ASCT) and succinyl-CoA synthetase (Van 
Hellemond et al., 1998). Acetyl-CoA then can enter the TCA cycle or be converted to 
acetate, which can also be excreted from the cells (Rainey and MacKenzie, 1991). 
Through the TCA cycle, acetyl-CoA is further metabolized to a series of intermediates 
(Figure I-5), with the concomitant generation of ATP and NADH. The latter is used by 
the electron transport chain, localized in the inner mitochondrial membrane, for the 
production of more energy.   
Mannogen metabolism. In Leishmania, the excess of hexoses phosphates can be stored 
in the form of storage material called mannogen (previously designated as mannan) 
(Ralton et al., 2003). Mannogen includes a family of short-chain oligosaccharides 
composed of β-1,2-linked mannose residues. Mannogen de novo synthesis starts with 
the formation of a mannose-α-1,4-cyclic phosphate primer from mannose 1-
phosphate (M1P) (Sernee et al., 2006) (Figure I-5). The primer is elongated with at 
least three more β-1,2-linked mannoses, then dephosphorylated and made ready for 
further elongation with more mannose residues originating from guanosine 5’-
diphosphate (GDP)-mannose. 
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Figure I-5. Central metabolic pathways in Leishmania. Presented here are the central metabolic 
pathways taking place in the glycosomes, mitochondrion and cytosol of Leishmania. Included are the substrates 
(in grey, boxed), intermediates and end products (in black, boxed) of Glycolysis, Indicated with thick arrows are 
the major metabolite fluxes. The pathways in blue are believed to be more important in promastigotes while the 
ones in red are believed to be more important in the amastigote. Abbreviations: Fru - fructose, GAP - 
glyceraldehyde 3 phosphate, Glc - glucose, H-5-P - hexose 5-phosphate, Man - mannose, PEP - 
phosphoenolpyruvate, PGA - phosphoglyceric acid, PPP - pentose-phosphate pathway. Enzymes: 1 - hexokinase, 2 
- glucose 6-phosphate isomerise, 3 - phosphofructokinase, 4 - fructose 1,6-bisphosphate aldolase, 5 - 
triosephosphate isomerise, 6 - glyceraldehyde 3-phosphate dehydrogenase, 7 - phosphoglycerate kinase, 8 - 
glycerol 3-phosphate dehydrogenase, 9 - glycerol kinase, 10 - adenylate kinase, 11 - glucosamine 6-phosphate 
deaminase, 12 - mannose 6-phosphate isomerise, 13 - phosphomannomutase, 14 - GDP-mannose 
pyrophosphorylase, 15 - phosphoglycerate mutase, 16 - enolase, 17 - pyruvate kinase, 18 - phosphoenolpyruvate 
carboxykinase, 19 - malate dehydrogenase, 20 - fumarate hydratase, 21 - NADH-dependent fumarate reductase, 22 
- malic enzyme, 23 - alanine aminotransferase, 24 - aspartate aminotransferase, 25 - pyruvate phosphate dikinase, 
26 - citrate synthase, 27 - 2-ketoglutarate dehydrogenase, 28 - succinyl-CoA ligase, 29 - succinate dehydrogenase, 
30 - acetate–succinate CoA transferase, 31 - pyruvate dehydrogenase, 32 - citrate lyase, 33 - acetyl-CoA synthetase, 
34 - proline oxidation pathway, 35 - threonine oxidation pathway, 36 - ribulokinase, 37 - ribokinase, 38 - 
xylulokinase, 39 - amylase-like protein, 40 - sucrase-like protein. 
Credit: Opperdoes and Coombs, 2007 
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The mannogen oligosaccharides are long about 5-40 residues and accumulate to 
milimolar concentrations in the cytosol. Mannogen is stored by both promastigotes 
and amastigotes. In amastigotes, mannogen was shown to be important for parasite 
virulence (Sernee et al., 2006). 
I.1.4.3.   Energy metabolism 
The electron transport chain of Leishmania comprises of complex I (NADH 
dehydrogenase), complex II (succinate dehydrogenase), complex III (cytochrome bc 
oxidoreductase) and cytochrome c - complex IV (cytochrome oxidase). The complex 
chain functions by oxidizing electron donors, such as NADH and succinate produced 
in the TCA cycle, and generating a transmembrane electrochemical gradient. The 
gradient is used by the F0F1-ATP synthase to generate ATP by oxidative 
phosphorylation (Besteiro et al., 2005). 
I.1.4.4.   Lipid metabolism 
I.1.4.4.1.   Fatty acid biosynthesis 
Two pathways for fatty acid synthesis are believed to operate in Leishmania, 
de novo fatty acid synthesis type II (FASII) and fatty acid elongation (FAE) 
(Ramakrishnan et al., 2013). Both pathways rely on consecutive addition of two 
carbon (C2) units to a growing carboxylic chain. The difference between the two 
pathways is that the growing chain is held by a carrier, more specifically, an acyl 
carrier protein (ACP) in the case of FASII, or a primer, in the case of FAE. 
Usually, the FASII synthase is comprised of several different individual components, 
in contrast to the FASI system which is a single multimeric complex (Figure I-6). The 
FASII synthesis involves an ACP, to which the synthesized fatty acid (FA) is linked, a 
carbon source, which is malonyl-CoA, and acetyl-CoA carboxylase, ketoacyl reductase, 
dehydratase and enoyl reductase. The synthesis starts with the production of 
malonyl-CoA from two molecules of acetyl-CoA by the ACC. Generated malonyl-CoA is 
decarboxylatively condensated to the ACP to start a two carbon chain. The two 
carbons are then successively reduced by a ketoacyl reductase, a dehydratase and an 
enoyl reductase (Figure I-6, D). Further elongation of the chain occurs via 
condensation with another molecule of malonyl-CoA (Ramakrishnan et al., 2013). 
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Figure I-6. Fatty acid biosynthesis. (A) Fatty acid synthase type I. (B) Fatty acid synthase type II. (C) 
Fatty acid elongation. (D) Saturated fatty acid biosynthesis via the fatty acid synthesis type II (FASII) pathway. (E) 
Saturated fatty acid biosynthesis via fatty acid elongation (FAE) pathways. Presented here are the enzyme 
complexes and pathways involved in saturated fatty acid biosynthesis. Abbreviations:  Ac-CoA - acetyl-CoA, Mal-
CoA - malonyl-CoA, KAS -ketoacyl-ACP synthase, KAR - ketoacyl-ACP reductase, HAD - hydroxyacyl-ACP 
dehydratase, EAR - enoyl-ACP reductase, ELO - elongase, KCR - ketoacyl-CoA reductase, DEH - acyl-CoA 
dehydratase, ECR -enoyl-CoA reductase. 
Credit: Ramakrishnan et al., 2013 
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To date, FAE has not been fully characterized in Leishmania. Some information 
regarding this pathway is available from studies in T. brucei, T. cruzi and L. major, and 
genome comparison between Leishmania and Trypanosoma. Observed in T. brucei 
was that four genes encode potential elongases (ELOs) of which three may be 
involved in FA synthesis (Lee et al., 2006). The authors used a cell-free system 
comprised of membranes as the source of enzymes for FA synthesis, butyryl-CoA as 
the C4 primer and malonyl-CoA as the C2 donor, and showed that in wild-type 
membrane C4-CoA is efficiently elongated mostly to C14. Additionally, to investigate 
the role of the four ELOs, generated were also four ELO mutants, that is ∆elo1-4. The 
ELO1 was shown to mainly elongate chains from C4 to C10, which results in the 
conversion of the primer butyryl-CoA to decanoyl-CoA; ELO2 elongates from C10 to 
C14, thus converting decanoyl-CoA to myristoyl-CoA; and ELO3 elongates from C14 to 
C18, which leads to formation of steroyl-CoA from myristoyl-CoA (Figure I-6, E). C8 to 
C18 long FAs, both saturated and unsaturated, were observed in Leishmania as well, 
suggesting the operation of similar ELOs (Lee et al., 2006). However, the genome of L. 
major contains 12 tandemly linked homologous genes, instead of 4 ELO genes, which 
could be the reason why longer FA chains are observed in these parasites. ELO4 
elongates the unsaturated long-chain FA arachidonate.  
In addition to saturated FAs, Leishmania are able to synthesize unsaturated FAs as 
well. Unsaturated FAs are products of desaturase activities over saturated FAs. The 
unsaturated FAs are divided into monounsaturated (MUFA) and polyunsaturated 
(PUFA) FAs. The PUFA synthesis in Leishmania involves a stearoyl-CoA desaturase, 
two ELOs,  that is ∆6, which is specific for C18, and ∆5, which is specific for C20 
PUFAs, and five  desaturases, namely ∆12, ∆6, ∆5, ∆4, and ω3 (Tripodi et al., 2006; 
Livore et al., 2006; Uttaro, 2006). Thus, the Leishmania parasites, most probably using 
the stearate (octadecanoic acid) (C18:0) generated in the FAE pathway as a 
precursor, are able to synthesize C22 PUFAs and linoleic acid. 
I.1.4.4.2.   Glycerolipid synthesis 
The initial steps of glycerolipid biosynthesis occur in the glycosome. There 
glycerol 3-phosphate (G3P) can be produced by reduction of dihydroxyacetone 
phosphate (DHAP) by a glycosomal glycerol 3-phosphate dehydrogenase (G3PDH) or 
by glycerol phosphorylation by a glycosomal glycerol kinase (GK).  
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Figure I-7. Glycerolipid biosynthesis in Leishmania. Presented here is the pathway for generation 
of precursors for ether and ester phospholipid biosynthesis. Abbreviations: DHAP - dihydroxyacetone phosphate, 
G3P - glycerol 3-phosphate. 
 
 
DHAP or G3P are then acylated by the transfer of an acyl group from a fatty acyl-CoA 
by a DHAP acetyltrnasferase (DHAPAT) and G3P acetyltransferase (G3PAT), 
respectively (Hajra and Bishop, 1982). The resulting 1-acyl-DHAP is converted to 1-
alkyl-DHAP by a flavin adenine dinucleotide (FAD)-dependent alkyl DHAP synthase 
(Figure I-7). 1-Alkyl-DHAP is then reduced to 1-alkyl-G3P by an NADPH-dependent 1-
alkyl/acyl-DHAP reductase. Additionally, 1-acyl- DHAP can be reduced to 1-acyl-G3P 
by an NADPH-dependent 1-alkyl/1-acyl-DHAP reductase. While 1-alkyl-G3P is a 
precursor for ether phospholipid biosynthesis, 1-acyl-G3P is used for ester synthesis 
(Zufferey and Mamoun, 2006). 
I.1.4.4.3.   Phospholipid synthesis 
Synthesis of phosphatidilcholine and phosphatidylethanolamines. Phosphatidil-
cholines (PCs) and phosphatidylethanolamines (PEs) are synthesized via the Kennedy 
pathway (Kennedy and Weiss, 1956; Ramakrishnan et al., 2013). The first step of the 
pathway involves the phosphorylation of choline and ethanolamine by a 
choline/ethanolamine kinase (Gibellini et al., 2008), followed by activation to cytidine 
5’-diphosphate (CDP)-choline and CDP-ethanolamine by a choline-phosphate 
cytidylyltransferase and ethanolaminephosphate cytidylyltransferase, respectively 
(Figure I-8).  The CDP-choline and CDP-ethanolamine are then transferred to diacyl 
glycerol (or respective ether-type glycerol species) by choline/ethanolamine 
DHAP acyltransferase 
 
FAD-dependent alkyl 
DHAP synthase 
NADPH-dependent 
1-alkyl/acyl DHAP 
reductase 
NADPH-dependent 
1-alkyl/1-acyl DHAP 
reductase 
G3P acyltransferase 
 
NADH-dependent 
glycerol 3-phosphate 
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phosphotransferase to produce phosphatidylcholine and phosphatidylethanolamine, 
respectively (Figure I-8) (Signorell et al., 2008). Potential genes encoding the 
enzymes involved in the Kennedy pathways in Leishmania have been identified and 
annotated but have not been characterized (Ramakrishnan et al., 2013). An 
alternative way for PC generation by methylation of PE via PE N-methyltransferase is 
believed to operate in Leishmania since the organisms contain candidate genes for PE 
N-methyltransferases (Lykidis, 2007). Similarly, PEs can be formed by 
decarboxylation of phosphatidylserines (PS) and, though Leishmania possess 
candidate genes encoding PS decarboxylases, no experimental evidence exist to prove 
their functions. Finally, PE can be generated from sphingolipid degradation via a 
sphingosine1-phosphate lyase, a pathway whose central function in Leishmania is to 
provide PEs. 
Synthesis of phosphatidylserines. Phosphatidylserines can be synthesized via two 
pathways. The first pathway involves head group exchange with PC and PE under the 
action of PS synthase 1 and 2, respectively (Figure I-8). In the second pathway, PSs 
are synthesized from serine and CDP-diacyl glycerol via a prokaryotic type PS 
synthase (Vance and Tasseva, 2012). PSs are membrane components and are 
involved in targeting and cell signalling.  
Synthesis of phosphatidylinositol. Phosphatidylinositols (PIs) contain the cyclic 
polyalcohol myo-inositol which is formed from glucose. The phosphorylated glucose 
molecule, G6P, is first converted to myo-inositol 3-phosphate by an inositol 3-
phsophate synthase and then dephosphorylated to myo-inositol by inositol 3-
phosphate monophosphatase (Figure I-8). myo-Inosytol, in the final step of PI 
synthesis, is merged with CDP-diacylglycerol by a PI synthase (Michell, 2008). PI then 
can be used for the synthesis of a variety of important PI-containing phospholipids, 
including glycosylphosphatidylinositols (GPIs), involved in parasite:host interactions 
between Leishmania and the two hosts. 
Synthesis of phosphatidylglycerol and cardiolipins. The initial step of phosphatidyl-
glycerols and cardiolipins synthesis represents the activation of phosphatidic acid by 
cytidine 5’-triphosphate (CTP) to form CDP-diacylglycerol (Figure I-8) (Schlame, 
2008). Next, phosphatidylglycerophosphate (PGP) is produced by transferring of a 
phosphatidyl group from CDP-diacylglycerol to G3P by PGP synthase and 
dephosphorylated to phosphatidylglycerol by PGP phosphatase.  
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Figure I-8. Phospholipid biosynthesis in Leishmania. Nutrients that are taken up from the 
environment are indicated with black boxes. Major phospholipid classes are indicated with green circles. 
Abbreviations: 3KSR - 3-ketosphinganine reductase, CDS - cytidine diphosphate diacylglycerol synthase, CEPT - 
choline/ethanolamine phosphotransferase, CK - choline kinase, CLS - cardiolipin synthase, CT - choline-phosphate 
cytidylyltransferase, DAG - diacylglycerol, DHCD - dihydroceramide desaturase, DHCS - dihydroceramide synthase, 
EK - ethanolamine kinase, PMT - phosphoethanolamine N-methyltransferase, EPT - ethanolamine 
phosphotransferase, ET - ethanolamine-phosphate cytidylyltransferase, PEMT - PE N-methyltransferase, PGPP - 
PGP phosphatase, PGPS - PGP synthase, PIS - PI synthase, PSD - PS decarboxylase, PSS/PSS2 - PS synthase/PS 
synthase-2, SAM - S-adenosyl-L-methionine, SD - serine decarboxylase, SLS - sphingolipid synthase, SPL - 
sphingosine-1-phosphate lyase, SPT - serine palmitoyltransferase. 
Credit: Ramakrishnan et al., 2013 
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Cardiolipin is formed by transferring of another phosphatidyl group to phosphatidyl-
glycerol. Knock-down of PGP synthase and knock-out of cardiolipin synthase revealed 
that phosphatidylglycerols and cardiolipins are essential for Leishmania promastigote 
and amastigote survival (Serricchio and Butikofer, 2012a; b). 
I.1.4.4.4.   Sphingolipid synthesis 
Sphingophospholipid biosynthesis starts with the transfer of a palmitoyl group 
onto serine by serine palmitoyltransferase which leads to the formation of 3-
ketosphinganine. The latter is then reduced to dihydrosphingosine by 3-
ketosphinganine reductase and subsequently acylated to dihydroceramide by 
ceramide synthase. Dihydroceramide is converted to ceramide which is transferred 
from the endoplasmic reticulum (Mullen et al., 2012) to the Goldgi apparatus. There, 
several sphingolipid synthases transfer polar head groups from glycerophospholipids 
to ceramides, thus generating sphingophospholipids. Particularly, inositol 
phosphorylceramide (IPC) synthases transfer phosphoinositol from PI and 
ethanolamine phosphorylceramide synthases transfer phosphoethanolamine from PE 
(Tafesse et al., 2006). Sphingolipids were shown to be used mainly for ethanolamine 
phosphate generation for glycerophospholipid synthesis (Zhang et al., 2007). 
I.1.4.4.5.   Sterol biosynthesis 
Leishmania are not able to synthesize cholesterol so they take it up from the 
insect and mammalian host via Na+-independent high affinity and high specificity 
transporter(s) operating optimally at pH 7.5-8 (Zufferey and Mamoun, 2002). Instead, 
Leishmania synthesize C24-alkylated, ergostane-based sterols (Goad et al., 1984). 
Sterol biosynthesis pathway starts with the synthesis of isopentenyl pyrophosphate 
from HMG-CoA generated during leucine degradation (Ginger et al., 2000). Through 
the mevalonate pathway, HMG-CoA is consequently converted to mevalonate, 
mevalonate 5-phosphate and mevalonate 5-pyrophosphate under the action of a 
HMG-CoA reductase, a mevalonate kinase and phosphomevalonate kinase-
likeprotein. A diphosphomevalonate decarboxylase then converts mevalonate 5- 
pyrophsophate to isopentenyl pyrophosphate. The latter is condensed with 
dimethylallyl pyrophosphate to form squalene which is cyclizated into lanosterol. 
Finally, lanosterol is converted into ergosterol (Xu et al., 2014). The last stage of 
ergosterol synthesis does not occur in mammals which is why the enzymes involved 
in it, such as the C14a-sterol demethylase and the S-adenosyl-L-methionine: C24-D-
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sterol methyltransferase, are drug targets of considerable interest (Pomel et al., 
2015). 
I.1.4.4.6.   β-Oxidation of fatty acids 
A comprehensive genome comparison between T. brucei, T. cruzi and L. major 
revealed that Leishmania should be able to oxidize fatty acids via β-oxidation 
(Berriman et al., 2005). An unusual feature of the fatty acid β-oxidation in 
trypanosomatids is that it probably occurs in two organelles, the glycosomes and 
mitochondria, instead of the mitochondrion only as it is in mammals. How the two 
organelles contribute to the pathway, however, is still unknown. The pathway results 
in the oxidation of different chain-length fatty acids to acetyl-CoA, NADH and FADH2. 
Acetyl-CoA can be fed into the TCA cycle (Saunders et al., 2014) while NADH and 
FAD2 can be further oxidized and the released electrons used by the electron 
transport chain to generate ATP. Four different chain-length fatty acyl-CoA 
dehydrogenases are present in the Leishmania genome (Opperdoes and Michels, 
2008).  Three of the acyl-CoA dehydrogenases have mitochondrial targeting signals. 
Bifunctional enzymes and thiolases are also predicted to be present in the glycosomes 
and the mitochondrion. Leishmania are predicted to oxidize also unsaturated fatty 
acids judging by the presence of genes encoding a 3,2-trans-enoyl-CoA isomerise and 
2,4-dienoyl-CoA reductase in the genome of L. major (Opperdoes and Michels, 2008). 
I.1.4.5.   Nucleotide metabolism 
Leishmania lack the enzymes for de novo synthesis of purines and have to 
acquire them from the insect and mammalian hosts (Opperdoes and Michels, 2008). 
To salvage these essential nutrients, Leishmania express developmentally regulated 
plasma membrane and secreted nucleotidase/nucleases and purine nucleoside/ 
nucleobase transporters (Figure I-9) (Sopwith et al., 2002; Landfear et al., 2004; Joshi 
and Dwyer, 2007). The nucleotidase/nucleases hydrolyse and dephosphorylate, 
where needed, exogenous polynucleotides, nucleotide monophosphates and nucleaic 
acids and produce suitable for transporting substrates for the purine transporters 
NT1, NT2, NT3, and NT4 (Aronow et al., 1987; Vasudevan et al., 1998; Carter et al., 
2000; Al-Salabi et al., 2003; Sanchez et al., 2004; Ortiz et al., 2007). 
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Figure I-9. Purine salvage pathway in Leishmania promastigotes. Presented here are the 
purine nucleoside/nucleobase transporters (NTs) and purine biosynthesis pathways in Leishmania promastigotes. 
Abbreviations: Ado - adenosine, Pyr - pyrimidine nucleosides, Ino - inosine, Guo - guanosine, Hyp - hypoxanthine, 
Xan -xanthine, Ade - adenine, Gua - guanine. 
Credit: Landfear et al., 2004 
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When imported, purine nucleosides and nucleobases are converted to nucleotides by 
three phosphoribosyltransferases (PRTs), a cytosolic adenine PRT (APRT) and the 
glycosomal xanthine PRT (XPRT) and hypoxanthine-guanine PRT (HGPRT) (Boitz and 
Ullman, 2006 a, b). The nucleotides are then used by the parasites for the synthesis of 
DNA and RNA.  
Leishmania, as other trypanosomatids, are able to synthesize pyrimidines de novo. 
Precursors for the pyrimidine synthesis are L-glutamine, bicarbonate and L-aspartate 
which, upon the action of carbamoylphosphate synthase, aspartate carbamoyltrans-
ferase and dihydroorotase are converted to dihydroorotate. The latter is then 
oxidized by a cytosolic dihydroorotate dehydrogenase to orotate which is 
translocated to the glycosomes. There, the bifunctional orotidine 5-phsohphate 
decarboxylase/orotate phosphorybosyltransferase converts orotate to uridine 5-
monophaosphate (UMP) (Opperdoes and Michels, 2008). 
I.1.4.6.   Metabolism of cofactors and vitamins 
Not much is known about cofactor and vitamin metabolism in Leishmania. It 
has been established, based on studies of culture media, that Leishmania parasites are 
auxotrophic for biotin, biopterin, folate, pantothenate, pyridoxine, riboflavin, nicotin, 
and heme (Steiger and Steiger, 1976; Merlen et al., 1999). Similar to many other 
cofactors and vitamins, none of the genes involved in folate/biopterin biosynthesis 
are present in the parasites (Opperdoes and Michels, 2008). Instead, 12 genes 
encoding folate/biopterin transporters are found in the parasite genome. The 
folate/biopterin transporter genes BT1 of L. donovani and L. tarentolae and FT1 and 
FT5 of L. infantume have already been characterized (Lemley et al., 1999; Kundig et 
el., 1999; Richard et al., 2002; Richard et al., 2004). After it is imported, folate has to 
be activated to THF. Activation of folate can occur via two different enzymes, the 
bifunctional dihydrofolate reductase-thymidylate synthase and pteridine reductase 1 
(Beverly et al., 1986; Cunningham and Beverley, 2001). THF then can be used in one-
carbon metabolism (see I.1.4.1., Glycine), as well as catabolism, glycine and L-serine 
interconversions and L-methionine and thymidylate biosynthesis (Ouellette et al., 
2002).  
Contrary to the complete lack of genes for folate/biopterin byosynthesis, some genes 
involved in the final steps of the synthesis of a number of cofactors and vitamins are 
present in the Leishmania genome. For instance, the last three enzymes involved in 
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the synthesis of heme from succinyl-CoA, namely coproporphyrinogen III oxidase, 
protoporphyrinogen oxidase and ferrochelatase, and the last two enzymes of CoA 
synthesis, phosphopantetheine adenylyl transferase and dephospho-CoA kinase, most 
of which, similar to other genes in Leishmania, were most probably gained by lateral 
transfer from bacteria (Berriman et al., 2005).  
I.1.5.   Glucose transporter null mutant Leishmania mexicana 
Glucose is a primary nutrient supplying many heterotrophic organisms with 
energy and building blocks for the synthesis of many different biomolecules. For 
Leishmania, glucose is a major energy and carbon source which the parasites compete 
for with the invertebrate and vertebrate hosts. Exogenous glucose is taken up by L. 
mexicana promastigotes and amastigotes via three membrane transporters, GT1, GT2 
and GT3, which have discrete substrate affinities, sub-cellular localization and life 
cycle regulated expression (Burchmore and Landfear, 1998). Genomic and 
transcriptomic analyses revealed that the GT genes are closely related and 
transcribed at similar levels throughout the leishmanial life cycle. However, GT1 and 
GT3 are constitutively expressed in both life cycle stages of Leishmania while GT2 is 
~15-fold up-regulated in the promastigote forms. Structural analysis confirmed that 
the three permeases have 90% homology as they differed from one another mainly at 
their NH2 and COOH terminal domains. Fluorescence microscopy showed that GT1 is 
localized mainly in the flagellum while GT2 and GT3 are located on the surface 
membrane (Burchmore et al., 2003).  Transport assays eventually revealed that the 
GT permeases are the main glucose transporter in L. mexicana.  
Further function characterization of the three permeases involved the deletion of the 
GT locus and generation of a null mutant cell line, ∆lmgt, which was shown to have a 
characteristic phenotype (Burchmore et al., 2003; Rodriguez-Contreras and Landfear, 
2006; Rodriguez-Contreras et al., 2007; Feng et al., 2011). The Δlmgt promastigotes: 
 are not able to transport the hexoses D-glucose, D-fructose, D-mannose 
and D-galactose; 
 are not able to grow in the presence of D-glucose, D-fructose, D-
mannose or D-galactose when provided as sole carbohydrate sources; 
  CHAPTER I 
27 
 
 
Figure I-10. Two-dimensional gel electrophoresis of wild type (green) and Δlmgt 
(violet) promastigotes. (A) Electronic image of 2DE of wild type and Δlmgt promastigotes. (B) Topographic 
images of three gel regions. Box I: spot 1 – mitochondrial aldehyde dehydrogenase; Box II: spot 1 – D-lactate 
dehydrogenase and ribokinase, spot 2 – ribokinase, spot 4 – mitochondrial aldehyde dehydrogenase; Box III: spot 
1, nucleoside diphosphate kinase, spot 2 – mitochondrial aldehyde dehydrogenase, spot 3 – cyclophilin. 
Credit: Feng et al., 2011 
 
 grow more slow and to a lower cell density compared with the wild 
type promastigotes, even in the presence of D-glucose and an 
alternative energy source such as L-proline in the culture medium;  
 are more susceptible to oxidative stress compared with the wild type 
promastigotes; 
 are sensitive to nutrient starvation and alkaline pH; 
 are still able to synthesize the glycoconjugates lipophosphoglycan 
(LPG), proteophosphoglycan (PPG), small neutral glycosylinositol-
phospholipids (GIPLs), gp63, and secreted acid phosphatase (sAP) at 
reduce rate; 
 are still able to synthesize the storage carbohydrate mannogen, albeit 
at reduced level; 
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 are able to incorporate [14C]-alanine, [14C]-aspartate, [14C]-acetate and 
[14C]-glycerol into mannogen presumably via gluconeogenesis; 
 have different protein profile compared with the wild type 
promastigotes (Figure I-10); 
 are characterized with significantly up-regulation of ribokinase, 
hexokinase and two isomers of a mitochondrial aldehyde 
dehydrogenase; 
 reproduce less rapidly in the insect vector Lutzomyia longipalpis 
compared with the wild type promastigotes; 
 develop into metacyclic forms less efficiently; 
 are not viable as axenic amastigote. 
In 2009, Landfear and colleagues published another work on the ∆lmgt cell line 
where they described the isolation of suppressor mutants of the ∆lmgt null line. A 
genomic analysis showed that the suppressor mutants have amplified and 
overexpressed a low affinity hexose transporter designated GT4 (previously known 
as D2). A phenotypic analysis also revealed that the suppressor mutants were able to: 
 restore growth rate to that of wild type promastigotes grown in 
glucose-replete media; 
 restore to a certain extent their ability to proliferate within 
macrophages;  
 partially restore their ability to infect macrophages; 
 restore their ability to take up hexoses; 
 restore resistance to oxidative stress; 
 restore resistance to high temperatures; 
 store mannogen at increased rate compared with the wild type 
promastigotes. 
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The prior phenotypic characterization of the ∆lmgt promastigotes thus revealed that 
the deletion of the glucose transporters in L. mexicana is associated with significant 
metabolic changes. We have applied global proteomic and metabolomic profiling 
approaches such as stable isotope labelling by amino acids in cell culture (SILAC) and 
mass spectrometry-based untargeted and targeted metabolomics to investigate the 
metabolic changes in the ∆lmgt promastigotes. The approaches used in this project 
are introduced herein.   
I.2.   Proteomics 
High-paced and high-throughput genome sequence analysis and instrument, 
method, and bioinformatic tool development have provided fruitful environment for 
the blooming of modern -omics technologies. Omics approaches, including genomics, 
transcriptomics, proteomics, metabolomics, etc., aim to comprehensively elucidate 
the flow of information from gene to protein product and from a pathway to a system.  
Constant advances in large-scale sequencing have resulted in the generation of an 
increasing number of fully or partially sequenced genomes from a variety of 
organisms. Each genome can be used as a database from which further information 
can be derived. The genome, however, can be considered as a static system.  The 
proteome, which comprises all proteins encoded by a genome, and metabolome, 
which encompasses the low molecular weight compounds of a biological system, are 
extremely dynamic units, strongly depending on the organism’s physiology and 
surrounding environment. Considering that, a main goal of modern proteomics is to 
identify and quantify all, or as many as possible, of the proteins associated with a 
particular state of an organism or a cell type evoked by a specific environment, 
chemical treatment, or altered cell phenotype. Detection of proteome changes 
involves the implementation of adequate methodologies for sample preparation and 
sensitive and accurate tools for sample and data analysis. Thus, constant 
development of new or improvement of the existing methodologies is extremely 
valuable for more comprehensive and sophisticated proteomic investigations. For 
instance, until recently, two-dimensional gel electrophoresis (2-DE) was the standard 
proteomic technique used for detection of changes in protein expression. 2-DE, 
however, requires subsequent targeted protein identification. The search for 
alternative methods allowing simultaneous accurate identification and quantitation 
resulted in combining 2-DE with mass spectrometry (MS) (Gorg et al., 2004), an 
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analytical tool that can determine the type and amount of a molecule, whether it is a 
protein or a chemical compound for example. Thus, MS is able to generate 
quantitative in addition to structural information, which is why many of the current 
experimental platforms are MS-based. In terms of scope, an increasing number of 
quantitative studies focus not on the whole but on more discrete fractions of cellular 
proteome in order to identify and quantify a set of targeted proteins. One of the most 
widely applied techniques for targeted quantitative proteomics is selected reaction 
monitoring (SRM), also called multiple reaction monitoring (MRM). SRM is performed 
on triple quadrupole (QQQ) mass spectrometers in which a precursor ion with a 
specific m/z value is selected in the first quadrupole, fragmented in the second, and 
then the product ion selected in the third quadrupole. Thus, the main use of SRM is to 
overcome, though only to a certain extent, some of the disadvantages of discovery (or 
shotgun) proteomics with regard to reliable quantification of multiple proteins and 
proteins of low abundance in a high-throughput manner (Boja and Rodriguez, 2012). 
SRM has only recently been applied in peptide and protein quantification while it has 
been routinely used in clinical diagnostic and pharmaceutical industry for 
quantification of metabolites, drugs, hormones, etc. for many years (Boja and 
Rodriguez, 2012).  
The quantitative but global and untargeted nature of the proteomic analysis in this 
study did not require the use of targeted approaches such as SRM. Instead, to 
investigate the Leishmania proteome as thoroughly as possible, we included a 
prefractionation step with digitonin prior to the MS analysis. Prefractionation is used 
to increase the protein coverage, and in particular, to enrich low abundant proteins, 
and is usually performed by electrophoretic, chromatographic, or gradient 
centrifugation techniques (Foucher et al., 2006). Alternative methods also include 
depletion of the highly abundant proteins, immunoprecipitation, or precipitation with 
chemical compounds such as ammonium sulfate and digitonin (Righetti et al., 2005; 
Foucher et al., 2006). Digitonin is a detergent which binds and precipitates sterols 
present in membranes thus causing the intracellular or intraorganellar protein 
content to leak out through pores. A recently developed method exploited the 
intrinsic feature of digitonin to form pores and using increasing concentrations of the 
detergent, starting from micromolar and gradually increasing to milimolar 
concentrations, was able to enrich cytoplasmic and organellar proteins of Leishmania 
in sequential fractions (Foucher et al., 2006). We adopted this method and used it to 
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increase the scope of protein identification by fractionating the proteome of wild type 
and ∆lmgt promastigotes into five sub-cellular fractions. According to Foucher et al., 
2006, the first two fractions, resulting from using low concentrations of digitonin to 
damage the plasma membrane, were predicted to be enriched in plasma membrane 
and cytosolic proteins, the third and fourth fractions, resulting from using higher 
concentrations of digitonin to damage the intracellular/organellar membranes, were 
supposed to be enriched in organellar proteins, and the last fraction comprised of 
digitonin-insoluble proteins. Further to identification, however, we aimed to also 
compare and quantify the abundance of the proteins in each fraction which required 
the use of a quantitative labelling method subsequently to the digitonin-based 
fractionation. Based on the type of information provided by the quantitative methods, 
quantification can be divided into relative or absolute. A method for generation of 
relative quantitative information is label-free quantitation. Label-free methods do not 
require the use of a stable isotope containing compound to label proteins and are 
thus simpler, more straightforward, and more economic. Common to all label-free 
methods is the need for strict control of the experimental conditions, lack of 
fractionation, and, if possible, automated sample preparation. The quantitation in 
label-free is based on precursor signal intensity or on spectral counting. The former 
type of label-free quantitation relies on simple counting of the number of fragment-
ion spectra acquired for any given peptide while the later type of quantitation 
involves the measurement of the peak area (or signal intensity) of a peptide 
precursor ion. Although in some cases label-free approaches yield higher proteome 
coverage, the accuracy of the quantitative information lacks compared to that 
obtained from stable isotope labelling experiments. Thus, stable isotope-based 
approaches are more suitable for detection of subtle proteome changes and 
correspondingly, more and more studies, in search for precise quantitation, rely on 
stable isotopes such as 3H, 13C, 15N and 18O to chemically or metabolically label 
proteins (Ong and Mann, 2005). Stable heavy isotopes enable discrimination between 
labelled and unlabelled proteins and calculation of a stable isotope ratio gives 
quantitative information regarding the abundance of one or the other type of protein.  
Thus, the stable isotope techniques allow comprehensive investigation of complex 
protein mixtures and can provide relative as well as absolute quantitative 
information. 
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Two stable isotope labelling techniques, namely the metabolic stable isotope labelling 
by amino acids in cell culture and the chemical stable isotope dimethyl labelling were 
used in this project.  
I.2.1. Stable isotope labelling by amino acids in cell culture 
Stable isotope labelling by amino acids in cell culture (SILAC) is one of the 
novel quantitative proteomic techniques that were introduced in the previous decade. 
It was developed by Mann and colleagues and described for the first time in 2002 
(Ong et al., 2002). In their original study, the authors used deuterated L-leucine to 
investigate changes in the protein expression during muscle cell differentiation. 
SILAC, however, can be applied to every type of cells that can be cultured. 
Additionally, besides deuterated L-leucine, a heavy version of every proteinogenic 
amino acid can be used in SILAC. With time, L-arginine and L-lysine, usually enriched 
in carbon and nitrogen, were established as the most popular amino acids for SILAC 
labelling. SILAC relies on metabolic incorporation of unlabelled (or light) and heavy 
isotope amino acids obtained by the cells from the SILAC culture media (Figure I-11). 
When two cell populations are cultured in light and heavy SILAC media they 
incorporate the unlabelled or heavy-labelled amino acids into the synthesized new 
proteins. Thus, after a minimum of five or six cell divisions the respective amino acids 
should be completely replaced with the light and heavy amino acids. The cell cultures 
can then be combined and subjected to protein digested with a protease, usually 
trypsin which cuts after arginine and lysine. The resulting light- and heavy-labelled 
peptides will have different mass and will be easily distinguishable by a mass 
spectrometer. The MS spectra will contain intensity information regarding the 
distinct pairs of light (Figure I-11, black dot) and heavy (Figure I-11, red star) peptide 
species. Comparison of the signal intensities of the identical peptides will determine 
the change in abundance of the protein.    
To date, five studies have applied SILAC to Trypanosoma and four to Leishmania. Four 
of the five SILAC studies with trypanosomes quantified ~30% of the total proteome 
(Gunasekera et al., 2012; Urbaniak et al., 2012; Urbaniak et al., 2013; Guther et al., 
2014). Two of the studies investigated proteome remodelling during differentiation. 
The other two studies focused on the phosphoproteome and glycoproteome of T. 
brucei but were still able to obtain quantitative data for more than 3,000 proteins. 
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Figure I-11. Conventional stable isotope labelling by amino acids in cell culture 
workflow. Presented here is an elaborate schematic representation of a SILAC workflow consisting of an 
adaptation phase, during which cells are grown in light and heavy SILAC media until they fully incorporate the 
respective light and heavy amino acids, and an experimental phase, during which the two cell populations are 
differentially treated, inducing changes in the proteome. The labelled cells are then pooled together, lysed and 
analysed by MS.  
Credit: Ong and Mann, 2007 
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Three of the four SILAC studies with Leishmania investigated drug resistance while 
the fourth studied the L. donovani secretome (Chawla et al., 2011; Brotherton et al., 
2013; Brotherton et al., 2014; Silverman et al., 2008). In contrast to the SILAC studies 
with trypanosomes, those performed with Leishmania generated quantitative data for 
only between 50 and 150 proteins. This huge difference in the number of quantified 
proteins indicates that the SILAC approach may be biased toward high-abundance 
proteins and may only be good for measuring large changes in protein expression in 
Leishmania. Despite the much lower number of proteins quantified in Leishmania, 
many metabolic enzymes involved in central energy pathways such as glycolysis and 
TCA cycle were found significantly modulated in the tested parasites.  That suited our 
aims and SILAC was applied, in parallel with stable isotope dimethyl labelling, to 
probe the L. mexicana proteome. 
I.2.2. Stable isotope dimethyl labelling  
Stable isotope dimethyl labelling was introduced in 2003 by Chen and 
colleagues (Hsu et al., 2003). By contrast to the metabolic SILAC labelling, dimethyl 
labelling relies on chemical reductive amination of all primary amines (the N-
terminus and ε-amino groups of L-lysine residues). The primary amine first interacts 
with formaldehyde which leads to the formation of a Schiff base that is rapidly 
reduced by sodium cyanoborohydride to form secondary amines. The latter react 
with another formaldehyde unit to form dimethylamino group (Hsu et al., 2003). 
Stable isotope dimethyl labelling does not require growing of the cells/tissue/ 
organism of interest in specialized media/environment. When the protein samples 
are generated, they are subjected to protease digestion and then the resulting peptide 
samples are dimethyl labelled. Triplex dimethyl labelling can be achieved with 
formaldehyde and sodium cyanoborohydride as light labels, deuterated 
formaldehyde and sodium cyanoborohydride as intermediate labels and deuterated 
and 13C-labelled formaldehyde and sodium cyanoborodeuteride as heavy labels  
(Figure 12, A). This labelling generates a mass increase of 28 Da, 32 Da and 36 Da in 
the light-, intermediate- and heavy-labelled peptides, respectively. That corresponds 
to a 4Da difference between the light, intermediate and heavy peaks (Figure I-12, B). 
Differentially labelled peptide samples are subsequently combined and analyzed by 
MS/MS. 
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Since stable isotope dimethyl labelling occurs at the peptide level, and not at the 
protein level as the SILAC labelling does, the sample preparation is prone to 
introduction of more technical errors which could result in possible sample loss and 
variability. SILAC allows sample combination at the protein level which in theory 
should provide more precise and reproducible quantitative results.  However, 
compared to SILAC, dimethyl labelling is considerably less expensive. Additionally, 
while SILAC is restricted to cells grown in culture, dimethyl labelling is applicable to 
any type of samples. Both labelling techniques are straightforward, robust and highly 
efficient. However, our experience with L. mexicana wild type and ∆lmgt 
promastigotes revealed that SILAC depends on the metabolic specificities of the 
species of interest and may not be as efficient as predicted to be. 
To date, no study has applied stable isotope dimethyl labelling for investigation of the 
Leishmania proteome.  
I.3.   Metabolomics 
Contemporary metabolomics aims at investigating the metabolome comprised 
of all low molecular weight compounds, and more specifically, the non-genetically 
encoded substrates and products of enzymatic reactions or spontaneous conversions, 
of a biological system. The metabolome includes amino acids, organic acids, 
nucleotides, lipids, cofactors, vitamins, etc. These metabolites are very diverse and 
can spread over a wide range of concentrations. Metabolomics can provide qualitative 
  
A B H2N-YICDNQDTISSK (2+) 
Figure I-12. Triplex stable isotope dimethyl labelling. (A) Stable isotope dimethyl labelling 
reactions with formaldehyde and sodium cyanoborohydride as the light labels, deuterated formaldehyde and sodium 
cyanoborohydride as the intermediate labels, and deuterated and 13C-labelled formaldehyde and sodium 
cyanoborodeuteride as the heavy labels. (B) Representative peaks of light-, intermediate- and heavy-labelled species 
of the dimethyl labelled BSA YICDNQDTISSK peptide. 
Credit: Boersema et al., 2009 
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and quantitative information regarding metabolite structure, function, concentration 
and transformation paths, and can thus be used for the investigation of complex 
compound mixtures. The information generated can then be used to evaluate 
metabolites and map metabolite trafficking through metabolic networks and to 
pinpoint differences in phenotypes resulting from environmental influences, disease 
or genotype changes so that eventually a certain metabolome can be attributed to a 
certain phenotype. Currently, performing a comprehensive metabolomic analysis 
involves the implementation of several techniques. MS-based approaches are used to 
perform large-scale accurate quantitative analyses. However, they are still not 
capable to measure all compounds, even though a number of different methodologies, 
that include specific sample preparation and chromatographic separation prior to the 
MS analysis, have been developed.  
Careful sample preparation is essential in metabolomics. Recently, Likic and 
colleagues described a method where a quick quenching of cell cultures to about 0°C, 
followed by cold chloroform/methanol/water extraction of metabolites was used to 
capture a snapshot of the L. mexicana cell metabolism (de Souza et al., 2006). Besides 
cold chloroform/methanol/water extraction, methanol extraction at -40°C, hot 
ethanol extraction and rapid filtration have also been applied in metabolomic 
investigations (de Koning and van Dam, 1992; Kamleh et al., 2008; Ebikeme et al., 
2010). In our study, we have applied a slightly different cold chloroform/ 
methanol/water extraction to that applied by Likic, followed by either liquid 
chromatography (LC) (described in I.3.1.), for investigation of whole cell lysates and 
lipids, or gas chromatography (GC) (described in I.3.2.), for investigation of sugars, 
from the wild type and Δlmgt promastigotes. Besides mass spectrometry, we have 
also used nuclear magnetic resonance (described in I.3.3.) to elucidate carbon 
utilization by the Δlmgt promastigotes. 
I.3.1. Liquid chromatography - mass spectrometry 
High-performance liquid chromatography (HPLC) is one of the most common 
types of chromatography used currently in the metabolomic research field. In HPLC, 
the solvent (or the mobile phase) passes through a chromatographic column (the 
stationary phase) under pressure. The separation takes place in the column and 
involves interaction of the analytes with matrix inside the column. For how long a 
compound will interact with the stationary phase and thus be retained by it depends 
on the chemical nature of the compound and on the chemistries of the stationary 
  CHAPTER I 
37 
 
phase and of the solvent. The HPLC systems applied most frequently for metabolomic 
investigations are reverse-phase liquid chromatography (RPC) and hydrophylic 
interaction chromatography (HILIC). Reverse-phase chromatography is preferentially 
used for separation of lipophilic compounds and in our project it was used for 
untargeted lipidomic analysis of the wild type and Δlmgt promastigotes while 
hydrophylic interaction chromatography is suitable for separation of polar and 
charged metabolites and it was applied for global untargeted metabolomic analysis of 
the two types of cells (Lu et al., 2008; Watson, 2010). The separation, either by RPC or 
HILIC, was then followed by electrospray ionization (ESI) operating in alternating 
positive and negative mode so that both positive and negative ions are generated. 
After the ionization, our lipid samples were subjected to two fragmentation methods, 
namely collision-induced dissociation (CID) and higher-energy collision dissociation 
(HCD), and directed to an Orbitrap mass spectrometer while the untargeted 
metabolomic samples were directly analyzed by the Orbitrap. 
I.3.2. Gas chromatography - mass spectrometry 
Gas chromatography coupled to mass spectrometry (GC-MS) can be 
considered as one of the main techniques that lays behind the development of 
contemporary metabolomics. GC provides reproducibility and the highest resolution 
among the chromatographic techniques. When applied to complex mixtures, one of 
the most common types of GC, capillary GC, can result in the separation of hundreds 
of compounds.  
As the name suggests it, the mobile phase in GC is gas while the stationary phase is 
solid.  The analyzed compounds also have to be volatile or made volatile via 
derivatization. After the separation, the gas molecules are directed to an ionization 
unit, where electron ionization (EI) or chemical ionization (CI) occurs, which is then 
followed by a mass spectrometry analysis by a low resolution mass analyzer, such as 
quadrupole, or a high resolution mass spectrometer, such as time-of-fight (TOF) or 
Fourier transform ion cyclotron resonance (FT-ICR). A number of sugars and sugar 
phosphates that were known or presumed to be present in the L. mexicana wild type 
and glucose transporter null mutant promastigotes were analyzed. The derivatization 
of the sugars and sugar phosphates included methoxyamination and silylation (as 
described in II.6.3.). Then the silylated sugars were separated on a Trace GC Ultra gas 
chromatograph and analyzed on a quadrupole ion trap (ITQ) 900 mass spectrometer. 
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Table I-3. Comparison between nuclear magnetic resonance and mass spectrometry. 
Presented here in the form of a table are the advantages and disadvantages if NMR and MS. 
Credit: Roberts et al., 2011 
Apart for separation of sugars, GC has been extensively used for analysis of other 
metabolites of the central carbon metabolism such as organic acids, lipids, amino 
acids, nucleotides and etc. (Saunders et al., 2011; Saunders et al., 2014). 
I.3.3. Nuclear magnetic resonance 
Nuclear magnetic resonance (NMR) possesses a number of unique advantages 
over MS (Table I-3) and has been extensively used for metabolomic analyses. It 
requires minimal sample preparation, it is robust, non-destructive and rapid and it 
provides high-resolution, quantitative, reproducible and rich structural information. 
One of the main disadvantages of NMR, however, is the low sensitivity. Because of 
that, often the samples have to be at least several micrograms. An intrinsic quality of 
NMR is its ability to detect the spin properties of the atomic nuclei in a magnetic field. 
The NMR active nuclei include 1H, 31P, 13C and 15N.  1H 1D Fourier-transform NMR, 
which is the simplest and fastest type of NMR, is routinely used to investigate urine 
samples or cell extracts (Bingol and Bruschweiler, 2014). More complex mixtures, 
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however, require longer time for analysis and/or higher-dimentional NMR. 1H-, 13C- 
and 31P-NMR have been employed in a number of studies investigating for example 
the glucose and proline metabolism of trypanosomes, the phosphometabolome of 
trypanosomes, the changes in the metabolism of aconitase-deficient trypnosoma cell 
line and the changes in the urine and plasma of mice infected with trypanosomes 
(Mackenzie et al., 1982; Mackenzie et al., 1983; Besteiro et al., 2002; Coustou et al., 
2003; Coustou et al., 2005; Coustou et al., 2006; Coustou etal., 2008; Riviere et al., 
2009; Moreno et al., 2000; Wang et al., 2008; Ebikeme et al., 2010; van Weelden et al., 
2003; Lamour et al., 2005). 1H-, 13C- and 31P-NMR were also used to elucidate the lipid 
profile of L. donovani promastigotes, to analyze the phosphometabolome of L. major 
and to investigate the involvement of leucine in sterol biosynthesis,  (Adosraku et al., 
1993; Moreno et al., 2000; Ginger et al., 2001). In our metabolomic study, 1H 1D NMR 
was used to investigate the utilization and metabolization of several enriched and 
non-enriched carbon sources, including D-glucose, L-proline, L-threonine and 
glycerol. Additionally, NMR was combined to LC-MS which helped us perform an 
isotope tracing analysis and elucidate the fate of the mentioned carbon sources in the 
wild type and Δlmgt promastigotes. 
I.4.   Aims 
Phenotypically, the ∆lmgt promastigotes were shown to differ considerably 
from the wild type cells of Leishmania mexicana. Distinguishable features of the 
mutant strain were altered mRNA and protein expression, reduced cell size, growth, 
and metacyclogenic capability, increased sensitivity to nutrient starvation, elevated 
temperatures, and oxidative stress, and inability to utilize hexoses as carbon and 
energy sources, yet, ability, even at a reduced rate, to synthesize glycoconjugates and 
mannogen involved in pathogenicity. To be able to synthesize hexose-containing 
macromolecules such as glycoconjugates and mannogen, however, the ∆lmgt 
promastigotes have to switch to using carbon sources other than sugars, and to 
modulate their metabolism for optimal use of the alternative carbon sources for 
catabolic and anabolic purposes. To test this hypothesis, we set our aims to:  
 investigate whether the ∆lmgt promastigotes use alternative energy and 
carbon sources and whether amino acids and lipids represent such 
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 determine which catabolic and anabolic pathways are altered as a result of 
possible utilization of alternative carbon and energy sources by the ∆lmgt 
promastigotes 
 represent, in a global and quantitative manner, the metabolomic changes in 
central carbon metabolism in the ∆lmgt promastigotes. 
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CHAPTER II.   Materials and methods  
II.1.   Global proteomic characterization of Δlmgt promastigotes by 
stable isotope labelling by amino acids in cell culture 
II.1.1.   Serum dialysis 
Heat-inactivated fetal bovine serum (iFBS) (Life Technologies) was dialyzed 
using SnakeSkin Dialysis Tubing, 3.5K molecular weight cut-off (MWCO) (Thermo 
Scientific) against 1x phosphate buffer saline (PBS) at 4°C for 24 hours. 
II.1.2.   Cell culturing 
Adaptation phase 
Wild type and Δlmgt promastigotes were grown in triplicate cultures at 27°C 
in RPMI 1640 media (Life Technologies) supplemented with 10% iFBS (PAA 
Laboratories) and were adapted to RPMI 1640 media with 10% dialyzed serum (DS) 
(Figure II-1) for two passages and four changes of the fresh medium. Each sub-culture 
was initiated at cell density of 1.0 x 106 cells mL-1 by sub-passaging early-log phase 
cells in fresh medium. 
Experimental phase 
Adapted early-log phase promastigotes were sub-passaged and grown for six 
consequence passages in triplicate cultures at 27°C in light and heavy RPMI 1640 
media (Thermo Scientific). Wild type promastigotes were grown in light medium 
containing L-Lysine-2HCl and 10% DS. Δlmgt promastigotes were grown in heavy 
medium containing 6-13C-L-Lysine-2HCl and 10% DS. Each sub-culture was initiated 
at cell density of 1.0 x 106 cells mL-1 by sub-passaging mid-log phase cells in fresh 
medium. 
II.1.3.   Protein extraction 
Mid-log phase light- and heavy-labelled wild type and Δlmgt promastigotes 
were harvested by centrifugation at 1,000 x g for 10 minutes at 4°C, washed twice 
with 1x cold PBS, re-suspended in SDT lysis buffer (4% (w/v) sodium dodecyl 
sulphate (SDS) (Sigma-Aldrich), 100 mM (w/v) Tris base (Thermo Scientific) 
/hydrochloric acid (HCl) (pH 7.6), 0.1 M (w/v) dithiothreitol (Melford) containing 
cOmplete Protease Inhibitor (PInh) Cocktail (Roche) and lysed by 3 brief cycles of 
sonication with Soniprep 150 (MSE). 
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Figure II-1. Stable isotope labelling by amino acids in cell culture workflow. Cell culturing 
– wild type and ∆lmgt promastigotes (biological replicates, n=3) were cultured in HOMEM with 10% iFBS. 
Adaptation phase - wild type and ∆lmgt promastigotes were adapted to RPMI 1640 with 10% 3.5Da MWCO 
dialyzed iFBS for four passages. Experimental phase - wild type and ∆lmgt promastigotes were grown in light and 
heavy SILAC media for six passages. Protein extraction – light- and heavy-labelled proteins from wild type and 
∆lmgt promastigotes, respectively, were extracted and acetone precipitated. Protein digestion – equal amounts of 
light- and heavy-labelled proteins were combined (1:1) and digested according to the Filter aided sample 
preparation (FASP) protocol (Wisniewski et al., 2009). Sample analysis – peptide samples were analyzed by 1 
dimensional high-performance liquid chromatography (HPLC) coupled to tandem mass spectrometry (MS/MS). 
Data analysis – MS data were analyzed by Mascot Distiller and MaxQuant. WT - wild type promastigotes, Δlmgt - 
Δlmgt promastigotes, MWCO – molecular weight cut-off. 
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II.1.4.   Acetone precipitation 
Cell lysates were mixed with cold 100% acetone (1:4), incubated overnight at -
20°C, wash twice with cold 80% acetone by centrifugation at 10,000 x g for 10 
minutes at 4°C and re-suspended in SDT buffer. 
II.1.5.   Estimation of protein concentration 
Protein concentration of each sample was determined by protein assay (Bio-
Rad) according to the manufacturer’s instructions.  
II.1.6.   Protein digestion 
50 µg of light- and heavy-labelled protein were combined and subjected to 
digestion with MS Grade trypsin and LysC (Promega) according to the Filter aided 
sample preparation (FASP) protocol (Wisniewski et al., 2009). Digested samples were 
dried using vacuum Contentrator 5301 (Eppendorf). 
II.1.7.   Analysis by LC-MS/MS 
Peptide samples were loaded on an Acclaim PepMap 100 C18 µ-Precolumn 
cartridge (5 mM x 300 μM ID, 5 μM, 100Å) (Thermo Scientific), washed for 7 minutes 
with 0.1% trifluoroacetic acid (TFA) (Sigma-Aldrich) and 2% acetonitrile (ACN) 
(Thermo Scientific) at a flow rate of 30 µL/min, then separated through an Acclaim 
PepMap 100 C18 Column (150 mM x 75 μM ID, 3 μM, 100Å) (Thermo Scientific). The 
gradient, at a flow rate of 300 ηL/min, was 4-40% 80% ACN in 0.08% formic acid 
(FrA) (Sigma-Aldrich) over 80 minutes, then 40-100% 80% ACN in 0.08% FrA over 
40 minutes. Peptide ions were detected by Orbitrap Elite mass spectrometer (Thermo 
Scientific). The precursor scan (m/z 400-2000) was set to trigger data dependent 
MS/MS acquisition of the 20 most intense ions. The exclusion duration was set to 12 
seconds. 
II.1.8.   Data analysis 
II.1.8.1.   Data analysis by Mascot Distiller 
Raw MS/MS data were analyzed by Mascot Distiller (Version 2.5.1.0) (Matrix 
Sciences) using the Mascot search engine (http://www.matrixscience.com/search 
intro.html) against Leishmania mexicana FASTA database generated by TriTrypDB 
(Aslett et al., 2010) on 30/06/2012 (8250 sequences; 5180460 residues). 
Carbamidomethyl (C) was set as a fixed modification while Oxidation (M) was set as a 
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variable modification. The peptide and fragment mass tolerances were set to ± 0.3 Da. 
2 missed cleavages were allowed. Quantitation method was SILAC K+6 (MD). The 
reported ratio was light over heavy (L/H), with a coefficient of 1.0. Protein 
significance was calculated by Mascot Distiller via the following comparison equation: 
                                                               x - µ  ≤ t*    
where N is the number of peptide ratios, s is the standard deviation, x the mean of the 
peptide ratios (s and x calculated in log space), µ is a ratio with a true value of 0 in log 
space, and t is Student’s t test for N-1 degrees of freedom and a two-sided confidence 
level of 95%. Significantly modulated are the proteins that are different from unit, 
that is 1. 
II.1.8.2.   Data analysis by MaxQuant 
To determine the labelling efficiency of the SILAC experiment, the raw SILAC 
data were analyzed with MaxQuant (Cox and Mann, 2008; Cox and Mann, 2009). First, 
the Leishmania mexicana FASTA file containing 8392 canonical and isoform 
sequences was downloaded from UniProt (www.uniprot.org/) and configured in an 
appropriate for the MaxQuant programme format by the AndromedaConfig software 
(Cox et al., 2011). Using the Andromeda search engine, MaxQuant analyzed the raw 
data applying the following setting: heavy-labelled – Lys6, variable modifications – 
Acetlyl (protein N-term) and Oxidation (M), variable modification – Carbamidomethy-
lation (C) and a maximum of 2 missed cleavages. The proteinGroups.txt file generated 
by MaxQuant was used by Perseus (http://www.perseus-framework.org/) to 
eliminate the falsely discovered proteins and perform quantitation. The reported 
ratio was heavy over light (H/L). 
II.1.8.3.   Estimation of labelling efficiency 
Generated by MaxQuant was a peptide.txt output file. The file was used by the 
R software to calculate the level of incorporation of heavy L-lysine into proteins by 
the equation: incorporation: (1 – 1/ratio H/L+1). The incorporation efficiency was 
estimated based on the median of the distribution obtained by plotting the 
incorporation of all quantified peptides. Indicated in the plot with 0 is the 0% 
incorporation while 100 means 100% incorporation.   
 
√N 
s 
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II.2.   Global proteomic characterization of Δlmgt promastigotes by 
stable isotope dimethyl labelling 
II.2.1.   Cell culturing 
Wild type and Δlmgt promastigotes were grown at 27°C in modified 
hemoflagelated media, HOMEM (Berens et al., 1976), supplemented with 10% iFBS 
(Figure II-2). Each sub-culture was initiated at cell density of 1.0 x 106 cells mL-1 by 
sub-passaging mid-log phase cells in fresh medium. 
II.2.2.   Sub-cellular fractionation 
Sub-cellular fractionation was performed according to a previously described 
method (Foucher et al., 2006). Briefly, mid-log phase wild type and Δlmgt 
promastigotes were harvested by centrifugation at 1,000 x g for 10 minutes at 4°C, 
washed twice with HEPES-sodium chloride (Thermo Scientific) and re-suspended in 1 
mL of re-suspension buffer [75 mM Tris base (VWR International)/hydrochloric acid 
(pH 7.4), 145 mM sodium chloride (VWR International) and 11mM potassium 
chloride (VWR International)] containing PInh. 500 µL of the wild type and Δlmgt 
suspensions were incubated with 20 µM digitonin (Sigma-Aldrich) for 5 minutes at 
room temperature (RT) and mixed with 200 µL of 300 mM sucrose (Thermo 
Scientific). Centrifugation at 8,000 x g for 5 minutes at 4°C generated supernatants 
that represented wild type and Δlmgt fraction I. The remaining pellets were re-
suspended in 500 µL of re-suspension buffer and treated in the same way described 
above but using 200 µM digitonin to generation fraction II. Fractions III and IV were 
generated using 1 mM and 10 mM digitonin, respectively. Fraction V was generated 
by re-suspending fraction IV pellets in 600 µL of re-suspension buffer. 
II.2.3.   Acetone precipitation 
Generated fractions were precipitated as described in II.1.4. 
II.2.4.   Estimation of protein concentration 
Protein concentration of each sample was determined by protein assay (Bio-
Rad) according to the manufacturer’s instructions.  
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Figure II-2. Stable isotope dimethyl labelling workflow. Cell culturing – wild type and ∆lmgt 
promastigotes (biological replicates, n=3) were cultured in HOMEM with 10% iFBS. Sub-cellular fractionation - 20 
µM, 200 µM, 1mM, and 10 mM of digitonin were used to generate five sub-cellular fractions: two cytosolic, two 
organellar and one containing digitonin-insoluble material. Protein extraction - proteins from each fraction were 
extracted and acetone precipitated. Protein digestion – equal amounts of proteins were digested according to the 
Filter aided sample preparation (FASP) protocol (Wisniewski et al., 2009) and stable isotope dimethyl labelled. 
Sample analysis – light and heavy peptide samples were combined (1:1) and analyzed by 1 dimensional high-
performance liquid chromatography (HPLC) coupled to tandem mass spectrometry (MS/MS). Data analysis – MS 
data were analyzed by Mascot Distiller. WT - wild type promastigotes, Δlmgt - Δlmgt promastigotes,  I – fraction I, 
II – fraction II, III- fraction III, IV – fraction IV, and V – fraction V. 
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II.2.5.   SDS-PAGE 
10 µg of protein were mixed with 1x Laemmli sample buffer (Bio-Rad) (1:1), 
heated to 95°C for 3 minutes in a Thermo mixer comfort (Eppendorf) and loaded on 
4-20% Mini-PROTEAN TGX pre-cast gels. Gels were run in a Mini-PROTEAN Tetra Cell 
electrophoresis system (Bio-Rad) with 1x Tris/Glycine/SDS buffer (Bio-Rad). 
Electrophoresis was performed according to the manufacturer’s instructions. SDS-
PAGE gels were stained by incubation in fixing solution [40% (v/v) ethanol VWR 
International, 10% (v/v) glacial acetic acid (Sigma-Aldrich)] for 1-2 hours, followed 
by incubation in staining solution [10% (w/v) ammonium sulfate (VWR 
International), 1% (w/w) orthophosphoric acid (Thermo Scientific), 0.1% (w/v) 
Coomassie Brilliant Blue G-250 (Sigma-Aldrich), 25% methanol (v/v) (Sigma-
Aldrich)]. Gels were destained with distilled water. 
II.2.6.   Protein digestion  
25 µg of protein were subjected to digestion according to the FASP protocol. 
Digested samples were dried using vacuum Contentrator 5301 (Eppendorf). 
II.2.7.   Stable isotope dimethyl labelling 
Peptide samples were reconstituted with 90 µL of 100 mM sodium acetate 
(VWR International). Wild type samples were light-labelled with 10 µL of 4% 
formaldehyde and 10 µL of 1 M sodium cianoborohydride for 5 minutes at RT. Δlmgt 
samples were heavy-labelled with 10 µL of 4% deuterated formaldehyde and 10 µL of 
1M sodium cianoborohydride for 1 hour at RT. The labelling reaction was quenched 
with 10 µL of 4% ammonium hydroxide. The labelled samples were desalted 
according to FASP and dried in Concentrator 5301. 
II.2.8.   Analysis by LC-MS/MS 
Labelled peptide samples were analyzed as described in II.1.7. 
II.2.9.   Data analysis 
Raw MS/MS data were analyzed by Mascot Distiller (Version 2.5.1.0) (Matrix 
Sciences) using the Mascot search engine (http://www.matrixscience.com/search 
intro.html) against Leishmania mexicana FASTA database generated by TriTrypDB on 
30/06/2012 (8250 sequences; 5180460 residues).  The quantitation method was 
Dimethylation (MD). Carbamidomethyl (C) was set as a fixed modification. Oxidation 
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(M) was set as a variable modification. The peptide and fragment mass tolerances 
were set to ± 0.3 Da. 2 missed cleavages were allowed. The report ratio was light over 
heavy (L/H), with a coefficient of 1.0.  
II.3.   Global metabolomic characterization of Δlmgt promastigotes  
II.3.1.   Cell culturing 
Wild type and Δlmgt promastigotes were grown in triplicate cultures at 27°C 
in HOMEM supplemented with 10% iFBS. Each sub-culture was initiated at cell 
density of 1.0 x 106 cells mL-1 by sub-passaging mid-log phase cells in fresh medium. 
II.3.2.   Chloroform/methanol/water extraction 
Metabolite extraction was performed according to a previously described 
method (de Souza et al., 2006). Briefly, wild type and Δlmgt promastigote cultures 
containing 3.0 x 108 cells in total were quickly quenched to 4°C by immersion in dry 
ice/ethanol bath. The cooled-down cells were harvested and washed twice with 10 
mL of 1x PBS by centrifugation at 1,000 x g for 10 minutes at 4°C. Washed cell pellets 
and 10 µL of spent media were subjected to a chloroform (Thermo 
Scientific)/methanol/water (1:3:1, v/v/v) extraction by shaking the mixtures for 1.5 
hours at 4°C.  
II.3.3.   Analysis by LC-MS 
Metabolite extracts were separated on a ZIC-pHILIC column (SeQuant). The 
gradient, at a flow rate of 300 μL/min, was 80-20% 80% ACN in 0.08% FrA over 30 
minutes, 5% 80% ACN in 0.08% FrA over 10 minutes, and 80% 80% ACN in 0.08% 
FrA over 6 minutes. The spray voltage, capillary temperature and maximum spray 
current were 3.5-4.5 kV, 275°C and 100, respectively. Samples were analyzed on an 
Orbitrap Exactive mass spectrometer (Thermo Scientific) operating in alternating 
positive and negative modes with a mass range of 70-1400 amu.  
II.3.4.   Data analysis 
Raw MS data were analyzed with IDEOM using the default parameters (Creek 
et al., 2012). Metabolite identification was based on accurate mass and predicted 
retention time. Retention times of 239 compounds were verified against 
unambiguous standard mixes. 
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II.4.   Global metabolomic characterization of SILAC-labelled Δlmgt 
promastigotes  
2.0 x 108 SILAC-labelled wild type and Δlmgt promastigotes, grown as 
described in II.1.2., were subjected to global metabolomic analysis as described in 
II.3. 
II.5.   Targeted glycomic characterization of Δlmgt promastigotes  
II.5.1.   Cell culturing 
Wild type and Δlmgt promastigotes were grown as described in II.2.1.. 
II.5.2.   Chloroform/methanol/water extraction 
3.0 x 108 promastigotes were subjected to a chloroform/methanol/water 
extraction as described in II.3.2. 
II.5.3.   Derivatization 
100 µL of the extracted samples were transferred into 9 mm screw cap 
borosilicate glass 1.5 mL tapered vials (VWR). 1 nmol of 13C-D-glucose was added to 
each aliquoted sample.  Samples were dried in a ReactiVap (Thermo Scientific), with a 
gentle nitrogen stream at 60°C for 30 minutes. 10 µL of 40 mg/mL (w/v) 
methoxyamine (Sigma-Aldrich)-HCL in pyridine (Sigma-Aldrich) was added to each 
dried vial, vortexed for 30 seconds and incubated at 60°C for 120 minutes. Following 
the methoximation step, 90 µL of N-Methyl-N-(trimethylsilyl) trifluoroacetamide 
(MSTFA) (Thermo Scientific) plus 1% trimethylchlorosilane (Thermo Scientific) were 
added, followed by a further 30 seconds of vortexing.  Silylation was performed by 
incubation at 80°C for a further 120 minutes.   
II.5.4.   Analysis by GC/MS 
1 µL of derivatized sample was injected into a Split/Splitless injector at 200°C 
using a 1 in 10 split flow using a Trace GC Ultra gas chromatograph (Thermo 
Scientific).  Helium carrier gas at a flow rate of 1 mL/min was used for separation on 
a TraceGOLD TG-5MS GC column, 30 m length × 0.25 mm inner diameter × 0.25 µm 
film thickness (Thermo Scientific). The initial oven temperature was held at 40°C for 
1 minute, followed by an initial gradient of 33°C/min ramp to 155°C.  Separation of 
sugars was performed using a gradient of 10°C/min from 155°C to 330°C with a 1 
minute final temperature hold at 330°C.  Eluting peaks were transferred through an 
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auxiliary transfer temperature of 250°C into an ITQ 900 mass spectrometer (Thermo 
Scientific).  The electron impact ionisation was set to 70 eV energy while the emission 
current was 250 µA with an ion source of 250°C.  A filament delay of 6 minutes was 
used to prevent excess reagents from being ionised.  Enhanced selectivity and 
sensitivity was achieved using selective reaction monitoring (SRM) determined from 
pure chemical standards for quantitation of metabolites.  Fragment ions were isolated 
using a 2 m/z window and excited using collision-induced dissociation (CID). Selected 
MS2 fragment ion was detected using 6 m/z window.  
II.5.5.   Data analysis  
Peak detection and quantitation of samples were processed using Xcalibur 
software (Thermo Scientific). Calibration curves were calculated using serial dilution 
of pure standard mixtures with a fixed addition of 1 nmol of 13C-D-glucose.  A 7-point 
calibration curve was then calculated for each compound and this was used to 
calculate the amount of detected metabolite in the extracted samples. 
II.6.   Stable isotope tracing analysis  
II.6.1.   Cell culturing 
Mid-log phase wild type and Δlmgt promastigotes (biological replicates, n=3) 
were incubated for 48 hours at 27°C in RPMI 1640 media supplemented with 10% 
iFBS and 11 mM 13C-D-glucose instead of D-glucose. The cells were then harvested 
and washed twice with 10 mL of 1x PBS by centrifugation at 1,000 x g for 10 minutes 
at RT. 
II.6.2.   Chloroform/methanol/water extraction 
3.0 x 108 wild type and Δlmgt promastigotes were subjected to a chloroform/ 
methanol/water extraction as described in II.3.2. 
II.6.3.   Analysis by LC-MS 
Samples were analyzed as described in II.3.3. 
II.6.4.   Data analysis  
As previously described by Barrett and colleagues, the raw MS data were 
analyzed with the R-based IDEOM software using the default parameters (Creek et al., 
2012). Metabolite identification was based on accurate mass and predicted retention 
time. Retention times of 239 compounds were verified against unambiguous standard 
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mixes. The generated by IDEOM .mzXML files were used by the mzMatch-ISO 
software as described by Chokkathukalam et al., 2013. 
II.7.   Nuclear magnetic resonance  
II.7.1.   Cell culturing 
Wild type and Δlmgt promastigotes were grown as described in II.2.1. 
II.7.2.   Incubation with carbon sources 
2.0 x 108  wild type and Δlmgt promastigotes were harvested and washed with 
10 mL of 1x PBS by centrifugation at 1,000 x g for 10 minutes at RT, re-suspended in 
5 mL of 1x PBS containing 4 mM non-enriched (12C) and enriched (13C) carbon 
sources in the following combinations: 
 PBS  
 13C-D-glucose  
 12C-L-proline + 13C-D-glucose  
 12C-D-glucose + 13C-L-proline 
 13C-L-proline 
 12C-L-threonine + 13C-D-glucose  
 12C-D-gllucose + 13C-L-threonine  
 13C-L-threonine  
 12C-glyerol  
 12C-glyerol + 13C-D-glucose  
The cells were incubated with the carbon sources for 6 hours at 27°C. Cell viability 
was checked microscopically on every hour. After 6 hours of incubation, the cell 
suspensions were centrifuged at 1000 x g for 10 minutes at 4°C to collect the spent 
incubation medium. An aliquot of 500 µL of each supernatant was taken for 1H-NMR 
analysis. The suspensions were then vortexed to break the cell pellets and subjected 
to a metabolite extraction as described in II.3.2.  
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II.7.3.   Sample and data analyses 
The sample and data analyses were performed as described by Bringaud and 
colleagues (Millerioux et al., 2012; Millerioux et al., 2013). Briefly, 50 µL of maleate 
solution in D2O (20 mM) were added to each sample (500 µL) as an internal standard. 
The samples (550 µL) were then loaded to a 125.77 MHz Bruker DPX500 
spectrometer equipped with a 5-mm broadband probe head. The acquisition 
conditions were 90° flip angle, 5,000 Hz spectral width, 32 K memory size and 9.3 
seconds total recycle time. The relaxation delay was 6 seconds for a nearly complete 
longitudinal relaxation. The 1H-NMR spectrum measurements were taken at 25°C, 
with 256 scans and scan time of approximately 40 minutes. The spectra were 
recorded with an electronic reference to access in vivo concentrations (ERETIC) 
method. The reference was placed at 0.2 ppm to avoid superposition on sample 
resonances. The resonance spectra of 12C-succinate at 2.35 ppm, 12C-pyruvate at 2.32 
ppm, 12C-lactate at 1.29 ppm, 12C-acetate at 1.85 ppm, 12C-alanine at 1.40 ppm, 13C-
succinate at 2.47 and 2.22 ppm, 13C-pyruvate at 2.44 and 2.18 ppm, 13C-lactate at 1.39 
and 1.16 ppm, 13C-acetate at 2.00 and 1.73 ppm and 13C-alanine at 1.53 and 1.29 ppm 
were integrated and the results were expressed relative to ERETIC peak integration. 
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CHAPTER III.   Quantitative characterization of carbohydrate 
metabolism of Δlmgt promastigotes by stable isotope dimethyl 
labelling and global metabolomics 
Leishmania are digenetic organisms involved in parasitism in insects and 
mammals. The insect sand fly vectors harbor the promastigote forms while the 
amastigote forms develop in the mammalian macrophages. The initial transformation 
of the amastigotes into promastigotes occurs when infected macrophages or free 
amastigotes are ingested by the insect during blood feeding (Kamhawi, 2006). 
Further in the promastigote development, the digested blood meal is followed by 
sugar-rich meals consisting of honeydew and plant sap (Schlein and Jacobson, 1999). 
The insect diet thus subjects the promastigotes to various carbon sources. Common to 
both types of meals, however, is the presence of sugars. The more complex sugars 
seem to be pre-digested by the combined action of glycosidases secreted by both the 
Leishmania cells and the sand fly vectors (Jacobson et al., 2001). The resulting 
monosaccharides, such as D-glucose and other hexoses, are easily taken up by the 
Leishmania promastigotes (Rodriguez-Contreras et al., 2007). The transport of D-
glucose in Leishmania has been studied biochemically by a number of groups 
(Schaeffer et al., 1974; Zilberstein and Dwyer, 1984; Burchmore and Hart, 1995). 
Further information about the utilization of this important nutrient by the Leishmania 
parasites was gained by the genetic characterization of several putative 
glucose/hexose transporter genes, namely Pro1 of L. enriettii and L. donovani, D2 of L. 
donovani, and GT1, GT2, GT3 and GT4 of L. mexicana (Cairns et al., 1989; Langford et 
al., 1992; Bringaud et al., 1998; Burchmore and Landfear, 1998; Feng et al., 2009). In 
addition to hexoses, Leishmania are also able to transport myo-inositol (Drew et al., 
1995; Klamo et al., 1996), D-ribose (Pastakia and Dwyer, 1987; Maugeri et al., 2003; 
Naula et al., 2010) and sucrose (Singh and Mandal, 2011). 
D-Glucose is catabolised by Leishmania via the Embden-Meyerhof-Parnas glycolytic 
pathway, TCA cycle, glycosomal succinate fermentation and the interconnected 
respiratory chain and oxidative phosphorylation (Saunders et al., 2010). The above 
mentioned pathways were thoroughly investigated to identify and quantify the 
proteomic and metabolic changes in the carbohydrate metabolism in the 
promastigote parasites of Leishmania mexicana that were devoid of hexose transport 
activity and were thus not able to utilize hexoses, such as D-glucose, D-fructose, D-
mannose and D-galactose, pentoses, such as D-ribose, and amino sugars, such as 
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glucosamine and N-acetylglucosamine,  as carbon and energy sources (Burchmore et 
al., 2003; Rodriguez-Contreras et al., 2007; Naula et al., 2010; Naderer et al., 2010; 
Feng et al., 2013). A metabolic comparison between the wild type and the Δlmgt 
promastigotes showed that glycolysis, gluconeogenesis, and the synthesis of hexose-
containing macromolecules, including lipophosphoglycan (LPG), proteophos-
phoglycan (PPG), gp63 and mannogen, were among the affected by the deletion of the 
three glucose transporters metabolic pathways in the Δlmgt promastigotes 
(Rodriguez-Contreras and Landfear, 2006). That was corroborated by the following 
proteomics analysis which revealed that the glucose transporter mutation was 
associated with differential regulation of a number of proteins, some of which were 
metabolic enzymes (Feng et al., 2011). All discoveries revealed to that point directed 
our focus at investigating the carbon metabolism of the Δlmgt promastigotes from 
proteomic and metabolomic perspective. For that purpose, we have employed a 
number of quantitative approaches for investigation of the changes in the Δlmgt 
proteome and metabolome. The approaches included the relatively quantitative 
stable isotope dimethyl labelling, which shed light on the protein and enzyme 
dynamic in the Δlmgt promastigotes, the relatively quantitative untargeted 
metabolomic LC-MS analysis and the absolutely quantitative glycomic GC-MS and 
NMR analyses, which elucidates important features of the Δlmgt metabolome, and the 
stable isotope tracing analysis, which mapped the central carbon metabolism in the 
Leishmania parasites. Integration of all omic data allowed comprehensive 
investigation of the Δlmgt promastigotes and provided in-depth information about 
the Δlmgt cell metabolism. An emphasis in this chapter is placed on the changes in the 
carbohydrate metabolism of the Δlmgt promastigotes. The energy, amino acid, 
nucleotide and lipid metabolism is presented in the chapter IV. 
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III.1.   Results 
III.1.1.   Global quantitative proteomic characterization of 
carbohydrate metabolism of Δlmgt promastigotes 
III.1.1.1.   Confirmation of the glucose transporter null mutation in 
Δlmgt promastigotes 
Conventional polymerase chain reaction (PCR) was used for confirmation of 
the glucose transporter null mutation in the genome of the ∆lmgt promastigote cell 
line of Leishmania mexicana. For this purpose, genomic DNA obtained from wild type 
and Δlmgt promastigotes was used to amplify the three glucose transporters (GTs) 
LmGT1, LmGT2, and LmGT3.  The amplification results showed that PCR products of 
650 base pairs (bp), 498 bp, and 491 bp corresponding to LmGT1, LmGT2 and 
LmGT3, respectively, were present in the wild type promastigotes (Figure III-1, lanes 
2, 3, and 4, respectively). The three glucose transporter genes were not detected in 
the Δlmgt promastigotes (Figure III-1, lanes 5, 6, and 7, respectively).  
                                  
Figure III-1. Confirmation of the null mutation in the glucose transporter locus of 
Δlmgt promastigotes by PCR. DNA extracted from wild type and Δlmgt promastigotes was used as 
template for PCR amplification of GT1, GT2, and GT3. Amplification products were separated by electrophoresis 
on 1% TAE agarose gel and stained with SYBR Safe DNA Gel Stain. Lane 1: Molecular weight marker (250-10,000 
base pairs). Lane 2: Amplification product of 650 bp corresponding to LmGT1 in wild type promastigotes. Lane 3: 
Amplification product of 498 bp corresponding to LmGT2 in wild type promastigotes. Lane 4: Amplification 
product of 491 bp corresponding to LmGT3 in wild type promastigotes. Lane 5: Amplification product of ~3,000 
bp in Δlmgt promastigotes. Lane 6: Amplification product of ~3,000 bp. Lane 7: Amplification product of ~3,000 
bp.    
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III.1.1.2.   Quantitative proteomic characterization of carbohydrate 
metabolism of Δlmgt promastigotes by sub-cellular fractionation with 
digitonin and stable isotope dimethyl labelling  
To perform a comprehensive quantitative proteomic comparison between the 
wild type and ∆lmgt promastigotes, we subjected the two cell lines to sub-cellular 
fractionation with digitonin, followed by stable isotope dimethyl labelling, analysis of 
the labelled samples by one dimensional (1D) high-performance liquid 
chromatography (HPLC) coupled to electrospray ionization and Orbitrap-based 
tandem mass spectrometry (ESI-MS/MS), and data analysis by Mascot Distiller (MD) 
(Figure II-2). The digitonin-based fractionation was not chosen as a method for 
enrichment of a certain cellular component but as a mean to increase the protein 
coverage. The prefractionation resulted in the generation of five sub-cellular fractions 
per cell line. Based on published work (Foucher et al., 2006), the first two fractions 
were predicted to be enriched in plasma membrane and cytosolic proteins, the third 
and fourth fractions enriched in organellar proteins, and the last fraction comprised 
of digitonin-insoluble proteins. The five fractions were run on a 1D sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to get a general overview of 
the protein distribution among the fractions (Figure III-2). The ∆lmgt cytosolic 
fraction II and organellar fraction III showed high similarity and seemed to contain 
more proteins compared to the other three fractions. In general, however, all five 
fractions had different protein profile (Figure III-2). 
The stable isotope dimethyl labelling involved light-labelling of the wild type peptide 
samples while the Δlmgt peptide samples were heavy-labelled. The corresponding 
samples of each fraction were combined prior to the MS analysis and the MS data 
were analyzed with Mascot Distiller (MD). The Mascot search showed that virtually 
all peptides were dimethyl-labelled (see Figure III-3 for an example). Using the 
automatic decoy database search of the Mascot search engine, which applies 
algorithms for constructing decoy sequences described by Wang and colleagues 
(Wang et al., 2009), calculated were two protein false discovery rates (FDR) for each 
fraction: an identity FDR (iFDR), with a significance threshold of 0.05 (p<0.05), and a 
homology and identity FDR (i/hFDR), with a homology threshold of 5%. The idFDR 
and h/idFDR of each fraction are specified in Table III-1. Of the identified proteins, 
considered for further analysis were those with a protein score equal or above 100 
and a minimum of 2 matched peptides. Of the quantified proteins, considered as 
significantly modulated were the proteins with a fold-change equal or above 2. 
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Figure III-2. SDS-PAGE of the ∆lmgt promastigote proteome prefractionated with 
digitonin. ∆lmgt promastigotes were consecutively treated with 20 µM, 200 µM, 1mM, and 10 mM of digitonin 
to generate five sub-cellular fractions: two cytosolic fractions - fraction I and II; two organellar fractions - fraction 
III and IV; and one containing digitonin-insoluble material - fraction V. The proteins of each fraction were 
extracted and subjected to 1D SDS-PAGE analysis with 4-20% gel and the gel was stained with Coomassie brilliant 
blue. Abbreviations: L – ladder, I – fraction I, II – fraction II, III- fraction III, IV – fraction IV, and V – fraction V. 
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Figure III-3. Partial peptide summary of enolase identified as protein hit #1 in 
fraction I of the ∆lmgt promastigotes. Reported are: the accession number of enolase: LmxM.14.1160, 
the expected protein mass: 46743 kDa, the overall protein score: 2443, the number of MS/MS spectra matchs to 
the protein: 118, the number of sequences matched to the protein: 20, the query, the peptide score, the unique 
peptides, the peptide sequence, and the peptide modifications. 
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Fraction 
Identified 
proteins 
idFDR h/idFDR 
Modulated 
proteins 
Up-regulated 
proteins 
Down-regulated 
proteins 
I 621 
 
0.26 % 1.23 % 23 10 13 
II 654 
 
0.22 % 1.11 % 27 13 14 
III 812 
 
0.13 % 1.16 % 149 0 149 
IV 301 
 
0.25 % 3.12 %, 19 18 1 
V 711 
 
0.37 % 1.43 % 32 27 5 
 
Table III-1. Number of identified and significantly modulated proteins in the ∆lmgt 
promastigotes fractionated with digitonin. Wild type and ∆lmgt promastigotes were consecutively 
treated with 20 µM, 200 µM, 1mM, and 10 mM of digitonin to generate five sub-cellular fractions: two cytosolic, 
two organellar and one containing digitonin-insoluble material. The fraction proteins were extracted, digested 
with trypsin, Stable isotope dimethyl labelled and analyzed by 1D HPLC-ESI-MS/MS. The data were analyzed with 
Mascot Distiller. 
 
The results indicated that a similar number of proteins were identified and found 
significantly modulated in the two cytosolic fractions, namely 621 and 654 and 23 
and 27, respectively (Table III-1). The first organellar fraction was characterized with 
the highest number of identified and significantly modulated proteins among the five 
fractions, that is 812 and 149, respectively, while the second organellar fraction had 
the lowest number of identified and significantly modulated proteins, 301 and 19, 
respectively (Table III-1). Identified in the digitonin-insoluble fraction were 711 
proteins in total while significantly modulated were 32. Unique in fraction I were 6 
proteins, in fraction II were 8 proteins, in fraction III were 128 proteins, in fraction IV 
were 16 proteins, and in fraction V were 21 proteins again (Figure III-4). In general, 
proteins that were found in the first three fractions were not observed in the fourth 
and fifth fractions. Similarly, proteins of fraction IV and V were not found in the first 
three fractions.  
221 proteins in total, or 2.65% of the predicted Leishmania proteome, were found 
significantly modulated in the ∆lmgt promastigotes (Table III-1). Of them, 49 proteins 
were up-regulated, 151 were down-regulated and 10 proteins were present in 
several isoforms, some of which were up-regulated while others were down-
regulated (Supplemental table III-1). Evident from the protein distribution according 
to Light/Heavy ratio was that each fraction had a unique profile (Figure III-5).  
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Figure III-4. Distribution of the significantly modulated proteins between the ∆lmgt 
promastigote fractions. Presented are the number of unique and shared significantly modulated proteins 
between the ∆lmgt promastigote fractions. I – fraction I, II – fraction II, III- fraction III, IV – fraction IV, and V – 
fraction V. 
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Figure III-5. Distribution of the significantly modulated proteins in the ∆lmgt 
promastigote fractions according to Light/Heavy ratio. Distribution profile of fraction I (A), 
fraction II (B), fraction III (C), fraction IV (D) and fraction V (E). >10 - number of proteins with a Light/Heavy 
ratio equal or above 10; >5 - number of proteins with a Light/Heavy ratio equal or above 5; >2 - number of 
proteins with a Light/Heavy ratio equal or above 2; <10 - number of proteins with a Light/Heavy ratio below 
10; <5 - number of proteins with a Light/Heavy ratio below -5; <2 - number of proteins with a Light/Heavy 
ratio below -2. 
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Based on Gene Ontology (GO) terms, the significantly modulated proteins were 
grouped in 10 categories: binding proteins, cytoskeletal proteins, enzymes, 
hypothetical proteins, structural proteins, proteins with unknown function and 
proteins involved in movement, protein degradation, protein folding and protein 
synthesis (Figure III-6). Nearly half of the modulated proteins in the Δlmgt 
promastigotes were enzymes (Figure III-6). In turn, half of the enzymes were 
metabolic enzymes involved in amino acid, carbohydrate, energy, lipid and nucleotide 
metabolism, metabolism of vitamins and cofactors and metabolism of terpenoids and 
polyketides (Supplemental table III-1). Enzymes and other proteins involved in 
protein synthesis included ribosomal proteins of the small (40S) and large (60S) 
subunit, helicases, initiation factors, elongation factors and proteins participating in 
post-translational modifications (PTMs). The proteolytic proteins included 
proteasome proteins and other peptidases, such as aminopeptidases, calpaine-like 
cysteine peptidases and metallopeptidases. The proteins involved in protein folding 
included heat shock proteins of different size, T-complex proteins and chaperones.  
B                                                  Cyt eletal protei s                        Enzymes     
 
H othetical protei s                       M vement                                            P ein degradation 
 
Protein foldi g                                    Protein synthesis                               Structural protei s 
  
Protei s with u k own function  
Figure III-6. Pie chart illustrating the types of significantly modulated proteins in the  
∆lmgt promastigotes. Proteins were identified and quantified with Mascot Distiller. Protein categorization is 
based on gene ontology (GO) terms. 
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Figure III-7. Schematic representation of the proteomic changes in carbohydrate 
metabolism in the ∆lmgt promastigotes. Specified with pink arrows are the down-regulated enzymes 
while specified with light blue arrows are the up-regulated enzymes. Abbreviations: Glc - glucose, G6P - glucose 6-
phosphate, F6P - fructose 6-phosphate, F1,6B - fructose 1,6-bisphosphate, GAP - glyceraldehyde 3-phosphate, 
DHAP - dihydroxyacetone phosphate, G3P - glycerol 3-phosphate, Gly - glycerol, 1,3BPG - 1,3-bisphosphoglycerate, 
3PG - 3-phosphoglycerate, 2PG - 2-phosphoglycerate, PEP - phosphoenolpyruvate, Pyr - pyruvate, Lac - lactate, 
6PGl- 6-phosphogluconolactone, Gln6P – gluconate 6-phosphate, Ru5P – ribulose 5-phosphate, R5P – ribose 5-
phosphate, myo-I 1P - myo-inositol 1-phosphate, myo-I - myo-inositol, Gal - galactose, Gal1P - galactose 1-
phosphate, UDP-glc - uridine diphosphate glucose, UDP-gal - uridine diphsophate galactose, M6P - mannose 6-
phosphate, M1P - mannose 1-phosphate, GDP-Man - guanosine 5’-diphosphate mannose, OAA - oxaloacetate, Cit - 
citrate, cis-A - cis-aconitate, Isoc - isocitrate, α-K - α-ketoglutarate, Suc-CoA - succinyl-CoA, Suc - succinate, Fum - 
fumarate, Mal - malate, Ac-CoA - acetyl-CoA, Ac - acetate, HXK - hexokinase, G6PI - glucose 6-phosphate isomerase, 
PFK - 6-phospho-1-fructokinase, F1,6BA - fructose 1,6-bisphosphate aldolase, TI – triosephosphate isomerase, 
GAPDH - glyceraldehyde 3-phosphate dehydrogenase, PGK - phosphoglycerate kinase, PGAM - phosphoglycerate 
mutase, ENO - enolase, PYK - pyruvate kinase, PPDK - pyruvate phosphate dikinase, GK - glycerol kinase, G3PDH - 
glycerol 3-phosphate dehydrogenase, LD - lactate dehydrogenase, DA - dihydrolipoamide acetyltransferase, DD - 
dihydrolipoamide dehydrogenase, PEPCK - phosphoenolpyruvate carboxikinase, GALE - uridine 5’-diphopshate 
glucose 4’-epimerase, PMI - phosphomannose isomerase, PMM - phosphomannomutase, GDPMP - guanosine 5’-
diphosphate mannose pyrophosphorylase, G6PDH - glucose 6-phophate dehydrogenase, 6PGls - 6-
phosphogluconolactonase, 6PDH - 6-phosphogluconate dehydrogenase, Ru5PI - ribulose 5-phosphate isomerase, 
I1PS - inositol 1-phosphate synthase, IPP - inositolphosphate phosphatase, CL - citrate lyase, CS - citrate synthase, 
AC - aconitase, ID - isocitrate dehydrogenase, ODH1 -  2-oxoglutarate dehydrogenase E1 component, ODH2 - 2-
oxoglutarate dehydrogenase E2 component, SCL - succinyl-CoA ligase, SCS - succinyl-CoA synthetase, SDF - 
succinate dehydrogenase flavoprotein, FH - fumarate hydratase, FRD - fumarate reductase, MDH - malate 
dehydrogenase, gMDH - glycosomal malate dehydrogenase, ME -  malic enzyme AS - acetyl-CoA synthetase, AL - 
acetyl-CoA ligase. 
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The binding proteins, along with many other proteins, were involved in ion, cofactor, 
NAD, GTP, ADP and ATP, RNA and DNA binding. The cytoskeletal proteins were 
mainly proteins involved in microtubule-based movement such as actin, tubulin, 
dynein heavy chain, kinesin and a number of flagellar proteins (Supplemental table 
III-1). 
Enzymes of carbohydrate metabolism 
Significantly modulated in the Δlmgt promastigotes were enzymes of 
glycolysis/gluconeogenesis, pentose phosphate pathway (PPP pathway), pyruvate 
metabolism, glycosomal succinate fermentation, tricarboxylic acid cycle (TCA cycle), 
fructose and mannose metabolism, and inositol phosphate metabolism (Figure III-8; 
Supplemental table III-1). The majority of the enzymes were detected in one fraction. 
A glycosomal glyceraldehyde 3-phosphate dehydrogenase and a malate 
dehydrogenase, however, were detected in two fractions and were down-regulated in 
one of the fractions but up-regulated in the other (Figure III-7; Supplemental table III-
1). A malic enzyme, involved in pyruvate metabolism, a glycosomal malate 
dehydrogenase of the glycosomal succinate fermentation, a fumarate hydratase of the 
glycosomal succinate fermentation and the TCA cycle, an uridine 5’-diphosphate 
(UDP)-glucose 4'-epimerase of the fructose and mannose metabolism, a succinyl-
CoA:3-ketoacid-CoA transferase (mitochondrial precursor), involved in synthesis and 
degradation of ketone bodies, and glycerol-3-phosphate dehydrogenase, linking 
glycerolipid metabolism with the gluconeogenesis, were significantly (>5-fold) down-
regulated in the Δlmgt promastigotes (Supplemental table III-1).  
III.1.2.   Global metabolomic characterization of carbohydrate 
metabolism of Δlmgt promastigotes  
III.1.2.1.   Untargeted metabolomic analysis of ∆lmgt promastigotes by 
LC-MS 
A major objective of this work was the global and untargeted metabolomic 
analysis of the wild type and ∆lmgt promastigotes. The relative quantitative 
comparison between the two cell lines was performed using a previously described 
method for metabolite extraction (biological replicates, n=3) (de Souza et al., 2006), 
1D polymeric hydrophilic interaction chromatography (pHILIC)-HPLC ESI-MS as an 
analytical platform and the R-based IDEOM software as a data analysis tool (Creek et 
al., 2012).  
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Figure III-8. Scoreplot of the Principal component analysis performed on the wild 
type and ∆lmgt promastigote and spent medium metabolomic samples. Wild type and 
∆lmgt promastigotes were grown in HOMEM media supplemented with 10% serum (biological replicates, n=3) 
and subjected to cold chloroform/methanol/water metabolite extraction. The metabolomic samples were 
analyzed with 1D ZIC-pHILIC-HPLC ESI-MS and the data were analyzed with IDEOM. WT - wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, S - spent media. 
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Figure III-9. Pie charts illustrating the types of significantly modulated metabolites 
in the ∆lmgt promastigotes (A) and spent media (B). Abbreviations: C - cofactors, V - 
vitamins, SM - secondary metabolites. 
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   Putative metabolite                               Map                        Pathway                     WT   ∆lmgt 
 
[FA trihydroxy(4:0)] 2,2,4-
trihydroxy-butanoic acid 
3 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
ND 50.03* 
Phosphodimethyl- 
ethanolamine 
8 Lipid Metabolism 
Glycerophospholipid 
metabolism 
ND 19.87* 
Phenylpyruvate 13 Amino Acid Metabolism 
Phenylalanine 
metabolism 
Phenylalanine, tyrosine 
and tryptophan 
biosynthesis 
1.00 17.32 
Glycerol 1 
Carbohydrate 
Metabolism 
Galactose metabolism 
Glycerolipid metabolism 
1.00 14.38 
2-Amino-3-
carboxymuconate 
semialdehyde 
1 Amino Acid Metabolism Tryptophan metabolism 1.00 13.55 
Nicotinate 4 
Metabolism of Cofactors 
and Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
Alkaloid biosynthesis II 
1.00 9.21 
Ethanolamine phosphate 2 Lipid Metabolism 
Glycerophospholipid 
metabolism 
Sphingolipid metabolism 
1.00 9.14 
3-(4-Hydroxyphenyl) 
pyruvate 
11 Amino Acid Metabolism 
Tyrosine metabolism 
Phenylalanine, tyrosine 
and tryptophan 
biosynthesis 
Alkaloid biosynthesis I 
1.00 7.87 
[FA hydroxy(14:0)] 3,11-
dihydroxy-tetradecanoic 
acid 
1 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
ND 7.84* 
Pentanoate 9 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
1.00 7.41 
Butanoic acid 8 
Carbohydrate 
Metabolism 
Butanoate metabolism 1.00 5.49 
 
Table III-2. Significantly increased metabolites in the ∆lmgt promastigotes. Specified in 
yellow are metabolites involved in Metabolism of cofactors and vitamins, in green, metabolites involved in Lipid 
metabolism, in blue, metabolites involved in Amino acid metabolism, and in pink, metabolites involved in 
Carbohydrate metabolism. Specified in yellow are the metabolites matched to authentic standards. Metabolites 
with unassigned function are not included.  
* - Metabolite detected in the ∆lmgt test samples and not detected (ND) in the wild type control samples are 
denoted by the control group having ND as a descriptor. The value in the ∆lmgt column is the average intensity of 
the compound in the ∆lmgt samples. 
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   Putative metabolite                               Map                        Pathway                     WT   ∆lmgt 
 
L-Glutamate 14 Amino Acid Metabolism 
 
Arginine and proline 
metabolism 
1.00 0.32 
L-Aspartate 4 Amino Acid Metabolism 
Alanine and aspartate 
metabolism 
1.00 0.31 
PA(34:1) 19 
Lipids: 
Glycerophospholipids 
Glycerophosphates 1.00 0.30 
PC(30:1) 29 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 0.28 
PI(34:2) 21 
Lipids: 
Glycerophospholipids 
Glycerophosphoinositols 1.00 0.27 
PE(30:0) 30 
Lipids: 
Glycerophospholipids 
Glycerophosphoethanola
mines 
1.00 0.25 
PE(32:0) 29 
Lipids: 
Glycerophospholipids 
Glycerophosphoethanola
mines 
1.00 0.25 
PA(32:2) 12 
Lipids: 
Glycerophospholipids 
Glycerophosphates 1.00 0.25 
[GP (16:0/18:0)] 1-
hexadecanoyl-2-(9Z-
octadecenoyl)-sn-glycero-3-
phospho-(1'-myo-inositol-
3'-phosphate) 
5 
Lipids: 
Glycerophospholipids 
Glycerophosphoinositol 
monophosphates 
1.00 0.25 
[PC (14:0)] 1-tetradecanoyl-
sn-glycero-3-
phosphocholine 
4 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 0.24 
L-Alanine 9 Amino Acid Metabolism 
Alanine and aspartate 
metabolism 
1.00 0.22 
PC(30:0) 32 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 0.22 
Lactose 6-phosphate 5 
Carbohydrate 
Metabolism 
Galactose metabolism 1.00 0.22 
PE(15:0/18:3(6Z,9Z,12Z)) 14 
Lipids: 
Glycerophospholipids 
Glycerophosphoethanola
mines 
1.00 0.21 
PC(30:2) 20 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 0.19 
Glutathione 3 Amino Acid Metabolism 
Glutamate metabolism 
Cysteine metabolism 
Glutathione metabolism 
1.00 0.15 
PC(28:0) 31 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 0.14 
Succinate 7 
Carbohydrate 
Metabolism 
TCA cycle 
Oxidative 
phosphorylation 
1.00 0.11 
[SP amino,dimethyl(18:0)] 
2-amino-14,16-
dimethyloctadecan-3-ol 
1 Lipids: Sphingolipids Sphingoid bases 1.00 0.07 
[SP] 1-deoxy-sphinganine 1 Lipids: Sphingolipids Sphingoid bases 1.00 0.05 
 
Table III-3. Significantly decreased metabolites in the ∆lmgt promastigotes. Specified in 
green are metabolites involved in Lipid metabolism, in blue, metabolites involved in Amino acid metabolism, and 
in pink, metabolites involved in Carbohydrate metabolism. Specified in yellow are the metabolites matched to 
authentic standards.  Metabolites with unassigned function are not included. 
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   Putative metabolite                               Map                        Pathway                     WT   ∆lmgt 
 
Orotate 2 Nucleotide Metabolism Pyrimidine metabolism 1.00 0.48 
Nonadecanoic acid 25 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
1.00 0.47 
[FA (17:0)] heptadecanoic 
acid 
30 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
1.00 0.44 
L-Proline 4 Amino Acid Metabolism 
Arginine and proline 
metabolism 
1.00 0.37 
[FA (18:1)] 9Z-octadecenoic 
acid 
57 Lipids: Fatty Acyls 
Fatty acid biosynthesis 
Biosynthesis of 
unsaturated fatty acids 
1.00 0.34 
L-Alanine 9 Amino Acid Metabolism 
Alanine and aspartate 
metabolism 
Cysteine metabolism 
D-Alanine metabolism 
1.00 0.30 
Succinate 7 
Carbohydrate 
Metabolism 
TCA cycle 
Oxidative 
phosphorylation 
Glutamate metabolism 
Alanine and aspartate 
metabolism 
Glycosomal succinate 
fermentation 
1.00 0.12 
 
Table III-4. Significantly decreased metabolites in the ∆lmgt promastigote spent 
media. Specified in blue are metabolites involved in Amino acid metabolism, in pink, metabolits involved in 
Carbohydrate metabolism, in green, metabolites involved in Lipid metabolism, and in bright pink, metabolites 
involved in Nucleotide metabolism. Specified in yellow are the metabolites matched to authentic standards. 
Specified in red are the metabolites with more than one isomeric peak. Metabolites with unassigned function are 
not included. 
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Using the Principal component analysis, IDEOM calculated the variability between the 
wild type and Δlmgt cell and spent medium samples (Figure III-8). The analysis 
showed distinct grouping of the wild type and Δlmgt samples. 799 metabolites in total 
were identified in the untargeted analysis, of which 79 showed statistically significant 
differences (with p<0.05) and a fold-change equal or above 2 in the promastigotes 
and 43 in the spent media (Supplemental table III-2). 11 of the cell metabolites and 6 
of the excreted metabolites were identified against authentic standards. The rest of 
the metabolites were putatively identified. 
Three big categories of metabolites were represented in the promastigotes and these 
included metabolites of lipid and amino acid metabolism and metabolites with 
unassigned function (Figure III-9, A). Noteworthy, nearly half of the significantly 
modulated cell metabolites were lipids. In the spent media, amino acids, lipids and 
metabolites with an unassigned function again comprised the three big categories of 
modulated metabolites (Figure III-9, B). Compared to the wild type promastigotes 
and spent media, 37 of the ∆lmgt cell metabolites and 35 of the excreted metabolites 
were increased while 42 and 8, respectively, were decreased (Supplemental table III- 
2). In the Δlmgt promastigotes, increased was glycerol and butanoate were highly 
(>10-fold) and significantly (>5-fold) increased, respectively (Table III-2). while 
succinate, an intermediate of the TCA cycle, was highly decreased (Tables III-2 and 
III-3). The putatively identified deoxyribose was decreased in the cells but increased 
in the spent media which showed that the pentose was excreted by the Δlmgt 
promastigotes (Supplemental table III-3). Succinate, again, was significantly 
decreased in the Δlmgt spent media (Table III-4).   
III.1.2.2.   Targeted glycomic analysis of ∆lmgt promastigotes by GC-MS 
A main feature of the ∆lmgt promastigotes is the inability to take up the 
hexoses D-glucose, D-fructose, D-mannose and D-galactose and the pentose D-ribose 
(Rodriguez-Contreras et al., 2007; Naula et al., 2010). It was shown, however, that the 
Δlmgt cells were still able to synthesize important hexose-containing 
macromolecules, such as glycoconjugates and glycoproteins (Rodriguez-Contreras 
and Landfear, 2006). This prompted us to investigate the glycome of the ∆lmgt 
promastigotes by targeted gas chromatography (GC)-MS. 
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Name  Mean±SD 
           HOMEM + 10 % 
iFBS nM 
 
 
           WT nM                          ∆lmgt nM 
D-Glucose 261 ± 94 0.94 ± 0.06 12 ± 4 
D-Glucose 6-phosphate NF 615 ± 38 150 ± 19 
D-Fructose 6-phosphate NF 1000 ± 500 369 ± 154 ** 
D-Fructose 1,6-bisphosphate 617 ± 15 ** 647 ± 15  ** NF 
Glyceraldehyde 3-phosphate NF NF NF 
Dihydroxyacetone phosphate NF 1700 ± 600 NF 
2-phosphoglycerate 301 ± 172 4300 ± 2500 4200 ± 1900 
Phosphoenolpyruvate 35 ± 0.0 * 7700 ± 5900 7100 ± 3500 
D-Fructose 0.24  ± 0.06 0.007 ± 0.006 0.35 ± 0.13 
D-Fructose-1-phosphate NF 211 ± 0.0 * NF 
D-Mannose 0.78 ± 0.05 NF NF 
D-Mannose 6-phosphate NF NF NF 
D-Sorbitol 1.2 ± 0.3 5.5 ± 1.1 66 ± 27 
D-Mannitol 0.27 ± 0.14 NF NF 
L-Rhamnose NF NF NF 
Fucose NF NF NF 
D-Galactose NF NF NF 
Galactitol NF NF NF 
Raffinose NF NF NF 
Lactose NF NF NF 
Gluconate 6-phosphate 0.54 ± 0.014 ** 507 ± 155 398 ± 0.00 * 
Ribulose 5-phosphate NF 521 ± 174 NF 
D-Ribose 5-phosphate NF 1500 ± 600 521 ± 260 ** 
D-Ribose 0.06 ± 0.001 ** 0.087 ± 0.0 * 
 
0.28 ± 0.013 
2-Deoxyribose NF NF NF 
Erythrose 4-phosphate 1000 ± 500 NF 3400 ± 2000 
Sedoheptulose 7-phosphate NF 276 ± 4.8 62 ± 27 * 
D-Xylose NF NF NF 
D-Xylulose 0.009 ± 0.001 NF NF 
Xylitol 0.026 ± 0.013 0.45 ± 0.11 0.35 ± 0.17 
D-Arabinose 0.007 ± 0.0 0.46 ± 0.25 0.07 ± 0.05 ** 
Ribitol 0.04 ± 0.013 0.56 ± 0.3 1.4 ± 0.0 * 
myo-Inositol 4.3 ± 0.2 133 ± 39 350 ± 139 
myo -Inositol-1-phosphate NF 0.042 ± 0.02 0.150 ± 0.65 
Sucrose 0.027 ± 0.002 0.03 ± 0.02 0.093 ± 0.052 
Maltose NF NF NF 
D-Threose 0.2 ± 0.0 * 0.82 ± 0.35 ** 1.1 ± 0.00 * 
D-Erythrose NF NF NF 
2-deoxy-D-glucose NF NF NF 
 
Table III-5. Glycomic comparison between wild type and Δlmgt promastigotes. Wild 
type and ∆lmgt promastigotes were grown in HOMEM media supplemented with 10% serum (biological 
replicates, n=3) and subjected to cold chloroform/methanol/water metabolite extraction. The metabolomic 
samples were analyzed with 1D GC-MS and the data were analyzed with Xcalibur. Specified in pink are sugars and 
sugar phosphates involved in glycolysis/gluconeogenesis, in blue, sugars and sugar phosphates involved in 
fructose and mannose metabolism, in green, sugars and sugar phosphates involved in galactose metabolism, in 
violet, sugars and sugar phosphates involved in pentose phosphate pathway, in yellow, sugars and sugar 
phosphates involved in pentose and glucuronate interconversions, in orange, sugars and sugar phosphates 
involved in inositol phosphate metabolism, in grey, sugars involved in and in white, sugars involved in starch and 
sucrose metabolism, and sugars not involved in pathways. All values are in nanomoles/108 cells. NF - not found. 
 
No asterisk - a mean of three values, * - a mean of two values, ** - individual value.  
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Name  Mean±SD 
HOMEM +  
10 % iFBS nM 
   WT nM          ∆lmgt nM 
D-Glucose 261 ± 94 122 ± 22                          211 ± 17                     
D-Glucose 6-phosphate NF NF NF 
D-Fructose 6-phosphate NF 4 ± 0.0 * NF 
D-Fructose 1,6-biphosphate 617 ± 15 ** NF NF 
Glyceraldehyde  3-phosphate NF NF NF 
Dihydroxyacetone phosphate NF NF NF 
2-phosphoglycerate 301 ± 172 392 ± 0.0 * 156 ± 0.0 * 
Phosphoenolpyruvate 35 ± 0.0 * NF NF 
D-Fructose 0.24 ± 0.06 0.22 ± 0.02 0.19 ± 0.005 
D-Fructose-1-phosphate NF NF NF 
D-Mannose 0.78 ± 0.05 0.72 ± 0.02 0.72 ± 0.02 
D-Mannose 6-phosphate NF NF NF 
D-Sorbitol 1.2 ± 0.3 1 ± 0.11 0.99 ± 0.05 
D-Mannitol 0.27 ± 0.14 0.24 ± 0.0 * 0.17 ± 0.003 
L-Rhamnose NF NF NF 
Fucose NF NF NF 
D-Galactose NF NF NF 
Galactitol NF NF NF 
Raffinose NF NF NF 
Lactose NF NF NF 
Gluconate 6-phosphate 0.54 ± 0.014 ** 1.4 ± 0.4 ** NF 
Ribulose 5-phosphate  NF NF NF 
D-Ribose 5-phosphate NF NF NF 
D-Ribose 0.06 ± 0.001 ** 0.14 ± 0.001 0.1 ± 0.006 
2-Deoxyribose NF NF NF 
Erythrose 4-phosphate 1000 ± 500 1100 ± 100 750 ± 100 
Sedoheptulose 7-phosphate NF NF NF 
D-Xylose NF NF NF 
D-Xylulose 0.009 ± 0.001 0.046 ± 0.013 0.033 ± 0.0 ** 
Xylitol 0.026 ± 0.013 0.049 ± 0.003 ** 0.013 ± 0.006 ** 
D-Arabinose  0.007 ± 0.0 0.017 ± 0.003 0.009 ± 0.005 
Ribitol 0.04 ± 0.013 0.05 ± 0.0 ** 0.03 ± 0.001 
myo-Inositol 4.3 ± 0.2 5.2 ± 0.5 3 ± 0.1 
myo -Inositol-1-phosphate NF 185 ± 73 108 ± 27 
Sucrose 0.027 ± 0.002 0.055 ± 0.035  0.01 ± 0.002 
Maltose NF NF NF 
D-Threose 0.2 ± 0.0 * NF NF 
D-Erythrose NF NF NF 
2-deoxy-D-glucose NF NF NF 
       
Table III-6. Glycomic comparison between wild type and Δlmgt promastigote spent 
media. Specified in pink are sugars and sugar phosphates involved in glycolysis/gluconeogenesis, in blue, sugars 
and sugar phosphates involved in fructose and mannose metabolism, in green, sugars and sugar phosphates 
involved in galactose metabolism, in violet, sugars and sugar phosphates involved in pentose phosphate pathway, 
in yellow, sugars and sugar phosphates involved in pentose and glucuronate interconversions, in orange, sugars 
and sugar phosphates involved in inositol phosphate metabolism, in grey, sugars involved in and in white, sugars 
involved in starch and sucrose metabolism, and sugars not involved in pathways. All values are in nanomoles/108 
cells. NF - not found. 
 
No asterisk - a mean of three values, * - a mean of two values, ** - individual value.  
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Analyzed were the fresh media (HOMEM supplemented with 10% iFBS), the wild type 
and Δlmgt promastigotes and the wild type and Δlmgt promastigote spent media 
(biological replicates, n=3). 39 sugars were used as authentic standards: 8 
participating in glycolysis/gluconeogenesis, 8 in fructose and mannose metabolism, 4 
in galactose metabolism, 7 in PPP pathway, 5 in pentose and glucuronate 
interconversions, 2 in inositol phosphate metabolism, 2 in starch and sucrose 
metabolism and 3 belonging to no pathway (Tables III-5 and III-6). 18 sugars were 
detected in the fresh media, 22 in the wild type promastigotes, 19 in the Δlmgt 
promastigotes, 17 in the wild type spent media and 15 in the Δlmgt spent media. 
Glycolysis/gluconeogenesis  
D-Glucose was the metabolite with the lowest concentration among the 
detected glycolytic/gluconeogenic intermediates in both the wild type and Δlmgt 
promastigotes (Table III-5; Figure III-10). Importantly, the level of D-glucose in the 
Δlmgt promastigotes was higher compared to its level in the wild type promastigotes. 
Glucose 6-phosphate (G6P) and fructose 6-phosphate (F6P), however, had 
considerably lower concentrations. Glyceraldehyde 3-phosphate (GAP), fructose 1,6-
bisphosphate (F1,6P) and dihydroxyacetone phosphate (DHAP) were not detected in 
the Δlmgt promastigotes or spent mdia (Tables III-5 and III-6). 2-Phosphoglycerate 
(2PG) and phosphoenolpyruvate (PEP) had high concentrations similar to those in 
the wild type promastigotes (Figure III-10).   
Pentose phosphate pathway 
A considerable amount of G6P appears to be directed toward the PPP pathway 
judging by the concentrations of gluconate 6-phosphate (Gln6P) in the wild type and  
Δlmgt promastigotes (Table III-5; Figure III-10). Gln6P, ribose 5-phosphate (R5P) and 
sedoheptulose 7-phosphate (S7P) were decreased while D-ribose was increased in 
the Δlmgt promastigotes (Table III-5). Contrary to the wild type promastigotes, 
erythrose 4-phosphate (E4P) was detected at relatively high concentration in the 
Δlmgt promastigotes (Figure III-10).  
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Figure III-10. Quantitative glycomic map of glycolysis/gluconeogenesis and pentose 
phosphate pathway in the wild type (top) and  Δlmgt (bottom) promastigotes. Specified 
in red/blue is the average value of the respective metabolite in nanomoles/108 cells. Dashed lines indicate an 
indirect connection. Abbreviations: Glc - glucose, G6P - glucose 6-phosphate, F6P - fructose 6-phosphate, F1,6B - 
fructose 1,6-bisphophate,  GAP - glyceraldehyde 3-phosphate, DHAP - dihydroxyacetone phosphate, 2PG - 2-
phosphoglycerate, PEP - phosphoenolpyruvate, Gln6P - gluconate 6-phosphate, Rl5P - ribulose 5-phosphate, R5P - 
ribose 5-phosphate R - ribose, E4P - erythrose 4-phosphate, S7P - sedoheptulose 7-phosphate, 2Dr - 2-
deoxyribose, NF - not found. 
Adapted from KEGG. 
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Figure III-11. Quantitative glycomic map of inositol phosphate metabolism, galactose 
metabolism and fructose and mannose metabolism in the wild type (top) and Δlmgt 
(bottom) promastigotes. Specified in red/blue is the average value of the respective metabolite in 
nanomoles/108 cells. Dashed lines indicate an indirect connection. Abbreviations: Glc - glucose, G6P - glucose 6-
phosphate, F1,6B - fructose 1,6-bisphophate, Fru - fructose, F1P - fructose 1-phosphate, Man - mannose, M6P - 
mannose 6-phosphate, Sor - sorbitol, Mol - mannitol, Rha - rhamnose, Fuc - fucose, Gal - galactose, Gol - galactitol, 
Lac - lactose, Raf - raffinose, myo-I - myo-inositol, myo-I 1P - myo-inositol 1-phosphate, NF - not found. 
Adapted from KEGG. 
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Figure III-12. Quantitative glycomic map of starch and sucrose metabolism and 
pentose and glucuronate interconversions in the wild type (top) and Δlmgt (bottom) 
promastigotes. Specified in red/blue is the average value of the respective metabolite in nanomoles/108 cells. 
Dashed lines indicate an indirect connection. Abbreviations: Glc - glucose, Xl - xylose, Xll - xylulose, Xol - xylitol, 
Ara - arabinose, Rol - ribitol, Sucr - sucrose, Malt - maltose, NF - not found. 
Adapted from KEGG. 
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Inositol phosphate metabolism, galactose metabolism and fructose and 
mannose metabolism  
Small amounts of myo-inosito (myo-I) and myo-inositol 1-phosphate (myo-I 
1P) were found in the wild type promastigotes (Figure III-11). In the Δlmgt cells, the 
two compounds were present at slightly higher concentrations (Figure III-11). Similar 
to D-glucose, the level of D-fructose (Fru) was higher in the Δlmgt promastigotes. 
F1,6BP and fructose 1-phosphate (F1P) were not present in the Δlmgt promastigotes. 
D-Mannose (Man) was not detected. Also, none of the sugars of galactose metabolism 
were detected in the wild type and Δlmgt promastigotes. 
Starch and sucrose metabolism and pentose and glucuronate 
interconversions 
Sucrose (Sucr) was present at a higher level in the Δlmgt promastigotes 
(Figure III-12). Xylose (Xl) and xylulose (Xll), from the pentose and glucuronate 
interconversions, were not detected but xylitol (Xol), arabinose (Ara) and ribitol (Rol) 
were found at more or less similar levels in the wild type and Δlmgt promastigotes. 
III.1.2.3.   Metabolomic analysis of ∆lmgt promastigotes by NMR and LC-
MS 
As part of our metabolic characterization of the ∆lmgt promastigotes, we 
performed 1D proton (1H) nuclear magnetic resonance (NMR) to investigate the 
carbon utilisation by the wild type and Δlmgt promastigotes. As a complementary 
analysis, the two types of promastigotes were further subjected to 1D pHILIC HPLC-
ESI-MS and stable isotope tracing with mzMatch-ISO (Chokkathukalam et al., 2013). 
For the NMR analysis, the two cell lines (biological replicates, n=3) were incubated 
for 6 hours in PBS with 4 mM non-enriched (12C) and enriched (13C) carbon sources 
in the follow combinations:  
 PBS [Condition 1 (C1)] 
 13C-D-glucose [condition 2 (C2; *glc)] 
 12C-L-proline + 13C-D-glucose [condition 3 (C3; pro+*glc)] 
 12C-D-glucose + 13C-L-proline [condition 4 (C4; glc+*pro)] 
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 13C-L-proline [condition 5 (C5; *pro)] 
 12C-L-threonine + 13C-D-glucose [condition 6 (C6; thr+*glc)] 
 12C-D-glucose + 13C-L-threonine [condition 7 (C7; glc+*thr)] 
 13C-L-threonine [condition 8 (C8; *thr)] 
 12C-glycerol [condition 9 (C9; glr)] 
 12C-glycerol + 13C-D-glucose [condition 10 (C10; glr+*glc)]. 
III.1.2.3.1.   Metabolomic analysis of ∆lmgt promastigotes by NMR 
Condition 1, C1, revealed that the short incubation without external carbon 
sources resulted in the excretion of 12C-acetate and 12C-succinate by the wild type and 
Δlmgt promastigotes, originating most probably from the intracellular reserve 
material mannogen (Ralton et al., 2003) (Table III-7; Supplemental figure III-1). The 
Δlmgt promastigotes excreted less 12C-acetate and only a small amount of 12C-
succinate (Table III-8; Supplemental figure III-1). When D-glucose was supplied as a 
sole carbon source in condition 2, *glc, the wild type promastigotes excreted less 12C-
acetate and 12C-succinate and more 13C-acetate and 13C-succinate (Table III-7; Figure 
III-13; Supplemental figure III-2). The Δlmgt promastigotes excreted similar amounts 
of 12C-acetate and 12C-succinate as the ones observed in condition 1. The addition of 
L-proline towards D-glucose in conditions 3 and 4, pro+*glc and glc+*pro, resulted 
in the excretion of less 13C-acetate and 13C-succinate from D-glucose but more from L-
proline by the wild type promastigotes (Table III-8; Figure III-13; Supplemental 
figures III-3 and III-4). Under condition glc+*pro the wild type promastigotes 
excreted also 13C-pyruvate (Table III-7; Figure III-13). The Δlmgt promastigotes 
excreted similar amounts of 12C-acetate and 12C-succinate as those observed in 
conditions C1 and *glc again.  Contrary to the previous two conditions where L-
proline and D-glucose were provided together, the results from condition 5, *pro, 
showed that L-proline alone is a less energogenic substrate for the wild type 
promastigotes (Table III-7; Supplemental figure III-5).  
 
 
 
* - 13C-labelled compound 
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Figure III-13. Schematic representation of carbon source utilization by Leishmania 
mexicana promastigotes. Abbreviations: Glc - glucose, G6P - glucose 6-phosphate, F6P - fructose 6-
phosphate, F1,6B - fructose 1,6-bisphosphate, GAP - glyceraldehyde 3-phosphate, 1,3BPG - 1,3-
bisphosphoglycerate, 3PG - 3-phosphoglycerate, 2PG - 2-phosphoglycerate, PEP - phosphoenolpyruvate, Pyr - 
pyruvate, OAA - oxaloacetate, α-K - α-ketoglutarate, Suc-CoA - succinyl-CoA, L-Thr - L-threonine, AcA - 
acetoaldehyde, Mal - malate, Fum - fumarate, Suc - succinate, Aa-CoA - acetoacetyl-CoA, Ac-CoA - acetyl-CoA, Ac - 
acetate. 
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Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
C1 - 7.3±2.4 - - 49.7±5.2 - 57.0±6.5 
C2 13.8±2.1 4.8±1.8 - 206.1±26.5 45.2±4.4 219.9±28.2 50.0±5.0 
C3 8.1±0.6 <5 - 209.0±49.0 <45 217.1±49.2 <50 
C4 21.6±0.5 <5 5.1±3.3 244.3±53.1 <45 271.0±56.0 <50 
C5 - <5 - - <45 - <50 
C6 - - - 121.5±7.7 47.2±7.5 121.5±7.7 47.2±7.5 
 
C7 - 8.3±4.5 - 13.5±4.5 
126.1±30.2* 
47.2±7.5 
13.5±4.5 
126.1±30.2* 
47.2±7.5 
C8 - - - 13.6±5.8 29.6±4.0 13.6±5.8 29.6±4.0 
C9 - - - - 24.7±8.7 - 24.7±8.7 
C10 - - - 126.9±5.9 41.5±1.2 126.9±5.9 41.5±1.2 
 
Table III-7. Non-enriched (12C) and enriched (13C) metabolic end products excreted 
by the Leishmania mexicana wild type promastigotes. Wild type promastigotes (biological 
replicates, n=3) were incubated for 6 hours in PBS with 4 mM of the following non-enriched and enriched carbon 
sources: no carbon sources - condition 1 (C1), 13C-D-glucose - condition 2 (C2), 12C-L-proline and 13C-D-glucose – 
condition 3 (C3), 12C-D-glucose and 13C-L-proline – condition 4 (C4), 13C-L-proline – condition 5 (C5), 12C-L-
threonine and 13C-D-glucose – condition 6 (C6), 12C-D-glucose and 13C-L-threonine – condition 7 (C7), 13C-L-
threonine – condition 8 (C8), 12C-glycerol – condition 9 (C9), and 12C-glycerol and 13C-D-glucose – condition 10 
(C10), and analyzed by 1H-NMR. All values are in nmoles/hour/108 cells. 
 
* - originating from D-glucose 
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Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
C1 - <3 - - 15.5±3.0 - <18 
C2 - <3 - - 13.5±6.2 - <18 
C3 - <3 - - <15 - <18 
C4 - <3 - - <15 - <18 
C5 - <3 - - <15 - <18 
 
C6 - - - - 
45.8±20.5** 
15.1 
- 
45.8±20.5** 
15.1 
C7 - - - 32.4±1.0 51.1±4.0 32.4±1.0 51.1±4.0 
C8 - - - 30.8±9.6 17.5±3.8 30.8±9.6 17.5±3.8 
C9 - - - - 12.7±0.7 - 12.7±0.7 
C10 - - - - 15.6±0.5 - 15.6±0.5 
 
Table III-8. Non-enriched (12C) and enriched (13C) metabolic end products excreted 
by the Δlmgt promastigotes. Δlmgt promastigotes (biological replicates, n=3) were incubated for 6 hours 
in PBS with 4 mM of the following non-enriched and enriched carbon sources: no carbon sources - condition 1 
(C1), 13C-D-glucose - condition 2 (C2), 12C-L-proline and 13C-D-glucose – condition 3 (C3), 12C-D-glucose and 13C-L-
proline – condition 4 (C4), 13C-L-proline – condition 5 (C5), 12C-L-threonine and 13C-D-glucose – condition 6 (C6), 
12C-D-glucose and 13C-L-threonine – condition 7 (C7), 13C-L-threonine – condition 8 (C8), 12C-glycerol – condition 
9 (C9), and 12C-glycerol and 13C-D-glucose – condition 10 (C10), and analyzed by 1H-NMR. All values are in 
nmoles/hour/108 cells. 
 
** - originating from L-threonine 
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When labelled D-glucose was provided in combination with unlabelled L-threonine in 
condition 6, thr+*glc, the wild type promastigotes excreted the same amount of 12C-
acetate from mannogen as in the previous conditions but twice as less 13C-acetate 
from D-glucose (Table III-7; Supplemental figure III-6). The Δlmgt promastigotes, on 
the other hand, excreted two types of 12C-acetate: one originating from mannogen, 
the amount of which was the same as in the previous conditions, and one produced 
from L-threonine, which was 3 times more (Table III-8; Figure III-13; Supplemental 
figure III-6). Switching the labelling of D-glucose and L-proline in condition 7, 
glc+*thr, revealed that the wild type promastigotes produced the same amounts of 
12C-acetate and 12C-succinate from mannogen, approximately 3 times more 12C-
acetate from 12C-D-glucose and a small amout of 13C-acetate from 13C-L-threonine 
(Table III-7; Supplemental figure III-7). That showed that the wild type promastigotes 
preferentially utilized D-glucose when L-threonine was the alternative carbon source. 
When the heavy-labelled variant of the amino acid was provided as a sole carbon 
source in condition 8, *thr, the wild type promastigotes excreted the same small 
amount of heavy-labelled acetate as that observed in the previous condition but 
approximately twice as less acetate originating from mannogen compared to all 
previous conditions (Table III-7; Supplemental figure III-8). That indicated that L-
threonine is still an important carbon source for the promastigotes. For the Δlmgt 
promastigotes, L-threonine appear to be a primary source for acetate judging by the 
higher levels of acetate in all three conditions with L-threonine (Table III-7; 
Supplemental figures III-6, III-7 and III-8). In the penultimate condition, condition 9, 
glr, where glycerol was provided as a sole carbon source, the two types of 
promastigotes excreted 12C-acetate only (Tables III-7 and III-8; Supplemental figure 
III-9). Finally, in the last condition, glr+*glc, where glycerol was combined with 13C-
D-glucose, the wild type promastigotes excreted the same amounts of 12C-acetate 
from mannogen and 13C-acetate from D-glucose as those observed in condition 6 
while the Δlmgt promastigotes excreted the same amount of 12C-acetate as that in the 
previous conditions, except for those with L-threonine (Table III-8; Supplemental 
figure III-10). 
III.1.2.3.2.   Metabolomic analysis of carbohydrate metabolism of 
∆lmgt promastigotes by LC-MS and stable isotope tracing analysis 
We have taken advantage of the heavy isotope nature of some of the carbon 
sources used in the NMR analysis and subjected the two lines of Leishmania 
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promastigotes grown for 6 hours under the 10 NMR conditions to a stable isotope 
tracing analysis. With regard to this analysis, however, two points have to be clarified. 
First, a similar to condition 2 (*glc) analysis was performed beforhand and it involved 
incubation of the wild type and Δlmgt promastigotes in defined media supplemented 
with serum and 13C-D-glucose for 48 hours. This condition was designated  condition 
0 (C0; *glc0) and helped us pinpoint metabolic differences between nutrient-replete 
(condition 0) and nutrient-restricted conditions (the NMR conditions). Second, the 
stable isotope tracing analysis is not quantitative. As said before, it was used to 
elucidate the metabolic fate of the carbon sources in the wild type and Δlmgt 
promastigotes.   
The data were analyzed with IDEOM and mzMatch-ISO (Creek et al., 2012; 
Chokkathukalam et al., 2013). The PCA analysis, performed with IDEOM, revealed 
distinct separation between the wild type and Δlmgt C1-C5 cell and spent medium 
samples (Figure III-14). The C6-C10 wild type cell samples were also separated from 
the Δlmgt samples (Figure III-15). The C6-C10 Δlmgt cell samples, additionally, were 
separated into two groups indicating that the Δlmgt promastigotes incubated with 
12C-glycerol (C9) and 12C-glycerol + 13C-glucose (C10) had distinct metabolic 
phenotype (Figure III-15, A). The C6-C10 spent medium samples showed hardly any 
separation between each other (Figure III-15, B). A certain pattern, however, was still 
observed. The wild type C6 (thr+*glc) samples were grouped separately from the 
rest of the samples. The Δlmgt C6, C7 and C8 samples (with L-threonine) were 
clustered together with the wild type C7 and C8 samples while the Δlmgt C9 and C10 
samples (with glycerol) were grouped with the wild type C9 and C10 samples (Figure 
III-15, B).  
15 pathways of carbohydrate metabolism were investigated with mzMatch-ISO. All 
necessary information regarding metabolites and pathways was extracted from the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database and MetaCyc. 
The pathways were used as reference pathways only. Analysis of 13 of the 15 
carbohydrate pathways gave inconclusive information. One to maximum 4 
metabolites of butanoate metabolism, C5-branched dibasic acid metabolism, 
glyoxylate and dicarboxylate metabolism and propanoate metabolism were detected.  
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Figure III-14. Scoreplots of the Principal component analysis performed on the wild 
type and ∆lmgt promastigote (A) and spent medium (B) metabolomic samples 
generated after incubation under conditions C1, C2, C3, C4 and C5. Wild type and Δlmgt 
promastigotes (biological replicates, n=3) were incubated for 6 hours in PBS (condition 1, C1), in PBS with 13C-D-
glucose (condition 2, C2), in PBS with 12C-L-proline + 13C-D-glucose (condition 3, C3), in PBS with 12C-D-glucose + 
13C-L-proline (condition 4, C4) and in PBS with 13C-L-proline (condition 5, C5), and subjected to cold 
chloroform/methanol/water metabolite extraction. The samples were analyzed by 1D pHILIC HPLC-ESI-MS and 
the data were analyzed with IDEOM. WT - wild type promastigotes, Δlmgt - Δlmgt promastigotes. 
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Figure III-15. Scoreplots of the Principal component analysis performed on the wild 
type and ∆lmgt promastigote (A) and spent medium (B) metabolomic samples 
generated after incubation under conditions C6, C7, C8, C9 and C10. Wild type and Δlmgt 
promastigotes (biological replicates, n=3) were incubated for 6 hours in PBS with 12C-L-threonine + 13C-D-glucose 
(condition 6, C6), in PBS with 12C-D-glucose + 13C-L-threonine (condition 7, C7), in PBS with 12C-L-proline and 13C-
L-threonine (condition 8, C8), in PBS with 12C-glycerol (condition 9, C9) and in PBS with 12C-glycerol + 13C-D-
glucose (condition 10, C10), and subjected to cold chloroform/methanol/water metabolite extraction. The samples 
were analyzed by 1D pHILIC HPLC-ESI-MS and the data were analyzed with IDEOM. WT - wild type promastigotes, 
Δlmgt - Δlmgt promastigotes. 
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For instance, itaconate was the only one of the C5-branched dibasic acid metabolism 
intermediates that was authentically identified and labelled in the wild type 
promastigotes. Similarly, 3-hydroxybutanoate, 2-hydroxyglutarate and butanoate 
were the only intermediates of butanoate metabolism that were detected. The first 
two metabolites were authentically identified and universally labelled in the wild 
type promastigotes while butanoate was unlabelled. This shows that our data are 
incomplete and do not allow further interpretation.  Moreover, many intermediates of 
amino sugar and nucleotide sugar metabolism, ascorbate and alderate metabolism, 
fructose and mannose metabolism, galactose metabolism, glycolysis/ 
gluconeogenesis, inositol phosphate metabolism, pentose phosphate pathway, 
pentose and glucuronate interconversions, pyruvate metabolism and starch and 
sucrose metbaolism are isomers of each and their identification remained 
unconfirmed. Nevertheless, we could say that UDP-hexoses, GDP-hexoses, N-acetyl-D-
hexosamine 1/6-phosphates, UDP-N-acetyl-D-hexoseamines, hexoses, hexose 
phosphates, pentoses and pentose phosphates are among the labelled metabolites in 
the wild type promastigotes incubated with D-glucose. Additionally, oligosaccharides 
such as cellotriose, cellotetraose, cellopentaose and cellohexaose were also identified 
as labelled in the wild type promastigotes incubated with D-glucose but only 
putatively. 
Glycolysis/gluconeogenesis 
The first stage of D-glucose catabolism in Leishmania occurs via glycolysis 
which is partially compartmentalized in the glycosomes (Hart and Opperdoes, 1984). 
Corroborating with a previous study on L. mexicana promastigotes (Saunders et al., 
2011), all detected glycolytic/gluconeogenic intermediates were labelled in condition 
*glc0 wild type promastigotes (Figure III-16). D-Glucose was authentically identified 
in conditions *glc, pro+*glc, thr+*glc and glr+*glc wild type promastigotes. G6P, 
F6P, 2PG, 3PG and PEP were authentically identified in all conditions whereas 
glyceraldehyde 3-phosphate/dihydroxyacetone phosphate was putatively identified. 
All of the listed glycolytic/gluconeogenic intermediates were universally labelled in 
conditions *glc0, *glu, pro+*glc, *pro, thr+*glc and glr+*glc wild type 
promastigotes and in conditions glc+*pro and *pro Δlmgt promastigotes. Pyruvate 
was also putatively identified and was universally labelled in conditions *glc, 
pro+*glu, thr+*glu and glr+*glu wild type promastigotes and in conditions glc+*pro 
and *pro Δlmgt promastigotes. 
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Figure III-16. Labelling pattern of glucose 6-phosphate, fructose 6-phosphate, 2-
phosphoglycerate and phosphoenolpyruvate in wild type and Δlmgt promastigotes 
incubated with 13C-D-glucose. Abbreviations: UL- Unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-
13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-
labelled carbon, WT – wild type promastigotes, ∆lmgt - ∆lmgt promastigotes.  
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Figure III-17. Labelling pattern of citrate, α-ketoglutarate, succinate, fumarate and 
malate in wild type and Δlmgt promastigotes incubated with 13C-D-glucose. 
Abbreviations: UL- Unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-labelled 
carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-labelled carbon, WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes.  
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Tricarboxylic acid cycle 
The second stage of D-glucose catabolism in Leishmania involves the 
mitochondrially operating tricarboxylic acid cycle (TCA cycle) which is linked to the 
final component of the cellular respiratory machinery, the electron transport chain 
(see Chapter IV). The cycle consists of eight steps and involves nine intermediates. 
Authentically identified and universally labelled in condition *glc0 wild type 
promastigotes were citrate, α-ketoglutarate, succinate, fumarate and malate (Figure 
III-17). Citrate, malate, succinate and fumarate were authentically identified and 
universally labelled also in conditions *glc, pro+*glc and *pro wild type 
promastigotes and in conditions glc+*pro and *pro Δlmgt promastigotes. Malate, 
succinate and fumarate were labelled also in conditions thr+*glc and glr+*glc wild 
type promastigotes. cis-Aconitate was authentically identified and found universally 
labelled in conditions *glc and pro+*glc wild type promastigotes and in conditions 
glc+*pro and *pro Δlmgt promastigotes. 
The third stage of D-glucose catabolism involves reoxidation of reduced coenzymes 
such as NADH and FADH2 generated in glycolysis and TCA cycle by the electron 
transport chain for the production of energy in the form of ATP (see Chapter IV). The 
role of D-glucose, however, is not limited to an energy source. D-Glucose is an 
important source for anabolic precursors, such as nucleotides, amino acids and lipids, 
which are involved in macromolecular synthesis. For instance, the phosphorylated 
form of D-glucose, glucose 6-phosphate, is catabolized in the pentose phosphate 
pathway for the synthesis of ribose 5-phosphate (R5P). R5P is a precursor for 
nucleotides (Maugeri et al., 2003) which are the building blocks of DNA and RNA. 
Fructose 6-phosphate can be used for the synthesis of GDP-mannose which is the 
main mannose donor for glycoconjugate and mannogen biosynthesis (Ilg et al., 1999; 
Ralton et al., 2003). Dihydroxyacetone phosphate is involved in ether-lipid 
biosynthesis (Heise and Opperdoes, 1997) whereas pyruvate can be converted to 
acetyl-CoA which is a fatty acid precursor. Ether lipids and fatty acids are precursors 
for phospholipids and triacylglycerols which are major structural lipids in cell 
membrane. Pyruvate, oxaloacetate and α-ketoglutarate are sources of L-alanine, L-
aspartate and L-asparagine, and L-glutamate and L-glutamine, respectively 
(Opperdoes and Michels, 2008) (see Chapter IV), all of which are involved in protein 
synthesis. 
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III.2. Discussion 
A number of recent studies have aimed at comprehensive identification and 
quantitation of new and known proteins and metabolites in order to elucidate new 
aspects of trypanosomatid metabolism. Some proteomic and metabolomic studies 
have focused on global and comparative profiling of the trypanosomatid development 
(Drummelsmith et al., 2003; Rosenzweig et al., 2008a). Other studies have been 
interested in more specific components of the proteome and metabolome, such as the 
phosphoproteome (Urbaniak et al., 2013), the glycoproteome (Guther et al., 2014) or 
central carbon metabolism (Saunders et al., 2011).  
With regard to proteomics, the aim of this study was to develop a gel-free 
methodology for global quantitative comparison between L. mexicana wild type and 
Δlmgt promastigotes. The methodology involved prefractionation of the wild type and 
Δlmgt promastigote proteomes with digitonin and consecutive analysis of the 
resulting fractions by mass spectrometry (MS). The digitonin fractionation was 
developed by Oullette and colleagues in 2006 and was successfully used for 
comparative proteomic analysis of L. infantum promastigotes and amastigotes 
(Foucher et al., 2006). The method involves the use of increasing amounts of 
digitonin, which precipitates sterols and forms pores in the plasma and organellar 
membranes, to successively extract cytosolic, organellar and digitonin-insoluble 
proteins. In our study, the 5 fractions generated with digitonin were directly analyzed 
by MS. Oullette and colleagues, however, used 2D gel electrophoresis to further 
separate the protein fractions prior to analyzing some of the gel spots by MS. The MS 
analysis showed that the presence of most of the proteins in a certain fraction is 
indicative for their localization in the cells. A comparison between our data and 
several other papers indicated that the same principle applied for the proteins 
detected in the five fractions generated in our study (Colasante et al., 2006; Guther et 
al., 2014). However, the digitonin-based fractionation was not chosen as a method for 
enrichment of a certain cellular component. Rather, it was used solely to increase the 
protein coverage. Compared to preliminary experiments where around 1% of the 
predicted Leishmania proteome was found differentially expressed in the Δlmgt 
promastigotes, the prefractionation allowed us to see more than 2 times more 
proteins differentially regulated in the Δlmgt cells. The modulated proteins included 
binding proteins, cytoskeletal proteins, enzymes, hypothetical proteins, structural 
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proteins, proteins involved in movement, protein degradation, protein folding and 
protein synthesis, and proteins with unknown function (Figure III-6). The largest 
category, that of the enzymes, comprised ~40% of all significant proteins. The 
majority of the significantly modulated enzymes were metabolic enzymes involved in 
amino acid, carbohydrate, energy, lipid and nucleotide metabolism and metabolism of 
terpenoids and polyketides (Supplemental table III-1). Discussed below will be all 
enzymes with known function that belong to metabolic pathways of the carbohydrate 
metabolism.  
With regard to metabolomics, the aim of this study was to complement the proteomic 
data by investigating the central carbon metabolism of the Δlmgt promastigotes. Prior 
characterization of the Δlmgt promastigotes has revealed that the gene deletion of the 
hexose transporters is accossiated with a number of phenotypic modulations, 
including significant changes in pathways of carbohydrate metabolism, such as the 
gluconeogenesis and glycoconjugate biosynthesis (Rodriguez-Contreras and 
Landfear, 2006). These studies provided valuable yet partial information regarding 
the changes in the Δlmgt promastigote metabolism. So, to expand on the proteomic 
information gathered by us, we decided to also perform comprehensive untarget and 
targeted metabolomic analyses, driven by the following questions: 
 are the changes in the Δlmgt promastigote metabolism restricted to the 
carbohydrate metabolism? 
 are other components of carbon metabolism, including amino acid, energy, 
lipid and nucleotide metabolism, affected? 
 are alternative carbon sources used by the Δlmgt promastigotes to sustain 
their energy needs and which are they? 
Significant changes in the carbon metabolism of the Δlmgt promastigotes were 
detected. Only carbohydrate metabolism will be discussed in this chapter. Amino acid, 
energy, lipid and nucleotide metabolism are discussed in Chapter IV.  
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Carbohydrate metabolism 
Glycolysis/gluconeogenesis 
 The continuous influx of energy is a necessity for maintaining cell growth, 
homeostasis, and development. In heterotrophic organisms, the flux of energy is 
fulfilled by the acquisition of nutrients which are biochemically converted to high 
energy intermediates such as ATP. A major nutrient and source of energy for many 
organisms is D-glucose. L. mexicana can acquire D-glucose from the host by the GT1, 
GT2, GT3, and GT4 transporters (Burchmore and Landfear, 1998; Feng et al., 2009). 
After internalization, most of D-glucose is directed towards the glycosomes, 
specialized peroxisome-related organelles, where it is metabolized via glycolysis to 3-
phosphoglycerate (3PG) (Hart and Opperdoes, 1984; Michels et al., 2006). 3PG is then 
transported to the cytosol, where the last few steps of glycolysis occur, and lead to the 
production of pyruvate. The reverse pathway in which the end product of glycolysis, 
pyruvate, and a number of other metabolites such as acetate, lactate, and some 
glucogenic amino acids, are converted back to D-glucose is designated as 
gluconeogenesis. Gluconeogenesis shares most but not all of its enzymes with 
glycolysis. Nevertheless, some key gluconeogenic enzymes, such as fructose 1,6-
bisphosphatase, were shown to also be present in the Leishmania glycosomes 
(Michels et  al., 2006). 
Naturally, our analysis of the glucose transporter null-mutant promastigotes started 
with investigating the glycolytic/gluconeogenic pathway. As expected, the stable 
isotope tracing analysis revealed that none of the intermediates of the pathwy were 
heavy-labelled in the Δlmgt promastigotes (Figure III-18). The global untargeted 
metabolomic data did not reveal anything significant with respect to the pathway 
(Tables III-2, III-3 and III-4). The quantitative proteomic and glycomic data, however, 
provided valuable information regarding the way glycolysis/gluconeogenesis 
operates in the Δlmgt promastigotes. First, the glycomic data showed that D-glucose 
was maintained roughly at a 12 times higher level in the Δlmgt promastigotes in 
comparison with the wild type promastigotes. This observation, along with the notion 
that the last gluconeogenic enzyme, namely glucose 6-phosphatase which converts 
glucose 6-phosphate (G6P) to D-glucose, appears to be missing from Leishmania 
(Rodriguez-Contreras and Landfear, 2006), suggests that gluconeogenesis in 
Leishmania, and in the Δlmgt promastigotes, serves to generate G6P but not D-
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glucose. Thus, taking into account that, on one hand, Leishmania are not able to 
synthesize D-glucose via gluconeogenesis and, on the other hand, that the levels of 
two specific sugars, namely sucrose and fructose, are also increased in the Δlmgt 
promastigotes, we assumed that the glucose transporter null-mutant promastigotes 
most probably use alternative sources for the production of D-glucose. Sucrose, most 
probably present in the serum supplementing the culture media, appears to be such 
source for the Δlmgt promastigotes. It is a disaccharide made from D-glucose and D-
fructose and under the action of sucrase, it is cleaved into the two monosaccharides. 
Leishmania are capable of breaking down sucrose extracellularly, by secreting 
sucrase, and intracellularly (Jacobson et al., 2001; Singh and Mandal, 2011). 
Intracellular sucrase acts upon sucrose internalized by a two component symport 
system that is characterised with high specificity for sucrose and high and low affinity 
dual kinetics (Singh and Mandal, 2011). Other sources of D-glucose, in addition to 
sucrose, may also be used by the Δlmgt promastigotes although our data did not 
specify any other such metabolites. 
The higher level of D-glucose and up-regulated hexokinase in the Δlmgt 
promastigotes (Feng et al., 2011) indicate that the hexose is used for the generation of 
G6P. The levels of G6P and fructose 6-phosphate (F6P), however, were 3 to 4-fold 
lower in the Δlmgt promastigotes compared with the wild type promastigotes. The 
two intermediates are key precursors for a number of important metabolites. G6P can 
be directed toward the pentose phosphate pathway (PPP) for the synthesis of ribose 
5-phosphate and reducing equivalents (see Pentose phosphate pathway), while F6P 
can be directed toward the nucleotide sugar and mannose metabolism which, in turn, 
provide precursors for the synthesis of a variety of glycoconjugates and the reserve 
material of Leishmania called mannogen (see Fructose and mannose metabolism) 
(Maugeri et al., 2003; Garami et al., 2001; Ralton et al., 2003). The next three 
intermediates, fructose 1,6-bisphosphate (F1,6B), glyceraldehyde 3-phosphate (GAP) 
and dihydroxyacetone phosphate (DHAP), were not detected in the wild type or 
Δlmgt promastigotes. It is possible that the three intermediates are metabolized right 
after synthesis and only trace quantities, below the limit of detection of the GC-MS 
method used in this project, are present in the cells. Three points regarding GAP are 
of relevance. First, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) isoforms 
were found both up- and down-regulated in the Δlmgt promastigotes (Supplemental 
table III-1).  
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Figure III-18. Schematic representation of glycolysis/gluconeogenesis in Δlmgt 
promastigotes incubated with 13C-D-glucose. Presented here are integrated quantitative proteomic, 
glycomic and stable isotope tracing data. Specified with light blue arrows are the up-regulated enzymes while 
specified with pink arrows are the down-regulated enzymes. Specified in dark blue are the glycolitic intermediates 
quantified by GC-MS. Indicated next to each quantified metabolite is its concentration in nanomoles (nM). 
Abbreviations: Glc - glucose, G6P - glucose 6-phosphate, F6P - fructose 6-phosphate, F1,6B - fructose 1,6-
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Considering that different isoforms of glycolytic/gluconeogenic enzymes, such as 
enolase (Avilan et al., 2011), often have kinetic properties facilitating changes in the 
flux in the glycolytic or gluconeogenic direction in accordance with the cellular needs, 
it could be hypothesized that one of the isoforms contributes to glycolysis while the 
other is involved in gluconeogenesis. Second, under the action of GAPDH, GAP is 
converted to glycerate 1,3-bisphosphate with the simultaneous reduction of NAD+ to 
NADH. The generated NADH, however, has to be re-oxidised so that the glycosomal 
NAD+/NADH balance is maintained. It was proposed that three pathways are involved 
in the maintenance of this balance in trypanosomatids: a glycosomal succinate 
fermentation, a glycerol 3-phosphate (G3P)/DHAP shuttle and a glycosomal glycerol 
production pathway (Ebikeme et al., 2010). When cultured with abundance of D-
glucose, the glycosomal succinate fermentation has been shown to be the primary 
mechanism by which Leishmania maintain this balance and only insignificant amount 
of NAD+ is regenerated via the DHAP/glycerol 3-phsophate (G3P) shuttle (see 
Glycosomal succinate fermentation) (Hart and Coombs, 1982; Cazzulo et al., 1985; 
Saunders et al., 2011). Third, GAP is the point linking lipid and carbohydrate 
metabolism. Glycerol, an intermediate of glycerolipid metabolism, enters 
gluconeogenesis in Leishmania via glycerol kinase (GK) (Figure III-18) (Rodriguez-
Contreras and Hamilton, 2014). G3P generated by GK is converted to DHAP by a 
glycerol 3-phosphate dehydrogenase (G3PDH) and then fuelled into gluconeogenesis. 
A previous study showed that 14C-glycerol is incorporated in mannogen by the Δlmgt 
promastigotes which confirmed that glycerol is used as a glucogenic precursor for the 
synthesis of G6P (Rodriguez-Contreras and Landfear, 2006). Our proteomic analysis, 
however, revealed that a glycosomal/mitochondrial NAD+-dependent G3PDH was 
highly (>10-fold) decreased in the Δlmgt promastigotes which indicates that glycerol 
may not be a preferred glucogenic source for the Δlmgt promastigotes. The highly 
increased level of glycerol in the mutant promastigotes (Table III-2), on the other 
hand, suggests that it is probably needed in glycerolipid biosynthesis. 
The last intermediates of the glycolytic pathway are 1,3-bisphosphoglycerate, 3PG, 
2PG, PEP, and pyruvate. Leishmania express two phosphoglycerate kinase (PGK) 
enzymes - a cytosolic PGKB and a glycosomal PGKC (Kaushik et al., 2012), both of 
which were found down-regulated in the Δlmgt promastigotes. PGK catalyzes the 
interconversion of 1,3-bisphosphoglycerate and 3PG. The latter can then be 
interconverted to 2PG by phosphoglycerate mutase. In the cytosol, 2PG is converted 
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to PEP by the enzyme enolase (ENO) (Figure III-18), which was confirmed as down-
regulated in the Δlmgt promastigotes by a 2D difference gel electrophoresis (2D-
DIGE) analysis (in preparation). In the cytosol, PEP can either be re-imported into the 
glycosomes and reduced to succinate via the glycosomal succinate fermentation or 
irreversibly converted to pyruvate by a cytosolic pyruvate kinase (Michels et al., 
2006). The PEP-to-pyruvate conversion is responsible for the net glycolytic ATP 
production. The pyruvate kinase catalyzing the reaction, however, was found down-
regulated in the Δlmgt promastigotes. The decreased activity of the enzyme could be 
associated with redirection of the majority of PEP into gluconeogenesis. Indeed, the 
glycomic data revealed that the levels of PEP and 2PG in the Δlmgt promastigotes are 
close to those in the wild type promastigotes (Table III-5; Figure III-10). Furthermore, 
the stable isotope tracing analysis revealed that pyruvate, PEP, 2PG, 3PG, and 
GAP/DHAP contain much more 3-13C isotopomers in the wild type promastigotes 
incubated with 13C-D-glucose whereas those in the Δlmgt promastigotes incubated 
with the glucogenic amino acid 13C-L-proline contain equal amounts of 2-13C and 3-
13C isotopomers. Similarly, in the Δlmgt promastigotes incubated with 13C-L-proline, 
F6P and G6P contain more 2-13C, 3-13C and 4-13C isotopomers resulting from 
gluconeogenesis while the wild type promastigotes incubated with 13C-D-glucose 
contain more 5-13C and 6-13C isotopomers resulting from catabolism of D-glucose. 
Altogether, these data confirm that glycolysis/gluconeogesis operates in a 
gluconeogenic mode. Furthermore, the similar levels of PEP and 2PG in the wild type 
and mutant promastigotes show that the Δlmgt promastigotes strive to maintain a 
stable influx of glucogenic compounds into the pathway. At the same time, however, 
the enzymes G3PDH, PEPCK and PPDK which participate in the entry of glycerol, L-
aspartate, and L-alanine in gluconeogenesis, respectively (Rodriguez-Contreras and 
Hamilton, 2014), are down-regulated in these promastigotes. Moreover, the last 
intermediates of gluconeogenesis, including F6P and G6P, have decreased levels in 
the Δlmgt promastigotes. Concisely, it could be concluded that both D-glucose and 
gluconeogenesis are used to generate G6P but that gluconeogenesis is not able to 
meet the requirements for glycolytic/gluconeogenic biosynthetic precursors in the 
Δlmgt promastigotes.  
The data discussed above were obtained with Δlmgt promastigotes grown in defined 
media supplemented with serum. When the Δlmgt promastigotes were maintain in 
buffer (PBS) supplemented with no carbon sources or with either one or two of the 
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following sources - D-glucose, L-proline, L-threonine and glycerol, some variations in 
the pathway were observed. The stable isotope tracing revealed that the glycolytic/ 
gluconeogenic intermediates in the wild type promastigotes were heavy-labelled only 
in the conditions where 13C-D-glucose was supplied as a carbon source, conditions 
*glc, pro+*glc, thr+*glc and glr+*glc, and in condition *pro  where 13C-L-proline was 
provided as a sole carbon source. Thus, as shown before (Krassner, 1969; Krassner 
and Flory, 1972), D-glucose and L-proline are major nutrients for the L. mexicana wild 
type promastigotes and they are able to sustain cell growth when provided as sole 
carbon sources or in combination with one another. In the Δlmgt promastigotes, the 
glycolytic/gluconeogenic intermediates were heavy-labelled only in the two 
conditions with 13C-L-proline, glc+*pro and *pro, which confirmed that L-proline is 
among the glucogenic precursors used by the Δlmgt promastigotes for the synthesis 
of hexose phosphates (see Arginine, glutamate and proline metabolism). It must be 
added, however, that in contrast to the lack of labebelling in the Δlmgt promastigotes 
grown in defined media supplemented with serum and 13C-D-glucose, condition 
*glc0, minor labelling of 2PG, 3PG and PEP was observed in conditions *glc and 
pro+*glc Δlmgt promastigotes. That indicates that when no nutrients other than D-
glucose alone or D-glucose and L-proline are available in the environment, the Δlmgt 
promastigotes might possibly up-regulate the alternative GT4 glucose transporter 
(previously known as  D2). Lastly, it should be noted that minor labelling was 
observed in some of the glycolytic/gluconeogenic intermediates in the conditions 
with 13C-L-threonine showing that the amino acid is not preferentially fed into 
gluconeogenesis in the Δlmgt promastigotes (see Glycine, serine and threonine 
metabolism).  
Fructose and mannose metabolism 
The hexose sugars D-fructose and D-mannose are also substrates of LmGT 
transporters, so the Δlmgt promastigotes are not able to acquire these potential 
carbon sources (Rodriguez-Contreras et al., 2007). Nevertheless, the level of D-
fructose in the Δlmgt cells was 50 times higher compared to its level in the wild type 
promastigotes (Table III-5). Similar to D-glucose, D-fructose is phosphorylated before 
entering the intermediary metabolism by either hexokinase (Pabon et al., 2007) or 
fructokinase.  
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Figure III-19. Structure and synthesis of mannose-containing glycoconjugates in 
Leishmania mexicana. (A) Structure of (1) LPG, (2) PPG, (3) protein PGI anchor, (4) GIPL iM3 and (5) 
protein N-glycan. Enlarged and underlined are mannose residues donated from dolicholphosphate-mannose while 
those donated from GDP-mannose are italic and bolded. (B) Mannose activation pathway and biosynthesis of 
glycoconjugates in Leishmania mexicana. Specified with pink arrows are the down-regulated reactions in the 
Δlmgt promastigotes.  
Credit: Garami et al., 2001 
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D-Fructose can be phosphorylated at 1st or 6th position to produce fructose 1-
phosphate (F1P) and F6P, respectively, which can be fuelled into glycolysis. The 
glycomic data showed that while F6P was present in the Δlmgt promastigotes, though 
approximately 3 times less compared with the wild type promastigotes, F1P was not 
(Table III-5). The negligible amount or absence of F1P in the Δlmgt promastigotes 
indicated that fructose is mainly phosphorylated to F6P. Another source of F6P could 
be D-sorbitol, originating most probably from the serum supplementing the culture 
media, and whose level, similar to that of D-glucose, was 12 times increased in the 
Δlmgt promastigotes (Table III-5). F6P can be converted to mannose 6-phosphate 
(M6P) by phosphomannose isomerase (PMI) and directed toward the mannose (Man) 
metabolism (Figure III-19). Phosphomannose isomerase, however, was found down-
regulated in the Δlmgt promastigotes and Man and M6P were not detected in the wild 
type or Δlmgt promastigotes (Table III-5). Thus, from the glycomic and proteomic 
data, it might be assumed that the level of free Man in the wild type and Δlmgt 
promastigotes is maintained really low and that the influx of F6P into Man 
metabolism is decreased in the Δlmgt promastigotes. 
Man is a building block for two main types of macromolecules in Leishmania: the 
reserve material and virulence factor called mannogen (previously known as β-
mannan) (Ralton et al., 2003) and a spectrum of surface associated and secreted 
glycoconjugates such as lipophosphoglycan (LPG), proteophosphoglycans (PPGs), 
glycosylphosphatidylinositol (GPI)-anchored proteins, glycoinositolphospholipids 
(GIPLs), and N-glycans (Turco and Descoteaux, 1992; McConville and Ferguson, 1993;  
Ilg et al., 1999). Before being incorporated into glycoconjugates, Man has to be 
activated. The activation involves the conversion of M6P to mannose 1-phosphate 
(M1P) by phosphomannomutase (PMM), which was down-regulated in the Δlmgt 
promastigotes (Supplemental table III-1), followed by the conversion of M1P to GDP-
mannose (GDP-Man) by GDP-mannose pyrophosphorylase (GDPMP), which was also 
found down-regulated in the Δlmgt promastigotes by the 2D-DIGE analysis (in 
preparation), and finally, the conversion of GDP-Man to dolicholphosphate-mannose 
(Dol-P-Man) by dolicholphosphate-mannose synthase (DPMS). The products of the 
pathway, GDP-Man and Dol-P-Man, are the two central activated Man donors in 
mannosylation reactions of the glycoconjugate biosynthesis (Figure III-19) (Garami et 
al., 2001). Down-regulation of two of the three enzymes involved in the activation of 
these two metabolites renders the pathway down-regulated and the glycoconjugate 
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biosynthesis hindered in the Δlmgt promastigotes. These results corroborate with a 
previous study conducted with the Δlmgt promastigotes which investigated the 
synthesis of LPG, membrane PPG (mPPG), GILP, gp63 (an important leishmanial 
virulence factor), secreted acid phosphatase (a secreted glycoprotein enzyme), and 
mannogen by the Δlmgt promastigotes (Rodriguez-Contreras and Landfear, 2006). 
The study revealed that the Δlmgt promastigotes, first, did not use external sources 
for glycoconjugate biosynthesis, second, used gluconeogenesis for the synthesis of the 
necessary carbohydrate precursors, third, were able to properly N-glycosylate 
glycoproteins, and, fourth, were able to synthesize the glycoconjugates listed above 
and mannogen, although at reduced levels. Our proteomic data elucidated one 
significant difference with regard to gp63 though: the analysis performed by 
Rodriguez-Contreras and Landfear involved concentration of the membrane-bound 
and secreted gp63 from the Δlmgt promastigote culture medium and detection by 
Western blot, whereas our MS-based quantitative proteomic analysis was performed 
with promastigote cell lysate. As a result, while the previous study determined the 
level of gp63 in the Δlmgt spent media, our analysis elucidated the metalloprotease 
level in the promastigotes where four isoforms were found up-regulated 
(Supplemental table III-1). This is consistent with increased synthesis of gp63 but 
reduced efficiency of GPI anchor conjugation in the Δlmgt promastigotes. Another 
possibility is that gp63, as a protease, might have an additional intracellular function.  
Mannogen is a cytosolic carbohydrate reserve material comprised of β-1,2-linked 
mannose residues  (Ralton et al., 2003). The synthesis of mannogen was shown to be 
significantly impaired in the Δlmgt promastigotes, suggesting that gluconeogenesis 
was not able to fully compensate for the inability of the glucose transporter 
null0mutant promastigotes to acquire exogenous hexose precursors. Our NMR data 
revealed that the wild type promastigotes excreted acetate and succinate originating 
from an intracellular carbon source, possibly mannogen, along with the acetate and 
succinate produced from the different exogenous carbon sources used in the 
experiment (see Pyruvate metabolism and Tricarboxylic acid cycle). That confirmed 
that some amount of the internal carbon storage material is metabolized 
simulatenously with the catabolism of exogenous energy and carbon sources such as 
amino acids (see Amino acid metabolism). The Δlmgt promastigotes, except for the 
conditions with L-threonine, which was shown to be the primary precursor for 
acetate (see Pyruvate metabolism and Glycine, serine and threonine metabolism), 
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excreted acetate and succinate originating only from the storage material (Table III-
7). The levels of acetate and succinate produced, however, were reduced to less than 
half the levels measured in the wild type cells, consistent with reduced mannogen 
reserves in the Δlmgt cells. 
Galactose metabolism 
Galactose is another hexose the Δlmgt promastigotes cannot take up 
(Rodriguez-Contreras et al., 2007). The proteomic data indicated that UDP-glc 4'-
epimerase (GALE), which catalyzes the final step of the Leloire pathway of galactose 
catabolism, namely the conversion of UDP-galactose to UDP-glucose, was down-
regulated in the Δlmgt promastigotes. Similar to GDP-Man and Dol-P-Man, which are 
the main Man donors in mannosylation reactions, UDP-galactose (UDP-Gal) is the 
main source of glucosyl units for the synthesis of the glycan core of the GPI anchors 
by which many glycoconjugates such as LPG, GIPLs, PPGs and proteins such as gp63 
and gp46/PSA-2 are attached to the cell surface of Leishmania (McConville and 
Ferguson, 1993; Turco and Descoteaux, 1992; Ilg et al., 1999). The biosynthesis of GPI 
anchors is a complex multistep process that takes place in the endoplasmic reticulum 
and involves several transporters, enzymes and enzyme complexes (Hong and 
Kinoshita, 2009 and the references therein). In trypanosomatids, the exact 
mechanism and many of the enzymes involved in the lipid remodelling, and in the GPI 
biosynthesis as a whole, remains elusive. Furthermore, many of them are considered 
to be novel. None of the GPI biosynthetic enzymes listed above was differentially 
expressed in the Δlmgt promastigotes. Additionally and unfortunately, N-
acerylglucosamine was not detected in the wild type and Δlmgt promastigotes. It is 
worth saying, however, that the first enzyme of inositol synthesis, which catalyzes the 
conversion of G6P to myo-inositol-1-phosphate, was down-regulated in the Δlmgt 
promastigotes. That points out that another pathway important for the GPI 
biosynthesis is possibly suppressed in the Δlmgt promastigotes. 
Glycosomal succinate fermentation 
In the glycosomes, the re-imported PEP is first converted to oxaloacetate by 
PEPCK, which was down-regulated in the Δlmgt promastigotes. Then oxaloacetate is 
successively converted to malate, fumarate, and succinate by malate dehydrogenase 
(MDH), fumarate hydratase (FH), and NADH-dependent fumarate reductase (FRD), 
respectively. Three MDHs were found differentially expressed in the Δlmgt 
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promastigotes. A glycosomal MDH was significantly (>5-fold) down-regulated, 
isoforms encoded by a second MDH gene were down- and up-regulated, and a third 
MDH gene product was down-regulated (Supplementary table III-1). An FH was 
down-regulated in the second cytosolic and first organellar fractions (Supplemental 
table III-1). Additionally, an NADH-dependent FRD was down-regulated in the 
organellar fraction. It is known that T. brucei has a glycosomal FRD (FRDg) and two 
mitochondrial FRDs (FRDm1 and FRDm2) (Coustou et al., 2005). FRDg is a soluble 
glycosomal FRD transferring electrons from cofactors such as NADH or 
FADH2/FMNH2 to fumarate while FRDm1 and FRDm2 are subunits of a mitochondrial 
multimeric complex involved in transferring electrons from quinol to fumarate 
(Coustou et al., 2005). In our study, the NADH-dependent FRD was found 
differentially expressed in the first organellar fraction while most of the respiratory 
complex subunits were detected in the insoluble fraction. It could be hypothesized, 
therefore, that the NADH-dependent FRD is a glycosomal FRD. Thus, based on the 
down-regulated glycosomal MDH, FH, FRDg, and PEPCK and the decreased levels of 
malate and succinate in the Δlmgt promastigotes and spent media (see Tricarboxylic 
acid cycle), it can be concluded that the glycosomal succinate fermentation, which is 
considered as the main or sole pathway involved in maintaining the glycosomal ATP 
and redox balance (Saunders et al., 2011), is suppressed in the Δlmgt promastigotes. 
In addition to regenerating ATP and NAD+, the glycosomal succinate fermentation 
was shown to also be involved in supplying C4 dicarboxylic acids for the tricarboxylic 
acid cycle (TCA cycle) (Saunders et al., 2011). The reduced influx of C4 dicarboxylic 
acids from the glycosomal succinate fermentation suggests that other carbon sources 
may be used by the Δlmgt promastigotes to replenish the TCA cycle (see Amino acid 
metabolism).  
Pyruvate metabolism 
As a major glycolytic end product, a portion of the pyruvate produced is 
excreted by the Leishmania cells (Rainey and MacKenzie, 1991). The NMR data 
showed that a small amount of 13C-pyruvate was solely excreted when the wild type 
promastigotes were incubated with 12C-D-glucose in combination with 13C-L-proline 
(Table III-7). Thus, combined catabolism of D-glucose and L-proline in the wild type L. 
mexicana promastigotes leads to an increase in pyruvate production most probably 
resulting from increased respiratory activity (Krassner and Flory, 1972). Indeed, the 
amount of excreted end products by the wild type promastigotes was the highest in 
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the conditions with D-glucose and L-proline which suggests that oxidation of the two 
substrates together is more energogenic than oxidizing either one alone, oxidizing L-
threonine and glycerol alone or in combination with D-glucose (Table III-7). The NMR 
data also showed that the Δlmgt promastigotes did not secrete pyruvate.  
A second portion of pyruvate can be transported to the mitochondrion where it is 
decarboxylated to acetyl-CoA by the mitochondrial pyruvate dehydrogenase complex 
(PDC). The α subunit of the E1 component of the PDC was found up-regulated in the 
Δlmgt promastigotes (Figure III-18). Two other enzymes involved in the pyruvate-to-
acetate conversion, dihydrolipoamide acetyltransferase and dihydrolipoamide 
dehydrogenase, were also up-regulated in the Δlmgt promastigotes (Figure III-18), 
thus suggesting that pyruvate is converted to acetyl-CoA at a higher rate in the Δlmgt 
promastigotes. In the mitochondrion, acetyl-CoA can be fed into the TCA cycle, which 
appears to be the preferred route of catabolism of acetyl-CoA in the Δlmgt 
promastigotes (see Tricarboxylic acid cycle), or converted to acetate, which is 
another major metabolic end product of glucose metabolism which is excreted by the 
Leishmania cells (Rainey and MacKenzie, 1991). The NMR data showed that both the 
wild type and Δlmgt promastigotes excrete acetate (Tables III-7 and III-8). The wild 
type promastigotes excreted 12C-acetate when no exogenous carbon sources were 
available. When 13C-D-glucose, 13C-L-proline, and 13C-L-threonine were supplied as 
exogenous carbon sources, the wild type promastigotes exceted both 12C-acetate and 
13C-acetate (Table III-7). This confirmes that another carbon source, most probably 
an unlabelled intracellular reserve material such as mannogen, is utilized by the wild 
type promastigotes in parallel with the exogenous carbon sources. Furthermore, the 
data show that L-proline, L-threonine or glycerol, when supplied with D-glucose, can 
serve as precursors for the synthesis of acetate in the wild type promastigotes, as can 
D-glucose alone (Table III-7). In contrast, Δlmgt promastigotes excreted the same 
amount of 12C-acetate when no carbon sources were available and when D-glucose, L-
proline or glycerol were provided (Table III-8). The Δlmgt promastigotes, however, 
excreted more acetate when L-threonine was available as a carbon source. Thus, the 
NMR data revealed that L-threonine is an important precursor for acetyl-CoA in the 
Δlmgt promastigotes (see Glycine, serine and threonine metabolism).  
A further portion of pyruvate can be reversibly transaminated to L-alanine (see 
Alanine, aspartate andglutamate metabolism) or converted to lactate and 
subsequently excreted by the Leishmania cells (Rainey and MacKenzie, 1991). 
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Leishmania excrete D-lactate but not L-lactate (Darling et al., 1988). The NMR analysis 
did not detect D-lactate in the wild type or Δlmgt promastigote spent media. The 
proteomic data, on the other hand, showed that a D-lactate dehydrogenase-like 
protein, which interconverts pyruvate and D-lactate, was up-regulated in the Δlmgt 
promastigotes (Figure III-18). D-Lactate can be produced from methylglyoxal, a toxic 
byproduct of glycolysis, which is neutralized by the glyoxylase detoxification system 
of Leishmania (Opperdoes and Michels, 2008). The generated D-lactate can then be 
converted to pyruvate by the up-regulated D-lactate dehydrogenase-like protein and 
fed into gluconeogenesis (Figure III-18). 
Pentose phosphate pathway 
The main function of the pentose phosphate pathway (PPP) (also known as the 
hexose-monophopshate shunt) is to generate ribose 5-phosphate, used in the 
synthesis of nucleic acids, NADPH, used in redox reactions, and the 
glycolytic/gluconeogenic intermediates F6P and GAP. The pathway is divided into 
two phases, an oxidative phase which includes two irreversible oxidative reactions, 
and a non-oxidative phase that includes a series of reversible sugar-phosphate 
interconversions. The first two reactions of the oxidative phase, the irreversible and 
NADP+-dependent oxidation of G6P to 6-phosphoglucono-1,5-lactone (6PG1,5l) and 
the conversion of the latter to 6-phosphogluconate (6PG), are catalyzed by glucose 6-
phosphate dehydrogenase (G6PDH) and 6-phosphogluconolactonase (6PGIs), 
respectively. As observed previously in T. brucei (Heise and Opperdoes, 1999; 
Duffieux et al., 2000), glucose 6-phosphate dehydrogenase was found to have dual 
cytosolic and organellar localization and, along with 6-phosphogluconate 
dehydrogenase (6PDH), to be down-regulated in the Δlmgt promastigotes (Figure III-
20). Thus, the phase of the PPP pathway that is responsible for regeneration of 
NADPH seems to be down-regulated in the Δlmgt promastigotes. A main reason for 
that could be the reduced influx of G6P into the pathway. Another reason for the 
suppressed oxidative phase, however, could be a decreased demand for NADPH as a 
result of reduced glycosomal metabolism.  
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The non-oxidative phase was not so easy to decipher. Similar to a previous study 
(Colasante et al., 2006), the first enzymes of the non-oxidative phase, ribulose 5-
phosphate 3-epimerase and ribulose 5-phosphate isomerase, which convert ribulose 
5-phosphate (Ru5P) to xylulose 5-phosphate (Xl5P) and ribose 5-phosphate (R5P), 
respectively, were not detected. Ru5P, which was present in the wild type 
promastigotes, was absent from the Δlmgt promastigotes. This shows that G6P is 
probably not be the main source of R5P in the Δlmgt promastigotes. R5P itself was 3 
times less in the Δlmgt promastigotes compared with the wild type promastigotes 
(Table III-5). Next, transketolase, a thiamine pyrophosphate (TPP)-dependent 
enzyme that transfers two-carbon units from Xl5P to either R5P or erythrose 4-
phosphate (E4P) to produce GAP, and translaldolase, which interconverts 
sedoheptulose 7-phosphate (S7P) and GAP into F6P and E4P, were not significantly 
modulated in the Δlmgt promastigotes. Interestingly, E4P, which was not detected in 
the wild type promastigotes, was present at a relatively high level in the Δlmgt 
promastigotes while S7P levels were reduced (Table III-5). The decrease in S7P and 
increase in E4P suggests that the equilibrium of the interconversion of S7P and GAP 
to F6P and E4P is shifted towards the synthesis of F6P. Thus, a main function of the 
non-oxidative phase in the Δlmgt promastigotes could be to maintain the levels of 
F6P, while E4P is a side product accumulating in the process. Similarly, the increased 
level of D-ribose, along with the up-regulated ribokinase in the Δlmgt promastigotes 
(Feng et al., 2011), suggests that D-ribose is used for the synthesis of R5P (Table III-
5). Ribose is one of the sugars present in the honeydew the sand fly vectors of 
Leishmania feed upon (Cameron et al., 1995). Two studies have characterized ribose 
transporters in Leishmania. Pastakia and Dwyer determined that a specific carrier is 
involved in the transport of ribose in L. donovani promastigotes (Pastakia and Dwyer, 
1987). In the second study, Burchmore and colleagues revealed that the L. mexicana 
transporter GT2 can also transport ribose (Naula et al., 2010). The second study also 
showed that the Δlmgt promastigotes are not able to take up ribose. Besides import 
from the environment, however, ribose can be produced by cleavaging the ribose 
moieties of nucleosides. In the Δlmgt promastigotes, one nonspecific nucleoside 
hydrolase, which acts on nucleosides and hydrolyses them to ribose and the 
respective base (see Nucleotide metabolism), was found up-regulated in the Δlmgt 
promastigotes (in preparation). Thus, the up-regulated nucleoside hydrolase and the 
increased level of ribose in the Δlmgt promastigotes indicate that ribose is recycled 
and most probably used as a main precursor for the production of R5P.  
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Tricarboxylic acid cycle 
The tricarboxylic acid cycle (also known as the citric acid cycle or the Krebs 
cycle) is characterized with both catabolic and anabolic functions. Many catabolic 
pathways of carbohydrate, amino acid, and lipid metabolism lead to intermediates of 
the cycle and many TCA cycle intermediates are precursors for anabolic pathways. 
For instance, oxaloacetate (OAA) and malate (Mal) are precursors for the synthesis of 
G6P via gluconeogenesis, succinyl-CoA (Suc-CoA) is a precursor for the synthesis of 
porphyrins, α-ketoglutarate (α-K) and oxaloacetate are precursors for the synthesis 
of some amino acids, such as L-glutamate, L-glutamine, L-aspartate, and L-asparagine, 
and citrate (Cit) is a precursor for the synthesis of fatty acids. In Leishmania, the end 
product of glycolysis, pyruvate (Pyr), can be transported from the cytosol to the 
mitochondrion where it is converted to acetyl-CoA (Ac-CoA). Acetyl-CoA can be 
converted to acetate to yield ATP and then excreted by the cells (Rainey and 
MacKenzie, 1991), or it can be fed into the TCA cycle. In the TCA cycle, acetyl-CoA is 
oxidized to CO2 with the concomitant synthesis of key intermediates, ATP, NADH, and 
FADH2. The reduced coenzymes can then be used by the electron transport chain, 
localized in the inner mitochondrial membrane, for the production of more ATP (see 
Energy metabolism). 
A recent stable isotope labelling study has provided thorough information regarding 
the central carbon metabolism of the L. mexicana promastigotes grown in media with 
abundant D-glucose, with a particular focus on the TCA cycle (Saunders et al., 2011). 
The study showed that the cycle is fully functional in the Leishmania promastigotes. 
Using 13C-D-glucose, we observed that all detected TCA intermediates were heavy-
labelled in the wild type L. mexicana promastigotes (Figure III-21). Citrate was 
universally labelled which indicated that oxaloacetate was also universally labelled 
and the acetyl moiety of acetyl-CoA was 2-13C-labelled, although neither of the two 
metabolites was detected in condition *glc0 promastigotes. α-Ketoglutarate and 
succinate were also universally labelled thus demonstrating the lost of carboxylic 
groups in the form of CO2. The last intermediates of the cycle,  fumarate and malate, 
were also universally labelled (Figure III-21). α-Ketoglutarate, fumarate and 
oxaloacetate are precursors for the synthesis of L-glutamate and L-glutamine and L-
aspartate and L-asparagine, respectively, which were also found universally labelled 
in the wild type promastigotes (see Arginine, glutamate and proline and Alanine and 
aspartate metabolism).  
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Figure III-22. Histograms of malate and succinate in the wild type and Δlmgt 
promastigotes. 
 
 
In the Δlmgt promastigotes, the TCA intermediates were labelled only in conditions 
glc+*pro and *pro, in which 13C-L-proline was present, and slightly labelled in 
conditions glc+*thr and *thr, where 13C-L-threonine was provided as a carbon 
source. That shows that L-proline is used to replenish the TCA cycle intermediates in 
the Δlmgt promastigotes (see Arginine and proline metabolism), and only a small 
amount of L-threonine contributes to that (see Glycine, serine and threonine 
metabolism). The untargeted metabolomic data revealed that malate and succinate 
were decreased in the Δlmgt promastigotes compared with the wild type 
promastigotes (Figure III-22). The NMR analysis confirmed that the Δlmgt 
promastigotes excreted less succinate compared with the wild type promastigotes 
(Table III-8). The analysis elaborated also that: 
 wild type and Δlmgt promastigotes excrete succinate when incubated without 
exogenous carbon sources, thus indicating that both cell lines rely on reserves, 
most probably mannogen; 
 the higher amount of labelled succinate originating from 13C-D-glucose, when 
the latter was provided as a sole carbon source, compared to the one produced 
from the intracellular carbon source showed that the sugar, as expected, was 
actively metabolized by the wild type promastiogtes when available; 
 the amount of succinate produced from D-glucose decreased when L-proline 
was provided as an additional carbon source while the amount of succinate 
produced from L-proline increased; that indicated that the contribution of L-
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proline to the TCA cycle anaplerosis in the wild type promastigotes is greater 
when both nutrients are utilized together; 
 the amount of succinate excreted by the wild type promastigotes when 
incubated with D-glucose and L-threonine was comparable to that of the wild 
type promastigotes incubated with no carbon sources; that showed again that 
the majority of L-threonine is not fed into the TCA cycle in the wild type 
promastigotes; 
 last, the Δlmgt promastigotes excreted more or less the same small amount of 
succinate when incubated with no carbon sources or with D-glucose and L-
proline. 
In conclusion, the proteomic characterization revealed that a considerable number of 
reactions of the TCA cycle were regulated in the Δlmgt promastigotes, that more than 
one enzyme is involved in the catalysis of some reactions, and that the pathway was 
up-regulated at the points of entry of acetyl-CoA and α-ketoglutarate. L-Alanine was 
shown to be converted to acetyl-CoA and used in the TCA cycle anaplerosis in wild 
type L. mexicana promastigotes grown under D-glucose-replete conditions (Saunders 
et al., 2011). A number of other glucogenic and ketogenic amino acids can also be 
converted to acetyl-CoA and fed either in gluconeogenesis or the TCA cycle where 
they are used for the synthesis of G6P or oxidized for energy, respectively (see Amino 
acid metabolism). Lipid metabolism is also a source of acetyl-CoA. Another recent 
study of McConville and colleagues confirmed that fatty acids fuel the TCA cycle with 
acetyl-CoA (Saunders et al., 2014). The analysis elaborated further that β-oxidation of 
fatty acids, by which acetyl-CoA is generated, is stimulated in L. mexicana 
promastigotes grown in D-glucose-restricted conditions and that acetyl-CoA is used 
for the synthesis of L-glutamate and L-glutamine via the TCA cycle. β-Oxidation of 
fatty acids in the Δlmgt promastigotes, however, appears to be down-regulated (see 
Lipid metabolism). Moreover, in the Δlmgt promastigotes, the cycle seems to utilize 
much more L-glutamate than it generates. L-Glutamate and L-proline, via L-
glutamate, can enter the TCA cycle via α-ketoglutarate. The labelled TCA cycle 
intermediates in the conditions with heavy L-proline confirmed that the amino acid is 
used to replenish the TCA cycle intermediates in the Δlmgt promastigotes (see 
Arginine, glutamate and proline metabolism). Finally, in addition to L-alanine, L-
aspartate, which can enter the TCA cycle via fumarate or oxaloacetate, was also 
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shown to be used in TCA cycle anaplerosis (Saunders et al., 2011). Thus, other amino 
acids besides L-proline are most probably mobilized as carbon sources for the TCA 
cycle in the Δlmgt promastigotes (see Amino acid metabolism). In addition to the 
reactions feeding acetyl-CoA and α-ketoglutarate to the TCA cycle, the succinate-to-
fumarate conversion catalyzed by succinate dehydrogenase (SDH) was also up-
regulated in the Δlmgt promastigotes (Figure III-21). Succinate dehydrogenase is 
complex II of the electron transport chain that links the TCA cycle with the cellular 
respiration. It catalyzes the oxidation of succinate to fumarate and transfers the 
electrons yielded in the reaction to ubiquinone which is reduced to ubiquinol (see 
Energy metabolism). The significantly reduced level of succinate in the Δlmgt 
promastigote (Figure III-22) and up-regulated oxidation of succinate indicate that the 
TCA cycle is one of the main participants in energy generation in the Δlmgt 
promastigotes. Thus, the integrated multi-omic data depicted a quite dynamic and 
complicated TCA cycle with a key role in the Δlmgt promastigote metabolism.  
III.3. Summary 
The thorough analysis of carbohydrate metabolism in the glucose transporter 
null mutant Leishmania revealed that the inability of the insect form to utilize 
exogenous D-glucose as an energy and carbon source leads to a distinct shift in key 
pathways of central carbon metabolism. D-Glucose transport deficiency in the Δlmgt 
promastigotes results in utilization of alternative sugars such as sucrose which 
appears to be the main source of D-glucose and D-fructose for these organisms 
(Figure III-23). The produced D-glucose is used for the synthesis of G6P but it is not 
further catabolized via glycolysis. Instead, gluconeogensis is the dominant pathway 
which also functions toward the synthesis of G6P. Gluconeogesis, however, is still 
ineffective in meeting the biosynthetic requirements of the Δlmgt promastigotes 
because pathways for which G6P is the main precursor, such as inositol synthesis and 
the PPP pathway, have decreased activity in these organisms. Exogenous inositol 
and/or lipid metabolism appear to be the main source(s) for inositol while D-ribose, 
originating most probably from nucleotide degradation, is used, instead of G6P, for 
the synthesis of R5P (Figure III-23). The decreased influx of G6P in the PPP further 
impacts the regeneration of NADPH which is believed to be the main reason behind 
the high sensitivity of the Δlmgt promastigotes to oxidative stress.  
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Figure III-23. Schematic representation of the changes in carbohydrate metabolism in 
the Δlmgt promastigotes. Specified with red arrows are the down-regulated enzymes while indicated in 
blue are the up-regulated enzymes. Abbreviations: F6P - fructose 6-phosphate, R5P – ribose 5-phosphate, myo-I 
1P - myo-inositol 1-phosphate, myo-I - myo-inositol, UDP-glc - uridine 5’-diphosphate glucose, UDP-gal - uridine 5’-
diphsophate galactose, AMP - adenosine 5’-monophosphate, ADP - adenosine 5’-diphosphate, ATP - adenosine 5’-
triphosphate, GMP - guanosine 5’-monophosphate, GDP - guanosine 5’-diphosphate, GTP - guanosine 5’-
triphosphate, NAD - nicotinamide adenine dinucleotide, NADP - nicotinamide adenine dinucleotide phosphate, 
FAD - flavin adenine dinucleotide, CoA - coenzyme A, Pi - inorganic phosphate, HXK - hexokinase, GAPDH - 
glyceraldehyde 3-phosphate dehydrogenase, PGK - phosphoglycerate kinase, ENO - enolase, PYK - pyruvate 
kinase, PPDK - pyruvate phosphate dikinase, GK - glycerol kinase, G3PDH - glycerol 3-phosphate dehydrogenase, 
DA - dihydrolipoamide acetyltransferase, DD - dihydrolipoamide dehydrogenase, PEPCK - phosphoenolpyruvate 
carboxikinase, GALE - uridine 5’-diphopshate glucose 4’-epimerase, G6PDH - glucose 6-phophate dehydrogenase, 
6PDH - 6-phosphogluconate dehydrogenase, RK - ribokinase, I1PS - inositol 1-phosphate synthase, PMI - 
phosphomannose isomerase, PMM - phosphomannomutase, GDPMP - 5’-guanosine diphosphate mannose 
pyrophosphorylase, CS - citrate synthase, ODH1 -  2-oxoglutarate dehydrogenase E1 component, ODH2 - 2-
oxoglutarate dehydrogenase E2 component, SCL - succinyl-CoA ligase, SCS - succinyl-CoA synthetase, SDF - 
succinate dehydrogenase flavoprotein, FH - fumarate hydratase, FRD - fumarate reductase, MDH - malate 
dehydrogenase, gMDH - glycosomal malate dehydrogenase, ME -  malic enzyme, AS - acetyl-CoA synthetase, ASCT - 
acetate:succinate CoA transferase. 
 
 
D-Fructose, produced from the break down of sucrose, is phosphorylated to F6P. F6P, 
through GDP-Man, is used for the synthesis of a variety of Man-containing 
macromolecules such as glycoconjugates and mannogen. The levels of certain 
glycoconjugates and mannogen, however, are decreased in the Δlmgt promastigotes 
which again shows that D-glucose, D-fructose, and gluconeogenesis are not able to 
provide enough precursors for biosynthetic purposes. Down-regulated in the Δlmgt 
promastigotes is also the glycosomal succinate fermentation. Changes in the 
glycosomal succinate fermentation affect the glycosomal redox/energy balance and 
the contribution of dicarboxylic acids to the TCA cycle. Instead of dicarboxylic acids 
from the glycosomal succinate fermentation, a substantial part of pyruvate and L-
threopnine appear to be preferentially converted to acetyl-CoA and fed into the TCA 
cycle. Furthermore, amino acids such as L-alanine, L-aspartate, L-glutamate, and L-
proline are also oxidize in the TCA cycle for the production of energy in the ∆lmgt 
promastigotes. Altogether, our study confirmed that Leishmania promastigotes rely 
heavily on D-glucose for optimal functioning and showed that when the latter cannot 
be utilize as a carbon and energy source, due to a genetic ablation of the three 
primary glucose transports, the organisms alter their metabolism to use i/ alternative 
- Down-regulated irreversible reaction 
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- Indirect reaction 
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sugars for the production of D-glucose, ii/ alternative carbon sources, such as amino 
acids, glycogen, and acetate, for the production of biosynthetic precursors, and iii/ 
alternative sources, such as amino acids, for the generation of energy. Alternative 
metabolism, thus, appears to be essential for Leishmania  adaptation and survival in 
conditions with a varying nutrient content and fluctuating nutrient levels. 
Investigating the utilization of secondary (in terms of consumption) and/or less 
abundant nutrients such as di- and trisaccharides, glucogenic and ketogenic amino 
acids, and lipids as alternative carbon and energy sources, as well as elucidating the 
kinetics of the pathways involved in the metabolization of these sources, will shed 
light on the copmplexity of the central carbon metabolism and will point out essential 
processes as drug targets. Our data showed that one such process could be the 
defence against oxidative stress. 
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CHAPTER IV.   Quantitative characterization of amino acid, 
energy, nucleotide and lipid metabolism of Δlmgt promastigotes 
by stable isotope dimethyl labelling and global metabolomics 
Essential substrates for Leishmania, besides carbohydrates, include amino 
acids, lipids, nucleotides, cofactors, and vitamins. In the insect vector, amino acids and 
proteins are among the blood meal nutrients. Additionally, amino acids are abundant 
in the honeydew and plant sap on which the sand flies primarily feed (Sandstrom and 
Moran, 2001; Weibull et al., 1990). In the parasitophorous vacuole of the mammalian 
host macrophages, a variety of low-molecular-weight metabolites, including amino 
acids and peptides, may be generated by the hydrolytic enzymes localized in this 
compartment. Moreover, it has been shown that amastigotes can up-regulate the 
expression of certain cysteine proteases, offering a mechanism to provide additional 
sources of amino acids (Besteiro et al., 2007). In axenic cultures, both promastigotes 
and amastigotes are typically maintained in media that are rich in amino acids 
(Berens et al., 1976). From these niches, amino acids can be taken by Leishmania by a 
large family of amino acid permeases (AAP), some of which have already been 
characterized. For instance, AAP3, AAP7 and AAP24 of L. donovani transport L-
arginine, L-lysine and L-proline and L-alanine, respectively (Shaked-Mishan et al., 
2006; Inbar et al., 2012; Inbar et al., 2013). Characterized in Leishmania were also an 
L-glutamate, L-methionine and L-serine transport systems (Paes et al., 2008; 
Mukkada and Simon, 1977; dos Santos et al., 2009). The imported amino acids can 
enter the intracellular free amino acid pool. L-Alanine, L-ornithine, L-glutamine and 
glycine were shown to be the main constituents comprising the pool of free amino 
acids in the promastigotes, although the cells maintain most of the amino acids 
present at all time (Simon et al., 1983; Shaked-Mishan et al., 2006). Amino acids are 
important sources of carbon and energy, essential building blocks for protein and 
polyamine biosynthesis, and osmolytes (Naderer and McConville, 2008, Blum, 1996). 
When used as energy sources, some amino acids can be partially oxidized to pyruvate, 
α-ketoglutarate, succinate, fumarate, oxaloacetate and acetyl-CoA and consequently 
directed to gluconeogenesis for the synthesis of D-glucose or oxidized in the TCA 
cycle to CO2 with the generation of ATP and NADH (Figure IV-1).  
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Figure IV-1. Schematic representation of amino acid catabolism.  
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Another class of important nutrients for Leishmania are lipids. Contrary to 
promastigotes, amastigotes develop in a sugar-poor environment where β-oxidation 
of fatty acids appears to be of central importance for the parasite viability (Hart and 
Coombs, 1982; Opperdoes and Michels, 2008). β-Oxidation of fatty acids results in the 
breakdown of fatty acids to acetyl-CoA, NADH and FADH2. Acetyl-CoA is further 
oxidized in the TCA cycle while the NADH and FADH2 produced are directed toward 
the electron transport chain for the production of ATP. Thus, besides amino acids, 
fatty acids could be important energy sources for Leishmania. In addition to energy 
sources, lipids are essential structural components and building blocks of a variety of 
glycoconjugates. Expressed on the promastigote surface are mainly 
lipophosphoglycan (LPG) and GPI-anchored proteins. LPG was shown to have a 
number of functions including the attachment of the promastigotes to the insect 
stomach epithelium, protection against oxidative radicals and nitric oxide upon 
promastigote phagocytosis, protection against lysis by the complement system, and 
hindrance of phagolysosome maturation (Novozhilova and Bovin, 2010 and the 
references therein). gp63, the major surface protein of the Leishmania promastigotes, 
on the other hand, is involved in protein hydrolysis, e.g. of protein of the extracellular 
matrix or the opsonizing components of the complement system, as well as receptor-
mediated interactions with the host macrophages and with the complement cascade 
(Novozhilova and Bovin, 2010 and the references therein). 
Nucleotide metabolism is also important in Leishmania biology. While the insect and 
mammalian hosts of Leishmania have the ability to synthesize purines de novo, 
Leishmania are auxotrophic for these important nutrients and must salvage them 
from the host environments. Two high-affinity nucleoside transporters, NT1 and NT2, 
which belong to the equilibrative nucleoside transporter (ENT) family, were detected 
through biochemical and genetic approaches in L. donovani promastigotes (Aronow et 
al., 1987; Vasudevan et al., 1998; Carter et al., 2000). NT1 is encoded by two closely 
related genes, NT1.1 and NT1.2, and transports adenosine and uridine. NT1.1 was 
suggested to transport also thymidine and cytidine while NT1.2 can also mediate the 
uptake of inosine and guanosine (Vasudevan et al., 1998; Carter et al., 2000; de 
Koning et al., 2005). NT2 is encoded by a single gene and is involved in the transport 
of inosine and guanosine only (Carter et al., 2000). Functioning in L. major are also 
the nucleobase transporters NBT1 (Al-Salabi et al., 2003), NT3 (Sanchez et al., 2004) 
and NT4 (Ortiz et al., 2007). The NBT1 was shown to be a high-affinity permease with 
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specificity for adenine, hypoxanthine and the antileishmanial hypoxanthine analogue 
allopurinol (Al-Salabi et al., 2003). Functional characterization of the NT3 and NT4 
genes in L. major revealed that NT3 is the principle nucleobase transporter in 
promastigotes which mediates the uptake of hypoxanthine, xanthine, adenine and 
guanine (Sanchez et al., 2004). NT4 was shown to be a low-affinity transporter of 
adenine at neutral pH (Ortiz et al., 2007). At acidic pH, however, the NT4 transporter 
is activated to transport hypoxanthine, guanine, and xanthine as well (Ortiz et al., 
2009). Besides purine nucleoside/nucleobase transporters, implicated in the purine 
salvage pathway are also a number of plasma membrane and secreted nucleotidase/ 
nucleases, hydrolases, phosphorybosyl transferases, kinases and deaminases 
(Sopwith et al., 2002; Landfear et al., 2004; Joshi and Dwyer, 2007; Colasante et al., 
2006). 
Contrary to purines, Leishmania are able to synthesize as well as take some 
pyrimidines from the environment. The first pyrimidine transporter of Leishmania 
was described in 2005 by de Koning and colleagues.  They showed that the U1 
transporter of L. major is a high-affinity, high-specificity uracil transporter that does 
not transport other pyrimidine or purine nucleobases or pyrimidine nucleosides 
(Papageorgiou et al., 2005).  
Purines and pyrimidines are essential nutrients with versatile functions in cellular 
metabolism. Adenosine 5’-triphosphate (ATP) is used as a universal source of energy 
in energy transfer processes, cyclic adenosine 5’-monophosphate (cAMP) and cyclic 
guanosine 5’-monophosphate (cGMP) are key second messengers, nucleotides are 
precursors for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis and 
nucleotide derivatives are important cofactors. 
While chapter III elaborated on the changes in carbohydrate metabolism in the ∆lmgt 
promastigotes, this chapter focuses on Leishmania proteins and metabolites that are 
involved in amino acid, energy, lipid and nucleotide metabolism. The applied 
proteomic and metabolomic approaches included stable isotope dimethyl labelling, 
untargeted LC-MS analysis and NMR analysis. The NMR analysis involved incubation 
of wild type and ∆lmgt promastigotes with stable isotope labelled D-glucose, L-
proline and L-threonine (see III.1.2.3. for details), which allowed us to perform a 
stable isotope tracing analysis and elucidate the preferences of the ∆lmgt 
promastigotes for carbon sources. 
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IV.1.   Results 
IV.1.1.   Quantitative proteomic characterization of amino acid, 
energy, nucleotide and lipid metabolism of Δlmgt promastigotes by 
sub-cellular fractionation with digitonin and stable isotope dimethyl 
labelling 
The quantitative proteomic characterization of the ∆lmgt promastigotes 
involved sub-cellular fractionation with digitonin coupled to stable isotope dimethyl 
labelling and 1D HPLC ESI-MS/MS analysis. 5 sub-cellular fractions were generated, 
and analysed to enhance proteomic coverage over that expected with unfractionated 
cell lysates (see Chapter III). A total of 217 proteins were significantly modulated 
when ∆lmgt promastigotes were compared with wild type. Nearly half of the 
modulated proteins in the ∆lmgt promastigotes were enzymes (Figure III-7). In turn, 
half of the enzymes were metabolic enzymes involved in amino acid, carbohydrate, 
energy, lipid and nucleotide metabolism, metabolism of vitamins and cofactors and 
metabolism of terpenoids and polyketides (Supplemental table III-1). Further to the 
enzymes of carbohydrate metabolism (see Chapter III, III.1.1.2.), enzymes of amino 
acid, energy, lipid and nucleotide metabolism were also investigated. 4 pathways and 
7 enzymes of amino acid metabolism, 6 enzymes of energy metabolism, 8 enzymes of 
nucleotide metabolism and 3 enzymes of lipid metabolism were differentially 
regulated. Glutamate dehydrogenase, alanine aminotransferase and arginase were 
down-regulated by >10-fold, >5-fold and >2-fold, respectively (Supplemental table 
III-1). Enzymes of L-methinine, L-lysine and glycine metabolism were also modulated 
in the ∆lmgt promastigotes (Supplemental table III-1). 
The majority of the enzymes involved in energy metabolism were detected in the 
second fraction enriched with glycosomal and mitochondrial proteins and the 
fraction with digitonin-insoluble proteins. Detection of most respiratory complex 
subunits in the last fractions is indicative of the highly hydrophobic nature of these 
proteins (Maslov et al., 2002). The regulated enzymes were a putative cytochrome c 
oxidase subunit V and 4 subunits of complex V: ATPase α subunit, ATPase β subunit, 
ATP synthase F1 subunit γ protein and ATP synthase, ε chain and most of them were 
up-regulated (Supplemental table III-1). 
A considerable number of enzymes of nucleotide metabolism were differentially 
expressed in the ∆lmgt promastigotes.  In view of their importance and the inability of 
the Leishmania parasites to synthesize purines (Opperdoes and Michels, 2008), the 
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majority of the modulated enzymes belonged to purine salvage pathway. In turn, the 
majority of the enzymes of the purine metabolism, namely an adenosine kinase, an 
adenine phosphoribosyltransferase, a guanine deaminase, a bifuntional 3’-
nucleotidase/ nuclease precursor, a nucleoside hydrolase-like protein and a xanthine 
phosphoribosyltransferase, were down-regulated (Supplemental table III-1) while 
up-regulated in the ∆lmgt promastigotes was a nonspecific nucleoside hydrolase. Of 
the pyrimidine metabolism, only aspartate carbamoyltransferase was modulated.   
Finally, the 3 differentially expressed enzymes of lipid metabolism were the 
significantly up-regulated β-ketoacyl-CoA reductase which participates in fatty acid 
biosynthesis, the down-regulated electron transfer flavoprotein, α polypeptide which 
links β-oxidation of fatty acids with cellular respiration and alkyl dihydroxyacetone-
phosphate synthase which is involved in glycerolipid biosynthesis. 
IV.1.2.   Global metabolomic characterization of amino acid, energy, 
nucleotide and lipid metabolism of Δlmgt promastigotes  
The untargeted metabolomic characterization of the ∆lmgt promastigotes 
involved cold chloroform/methanol/water extraction and 1D pHILIC-HPLC ESI-MS 
analysis (see Chapter III, III.1.2.). The data revealed that 79 of the cell metabolites 
and 43 of the metabolites excreted by promastigotes were significantly modulated 
(Supplemental tables III2 and III-3). Lipids and amino acids comprised the two 
largest groups of the significantly modulated metabolites in the cells and the spent 
media. 6 metabolites of amino acid metabolism were authentically identified. The 
glucogenic amino acids L-alanine, L-aspartate and L-glutamate were significantly 
down-regulated in the ∆lmgt promastigotes compared to the wild type promastigotes 
(Figure IV-2). L-Alanine and L-proline were decreased in the ∆lmgt spent media as 
well (Figure IV-2). Glutathione, an important antioxidant for trypanosomatids, was 
also decreased in the ∆lmgt promastigotes (Figure IV2) while phenylpyruvate was 
increased in the ccells but decreased in the spent media (Figure IV-3). 
Lipids represented more than half of the significantly modulated metabolites in the 
∆lmgt promastigotes (Figure III-9). There were fatty acids, glycerophosphocholines, 
glycerophosphoethanolamines, glycerophosphoserines and sphingoid bases. 
Authentically identified, however, were only phosphoethanolamine and 
phosphocholine which were increased in the ∆lmgt promastigotes (Figure IV-3). 
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Figure IV-2. Histograms of L-alanine (A), L-aspartate (B), L-glutamate (C) and 
glutathione (D) in the wild type and Δlmgt promastigotes and of L-alanine (E) and L-
proline (F) in the wild type and Δlmgt promastigote spent media. 
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Figure IV-3. Histograms of L-phenylpyruvate (A), phosphoethanolamine (B), 
phosphocholine (C) and cytosine (D) in the wild type and Δlmgt promastigotes and of 
L-phenylpyruvate (E) and orotate (F) in the wild type and Δlmgt promastigote spent 
media. 
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Of the metabolism of cofactors and vitamins, nicotinate had significantly increased 
level in the ∆lmgt promastigotes (Supplemental table III-2). Finally, of nucleotide 
metabolism, cytosine was slightly increased in the ∆lmgt promastigotes while orotate 
was significantly decreased in the spent media (Figure IV-3).  
IV.1.3.   Stable isotope tracing analysis of amino acid, energy, 
nucleotide and lipid metabolism of Δlmgt promastigotes  
The stable isotope tracing analysis of the Δlmgt promastigote carbohydrate 
metabolism revealed that sugars and intermediates of glycolysis/gluconeogenesis, 
fructose, mannose and galactose metabolism, pentose phosphate pathway, TCA cycle 
and other pathways were heavy-labelled only in the conditions with 13C-L-proline and 
13C-L-threonine (see III.1.2.3. for details about the ten NMR conditions). 13C-D-
glucose was supplied in conditions *glc0, *glc, pro+*glc, thr+*glc and glr+*glc, 13C-
L-proline in conditions glc+*pro and *pro and 13C-L-threonine in conditions glc+*thr 
and *thr. In addition to the 15 pathways of carbohydrate metabolism, 12 pathways of 
amino acid, lipid and nucleotide metabolism were investigated.  
Amino acid metabolism 
Alanine and aspartate metabolism 
In addition to using exogenous L-alanine (Inbar et al., 2013), Leishmania are 
able to synthesize the amino acid from pyruvate via a cytosolic alanine 
aminotransferase. L-Alanine, along with L-aspartate, L-asparagine and 4-
aminobutanoate, was authentically identified and universally labelled in conditions 
*glc0, *glc, pro+*glc, thr+*glc and glr+*glc wild type promastigotes and in 
conditions glc+*pro and *pro ∆lmgt promastigotes (Figure IV-5; Supplemental table 
IV-1). The universal labelling of L-alanine (Figure IV-4) indicates that pyruvate, 
produced from D-glucose in the wild type promastigotes and from L-proline in the 
∆lmgt promastigotes is transaminated to L-alanine. Similarly, the universal labelling 
of L-aspartate and L-asparagine (Figure IV-4) shows that the two amino acids are 
synthesized from oxaloacetate by a mitochondrial aspartate aminotransferase and 
asparagine synthase, respectively (Opperdoes and Michels, 2008). Putatively 
identified and labelled in the wild type promastigotes were also L-argininosuccinate 
and adenylosuccinate which means that L-aspartate may also be produced from 
fumarate.  
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Figure IV-4. Labelling pattern of L-alanine, L-aspartate, L-asparagine, L-glutamate and 
L-glutamine in wild type and Δlmgt promastigotes incubated with 13C-D-glucose. Wild 
type and ∆lmgt promastigotes (biological replicates, n=3) were grown with 13C-D-glucose (condition 0) and 
subjected to cold chloroform/methanol/water metabolite extraction. The metabolomic samples were analyzed 
with 1D pHILIC-HPLC ESI-MS and the data were analyzed with mzMatch-ISO. UL- Unlabelled carbon, +1 - 1-13C-
labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes.  
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Figure IV-5. Schematic representation of amino acid metabolism in wild type and 
Δlmgt promastigotes. Abbreviations: Pyr - pyruvate, Ala - L-alanine, Asp - L-aspartate, Asn - L-asparagine, 
Ser - L-serine, Cys - L-cysteine, Cyst - L-cystathionine, Hey - L-homocyetine, Met - L-methionine, AdoMet - S-
adenosyl-L-methionine, Glyc - glycine, Thr - L-threonine, Suc CoA - succinyl-CoA, GSH - glutathione, T(SH)2 - 
trypanothione, Spd - spermidine, Spm - spermine, Put - putrescine, Orn - L-ornithine, Arg - L-arginine, Arg-suc - L-
agrinine-succinate, Adl-suc - adenylosuccinate, Citl - L-citrulline, Pro - L-proline, 4Ab - 4-aminobutanoate, Suc s - 
succinate semialdehyde, Suc - succinate, α-K - α-ketoglutarate, Fum - fumaretae, Oa - oxaloacetate, Glu - L-
glutamate, Gmn - L-glutamine.   
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In the ∆lmgt promastigotes, L-aspartate and L-asparagine were labelled only in the 
conditions with 13C-L-proline which underlines the significance of L-proline for the 
∆lmgt promastigotes (see Discussion). 
Arginine, glutamate and proline metabolism 
L-Arginine, one of the amino acids Leishmania are auxotrophic for, is taken up 
by the high affinity, high specificity L-arginine permease AAP3 (Shaked-Mishan et al., 
2006) while L-proline is imported by AAP24 (Inbar et al., 2013). L-Arginine, along 
with L-citrulline and L-ornithine, was unlabelled in the wild type and ∆lmgt 
promastigotes and L-proline was labelled only in the conditions where it was used as 
an enriched carbon source (Figure IV-5). L-Glutamate and L-glutamine were 
universally labelled in conditions *glc0, *glc, pro+*glc, glc+*pro, *pro, thr+*glc and 
glr+*glc wild type promastigotes and in conditions glc+*pro and *pro ∆lmgt 
promastigotes (Figure IV-5; Supplemental table IV-1). That shows that L-glutamate 
can be synthesized either from D-glucose via α-ketoglutarate or from L-proline (see 
Discussion). A small amount of L-glutamate and L-glutamine was also labelled in the 
∆lmgt promastigotes incubated with 13C-L-threonine.  
Cysteine and methionine metabolism 
Leishmania are not able to take up L-cysteine from the environment (Williams 
et al., 2009) so they synthesize it intracellularly. The slight labelling of L-serine (see 
Glycine, serine and threonine metabolism) and L-cysteine indicates that a portion of 
L-serine is converted to L-cysteine in condition *glc0 wild type promastigotes. 
Alternatively, L-cysteine can be synthesized from L-homocysteine via the reverse 
trans-sulfuration pathway (Williams et al., 2009). Although L-cysteine remained 
unlabelled in all 10 conditions, a small amount of L-cystathionine, an intermediate in 
the trans-sulfuration pathway, was found labelled in conditions *glc0, *glc, pro+*glc, 
glc+*pro, *pro, thr+*glc, glc+*thr, *thr and glr+*glc wild type promastigotes and in 
conditions glc+*thr and *thr ∆lmgt promastigotes. That shows that all three carbon 
sources used in this experiment, D-glucose, L-proline and L-threonine, can serve as 
precursors for the synthesis of L-cysteine. However, it appears that the synthesis of L-
cysteine via the reverse trans-sulfuration pathway in wild type promastigotes 
incubated for a short period of time with a restricted number of nutrients is minimal. 
The amino acid was unlabelled in the ∆lmgt promastigotes. 
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Consistent with the minimal labelling of L-cysteine, L-methionine was also only 
slightly labelled in condition 0 wild type promastigotes and it was unlabelled in all 10 
conditions and in the ∆lmgt promastigotes. L-Methionine, in the form of S-adenosyl-L-
methionine (AdoMet), is a universal methyl donor in methylation reactions. AdoMet 
was authentically identified and found labelled in conditions *glc and pro+*glc wild 
type promastigotes and in conditions glc+*pro and *pro ∆lmgt promastigotes 
(Figure IV-5). It must be noted, however, that the adenosine moiety of AdoMet was 
labelled, indicating that both D-glucose and L-proline can be precursors for purines 
(see Discussion).  
Glutathione metabolism 
Glutathione [γ-glutamyl-cysteinyl-glycine, (GSH)] is among the four major low 
molecular weight thiols synthesized by trypanosomatids. The compound is produced 
from L-glutamate, L-cysteine and glycine. Glutathione was only putatively identified 
and found labelled in conditions *glc, pro+*glc and *pro wild type promastigotes and 
condition glc+*pro and *pro ∆lmgt promastigotes (Figure IV-5). In turn, glutathione, 
along with the polyamine spermidine, is involved in the synthesis of trypanothione, 
the major antioxidant of the oxidative defence system of trypanosomatids 
(Steenkamp, 2002). Trypanothione, unfortunately, was not detected. On the other 
hand, the oxidized forms of both glutathione and trypanothione, glutathione disulfide 
and trypanothione disulfide, respectively, were putatively identified and labelled in 
conditions *glc0, *glc, pro+*glc and *pro wild type promastigotes and conditions 
glc+*pro and *pro ∆lmgt promastigotes. Trypanothione disulfide was additionally 
labelled in conditions thr+*glc, glc+*thr, *thr and glr+*glc wild type promastigotes. 
Glycine, serine and threonine metabolism 
Glycine is a small amino acid that can be produced from L-threonine and L-
serine (Opperdoes and Coombs, 2007). A small amount of the authentically identified 
L-serine and glycine was labelled in conditions *glc0, *glc, pro+*glc, *pro and 
glr+*glc wild type promastigotes and in conditions glc+*pro, *pro, glc+*thr and *thr 
∆lmgt promastigotes (Figure IV-5). Additionally, glycine was labelled in conditions 
glc+*thr and *thr wild type promastigotes, which suggested that glycine is mainly a 
product of L-threonine degradation, while L-serine was labelled in conditions 
thr+*glc and *thr wild type promastigotes, which shows that L-serine can be 
synthesized from both D-glucose and L-threonine. L-Threonine was unlabelled in the 
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wild type and ∆lmgt promastigotes except for the conditions where it was used as a 
heavy-labelled carbon source. Thus, our tracing data revealed that L-proline, via 
pyruvate and L-serine, and L-threonine are precursors for the synthesis of glycine in 
the ∆lmgt promastigotes.  
Nucleotide metabolism 
Purine metabolism 
In contrast with their hosts, Leishmania parasites are not able to synthesize 
purines de novo. Our tracing analysis confirmed that unlabelled nucleobases such as 
adenine, xanthine and hypoxanthine are taken up by condition *glc0 wild type 
promastigotes. Nevertheless, nucleosides and nucleotides were also found labelled in 
condition *glc0 wild type promastigotes which showed that the sugar moiety 
originated from 13C-D-glucose. More important, however, was the observation that 
some nucleotides were also slightly labelled in condition *glc0 ∆lmgt promastigotes 
(Figure IV-6). Adenosine, guanosine, adenosine 5-monophosphate (AMP), inosine 5-
monophosphate (IMP) and guanosine 5-monophosphate (GMP) were authentically 
identified. The rest of the detected purines were putatively identified. 
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Figure IV-6. Labelling pattern of adenosine and adenosine 5’-monophosphate (AMP) 
in wild type and Δlmgt promastigotes incubated with 13C-D-glucose. UL- Unlabelled carbon, 
+1 - 1-13C-labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-
13C-labelled carbon, +6 - 6-13C-labelled carbon, WT – wild type promastigotes, ∆lmgt - ∆lmgt promastigotes.  
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AMP and the putative ADP and ATP were some of the purine intermediates that were 
labelled in condition *glc0 wild and ∆lmgt promastigotes (Figure IV-6). In addition to 
conditions glc+*pro and *pro ∆lmgt promastigotes, in which the sugar moiety is 
synthesized from L-proline, AMP, ADP and ATP were also slightly labelled in 
conditions *glc and pro+*glc ∆lmgt promastigotes. The labelling in the ∆lmgt 
promastigotes in the conditions with heavy-labelled D-glucose shows, as suggested 
before, that the alternative GT4 glucose transporter is probably up-regulated. 
Additionally, the labelling shows that purines are extremely important for the ∆lmgt 
promastigote biology. The labelling pattern of the rest of the purines is presented in 
Supplemental table IV-2.  
Pyrimidine metabolism 
Pyrimidines are among the metabolites Leishmania are able to synthesize de 
novo. Similarly to purines, some of the detected pyrimidine intermediates, such as the 
putative UDP and UTP, were labelled in condition *glc0 wild type and ∆lmgt 
promastigotes. The putative identification, however, requires further confirmation. 
Orotate, uracil and cytidine were authentically identified and labelled in conditions 
*glc0, *glc and pro+*glc wild type promastigotes and conditions glc+*pro and *pro 
∆lmgt promastigotes. That shows that L-proline is a precursor for pyrimidine 
synthesis in the ∆lmgt promastigotes. Dihydrouracile and 5,6-dihydrothymine were 
putatively identified and found labelled in condition thr+*glc and glr+*glc wild type 
promastigotes. Similar to the putative UDP and UTP, further confirmation is needed.  
Lipid metabolism 
All lipids were putatively identified on the basis of mass measurements, 
without any structural analysis to resolve isomers.  
Biosynthesis of fatty acids 
The lipid profile of the leishmanial cell membranes has been a focus of many 
studies. The major lipids of Leishmania include choline, ethanolamine, inositol 
phospholipids, sterols and triglycerides and contain different length-chain fatty acids 
(Beach et al., 1979; Wassef et al., 1985). Several C16, C18, C20 and C22 fatty acids 
were found heavy-labelled in the wild type and ∆lmgt promastigotes.  
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Figure IV-7. Labelling pattern of oleic acid, stearic acid, icosanoic acid and behenic 
acid in wild type and Δlmgt promastigotes incubated with 13C-D-glucose. UL- Unlabelled 
carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled 
carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-labelled carbon, +7 - 7-13C-labelled carbon, +8 - 8-13C-labelled 
carbon, +9 - 9-13C-labelled carbon, +10 - 10-13C-labelled carbon, +11 - 11-13C-labelled carbon, +12 - 12-13C-labelled 
carbon, +13 - 13-13C-labelled carbon, +14 - 14-13C-labelled carbon, WT – wild type promastigotes, ∆lmgt - ∆lmgt 
promastigotes. * - the colours corresponding to the type of labelling above +14 are not presented. 
 
 
M
e
a
n
 p
e
a
k
 a
re
a
 
2.0E+07 
 
 
 
1.5E+07 
 
 
 
1.0E+07 
 
 
 
5.0E+06 
 
 
 
0.0E+00 
 
 
M
e
a
n
 p
e
a
k
 a
re
a
 
6.0E+07 
 
 
4.0E+07 
 
 
 
 
2.0E+07 
 
 
 
 
 
0.0E+00 
 
M
e
a
n
 p
e
a
k
 a
re
a
 
1.4E+06 
 
 
 
1.0E+06 
 
 
 
6.0E+05 
 
 
 
2.0E+05 
 
0.0E+00 
 
 
M
e
a
n
 p
e
a
k
 a
re
a
 
3.5E+05 
 
 
2.5E+05 
 
 
 
1.5E+05 
 
 
 
 
5.0E+05 
 
 
0.0E+00 
WT    ∆lmgt     WT    ∆lmgt     
Oleic acid                                                           Stearic acid                            
Icosanoic acid                                                     Behenic acid                            
WT    ∆lmgt     WT    ∆lmgt     
 +14* 
   
                                                                                                                                                                                                CHAPTER IV 
 131 
 
Oleic acid and stearic acid were universally labelled in condition *glc0 wild type 
promastigotes (Figure IV-7). Labelled in the condition *glc0 wild type promastigotes 
were also icosanoic acid (or arachidic acid) (Figure IV-7), behenic acid (Figure IV-7) 
and linoleic acid. Label incorporation in these fatty acids in the 10 NMR conditions 
was only minor, suggesting that fatty acid biosynthesis is decreased in the wild type 
promastigotes under nutrient restricted conditions. Labelled in conditions glc+*pro 
and *pro ∆lmgt promastigotes were icosanoic acid, behenic acid and lignoceric acid 
which shows that a portion of the acetyl-CoA synthesized from L-proline is directed 
toward lipid synthesis in the ∆lmgt promastigotes. Interestingly, no labelling was 
observed in the ∆lmgt promastigotes incubated with L-threonine which shows that 
acetyl-CoA produced from this amino acid is not used in lipid synthesis. 
Sphingolipid metabolism 
Sphingolipids are another heterogeneous group of important membrane-
anchored macromolecules that comprise about 5 - 10% of the Leishmania membrane 
lipids (Kaneshiro et al., 1986). The principal building blocks of sphingolipids are long-
chain bases or sphingoid bases. In yeast, the main sphingoid bases are sphinganine 
(dihydrosphingosine) and phytosphingosine (Dickson, 2008; Bartke and Hannun, 
2009). Sphinganine can contain 16, 18 or 20 carbons while phytosphinganine can 
contain 18 or 20 carbons (Lester and Dickson, 2001). The two types of sphingoid 
bases were putatively identified and found labelled in the wild type promastigotes 
(Supplemental figure IV-1). Both, sphinganine and phytosphingasine were 18-13C-
labelled in the wild type promastigotes incubated with 13C-D-glucose (Supplemental 
figure IV-1). In the ∆lmgt promastigotes, the putative sphinganine was labelled only 
in the conditions with 13C-L-threonine (Supplemental figure IV-1). That showed that a 
portion of L-threonine is converted to L-serine and used in sphingolipid synthesis in 
the ∆lmgt promastigotes. L-serine was found labelled in the ∆lmgt promastigotes in 
the conditions with 13C-L-proline but sphinganine and phytosphingosine were not 
detected.  
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IV.2.   Discussion 
Amino acid metabolism 
Alanine and aspartate metabolism 
L-Alanine is present at the highest concentration in the free amino acid pool in 
both promastigotes and amastigotes (Simon et al., 1983; Mallinson and Coombs, 
1989). As an osmoregulator, L-alanine (Ala) is one of the main solutes involved in 
maintaining the cell volume (Vieira et al., 1996). As a metabolite, L-alanine is one of 
the main end products of D-glucose catabolism in Leishmania (Darling et al., 1987). As 
such, it is excreted by the cells (Rainey and MacKenzie, 1991). While excreted, 
however, L-alanine can be simultaneously taken up as a nutrient and/or osmolite 
from the environment via transporter(s) (Inbar et al., 2013).  
In D-glucose-replete conditions L-alanine and/or L-aspartate are taken up at an 
increased rate and needed in TCA cycle anaplerosis and synthesis of L-glutamate 
(Saunders et al., 2011). Additionally, the two amino acids are glucogenic amino acids 
that can be converted to D-glucose via gluconeogenesis (Figure IV-1). An 
incorporation analysis performed with 14C-L-alanine and 14C-L-aspartate revealed 
that mannogen was radiolabelled when the ∆lmgt promastigotes were incubated with 
either of the amino acids thus confirming that they are used in gluconeogenesis in the 
∆lmgt promastigotes (Rodriguez-Contreras and Landfear, 2006). L-Alanine, under the 
action of alanine aminotransferase (ALT), can be transaminated to pyruvate (via the 
reaction presented below) and fed into gluconeogenesis via pyruvate phosphate 
dikinase (PPDK) (Rodriguez-Contreras and Hamilton, 2014). Similarly, L-aspartate 
can be converted to oxaloacetate via a mitochondrial aspartate aminotransferase or 
to fumarate via the consecutive action of an adenylosuccinate synthase, an 
adenylosuccinate lyase and an adenosine 5-monophosphate (AMP)-deaminase, and 
fed into the gluconeogenesis via phosphoenolpyruvate carboxykinase (PEPCK) 
(Opperdoes and Michels, 2008). 
                                        
 
α-Ketoglutarate                      L-Alanine                             L-Glutamate                Pyruvate 
+ + 
ALT 
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In the ∆lmgt promastigotes, alanine aminotransferase and PPDK were found down-
regulated (Supplemental figure III-1). Neither aspartate aminotransferase nor the 
enzymes of the purine-nucleotide cycle were found differentially regulated in the 
∆lmgt promastigotes. PEPCK, on the other hand, was also down-regulated 
(Supplemental table III-1). Considering that the levels of L-alanine and L-aspartate 
were significantly decreased in the ∆lmgt promastigotes (Figure IV-2, A and C), along 
with the down-regulation of PPDK and PEPCK, it could be proposed that the majority 
of L-alanine and L-aspartate is actively directed toward the TCA cycle to be oxidized 
for the generation of energy and only a small amount is used in the gluconeogenesis. 
Up-regulation of PPDK and PEPCK would have meant that L-alanine, L-aspartate and 
possibly other glucogenic amino acids are used primarily as glucogenic precursors. L-
Alanine and L-aspartate, although confirmed glucogenic sources for the ∆lmgt 
promastigotes, appear to be used mainly as energy sources by these promastigotes.  
Arginine, glutamate and proline metabolism  
It was demonstrated that L. donovani promastigotes incorporate 
approximately 20% of the internalized L-arginine into proteins while the majority of 
it remains unused within the amino acid pool or used for polyamine and derivative 
synthesis (Kandpal et al., 1995). An amino acid uptake assay performed with the 
∆lmgt promastigotes revealed that L-arginine is taken up at a decreased rate 
compared to the wild type promastigotes (Thesis: Lamasudin, 2012). The amino acid 
was found unlabelled in the wild type and ∆lmgt promastigotes (Figure IV-5). 
Unlabelled in both cell lines were also the immediate derivatives of L-arginine, L-
citruline and L-ornithine (Figure IV-5). The proteomic data specified that arginase 
(ARG), involved in the conversion of L-arginine to L-ornithine, was down-regulated in 
the ∆lmgt promastigotes (Supplemental table III-1). L-Arginine and L-ornithine are 
precursors for the synthesis of polyamines which in turn are involved in the synthesis 
of trypanothione (Colotti and Ilari, 2011) (see Glutathione metabolism). The next 
enzyme of the polyamine biosynthesis, after arginase, is ornothine decarboxylase 
which decarboxylates L-ornithine to putrescine. The latter, together with 
decarboxylated S-adenosyl-L-methionine (dAdoMet), is used for the synthesis of 
spermidine by a spermidine synthase while spermine synthase converts spermidine 
to spermine (Colotti and Ilari, 2011). In condition *glc0 wild type promastigotes, S-
adenosyl-L-methionine was not detected. It was found labelled only in condition *glc 
and pro+*glc wild type promastigotes and condition glc+*pro and *pro ∆lmgt 
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promastigotes (see Cysteine and methionine metabolism). Thus, dAdoMet was also 
most probably labelled in the wild type promastigotes. Unfortunately, putrescine, 
spermidine and spermine were not detected in the wild type or ∆lmgt promastiogtes. 
Trypanothione also was not detected (see Glutathione metabolism). Thus, 
considering that Leishmania are able to take up polyamines from the environment 
(Basselin et al., 2000), down-regulation of the initial step of the polyamine 
biosynthesis in the ∆lmgt promastigotes suggests that the main use of L-arginine is 
protein synthesis. Another possibility is that L-arginine is converted to 
phosphoarginine, a high-energy phosphagen that provides fast energy 
supply (Colasante et al., 2006). The compound, however, was not detected. 
Contrary to L-alanine and L-aspartate, which are taken up and utilized at an increased 
rate, L-glutamate and L-glutamine are barely used as carbon sources by wild type L. 
mexicana promastigotes grown under D-glucose-replete conditions (Saunders et al., 
2011). The fate of the two amino acids in the ∆lmgt promastigotes, however, appears 
to be different. In addition to being taken up from the environment (Paes et al., 2008), 
L-glutamate can be generated from L-proline via a mitochondrial Δ1-pyrroline-5-
carboxylate dehydrogenase and a pyrroline-5-carboxylate synthetase, or by 
transamination from α-ketoglutarate (Opperdoes and Michels, 2008). L-Proline and 
L-glutamate were authentically identified and found unlabelled and universally 
labelled, respectively, in condition *glc0 wild type promastigotes (Figure IV-6). That 
showed that L-glutamate was synthesized from α-ketoglutarate and not from L-
proline in the wild type promastigotes. The conversion of α-ketoglutarate to L-
glutamate (presented below) is catalised by the enzyme glutamate dehydrogenase 
(GDH). Two glutamate dehydrogenases are believed to operate in Leishmania, one 
mitochondrial NAD-dependent enzyme and one NADPH-dependent enzyme, possibly 
localized to the cytosol (Opperdoes and Michels, 2008). 
                                                                      
 
L-Glutamate                                                                        α-Ketoglutarate 
GDH 
+  NAD+  +  H2O                                                       +  Ammonia  +  NADH  +  H+ 
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The proteomic data showed that a glutamate dehydrogenase, with a dual presence in 
the cytosolic and organellar fraction, was found highly down-regulated in the ∆lmgt 
promastigotes (Supplemental table III-1). Additionally, the level of L-glutamate was 
decreased in the ∆lmgt promastigotes (Table III-3). Thus, similar to a starvation study 
performed with L. tropica promastigotes (Simon et al., 1983), the enzyme activity of 
glutamate dehydrogenase in the ∆lmgt promastigotes appears to be significantly 
decreased in the direction of production of L-glutamate. That indicates that the 
equilibrium of the L-glutamate-to-α-ketoglutarate interconversion (shown above) 
would be preferentially shifted toward the synthesis of α-ketoglutarate. That suggests 
that the amino acids is actively fuelled into the TCA cycle via α-ketoglutarate, a 
suggestion supported by the up-regulation of the E2 component of the oxoglutarate 
dehydrogenase complex (Figure III-21), and possibly utilized as a glucogenic 
precursor. In addition to α-ketoglutarate, L-glutamate could also possibly be fed into 
the TCA cycle via 4-aminobutanoate, succinate semialdehyde and succinate, the 
former and the last of which were authentically identified and universally labelled 
while succinate semialdehyde, unfortunately, was not detected in the promastigotes. 
The next amino acid of interest to the ∆lmgt promastigotes metabolism is L-
glutamine. An amino acid uptake assay revealed that L-glutamine was taken up by the 
∆lmgt promastigotes at an increased rate compared to the wild type promastigotes 
(Thesis: Lamasudin, 2012). The amino acid was authentically identified and found 
universally labelled in condition *glc0 wild type promastigotes (Figure IV-4). That 
showed that L-glutamine was synthesized from L-glutamate via a glutamine 
synthetase. The L-glutamate-to-L-glutamine conversion plays a central role in 
nitrogen metabolism. Glutamine synthetase, along with a number of enzymes, 
including glutamate dehydrogenase (GDH), are believed to be involved in maintaining 
nitrogen and carbon balance (Miffin and Habash, 2002). GDH, in particular, is 
proposed to facilitate the recycling of the carbon incorporated into proteins back to 
carbon metabolism and the TCA cycle. The opposite conversion of L-glutamine to L-
glutamate does not seem to occur in trypanosomatids (Opperdoes and Coombs, 
2007). Thus, the amino acid cannot be used as a glucogenic precursor. In Leishmania, 
L-glutamine is a nitrogen donor (Manhas et al., 2014) and is involved in de novo 
pyrimidine and amino sugar biosynthesis (Carter et al., 2008; Opperdoes and Michels, 
2008; Naderer et al., 2008). The increased uptake of L-glutamine possibly indicates 
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an increased requirement for amino sugars and pyrimidine nucleotides (see 
Nucleotide metabolism).  
Besides α-ketoglutarate and L-glutamine, authentically identified and universally 
labelled in the ∆lmgt promastigotes was also N-acetyl-L-glutamate. N-Acetyl-L-
glutamate can be converted to L-ornithine via N-acetyl-L-ornithine, which, as 
expected, was only 2-13C-labelled from the acetyl moiety. N-Acetyl-L-glutamate is also 
involved in activation of carbamoyl phosphate synthetase in the urea cycle. The cycle, 
however, does not appear to be fully operational in Leishmania. The organisms have 
the initial enzymes of the cycle, namely carbamoylphosphate synthase, 
argininosuccinate synthase and arginase, which shows that L-arginine, L-ornithine 
and urea could be formed, but lack the enzymes ornithine carbamoyltransferase and 
argininosuccinate lyase (Opperdoes and Coombs, 2007; Opperdoes and Michels, 
2008). Only arginase, as said above, was found down-regulated in the ∆lmgt 
promastigotes. 
The last amino acid to be discussed is L-proline. L-Proline is an abundant amino acid 
in the insect hemolymph which is utilized as an energy substrate during flight 
(Taylor, 1998). The insect forms of Leishmania have evolved to use L-proline as a 
major energy source, even in the presence of D-glucose (Bringaud et al., 2006). In 
trypanosomes, L-proline is taken up six times more when D-glucose is not available 
(Lamour et al., 2005). Similarly, the ∆lmgt promastigotes were shown to consume 
much more L-proline compared to the wild type promastigotes (Thesis: Lamasudin, 
2012). At the uptake peak, the ∆lmgt promastigotes consumed approximately 10,000 
times more L-proline in comparison with the wild type promastigotes. Additionally, 
compared to L-glutamine and L-serine, L-proline was taken up ten to hundreds of 
times more. When internalized, L-proline can be used in protein synthesis or 
metabolized in the central carbon metabolism. When used as an energy and carbon 
source, L-proline is oxidation to L-glutamate by a mitochondrial ∆1-pyrroline-5-
carboxylate dehydrogenase and a pyrroline-5-carboxylate synthetase and then fed 
into the TCA cycle via α-ketoglutarate (Opperdoes and Michels, 2008). It has to be 
emphasized that the oxidation of L-proline to L-glutamate is an important source of 
reducing equivalents which are directed toward oxidative phosphorylation for the 
generation of energy (see Energy metabolism). The isotope labelling analysis 
revealed that L-proline was converted to L-glutamate in the ∆lmgt promastigotes in 
the conditions where 13C-L-proline was provided as a carbon source. The label from 
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L-proline appeared in all detected TCA cycle intermediates, acetyl-CoA and all 
detected glycolysis/gluconeogenesis intermediates. In addition to being used in TCA 
cycle anaplerosis and gluconeogenesis, L-proline is implicated in stress protection, 
including oxidative stress, as it was proposed to function by stabilizing proteins and 
antioxidant enzymes, balancing the intracellular redox homeostasis (e.g., the ratio of 
NADP/NADPH and reduced glutathione/oxidized glutathione) (see Glutathione 
metabolism) and promoting cell signalling (Liang et al., 2013). L-Proline thus appears 
to be a substrate with versatile functions and of primary importance for the lmgt 
promastigotes of L. mexicana.  
Cysteine and methionine metabolism  
Neither of the two enzymes involved in the de novo synthesis of L-cysteine 
from L-serine, namely cysteine acetyltransferase and cysteine synthase (Williams et 
al., 2009), were differentially expressed in the ∆lmgt promastigotes which indicates 
that the L-serine-to-L-cysteine conversion may not be regulated at the level of protein 
abundance in the ∆lmgt promastigotes. Alternatively, L-cysteine can be generated via 
the reverse trans-sulfuration pathway involving cystathionine β-synthase and 
cystathionine γ-lyase (Figure IV-8) (Williams et al., 2009). The final step of the 
pathway, in which L-cystathionine, under the action of cystathionine γ-lyase (CSE), is 
broken down to L-cysteine, 2-oxobutanoate and ammonia, was differentially 
regulated in the ∆lmgt promastigotes. Isoforms of the enzyme, however, were found 
both up- and down-regulated in the Δlmgt promastigotes (Supplemental table III-1). 
In particular, the down-regulated isoform was found in the organellar fraction while 
the up-regulated was in the digitonin-insoluble fraction. In L. major, both cysteine 
synthase and cystathionine γ-lyase were localized to the cytosol where the L-cysteine 
synthesis was proposed to take place (Giordana et al., 2014). Considering our 
proteomic data, we could hypothesize that the enzyme(s) catalyzing the final stage of 
the reverse trans-sulfuration pathway may have dual localization. The conversion of 
L-homocysteine to L-cysteine, which in turn is involved in the synthesis of iron-sulfur 
clusters found in a number of enzymes, and of trypanothione (see Glutathione 
metabolism) (Giordana et al., 2014), thus appears to be decreased in the ∆lmgt 
promastigotes. The organellar activity of cystathionine γ-lyase, at the same time may 
be due to unrelated to L-cysteine synthesis function. In T. cruzi, cystathionine γ-lyase 
was implicated in the maintenance of the cellular redox balance (Pineyro et al., 2011).  
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Figure IV-8. L-Methionine metabolism in trypanosomatids. Abbreviations: AdoHcy - S-
adenosylhomocysteine, AdoMet - S-adenosylmethionine, cys - cysteine, cysth - cystathionine, dcAdoMet - 
decarboxylated S-adenosylmethionine, GSH - reduced glutathione, hcy - homocysteine, met - methionine, MTA - 
methylthioadenosine, MTR - 5′-methylthioribose, MTR-1-P - 5′-methylthioribose-1-phosphate, put - putrescine, 
spd - spermidine, THF - tetrahydrofolate, AdoHcy hydrolase - S-adenosylhomocysteine hydrolase, AdoMetDC - S-
adenosylmethionine decarboxylase, AT - unspecific aminotransferase, CBS - cystathionine β-synthase, CdMS - 
cobalamin-dependent methionine synthase, CiMS - cobalamin-independent methionine synthase, CLS - 
cystathionine γ-liase, MAT - methionine adenosyltransferase, MTAN - methylthioadenosine nucleosidase, MTAP - 
methylthioadenosine phosphorylase, MTRK - 5′-methylthioribose kinase, SpdS - spermidine synthase, 
ODC/AdoMetDC - bifunctional ornithine decarboxylase/S-adenosylmethionine decarboxylase. 
Credit: Reguera et al., 2006 
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Leishmania synthesize L-methionine from L-cysteine by a methionine synthase or 
from L-homocysteine via a homocysteine S-methyltransferase (HMT) (Opperdoes and 
Coombs, 2007). Neither methionine synthase nor HMT was detected in the ∆lmgt 
promastigotes. Another enzyme involved in the synthesis of L-methionine from L-
homocysteine, namely 5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase (MetE), however, was down-regulated in the ∆lmgt promastigotes. 
Down-regulation of cystathionine γ-lyase, involved in L-cysteine synthesis, and MetE, 
involved in L-methionine, would result in accumulation of L-homocysteine. The 
amino acid, however, was not among those observed to be significantly modulated in 
the ∆lmgt promastigotes. Down-regulated was also the putative methylthioadenosine 
phosphorylase which catalyzes the initial step in the methionine salvage pathway, 
that is the reversible phosphorylation of 5-methylthioadenosine (MTA) to adenine 
and 5-methylthioribose 1-phosphate (Figure IV-8). This would mean that less 
adenine would be produced and at the same time less ATP would be engaged in the 
formation of MTA. MTA is a major byproduct of polyamine biosynthesis which is 
recycled to L-methionine via the methionine salvage pathway. The polyamine 
biosynthesis was presumed down-regulated in the ∆lmgt promastigotes (see Arginine 
and proline metabolism) which is possibly linked to down-regulation of the 
methionine salvage pathway as well.  Thus, two enzymes of two alternative pathways 
for synthesis of L-methionine are down-regulated in the ∆lmgt promastigotes. We 
could therefore speculate that the more or less similar levels of L-methionine in the 
wild type and ∆lmgt promastigotes are due to uptake of the amino acid from the 
environment by the latter (Mukkada and Simon, 1977). L-Methionine is another 
important sulfur-containing amino acid involved in protein synthesis and possibly 
also in protein activation and inactivation (Drazic and Winter, 2014). In addition to 
protein synthesis, L-methionine, in the form of S-adenosyl-L-methionine (AdoMet), is 
a methyl donor in all but one known trans-methylation reactions, an aminopropyl 
group donor in spermidine and spermine biosynthesis and a precursor for 
glutathione biosynthesis (Figure IV-8) (Reguera et al., 2006). Additionally, AdoMet is 
a precursor for 5-deoxyadenosyl radicals which are involved in biological processes 
such as DNA precursor biosynthesis, biodegradation pathways, DNA repair and 
transfer RNA (tRNA) modification (Fontecave et al., 2004; Lu, 2000). Thus, AdoMet 
may have non-metabolic function(s) but still influence the metabolism of the ∆lmgt 
promastigotes.  
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Glutathione metabolism 
Involved in the synthesis of glutathione (GSH) are the enzymes γ-
glutamylcysteine synthetase, which ligates L-glutamate and L-cysteine into γ-L-
glutamyl-L-cysteine, and glutathione synthase, which conjugates the product of the 
first reaction with glycine (Irigoin et al., 2008). Glutathione is then transferred, in an 
ATP-dependent manner, to one of the amino acids of spermidine to form 
glutathionylspermidine, which is catalyzed by glutathionylspermidine synthetase. 
The addition of the second glutathione molecule is catalyzed by trypanothione 
synthase and leads to the synthesis of trypanothione (N1,N8-bis-(glutathionyl)-
spermidine). Glutathionyl-spermidine synthetase, however, has not yet been reported 
for Leishmania, and trypanothione synthase was not detected in the promastigotes. 
Not detected in the wild type and ∆lmgt promastigotes grown under any of the 10 
NMR conditions were also glutathione and trypanothione. Trypanothione plays a 
central role in antioxidant defence system of Leishmania (Steenkamp, 2002). While 
mammalian thiol redox homeostasis is maintained by glutathione/glutathione 
reductase, Leishmania redox network relies on trypanothione/trypanothione 
reductase (Irigoin et al., 2008). Trypanothione is maintained in the reduced form by 
the NADPH-dependent flavoenzyme trypanothione reductase (TR). Although the 
oxidative phase of the pentose phosphate pathway, the phase in which NADPH is 
regenerated, was down-regulated in the ∆lmgt promastigotes (see Pentose phosphate 
pathway), the trypanothione reductase that was differentially regulated in these 
parasites was below the threshold of 2-fold-change and was thus considered as 
insignificantly regulated. The next enzyme of the thiol-redox system, tryparedoxin 
(TXN), upon which the reduced trypanothione acts, was down-regulated in the ∆lmgt 
promastigotes. Tryparedoxins are electron donors involved in the reduction of 
peroxides by tryparedoxine peroxidase, the formation of deoxyribonucleotides by the 
trypanosomal ribonucleotide reductase and the conversion of dehydroascorbate to 
ascorbate and of glutathione disulfide to glutathione (Figure IV-9) (Irigoin et al., 
2008; Steenkamp, 2002 and the references therein). In addition to tryparedoxin, 
down-regulated in the ∆lmgt promastigotes were a tryparedoxin peroxidase and a 
type II tryparedoxin peroxidase (Supplemental table III-1). As said above, both 
tryparedoxin and tryparedoxin peroxidase are involved in peroxide neutralization. 
Hydrogen peroxide (H2O2) was chosen as the reactive oxygen species to test the 
antioxidant capacity of the ∆lmgt promastigotes. 
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Figure IV-9. Trypanothione metabolism in Leishmania. Specified with a pink arrow is the down-
regulated reaction in the Δlmgt promastigotes. Abbreviations: T(SH)2 - dihydrotrypanothione, TS2 - trypanothione 
disulfide, GSH - glutathione, GSSG - glutathione disulfide, TryR - trypanothione reductase, TXN - tryparedoxin, 
TXNox - oxidized tryparedoxin, TXNred - reduced tryparedoxin, RR - ribonucleotide reductase, H2O2 - hydrogen 
peroxide, TXNPx - tryparedoxin peroxidase, GPx - glutathione peroxidase, Apx - ascorbate-dependent 
hemoperoxidase, dhAsc - dehydroascorbate, Asc - ascorbate, ·NO - nitric oxide, O2·- - superoxide radical, R· - 
radical, ROOH - hydroperoxides, A - one-electron oxidant, Aox - oxidised one-electron oxidant, Ared - reduced one-
electron oxidant, GPx-I and GPx-II - glutathione peroxidase-like tryparedoxin peroxidases I and II.  
Credit: Irigoin et al., 2008 
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The ∆lmgt promastigotes were shown to be highly sensitive to oxidative stress 
(Rodriguez-Contreras et al., 2007) which could be accounted for by reduced 
generation of NADHP and decreased activity of the thiol-redox system.  
Glycine, serine and threonine 
The glycine cleavage system (GCS) is part of the folate biosynthesis pathway 
which is an important source of one-carbon units used in a number of biosynthetic 
pathways, such as the pyrimidine, purine and L-methionine biosynthesis. GCS is 
comprised of four proteins: T-protein [tetrahydrofolate (THF) requiring 
aminomethyltransferase, or glycine synthase], P-protein (pyridoxal phosphate 
containing glycine decarboxylase), L-protein (lipoamide dehydrogenase) and H-
protein (lipoic acid containing carrier). Genes for all four proteins are expressed in L. 
infantum and their expression is triggered by high levels of glycine (Muller and 
Papadopoulou, 2010). The P-protein was not detected in the promastigotes. A 
putative pyridoxal kinase which reversibly phosphorylates pyridoxal to pyridoxal 5-
phosphate, the coenzyme of the P-protein, however, was found down-regulated in the 
Δlmgt promastigotes (Supplemental table III-1). The H protein, considered as the core 
protein, was also found down-regulated in the Δlmgt promastigotes. Glycine was not 
detected in condition *glc0 Δlmgt promastigotes but it was universally labelled in the 
conditions with heavy L-proline. This shows that the amino acid is still synthesized in 
the Δlmgt promastigotes but possibly at a decreased rate. Glycine can be synthesized 
from L-serine via a serine hydroxymethyltransferase (SHMT) and the 
tetrahydrofolate (THF)-dependent glycine cleavage system or from L-threonine by 
SHMT (Opperdoes and Coombs, 2007). Instead for the synthesis of glycine and the 
generation of one-carbon units, L-serine could be mainly directed toward the 
synthesis of pyruvate in the Δlmgt promastigotes, although our data did not provide 
conclusive evidence for that. The NMR data, instead, suggested that L-threonine may 
be the primary source of glycine in the Δlmgt promastigotes. L-Threonine is a major 
carbon source for cultured T. brucei procyclic forms (Cross et al., 1975). It is believed 
to be a preferred source for production of acetate via acetyl-CoA over D-glucose 
(Cross et al., 1975; Linstead et al., 1977). In T. brucei, L-threonine is catabolised to 
acetyl-CoA and glycine via a threonine dehydrogenase and an acetyl-CoA:glycine C-
acetltrasnferase (Linstead et al., 1977). Leishmania, however, lacks threonine 
dehydrogenase (Opperdoes and Michels, 2008). Instead, the parasites can convert L-
threonine to α-ketobutyrate or glycine (Figure IV-10).  
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Figure IV-10. Glycine, L-serine and L-threonine metabolism. Specified with green arrows are 
reactions of glycine, serine and threonine metabolism occurring in Leishmania. 
Credit: Ogawa et al., 2000 
 
L-Threonine can be converted to α-ketobutyrate by a serine/threonine dehydratase 
(STD) and subsequently oxidized to succinyl-CoA (Opperdoes and Coombs, 2007). 
Succinyl-CoA can then be converted to acetyl-CoA. Acetate can be produced from 
acetyl-CoA either by a cytosolic acetyl-CoA synthetase, which was found down-
regulated in the Δlmgt promastigotes (Figure IV-11), or by a glycosomal 
acetate:succinate CoA transferase (ASCT) and succinyl-CoA ligase (SCL) (van 
Hellemond et al., 1998; Riviere et al., 2004). Acetate:succinate CoA transferase acts by 
transferring the CoA moiety of acetyl-CoA to succinate to produce acetate and 
succinyl-CoA. The latter can then be converted back to succinate by succinyl-CoA 
synthetase which results in the production of ATP (van Hellemond et al., 1998). 
Acetate:succinate CoA transferase was not detected but succinyl-CoA ligase [GDP-
forming] β-chain was found down-regulated in the Δlmgt promastigotes (Figure IV-
11; Supplemental table III-1). A putative succinyl-CoA synthetase α subunit was also 
detected and it was down-regulated (Figure IV-11).  
L-Threonine can be converted to glycine in two ways. In the first, L-threonine is 
converted in a THF-dependent manner to glycine. In the second, the Cα-Cβ bond of L-
threonine are cleaved to generate glycine (Opperdoes and Coombs, 2007; Muller and 
Papadopoulou, 2010). The enzyme involved in both reactions is SHMT. SHMT is a 
pyridoxal 5-phosphate (PLP)-dependent enzyme whose primary function is to 
interconvert L-serine and THF to glycine and 5,10-methylene-THF.  
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Figure IV-11. Schematic representation of L-threonine catabolism in Δlmgt 
promastigotes incubated with 13C-D-glucose. Specified with light blue arrows are the up-regulated 
enzymes while specified with pink arrows are the down-regulated enzymes. Abbreviations: L-Thr - L-threonine, α-
Kb - α-ketobutyrate, Pro-CoA - propanoyl-CoA, 2Mm-CoA - 2-methyl-malonyl-CoA, Suc-CoA - succinyl-CoA, Suc - 
succinate, Aa-CoA - acetoacetyl-CoA, Ac-CoA - acetyl-CoA, Ac - acetate, CoA - coenzyme A, Acal - acetladehdye, Gly - 
glycine, STD - serine/threonine dehydratase, AS - acetyl-CoA synthetase, ASCT - acetate:succinate CoA transferase, 
SCL - succinyl-CoA ligase, SCS - succinyl-CoA synthetase, SHMT - serine hydroxymethyltransferase, ALDH - 
aldehyde dehydrogenase.  
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An alternative and THF-independent aldolase activity of SHMT involves the cleavage 
of β-hydroxyamino acids into glycine and aldehydes (Chiba et al., 2011). A 
transcriptomic analysis of the Δlmgt promastigotes revealed that SMHT mRNA was 
up-regulated (Feng et al., 2011). Our proteomic analysis, however, showed that SHMT 
was insignificantly regulated in the Δlmgt promastigotes. The produced by SHMT 
aldehyde can then be converted by aldehyde dehydrogenase to acetyl-CoA. A prior 
DIGE analysis, complemented by an LC-MS/MS analysis, revealed that a 
mitochondrial aldehyde dehydrogenase (mALDH) is up-regulated in the Δlmgt 
promastigotes (Feng et al., 2011). That was corroborated by the DIGE and LC-MS/MS 
analysis performed by us (in preparation). Thus, if we consider the up-regulated 
mALDH we could speculate that L-threonine is converted to acetyl-CoA primarily via 
SHMT in the Δlmgt promastigotes. Additionally, down-regulation of acetyl-CoA 
synthetase and succinyl-CoA ligase suggests that the conversion of acetyl-CoA to 
acetate is decreased in the Δlmgt promastigotes. Indead, the NMR analysis confirmed 
that the amount of acetate excreted by the Δlmgt promastigotes is considerably less 
compared to that excreted by the wild type promastigotes (Tables III-7 and III-8). 
This could mean that the majority of acetyl-CoA in the Δlmgt promastigotes is 
preferentially directed toward more important pathways such as the TCA cycle and 
lipid biosynthesis, and only a small amount is converted to acetate and excreted. 
Under standard culture conditions, the excretion of acetate and other partially-
oxidized end products results from consumption of higher amounts of D-glucose than 
can be utilized by the cells (Saunders et al., 2011). Excretion of less acetate and 
succinate shows that carbon sources such as L-proline, L-threonine and glycerol are 
more effectively catabolized in the Δlmgt promastigotes. 
Energy metabolism 
Mitochondria are the power stations of the cells. Located on the inner 
membrane, the mitochondrial electron transport chain (ETC) is involved in the 
generation of energy in the form of ATP. The ETC of trypanosomatids is comprised of 
a ubiquinone/ubiquinol pool and complex I (NADH dehydrogenase or 
NADH:ubiquinone reductase), complex II (succinate dehydrogenase or succinate: 
ubiquinone reductase), complex III (cytochrome bc oxidoreductase or ubiquinone: 
cytochrome c reductase) and cytochrome c - complex IV (cytochrome c oxidase) 
(Acestor et al., 2011). The transfer of electrons begins with oxidoreductive reactions 
in which coenzymes such as NAD and FAD are reduced by accepting electrons. The 
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electrons are then donated to the ubiquinone/ubiquinol pool and consequently 
transferred to the final electron acceptor, oxygen. Concomitantly, the produced 
protons are drawn across the inner mitochondrial membrane by complexes III and IV 
which generates an electrochemical gradient that is used by the F0/F1-ATP synthase 
(complex V) to produce ATP by oxidative phosphorylation (Besteiro et al., 2005).  
A number of studies with trypanosomatids belonging to the genera Trypanosoma, 
Leishmania, Crithidia and Burkholderia have focused on elucidating the exact 
structure and composition of the respiratory complexes and revealed that the 
complex subunits are encoded in the nuclear and kinetoplast-mitochondrial genomes 
and that an unexpectedly high number of the subunits were specific for the 
trypanosomatids (Speijer et al., 1996a, b; Horvath et al., 2000a, b; Maslov et al., 2002; 
Acestor et al., 2011; Gnipova et al., 2012).  
Complex I (NADH dehydrogenase, ND) is the largest one among the respiratory 
complexes. It is involved in transferring electrons from NADH to ubiquinone. The 
existence of the ND complex in trypanosomatids was questioned for a long time until 
genomic and proteomic studies provided evidence for its presence in these parasites 
(Duarte and Tomas, 2014). So far, 7-8 subunits are known to be encoded in the 
mitochondrial genome (Acestor et al., 2011; Duarte and Tomas, 2014). The ND1-ND5 
subunits are found to be homologous to the human ND proteins. 3 subunits, however, 
are homologous to the nuclearly encoded NDUFS2/ND7, NDUFS8/ND8 and 
NDUFS3/ND9. Nuclearly encoded in the trypanosomatids are the core subunits 
NDUFV1, NDUFV2, NDUFS1 and NDUFS7. Unfortunately, no enzymes associated with 
complex I were detected in our study. 
Complex II (succinate dehydrogenase, SDH) is the component of the electron 
transport chain that links the TCA cycle with the cellular respiration. It functions by 
oxidizing succinate to fumarate with the concomitant reduction of ubiquinone to 
ubiquinol. In trypanosomatids, SDH was shown to be a membrane-bound protein 
complex comprised of four core subunits, SDH1, SDH2, SDH3 and SDH4 (Acestor et 
al., 2011). The two hydrophilic SDH1 and SDH2 subunits are anchored on the inner 
mitochondrial membrane by the two hydrophobic subunits SDH3 and SDH4. 
Identified in our study was a putative SDH1 subunit, also known as succinate 
dehydrogenase flavoprotein. It was found up-regulated in the second organellar 
fraction (Supplemental table III-1) supporting its localization to the inner 
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mitochondrial membrane. In addition to the up-regulated SDH1 subunit, the level of 
succinate in the Δlmgt promastigotes was highly decreased which illustrating the key 
role of the substrate in energy generation in these parasites.   
Complex III (cytochrome c reductase) is involved in reoxidation of ubiquinol by 
transferring electrons to cytochrome c. The core of complex III in trypanosomatids is 
comprised of a mitochondrially encoded cytochrome b and the nuclearly encoded 
cytochrome c1 and the Rieske iron-sulfur protein (Acestor et al., 2011). It is known 
that cytochrome b5 can receive electrons from NADH-cytochrome b5 reductase and 
cytochrome P450 (Schenkman and Jansson, 2003). In one of our preliminary 
comparative proteomic experiments cytochrome P450 was found 100 times up-
regulated in the Δlmgt promastigotes compared to the wild type cells (data not 
included). With regard to the other two components of the complex, a study in T. 
brucei procyclic forms revealed that RNAi silencing of cytochrome c1 results in 
ablation of Rieske iron-sulfur protein and vice versa which shows strong co-
dependence between the two proteins (Horovath et al., 2005). Additionally, silencing 
of any of the subunits proved that both proteins are necessary for complex III 
assembly and activity. The study further elucidated that inactivation of complexes III 
and IV redirects, to a certain extent, the electron flow toward the trypanosome 
alternative oxidase (TAO). TAO, however, is presumed abcent in Leishmania (van 
Hellemond et al., 1998).   
Trypanosomatid cytochrome c - complex IV (cytochrome c oxidase) appears to be 
considerably dissimilar to that of other eukaryotic organisms (Gnipova et al., 2012). 
The core of the complex is comprised of 3 large mitochondrially encoded subunits 
and 10 smaller nuclear subunits (Speijer et al., 1996a; Horvath et al., 2000a). 
Additional subunits, however, are believed to also be associated with the complex. 
Surprisingly, 8 of the nuclear subunits do not have homologues in other eukaryotic 
cells (Speijer et al., 1996b). In the Δlmgt promastigotes, differentially regulated was a 
putative cytochrome c oxidase subunit V. It was up-regulated in the second organellar 
fraction (Supplemental table III-1). A putative cytochrome c oxidase subunit IV was 
also differentially regulated in the Δlmgt promastigotes but not significantly. In 2002 
Maslov and colleagues characterized subunit IV (COIV) of L. tarentolae (Maslov et al., 
2002). They found that COIV (trCOIV) is the largest subunit of cytochrome c oxidase, 
followed by subunit V (COV). They also showed that T. cruzi, T. brucei and L. major 
have homologous genes for trCOIV and detected the trCOIV polypeptides in procyclic 
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forms of T. brucei and promastigote forms of L. amazonensis. Regarding the function 
of COIV, the authors speculated, based on the peripheral localization of trCOIV toward 
the membrane and potential presence of an ATP-domain, that trCOIV have a 
regulatory function. If we assume that both COIV and COV have similar function it 
could be hypothesized that the regulation of complex IV in the Δlmgt promastigotes is 
more stringent with respect to more efficient production of energy.   
Complex V (F0F1-ATP synthase) of trypanosomatids is comprised of two component, 
F0 and F1. The F0 component is membrane bound and is involved in proton 
translocation while the F1 component is soluble and represents the catalytic core. In 
bacteria, F0 is comprised of three subunits in the following ratio – a1b1c6-12. In 
different eukaryotic cells, however, the number and type of subunits is increased and 
varies considerably. The F1 component of complex V has five subunits in the following 
ratio – α3β3γ1δ1ε1. The F1 α and β subunits of T. brucei have been characterized 
(Brown et al., 2001). The β subunit, which is the catalytic subunit of the human H+-
ATP synthase, was shown to be the largest subunit of F1. Besides the β subunit, 
differentially expressed in the Δlmgt promastigotes were also the α, γ and ε subunits 
of F1. Noteworthy, they were all up-regulated (Supplemental table III-1). Thus, up-
regulation of the majority of the subunits of the catalytic component of the ATP 
synthase shows that the ATP generation in the Δlmgt promastigotes is increased. At 
the same time, however, the increased generation of ATP appears to remain 
insufficient with respect to meeting the energy requirements of these cells judging by 
the decreased rate of many energy-consuming biosynthetic pathways, including non-
metabolic pathways such as RNA, DNA and protein synthesis (Supplemental table III-
1). So far, up-regulated in the Δlmgt promastigotes seem to be the synthesis of D-
glucose and the ATP production. The rest of the metabolic pathways are more or less 
down-regulated in the Δlmgt promastigotes. Partially down-regulated is also the TCA 
cycle which was shown to play a central role in energy metabolism in the Δlmgt 
promastigotes. Another complementary pathway that could contribute to energy 
production in the Δlmgt promastigotes is the β-oxidation of fatty acids which is 
presented below (see Lipid metabolism).  
Nucleotide metabolism 
Maintaining the nucleotide pool homeostasis is a fundamental factor 
influencing metabolic capabilities and functional viability of any given cell. Most 
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eukaryotic cells are able to synthesize purines and pyrimidines. Leishmania, however, 
are not able to synthesize purines de novo so they have to acquire them from the 
insect and mammalian hosts. The purine salvage pathway in Leishmania, or one of the 
salvage pathways, is proposed to involve a plasma membrane-associated bifuntional 
ecto-3’-nucleotidase/nuclease (ecto-3’-NT/NU) which can cleave extracellular 
polynucleotides and 3’-nucleotide monophosphates to nucleosides and nucleobases 
(Sopwith et al., 2002). Detected in the Δlmgt promastigotes was a putative down-
regulated 3’-NT/NU precursor. Down-regulation of the 3’-NT/NU precursor shows 
that the promastigotes may possibly use alternative mechanisms to generate 
nucleosides and nucleobases. It was additionally demonstrated that Leishmania 
synthesize and secrete a dithiothreitol-sensitive nuclease which can also hydrolyse 
extracellular polynucleotides and nucleic acids, including RNA and single- and 
double-stranded DNA (Joshi and Dwyer, 2007). The exogenous nucleosides and 
nucleobases preformed by the parasite enzymes are then imported by purine 
transporters. Various studies indicated that Leishmania are able to transport all 
naturally occurring nucleosides and nucleobases, including xanthine and xanthosine 
(Carter et al., 2008). The stable isotope tracing analysis confirmed the presence of 
unlabelled adenine and hypoxanthine in condition *glc0 wild type and Δlmgt 
promastigotes (Figure IV-12). No transporters, however, were found differentially 
expressed in the Δlmgt promastigotes but it is typical for such integral membrane 
proteins, which are of relatively low abundance, to be poorly represented in 
proteomic analyses. Thus, besides the decreased activity of the 3’-NT/NU precursor, 
no information about the purine requirements and transport in the Δlmgt 
promastigotes could be obtained from this investigation. It is not excluded, however, 
that a number of ecto-enzymes are co-expressed by the promastigotes in order to 
supply the parasites with purines. 
When imported, the nucleosides and nucleobases can be metabolised via several 
different ways. Nucleosides can be subjected to hydrolysis in which the N-glycosidic 
bond of purine and pyrimidine ribosides is hydrolysed to produce ribose and a 
respective nucleobase (Miller et al., 1984). A nonspecific nucleoside hydrolase was 
found up-regulated in the Δlmgt promastigotes by the 2D-DIGE analysis (in 
preparation) which is possibly involved in supplying the cells with higher amounts of 
ribose and/or nucleobases.  
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Figure IV-12. Schematic representation of purine metabolism in Δlmgt promastigotes 
incubated with 13C-D-glucose. Presented here are quantitative proteomic data. Specified with light blue 
arrows are the up-regulated enzymes while specified with pink arrows are the down-regulated enzymes. 
Abbreviations: Gn - guanine, Xn - xanthine, Hxn - hypoxanthine, An - adenine, Gs - guanosine, Xs - xanthosine, Is - 
inosine, As - adenosine, GMP - guanine 5’-monophosphate, GDP - guanosine 5’-diphosphate, GTP - guanosine 5’-
triphosphate, XMP - xanthosine 5’-monophosphate, IMP - inosine 5’-monophosphate, AMP - adenosine 5’-
monophosphate, ADP - adenosine 5’-diphosphate, ATP - adenosine 5’-triphosphate, DNA - deoxyribonucleic acid, 
RNA - ribonucleic acid, 5’-n - 5’-nucleosidase, AK - adenosine kinase, PNP - purine-nucleoside phosphorylase, GP - 
guanosone phosphorylase, GD - guanine deaminases, GMPS - GMP synthase, IMPD - IMP dehydrogenase, AMPD - 
AMP deaminases, XD - xanthine dehydrogenase, AD - adenine deaminases, APRT - adenine 
phosphoribosyltransferase, HGPRT - hypoxanthine-guanine phosphoribosyltransferase, XPRT - xanthine 
phosphoribosyltransferase.  
ADP 
ATP 
- Irreversible reaction 
- Reversible reaction 
- Up-regulated reaction 
- Down-regulated reaction 
- Heavy-labelled carbon 
- Unlabelled carbon 
- Phosphate 
- Not detected 
RNA 
DNA 
GDP 
GTP 
RNA
DNA 
   
                                                                                                                                                                                                CHAPTER IV 
 151 
 
At the same time, a nucleoside hydrolase-like protein was down-regulated which 
indicated that the Δlmgt promastigotes are tuning their enzyme activities in order to 
use certain substrates for the generation of specific nucleobases. For instance, the up-
regulated nonspecific nucleoside hydrolase (LmxM.18.1580) of L. mexicana is an 
ortholog/paralog to a putative inosine-guanine nucleoside hydrolase in L. braziliensis, 
L. infantum and L. major (TriTrypDB.org) and is most probably involved in inosine 
and guanine metabolism. The generated or imported nucleobases then can either be 
phosphorylated or deaminated. For instance, adenosine can be hydrolysed to adenine 
which can then be phosphorylated to AMP or deaminated first to hypoxanthine and 
then phosphorylated to IMP (Carter et al., 2008). Eventually, under the action of the 
glycosomal adenine phosphoribosyltransferase (APRT), hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT) and xanthine phosphoribosyltransferase 
(XPRT), the nucleobases adenine, guanine, hypoxanthine and xanthine can be 
converted to the nucleotides AMP, GMP, inosnine 5’-monophosphate (IMP) and 
xanthosine 5’-monophosphate (XMP), respectively (Colasante et al., 2006). APRT and 
XPRT, involved in adenine and guanine, and xanthine metabolism, respectively 
(Colasante et al., 2006), were down-regulated in the Δlmgt promastigotes. 
Additionally, an adenosine kinase, which reversibly phosphorylates adenosine to 
AMP, and a guanine deaminase, which converts guanine to xanthine, were also down-
regulated. Taken together, we could say:  
 that purine nucleotides are intermediates of significant importance for the 
Δlmgt promastigotes judging by the minimal heavy-labelling observed in some 
of them in condition *glc0 Δlmgt promastigotes (see IV.1.3.);  
 that purine salvage pathway is decreased in the Δlmgt promastigotes; 
 that the Δlmgt promastigotes recycle ribose via a nonspecific nucleoside 
hydrolases (see Pentose phosphate pathway). 
In contrast to purines, Leishmania are able to de novo synthesize pyrimidines from L-
glutamine, bicarbonate and L-aspartate (Opperdoes and Michels, 2008).  L-Glutamine 
was shown to be taken up by the Δlmgt promastigotes at an increased rate (Thesis: 
Lamasudin, 2012). The inability of Leishmania to convert L-glutamine into L-
glutamate, and thus be used a glucogenic precursor, means that the amino acid is 
used for biosynthetic purposes mainly. Of the five enzymes involved in the pyrimidine 
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synthesis, namely carbamoylphosphate synthase, aspartate carbamoyltransferase, 
dihydroorotase, dihydroorotate dehydrogenase and orotidine 5’-phosphate 
decarboxylase/orotate phosphoribosyltransferase, only a putative aspartate 
carbamoyltransferase, involved in the condensation of L-aspartate and carbamoyl-
phosphate into N-carbamoyl-L-aspartate, was found slightly down-regulated in the 
Δlmgt promastigotes (Supplemental table III-1). This indicates that the intial steps of 
the UMP synthesis are insignificantly down-regulated in the Δlmgt promastigotes. The 
slightly increased level of cytosine, a precursor for cytidine 5’-diphosphate (CDP) 
which is involved in phospholipid biosynthesis (see Phospholipid metabolism), thus 
could be accounted for uptake from the media, as it was observed in T. cruzi 
(Gutteridge and Gaborak, 1979). The minimal change in the activity of aspartate 
carbamoyltransferase and slightly different levels of orotate and cytosine in the Δlmgt 
promastigotes (Figure IV-3, E and F) compared to the wild type cells suggests that 
pyrimidine synthesis is not significantly affected by the deletion of the glucose 
transporters in the L. mexicana promastigotes. 
Lipid metabolism 
Fatty acid biosynthesis  
D-Glucose, L-proline and L-threonine were shown to be precursors, via acetyl-
CoA, for fatty acid (FA) biosynthesis in procyclic trypanosomes (Bringaud et al., 
2006). In Leishmania specifically are believed to operate two types of de novo FA 
synthesis - an unconventional FA elongation (FAE) and type II FA synthesis (FASII) 
(Ramakrishnan et al., 2013). The synthesis starts with the conjugation of two 
molecules of acetyl-CoA into a molecule of malonyl-CoA (Lee et al., 2006). Both 
pathways rely on consecutive addition of two carbon units from malonyl-CoA to a 
growing carboxylic chain. The difference between the two pathways is that the 
growing chain is held by a carrier, an acyl carrier protein (ACP) in the case of FASII 
and a primer in the case of FAE. The enzymes involved in the fatty acid synthesis are 
an acetyl-CoA carboxylase, a ketoacyl synthase, a ketoacyl reductase, a dehydratase 
and an enoyl-CoA reductase. Of the listed proteins, genes for an acyl carrier protein, a 
ketoacyl synthase and an enoyl-CoA reductase were found in the genome of L. major 
(Ramakrishnan et al., 2013). Our quantitative proteomic analysis revealed that only a 
putative β-ketoacyl-CoA reductase (3-ketoacyl-CoA reductase) was significantly up- 
regulated in the Δlmgt promastigotes (Supplemental table III-1).  
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Figure IV-13. Fatty acid elongation in trypanosomes. Specified with a light blue arrow is the up-
regulated reaction in the Δlmgt promastigotes. 
Credit: Lee et al., 2006 
 
β-Ketoacyl-CoA reductase catalyses the reduction of β-ketoacyl-CoA resulting from 
extending the growing acyl chain with two carbons (Figure IV-13) (Lee et al., 2006). 
The reduced β-ketoacyl-CoA is then dehydrated by a β-hydroxyacyl-CoA dehydrase 
and reduced again by an enoyl-CoA reductase. The four-step process yields a longer, 
saturated acyl-CoA. The longest fatty acid chain in trypanosomes can contain up to 18 
carbons (C18) but the presence of 12 tandemly linked homologous genes for 
elongases (ELOs) in L. major, compared to the four ELOs involved in fatty acid 
elongation in T. brucei, along with the presence of C22, C24 and C26 alkyl chains in 
LPG and C24 and C26 alkyl chains in gp63 suggest that Leishmania can synthesize 
longer fatty acids (Ferguson et al., 2009; Ramakrishnan et al., 2013). The long-chain 
fatty acids are the main precursors for the synthesis of phospholipids, sphingolipids 
and ergosterols. Fatty acid biosynthesis is thus important for the synthesis of a 
variety of lipids that are involved in the maintenance of the cellular integrity, which in 
turn was shown to be important for the proper functioning of the mitochondrial 
electron transport chain (ETC) in T. brucei (Guler et al., 2008). Only a single reaction 
of the fatty acid biosynthesis, however, was found regulated in the ∆lmgt 
promastigotes, namely the second step of the fatty acid elongation. In E. coli, the 
enzyme catalyzing the second step of the FA synthesis cannot be substituted by any 
other enzyme (Jansen and Steinbuchel, 2014). Additionally, β-ketoacyl-CoA reductase 
functions at the expence of NADPH (Figure IV-13).  
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Figure IV-14. β-Oxidation of fatty acids. Specified with a pink arrow is the down-regulated reaction in 
the Δlmgt promastigotes. 
Credit: oregonstate.edu 
 
 
NADPH is a crucial coenzyme for many cellular processes, including defense against 
oxidative stress via trypanothione (see Glutathione metabolism). The level of NADPH 
is presumably decreased in the glycosomes of the ∆lmgt promastigotes as a 
consequence of the suppressed oxidative phase of the pentose phosphate pathway 
which is responsible for the regeneration of NADPH (see Pentose phosphate 
pathway). It is not known whether the NADPH generated in the glycosomes could be 
directed towards redox reactions outside the glycosomes and vice versa, but it could 
not be excluded that other NADPH sources may also exist in the cells. The 
contribution of similar reactions in the maintenance of the glycosomal redox balance, 
however, is probably negligible. Thus, the up-regulation of β-ketoacyl-CoA reductase 
may suggest that the enzyme has a key role in fatty acid biosynthesis and could be 
linked to the up-regulated ETC in the ∆lmgt promastigotes. Though the evidence is 
based on up-regulation of a single enzyme, an increase in fatty acid synthesis in the 
∆lmgt promastigotes, in addition to the increased level of glycerol in these cells 
(Supplemental table III-2), supports the idea that, in addition to the short-term 
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carbohydrate reserve material mannogen, Leishmania can store fatty acids in the 
form of triglyceride, similar to T. cruzi (Rogerson and Gutteridge, 1980). This energy 
store, however, does not appear to be immediately used by the ∆lmgt promastigotes 
(see β-Oxidation of fatty acids) but it may have a function in the infectious forms of 
Leishmania, the amastigotes. 
In addition to saturated fatty acids, Leishmania are able synthesize unsaturated fatty 
acids as well (Lee et al., 2006). The unsaturated FAs are divided into mono- 
unsaturated (MUFA) and polyunsaturated (PUFA) FAs. The PUFA synthesis in 
Leishmania involves a stearoyl-CoA desaturase, two ELOs,  that is ∆6, which is specific 
for C18 PUFAs, and ∆5, which is specific for C20 PUFAs, and five  desaturases, namely 
∆12, ∆6, ∆5, ∆4, and ω3 (Tripodi et al., 2006; Livore et al., 2006; Uttaro, 2006). 
Leishmania are thought to be able to synthesize all the PUFAs they require by using 
the stearate generated in the FAE pathway as a precursor. Palmitate, stearate and 
oleate were found universally labelled in condition *glc0 wild type promastigotes 
grown under regular conditions (Figure IV-7). The labelling in conditions 2 - 10 wild 
type promastigotes was absent or negligible which showed that under nutrient-
restricted conditions the fatty acid synthesis in the wild type promastigotes is limited. 
On the other hand, minor labelling was observed in some unsaturated fatty acids in 
conditions glc+*pro, *pro, glc+*thr and *thr ∆lmgt promastigotes which showed 
that a small amount of L-proline and L-threonine are used as fatty acid precursors by 
the ∆lmgt promastigotes. 
β-Oxidation of fatty acids  
Sugar catabolism plays a central role in energy supply for Leishmania 
promastigotes. The main pathway performing the same function in amastigotes is β-
oxidation of fatty acids (Rosenzweig et al., 2008a; Brotherton et al., 2010). β-
Oxidation of fatty acids is another pathway that takes place in the glycosomes (Hart 
and Opperdoes, 1984; Berriman et al., 2005). It is believed, however, that the 
mitochondrion also plays a role in the process. How the two organelles contribute to 
the pathway, however, is still unknown.  
β-Oxidation of fatty acids involves the oxidation of fatty acids with different chain-
length to acetyl-CoA, NADH and FADH2. Acetyl-CoA can be oxidized in the TCA cycle 
(Saunders et al., 2014) while NADH and FAD2 can be directed to the electron 
transport chain for the generation of ATP. Four different chain-length fatty acyl-CoA 
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dehydrogenases are present in the Leishmania genome (Opperdoes and Michels, 
2008). Three of the acyl-CoA dehydrogenases have mitochondrial targeting signals. 
Bifunctional enzymes and thiolases are predicted to be present in the glycosomes and 
the mitochondrion as well. Leishmania are also predicted to be able to oxidize 
unsaturated fatty acids judging by the presence of genes encoding a 3,2-trans-enoyl-
CoA isomerise and 2,4-dienoyl-CoA reductase in the genome of L. major (Opperdoes 
and Michels, 2008). 
Palmitate, stearate and oleate, abundant in the serum supplementing culture media, 
are rapidly taken up by the L. mexicana amastigotes (Berman et al., 1987). 
Additionally, it was determined that the amastigotes are able to oxidize short-, 
medium- and long-chain fatty acids at a comparable rate which revealed that a large 
amount of energy could be generated via β-oxidation of fatty acids (Berman et al., 
1987). Due to the inability of the Δlmgt promastigotes to utilize exogenous 
carbohydrates, it could be assumed that besides amino acids, the ∆lmgt 
promastigotes would actively use fatty acids as energy sources as well. Surprisingly, 
our proteomic data disproved that assumption. The data revealed that the first and 
third steps of the β-oxidation of fatty acids, catalyzed by an acyl-CoA dehydrogenase 
and a short chain 3-hydroxyacyl-CoA dehydrogenase, respectively (Figure IV-19), 
were regulated in the ∆lmgt promastigotes but not significantly. The only enzyme of 
the β-oxidation pathway that was significantly modulated in the ∆lmgt promastigotes 
was a putative electron-transfer flavoprotein, α polypeptide (ETFA) which shuttles 
the electrons generated in the first step of the fatty acid oxidation to the membrane-
bound electron transfer flavoprotein:ubiquinone oxidoreductase (ETF-QO) of the 
mitochondrial respiratory chain which, in turn, transfers the electrons to the 
ubiquinone pool. The acyl-CoA dehydrogenase and the short chain 3-hydroxyacyl-
CoA dehydrogenase, included for illustrative purposes only, and the electron transfer 
protein were down-regulated in the ∆lmgt promastigotes. Thus, quite surprisingly, 
the decreased β-oxidation of fatty acids in the ∆lmgt promastigotes indicates that 
fatty acids do not appear to be energy sources for these cells. Instead, the fatty acids 
are probably used for the synthesis of the spectrum of phospholipids comprising the 
leishmanial membranes (see Phospholipid metabolism), for the synthesis of the lipid-
containing molecules anchoring proteins on the plasma membrane and for the 
synthesis of signalling molecules, all of which required for the parasite viability and 
infectivity.   
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Phospholipid metabolism 
Leishmania are able to utilize ether-lipids from the environment or synthesize 
them de novo (Opperdoes, 1984). The ether biosynthesis can occur via two pathways: 
the glycerol 3-phosphate (G3P) pathway or the dihydroxyacetone phosphate (DHAP) 
pathway.  A study by Heise and Opperdoes clarified that the ether-lipid biosynthesis 
in L. mexicana occurs via the DHAP pathway (Heise and Opperdoes, 1997). In the first 
three steps of the pathway DHAP is successively converted to 1-acyl-DHAP, 1-alkyl-
DHAP and 1-alkyl-glycerol 3-phosphate (G3P) by a DHAP acyltransferase (DHAPAT), 
a FAD-dependent alkyl DHAP synthase and an NADPH-dependent 1-alkyl/acyl DHAP 
reductase (Zufferey and Mamoun, 2006). Detected in the ∆lmgt promastigotes was 
only alkyl DHAP synthase which was found to be up-regulated (Supplemental table 
III-1). Although the three enzymes are sequestered in the glycosomes (Zufferey and 
Mamoun, 2006), alkyl DHAP synthase was found present in the insoluble fraction 
only, suggesting a high degree of hydrophobicity. Emanating from the essential role of 
DHAPAT for growth, survival during stationary phase, synthesis of ether lipids and 
virulence in L. major (Al-Ani et al., 2011), and the up-regulation of the alkyl DHAP 
synthase, we could allow ourselves to speculate again that, first, the reaction 
catalyzed by the alkyl DHAP synthase is the critical step in the ether-phospholipid 
biosynthesis in Leishmania and, second, that the pathway is increased in the ∆lmgt 
promastigotes. Ether lipids, in the form of 1-O-alkyl-glycerols, are components of a 
variety of glycoconjugates such as LPG, GILPs and GPI-anchored proteins (McConville 
and Ferguson, 1993). The down-regulated synthesis of GDP-Man, Dol-P-Man and 
UDP-Gal, involved in the synthesis of the glycan core of the GPI anchors (see Fructose 
and mannose and Galactose metabolism), along with the up-regulated alkyl DHAP 
synthase indicates that the bulk of ether lipids is not used for GPI anchor synthesis 
but it is possibly directed toward the synthesis of phospholipids. Ether-lipids are 
especially present in phosphatidylethanolamines (PEs) and phosphatidylserines 
(PSs). PEs, PSs, phosphatidylcholines (PCs) and phosphatidylinositol (PIs) constitute 
around 60-70% of Leishmania lipids (Zhang and Beverly, 2009 and the references 
therein). PCs are the most abundant phospholipids (30-40%) while PEs and PIs 
together comprise about 20% of the total cellular lipids (Zhang and Beverly, 2009).  
The first study on choline transport in Leishmania was reported by Zufferey and 
Mamoun in 2002.  They showed that L. major takes up choline via a carrier-mediated 
and Na+-independent process involving high affinity and high specificity 
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transporter(s) operating optimally at pH 7.5-8 (Zufferey and Mamoun, 2002). A year 
later, a study with fluorescent analogues of phosphatidylcholine (PC), phospha-
tidylethanolamine (PE), phosphatidylserine (PS) and sphingomyelin in L. infantum 
promastigotes revealed that PC, PE and PS are promptly taken up in a protein- and 
energy-dependent but temperature- and endocytosis-independent manner (Araujo-
Santos et al., 2003). In addition to taking up phospholipids such as PC, PE and PS, 
Leishmania are able to synthesize them. Phosphorylation of choline and ethanolamine 
to phosphocholine and phosphoethanolamine by a choline/ethanolamine kinase 
represents the first step of phospholipid biosynthesis via the Kennedy pathway 
(Gibellini et al., 2008; Kennedy and Weiss, 1956; Ramakrishnan et al., 2013). 
Phosphocholine and phosphoethanolamine were authentically identified and found 
increased in the ∆lmgt promastigotes compared to the wild type promastigotes 
(Figure IV-3, C and D). Phosphocholine and phosphoethanolamine are then activated 
to cytidine diphosphate (CDP)-choline and CDP-ethanolamine by a cholinephosphate 
cytidylyltransferase and ethanolaminephosphate cytidylyltransferase, respectively. In 
the ∆lmgt promastigotes, CDP-choline and CDP-ethanolamine were labelled only in 
the conditions with 13C-L-proline, which again confirmed the important function of L-
proline as a carbon source for the ∆lmgt promastigotes. Cytosine, a precursor for CDP, 
was also slightly increased in the ∆lmgt promastigotes (Figure IV-3, E).  
Altogether, the metabolomic data indicate that the ∆lmgt promastigotes still 
synthesize the precursors for PC and PE and that these precursors have increased 
levels in these cells. None of the proteins with known function modulated in the 
∆lmgt promastigotes belonged to the PC, PE, PI or PS synthesis (see Chapter I, 
I.1.5.4.3.). Although PCs and PEs are abundant glycerophospholipids in Leishmania, 
their role is not really known. PCs are possibly involved in defence against host 
oxidants (Zhang and Beverley, 2010). PIs are involved in the GPI anchor biosynthesis 
(Turco et al., 1989) and could be involved also in cell signalling and membrane 
trafficking. PSs facilitate the entry of the Leishmania promastigotes into the 
phagolysosomes and protect the cells from degradation by the host phagocytes 
(Zhang and Beverley, 2010 and the references therein). It appears that phospholipid 
synthesis is important for the ∆lmgt promastigotes, judging by the increased fatty 
acid and ether lipid biosynthesis and the increased levels of phosphocholine and 
phosphoethanolamine.  
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Figure IV-15. Sphingolipid biosynthesis in Saccharomyces cerevisiae. P - phosphate. 
Credit: Dickson, 2008 
 
It could be speculated that these macromolecules are important in maintaining the 
cellular integrity. Their specific role, however, is yet to be elucidated. 
Sphingolipid metabolism 
In addition to PC and PE, phosphocholine and phosphoethanolamine are also 
components of sphingomyelin. Leishmania, however, are not able to synthesize 
sphingomyelin or complex glycosphingolipids (Zhang and Beverley, 2010). Instead, 
they synthesize ceramides, unglycosylated inositol phosphorylceramide (IPC) and 
neutral glycosphingolipids (Zhang and Beverley, 2010 and the references therein). 
Myristoyl-CoA, which is believed to be preferentially utilized by Leishmania in the 
sphingolipid biosynthesis instead of palmitoyl-CoA (Hsu et al., 2007), the first enzyme 
of the sphingolipid biosynthesis, the PLP-dependent serine palmitoyltransferase 
which catalyzes the condensation of L-serine and myristoyl-CoA/palmytoil-CoA 
(Figure IV-15), as well as the rest of the enzymes of the pathway, were also not 
detected in the L. mexicana promastigotes. Two studies, focused on sphingolipid 
biosynthesis in Leishmania, were also not able to detect serine palmitoyltransferase 
subunit 2 which suggested that the biosynthetic pathway is down-regulated in 
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metacyclic promastigotes and amastigotes (Zhang et al., 2003; Denny et al., 2004). It 
was not evident from our data whether the sphingolipid synthesis was regulated in 
the ∆lmgt promastigotes or not.  
The other central intermediates in sphingolipid synthesis are ceramids (Figure IV-
15), composed of sphingosine and a fatty acid, while the end product of the synthesis, 
IPC, is comprised of a ceramide linked to an insitol phosphate. In fungi and 
Leishmania, IPC is a common sphingolipid but it is not present in mammals which 
makes it an interesting drug target (Zhang and Beverley, 2010 and the references 
therein). The majority of IPC in Leishmania is phosphoryl inositol N-
stearoylsphingosine (d18:1/18:0-IPC). The other IPC species present in these 
parasites is phosphoryl inositol N-stearoylhexadecesphing-4-enine (d16:1/18:0-IPC) 
(Zhang and Beverley, 2010). Other than that, little is known about the function of IPC. 
Up to date, there are no data suggesting that IPC can serve as an anchor for 
glycoconjugates. In general, one of the main roles of sphingolipids (of IPC mostly) is 
as structural components of the outer leaflet of the plasma membrane bilayer where 
they, along with sterols and GPI-anchored molecules, form specific sub-domains 
designated lipid rafts (Denny and Smith, 2004). In Plasmodium falciparum, another 
protozoan parasite that causes malaria in humans, lipid rafts are involved in 
parasitophorous vacuolar membrane biogenesis and trafficking of GPI-anchored 
proteins (Denny and Smith, 2004). It is not known yet whether lipid rafts have the 
same function in Leishmania or not. Besides structural role, sphingolipids such as 
sphingosine, sphingosine 1-phosphate, ceramide and ceramide 1-phosphate are 
involved in a number of signalling pathways including apoptosis, cell-to-cell 
recognition, growth and differentiation in mammalian cells (Zhang and Beverley, 
2010 and the references therein). It is believed that some of these molecules may 
have similar signalling function in Leishmania as well.  
IV.3. Summary 
Amino acids are alternative carbon and energy sources for many organisms. 
The uptake of amino acids such as L-glutamine, L-proline, and L-serine is increased in 
the glucose transporter null-mutant Leishmania. At the same time, the levels of L-
alanine, L-aspartate, L-asparagine, L-glutamate, L-glutamine, L-ornithine, and L-
proline are decreased in these organisms. These results indicate that the rate of 
utilization of amino acids by the Δlmgt promastigotes is increased.  
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Figure IV-16. Schematic representation of the changes in amino acid, energy, 
nucleotide and lipid metabolism in the Δlmgt promastigotes. Specified with blue arrows are 
the up-regulated enzymes while specified with red arrows are the down-regulated enzymes. Abbreviations: R5P – 
ribose 5-phosphate, DHAP - dihydroxyacetone phosphate, Gn - guanine, Xn - xanthine, An - adenine, As - 
adenosine, XMP - xanthosine 5’-monophosphate, IMP - inosine 5’-monophosphate, AMP - adenosine 5’-
monophosphate, ADP - adenosine 5’-diphosphate, ATP - adenosine 5’-triphosphate, GMP - guanosine 5’-
monophosphate, GDP - guanosine 5’-diphosphate, GTP - guanosine 5’-triphosphate, T(SH)2 - trypanothione, TS2 - 
trypanothione disulfide, NAD - nicotinamide adenine dinucleotide, NADP - nicotinamide adenine dinucleotide 
phosphate, FAD - flavin adenine dinucleotide, CoA - coenzyme A, Pi - inorganic phosphate, THF - tetrahydrofolate, 
H+ - proton, 3’-NT/NU - 3’-nucleotidase/nuclease, AK - adenosine kinase, GD - guanine deaminases, GMPS - GMP 
synthase, IMPD - IMP dehydrogenase, AMPD - AMP deaminases, XD - xanthine dehydrogenase, APRT - adenine 
phosphoribosyl-transferase, XPRT - xanthine phosphoribosyltransferase, β-KCR - β-ketoacyl-CoA reductase, ETF - 
electron-transfer flavoprotein, α polypeptide, TXN - tryparedoxin, MetE - 5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase, CSE - cystathionine γ-lyase, ALT - alanine aminotransferase, GDH - glutamate 
dehydrogenase, ARG - arginase, mALDH - mitochondrial aldehyde dehydrogenase, CS - citrate synthase, ODH1 -  2-
oxoglutarate dehydrogenase E1 component, ODH2 - 2-oxoglutarate dehydrogenase E2 component, SCL - succinyl-
CoA ligase, SCS - succinyl-CoA synthetase, SDF - succinate dehydrogenase flavoprotein, AS - acetyl-CoA synthetase, 
ASCT - acetate:succinate CoA transferase. 
 
This observation is further strengthened by the up-regulation of a number of 
enzymes that facilitate the entry of ketogenic and glucogenic amino acids, through 
acetyl-CoA and α-ketoglutarate, respectively, in the TCA cycle (Figure IV-16). On the 
other hand, some enzymes that fuel amino acids, such as L-aspartate and L-alanine, 
into gluconeogenesis and the gluconeogenesis itself are down-regulated which shows 
that a major part of the amino acids is used by the Δlmgt promastigotes for energy 
production and only a minor part for biosynthesis. Further to that, our data illustrate 
that alternative amino acid pathways for energy production and biosynthesis are 
activated in the Δlmgt promastigotes. L-Arginine, for instance, may not be the only 
precursor for L-ornitine. L-Glutamate, through N-acetyl-L-glutamate and N-acetyl-L-
ornithine, may also be a source for L-ornithine and polyamines. L-Proline, through L-
glutamate or 4-aminobutanoate (GABA) and succinate, may be fed into the TCA cycle 
and used both as a carbon and energy source.  L-Glutamine, similarly, may be fed into 
the TCA cycle via α-ketoglutaramate and α-ketoglutarate. L-Glutamine, furthermore, 
is utilized as a pyrimidine precursor by the Leishmania parasites. Our data showed 
that pyrimidine metabolism is not significantly modulated in the Δlmgt parasites. A 
significant number of enzymes of the purine salvage pathway, however, have altered 
expression in the Δlmgt promastigotes. The formation of nucleotides such AMP, GMP 
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and XMP is down-regulated which can affect i/ ATP synthesis, ii/ RNA and DNA 
synthesis, iii/ coenzyme synthesis, iv/ cyclic AMP and GMP synthesis, and v/ protein 
synthesis. It is evident from our proteomic data that a large number of enzymes 
involved in RNA and DNA synthesis and metabolism, and protein synthesis are down-
regulated in the Δlmgt promastigotes. Taken together, the data indicate that the Δlmgt 
promastigotes reduce energy-consuming processes such as RNA, DNA, and protein 
synthesis, while up-regulate energy generation through the electron transport chain 
and oxidative phosphorylation. Finally, our lipidomic study showed minimal changes 
in lipid metabolism in the Δlmgt promastigotes. Altogether, the data revealed that the 
Δlmgt promastigotes i/ have significantly decreased thiol-redox system, ii/ have 
decreased amino acid biosynthetic capacity, iii/ use exogenous amino acids as main 
alternative energy and carbon sources, iv/ use L-threonine as a main source of 
acetate, v/ use L-proline as a major carbon and energy source, vi/ use the TCA cycle, 
electron transport chain, and oxidative phosphorylation for energy production via 
amino acid catabolism, and vii/ use lipids as biosynthetic precursors but not as 
energy sources. Our proteomic and metabolomic analysis of the Δlmgt promastigotes 
thus showed that carbohydrate, amino acid, and energy metabolism are intimately 
linked in Leishmania, as in many other organisms. At the same time, these organisms 
appear not to use lipids as alternative energy sources when carbohydrates are not 
available. Utilization of exogenous lipids is yet to be thoroughly investigated in 
Lesihmania, however. Nonetheless, our data demostrate that Leishmania are still 
considerably flexible in terms of coping with changes in nutrient availability but, at 
the same time, unconventional in terms of carbon preferences which could be a 
fruitfulll ground for drug target hunting (see Chapter VI). 
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CHAPTER V.   Quantitative characterization of Δlmgt 
promastigotes by stable isotope labelling by amino acids in cell 
culture and global metabolomics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
In the field of proteomics, stable isotope labelling by amino acids in cell culture 
(SILAC) (Ong et al., 2002), combined with mass spectrometry (MS), has emerged as a 
promising methodology for obtaining quantitative proteomic information. The 
approach relies on complete metabolic incorporation of stable isotope amino acids 
into proteins during protein turnover. The metabolic labelling at the protein and 
organism level thus provides high-confidence quantitative information. Considering 
these advantages, SILAC was chosen as a suitable approach to fulfil one of the main 
objectives of this study: to identify and quantify the proteins that are differentially 
expressed in ∆lmgt promastigotes.  
SILAC depends upon efficient incorporation of labelled amino acids into the 
proteome. This requires that the biological system of interest is 
 auxotrophic for the chosen labelled amino acids 
 does not significantly metabolize or transaminate the chosen labelled amino 
acids 
 is able to grow in a defined media or media supplemented with serum that has 
been dialyzed to deplete unlabelled amino acids. 
These requirements are often overlooked in discussions of the utility of SILAC as a 
quantitative proteomic approach. In practice, most cells can be adapted to grow in 
SILAC-compatible media, but the consequences of this selection are rarely discussed. 
One possible adaptation is a biochemical remodeling that may result in an altered 
phenotype, and that may also compromise protein labelling efficiency.  
SILAC has been successfully applied to trypanosomatids, yet not as extensively as it 
has been to mammalian cells. To date, five studies have applied SILAC to Trypanosma 
and four to Leishmania. Two studies investigated the proteome remodelling in T. 
brucei during differentiation from bloodstream to procyclic forms (Urbaniak et al., 
2012; Gunasekera et al., 2012). The first study compared the long slender and 
procyclic forms while the second study followed the development of long slender to 
short stumpy forms and from short stumpy to procyclic forms. Both studies 
corroborated with each other on the observation that expression of the mitochondrial 
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proteins is higher in the procyclic forms. Later on, Urbaniak and colleagues 
investigated the specificities of the phosphoproteome of T. brucei bloodstream and 
procyclic forms (Urbaniak et al., 2013) while a separate study focused on the 
mitochondrial translation elongation factor-Tu in T. brucei (Cristodero et al., 2013). 
Finally, in their most recent study, Ferguson and colleagues employed SILAC to 
investigate the glycosome proteome of procyclic forms of T. brucei (Guther et al., 
2014). The isotope labelling technique was used in combination with epitope-tagging 
and magnetic bead pull-out assay which generated high-confidence data and allowed 
unambiguous identification of a high number of glycosomal proteins. Besides the 
seven glycolytic proteins, from hexokinase (HK) to phosphoglycerate kinase (PGK), 
the study confirmed the presence of enzymes belonging to the glycosomal glycerol 3-
phosphate/dihydroxyacetone phosphate (G3P/DHAP) shuttle, β-oxidation of fatty 
acids, ether-lpid synthesis, isoprenoid/sterol synthesis, methylglyoxal pathway, 
nucleotide sugar metabolism, purine salvage pathway, pyrimidine biosynthesis, 
peroxide and superoxide inactivation system and a number of Pex proteins and such 
involved in post-translational modifications and protein folding (Guther et al., 2014). 
With regard to Leishmania, three of the four studies have used SILAC to investigate 
drug-resistant strains of Leishmania, namely a paromomycin resistant strain of L. 
donovani (Chawla et al., 2011), an antimony resistant strain of L. infantum 
(Brotherton et al., 2013) and an amphotericin B resistant strain of L. infantum 
(Brotherton et al., 2014), while the fourth study provided thorough information about 
the L. donovani secretome (Silverman et al., 2008). The subject of interest of our 
study, however, was L. mexicana in which SILAC studies have not previously been 
reported. Thus, we had to develop a SILAC-based strategy for the analysis of the L. 
mexicana promastigotes (Figure II-1). The development and application of a SILAC-
based methodology to the L. mexicana wild type and ∆lmgt promastigotes, however, 
proved to be challenging for a number of reasons. The labelled amino acids that are 
routinely employed in SILAC studies are L-lysine and L-arginine, because these are 
the sites at which trypsin cleaves proteins, so the tryptic peptide produced should 
each carry one labelled amino acid. However, it is evident from previous studies that 
Leishmania are capable of metabolising exogenously acquired L-arginine (Kandpal et 
al., 1995; Colotti and Ilari, 2011). Thus, we elected to label parasites with L-lysine 
only in our experiments. Initially, we observed severly reduced growth of the wild 
type and ∆lmgt promastigotes in media supplemented with dialysed serum and it was 
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necessary to optomise serum dialysis conditions and to adapt the promastigotes to 
the SILAC culture media. After successfully adapting and growing the promastigotes 
in the SILAC media for more than 2-3 times the recommended minimum, we analyzed 
the SILAC-labelled protein samples by MS. The generated data provided surprising 
information for both the applicability of the SILAC method to the L. mexicana 
promastigotes and for understanding L-lysine metabolism.  
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V.1.   Results 
V.1.1.   Global proteomic characterization of Δlmgt promastigotes by 
stable isotope labelling by amino acids in cell culture 
V.1.1.1.  Growth of Δlmgt promastigotes in SILAC media 
Growth profiles of the wild type and ∆lmgt promastigotes (biological 
replicates, n=3) were investigated under regular culture conditions (as described in 
II.1.) in three media: HOMEM supplemented with 10% heat-inactivated fetal bovine 
serum (iFBS), RPMI 1640 supplemented with 10% iFBS, and light and heavy RPMI 
1640 supplemented with 10% 3.5K molecular weight cut-off (MWCO) dialyzed iFBS 
(DS). In accordance with previous observations (Burchmore et al., 2003), the ∆lmgt 
promastigotes grew slower and to a lower cell density compared to the wild type 
promastigotes when cultured in HOMEM with 10% iFBS (Figure V-1). To ensure full 
incorporation of the isotope-labelled L-lysine, both strains were adaptated to RPMI 
1640 with 10% DS for two passages before being trnasferred, at initial density of 1.0 
x 105 cells ml-1, to light and heavy RPMI 1640 with 10% DS. In the first passage, the 
wild type promastigotes reached a slightly higher average cell density in the light 
cultures compared to the heavy ones  (Figures V-2, A and V-3, A). In the second 
passage, after an initial drop, the promastigotes showed a slight recovery in growth 
but started dying quickly afterwards (Figures V-2, B and V-3, B). The light and heavy 
∆lmgt promastigotes gradually died out after the initiation (Figures V-2, C and V-3, C). 
To overcome the poor growth of promastigotes in the SILAC media, the initial cell 
density was increased from 1.0 x 105 cells ml-1 to 1.0 x 106 cells ml-1. Additionally, to 
ensure proper adaptation to the DS and establish stable cultures, the wild type and 
∆lmgt promastgotes were maintained for two passages in RPMI 1640 with DS with 
four changes of the fresh media. In the first passage, the wild type promastigotes 
doubled once, presumably as a result of metabolism of residual compounds from the 
non-dialysed serum, while the ∆lmgt promastigotes did not. After the initial growth of 
the wild type promastigotes, both cell lines entered a “shock” phase where the 
promastigotes stayed viable but did not multiply for a long period of time. That 
imposed the neccesity to supply fresh nutrients by changing the culture media. The 
culture media of the wild type promastigotes was changed three time for the period 
of slightly over a month after the initiation of the adaptation cultures whereas that of 
the ∆lmgt promastigotes was changed two times. Gradually, the promastigotes exited 
the shock stage and started dividing slowly.  
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Figure V-1. Growth rate of wild type and ∆lmgt promastigotes in HOMEM media
supplemented with 10% heat-inactivated fetal bovine serum. Wild type (WT) (black line, 
squares) and ∆lmgt (grey line, dots) promastigotes were grown in HOMEM media supplemented with 10% 
serum. Growth curve time point values are the mean values from three biological replicates. Error bars represent 
the standard deviation. 
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Figure V-2. Growth rate of wild type and ∆lmgt promastigotes in light RPMI 1640 
media supplemented with 10% dialyzed serum. First (A) and second (B) passage of wild type 
(WT) promastigotes (black line, squares) in light RPMI 1640 media supplemented with 10% 3.5K MWCO dialyzed 
serum. First (C) passage of ∆lmgt promastigotes (grey line, dots) in light RPMI 1640 media supplemented with 
10% 3.5K MWCO dialyzed serum. Growth curve time point values are the mean values from three biological 
replicates. Error bars represent the standard deviation. MWCO – molecular weight cut-off. 
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Figure V-3. Growth rate of wild type and ∆lmgt promastigotes in heavy RPMI 1640 
media supplemented with 10% dialyzed serum. First (A) and second (B) passage of wild type 
(WT) promastigotes (black line, squares) in heavy RPMI 1640 media supplemented with 10% 3.5K MWCO 
dialyzed serum. First (C) passage of ∆lmgt promastigotes (grey line, dots) in heavy RPMI 1640 media 
supplemented with 10% 3.5K MWCO dialyzed serum. Growth curve time point values are the mean values from 
three biological replicates. Error bars represent the standard deviation. MWCO – molecular weight cut-off. 
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Figure V-4. Growth rate of adapted to dialyzed serum wild type and ∆lmgt 
promastigotes in SILAC media. Wild type promastigotes (black line, squares) were grown in light RPMI 
1640 media supplemented with 10% 3.5K MWCO dialyzed serum. ∆lmgt promastigotes (grey line, dots) were 
grown in heavy RPMI 1640 media supplemented with 10% 3.5K MWCO dialyzed serum. Growth curve time point 
values are the mean values from three biological replicates. Error bars represent the standard deviation. MWCO – 
molecular weight cut-off. 
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Not unexpectedly, the wild type started proliferating sooner than the ∆lmgt 
promastigotes. When both cell lines reached mid-log phase, the promastigotes were 
passaged, at initial cell density of 1.0 x 106 cells ml-1, to fresh RPMI 1640 with DS. In 
the second passage, the promastigotes multiplied for another half a month, with a 
single change of the media. When the promastigotes reached mid-log phase again, the 
wild type promastigotes were transferred to light SILAC media with DS while the 
∆lmgt promastigotes were transferred to the heavy SILAC media with DS. In the 
SILAC media, the adapted promastigotes were cultured for six consequent passages. 
Between 7 and 8 days were necessary for the ∆lmgt promastigotes to double twice in 
the heavy RPMI 1640 in the first three passages. Gradually, the growth rate of the 
∆lmgt promastigotes increased, reaching approximately three doublings for the 
period of six days in the last passage (Figure V-4). The growth rate of the wild type 
promastigotes increased from approximately two and a half doublings in the first 
passages to three and a half in the last passages (Figure V-4).  Thus, the ∆lmgt 
promastigotes were cultured in the SILAC media for more than twice the 
recommended minimum of six doublings while the wild type were cultured for more 
than three times. 
V.1.1.2.   Examination of SILAC labelling efficiency in Leishmania    
mexicana promastigotes  
The incorporation efficiency of the heavy L-lysine was first investigated in the 
∆lmgt promastigotes. However, the unexpected results led to investigating the heavy 
L-lysine labelling efficiency in the wild type promastigotes as well. 
Initially, 10 µg of heavy-labelled proteins derived from the ∆lmgt promastigotes were 
subjected to digestion and analysis by 1D HPLC-ESI-MS/MS. Identified with 
MaxQuant (MQ) were 905, 891 and 697 proteins in sample I, II and III, respectively 
(Table V-1, top table). Slightly less proteins were found with Mascot Distiller (MD), i.e. 
786, 760 and 625 in sample I, II and III, respectively (Table V-1, bottom table). 
Evident from the Mascot search was that: 
 most of the peptides cut after L-arginine (R) (Figure V-5) did not 
contain L-lysine (K) and were therefore not used for quantitation; 
 many peptides cut after L-lysine or L-lysine-containing peptides were 
not heavy-labelled (Figure V-5). 
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 Identified 
proteins 
Modulated  
proteins 
Up-regulated 
proteins 
Down-regulated 
proteins 
Sample I 905 222 156 66 
Sample II 891 201 187 14 
Sample III 697 168 128 40 
  
 
 Identified 
proteins 
idFDR 
% 
h/iFDR 
% 
Quantified 
proteins 
Modulated 
proteins 
Up-
regulated 
proteins 
Down-
regulated 
proteins 
Sample I 786 0.23 1.39 129 35 33 2 
Sample II 760 0.20 1.62 119 43 43 0 
Sample III 613 0.24 1.43 84 21 21 0 
  
Table V-1. Identified, quantified and significantly modulated heavy-labelled proteins 
in the ∆lmgt promastigotes. Heavy-labelled proteins from ∆lmgt promastigotes (biological replicates, 
n=3) were digested with trypsin prior to analysis by 1D-HPLC-ESI-MS/MS. The data were analysed with MaxQuant 
(top table) and Mascot Distiller (bottom table). 
 
 
That led to further analysis of the raw MS data, determination of the incorporation 
efficiency by MQ and quantitative analysis of the heavy data by MD and MQ. Analysis 
of the raw MS data confirmed the presence of unlabelled and heavy-labelled peptides 
in the heavy samples (Figure V-5), noticeably exemplified by the doubly-charged 
QLFNPEQLVSGK peptide of α-tubulin (LmxM.13.0280) which was found in two forms,  
light and heavy, with m/z of 680.3669 and 683.3763, respectively (Figure V-6). Next, 
we used MQ and R to estimate the labelling efficiency in the ∆lmgt promastigotes. The 
analysis revealed that only half (52.1%) of the peptides were heavy labelled (Figure 
V-7, A). To illustrate the partial incorporation of the heavy L-lysine, we performed 
protein quantitation with the data from the ∆lmgt heavy samples generated by MD 
and MQ. The analysis, which was performed with the same settings and parameters 
that are used for analysis of tcombined light/heavy samples, showed that a 
considerable number of proteins were significantly modulated in the heavy I, II and 
III (Table V-1).  
Mascot Distiller 
MaxQuant 
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Figure V-5. Partial peptide summary of heat shock protein 70 identified as protein hit 
#1 in the heavy SILAC sample I. Reported are: the accession number of enolase: LmxM.28.2770, the 
expected protein mass: 71482 kDa, the overall protein score: 2481, the number of MS/MS spectra match to the 
protein: 74, the number of sequences matched to the protein: 25, the observed peptide mass, the number of 
misscleavages, the peptide score, the unique peptides, the peptide sequence, and the peptide modifications. 
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Figure V-6. Chromatogram of the doubly charged species of the peptide 
QLFNPEQLVSGK of α-tubulin in the heavy SILAC sample I. Presented here is an example of a 
light and a heavy form of a peptide in the heavy SILAC sample I. Reported are: the accession number of α-tubulin: 
LmxM.13.0280, the expected protein mass: 61058 kDa, the overall protein score: 2153, the number of MS/MS 
spectra match to the protein: 59, the number of sequences matched to the protein: 16, the query, the observed 
peptide mass, the peptide score, the unique peptides, the peptide sequence, and the peptide modifications.  
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Figure V-7. SILAC labelling efficiency in the Leishmania mexicana promastigotes. 13C-L-
lysine labelling efficiency in the ∆lmgt (A) and wild type (B) promastigotes. The ∆lmgt and wild type 
promastigotes were grown in heavy SILAC media supplemented with 3.5 kDa MWCO serum. The heavy-labelled 
proteins were extracted and subjected to digestion with trypsin, analysis of the peptide samples by 1D-HPLC-ESI-
MS/MS and analysis of the data by MaxQuant and R (as described in II.1.8.). The incorporation curve represents 
the distribution of the quantified peptides. The incorporation (in percents) was calculated according to the 
following equasion: peptide incorporation = 1- 1/(Ratio Heavy/Light + 1). Density is an arbitrary unit.  
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Except for one protein in sample I and II, which was significantly modulated (that is, 
had a fold-change above 2), all quantified proteins were insignificantly modulated. 
That again underlined the incomplete labelling efficiency in the heavy samples. 
Complete (>98%) labelling efficiency is a prerequisite for accurate quantitation based 
on isotope labelling and would be evident in detection of a minimal number of 
unlabelled peptides in the labelled samples. Our analysis of the heavy samples, 
however, showed that many peptides were unlabelled, despite maintenance of the 
promastigotes for many divisions in media where all L-lysine was heavy labelled. 
Taken together, our proteomic data (together with further metabolomic data 
presented in V.1.3.) suggested that L. mexicana promastigotes may not be auxotrphic 
for L-lysine. 
To exclude the possibility that the observed partial incorporation in the ∆lmgt 
promastigotes was due to metabolic adaptations resulting from deletion of D-glucose 
transport capacity, we grew wild type promastigotes in heavy SILAC media and 
estimated the labelling efficiency in the wild cell line as well. Analysis of the raw MS 
data revealed that many of the peptides were not labelled. Additionally, the labelling 
efficiency was determined to be pretty much the same as that in the ∆lmgt 
promastigotes (Figure V-7, B). That confirmed that L-lysine was incorporated into 
proteins in the same way in the wild type and ∆lmgt promastigotes. It also, however, 
raised the question of what exactly was the fate of this amino acid in the Leishmania 
promastigotes.  
V.1.2.   Global metabolomic characterization of SILAC-labelled Δlmgt 
promastigotes 
As a metabolic labelling technique, SILAC relies on in vivo incorporation of 
exogenously supplied stable isotope amino labelled acids into proteins. To avoid the 
incorporation of unlabelled amino acids, SILAC requires the use of defined medium, 
supplemented if necessary with serum that has been dialyzed to deplete amino acids. 
That in turn requires the cells under investigation to be grown in different that the 
regular culturing conditions. As described in V.1.1.1., the growth of the wild type and 
∆lmgt promastigotes was initially impaired when the promastigotes were cultured in 
media with dialyzed serum (Figures V-2 and V-3). Eventually, the promastigotes 
adapted to the dialyzed serum and grew in the SILAC media. Adaptation, however, 
was most probably associated with modulations in the cell metabolism.  
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Figure V-8. Distribution of the significantly modulated metabolites in the SILAC-
labelled ∆lmgt promastigotes (A) and spent media (B). SM - secondary metabolites, C - cofactors, 
V – vitamins, UF – unassigned function. 
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   Putative metabolite                               Map                        Pathway               WT   ∆lmgt 
 
Nonaprenyl-4-
hydroxybenzoate 
2 
Metabolism of Cofactors 
and Vitamins 
Ubiquinone-9 
biosynthesis  
1.00 20.28 
PC(18:4(6Z,9Z,12Z,15Z)/18:
4(6Z,9Z,12Z,15Z)) 
8 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 5.99 
[SP hydroxy(16:0)] N-
(hexadecanoyl)-4S-
hydroxysphinganine 
1 Lipids: Sphingolipids Ceramides 1.00 3.53 
[PC (22:6/22:6)] 1,2-di-
(4Z,7Z,10Z,13Z,16Z,19Z-
docosahexaenoyl)-sn-
glycero-3-phosphocholine 
3 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 3.42 
[FA methyl, hydroxy(5:0)] 
3R-methyl-3,5-dihydroxy-
pentanoic acid 
14 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
1.00 3.34 
PC(14:1(9Z)/22:6(4Z,7Z,10Z
,13Z,16Z,19Z)) 
8 
Lipids: 
Glycerophospholipids 
Glycerophosphocholines 1.00 3.32 
Sorbate 19 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
1.00 3.24 
PE(18:3(6Z,9Z,12Z)/P-
18:1(11Z)) 
15 
Lipids: 
Glycerophospholipids 
Glycerophosphoethanola
mines 
1.00 3.18 
 
Table V-2. Significantly increased metabolites in the SILAC-labelled ∆lmgt 
promastigotes. Specified in yellow, metabolites involved in metabolism of cofactors and vitamins, and in 
green, metabolites involved in lipid metabolism. Metabolites with unassigned function are not included. 
 
 
 
 
 
 
 
 
 
 
 
 
Is
o
m
er
s 
   
                                                                                                                                                                                                 CHAPTER V 
 180 
 
 
   Putative metabolite                               Map                        Pathway                WT   ∆lmgt 
 
Tetradecanoic acid 23 Lipid Metabolism Fatty acid biosynthesis 1.00 0.20 
L-Glutamate 14 Amino Acid Metabolism 
Arginine and proline 
metabolism 
Glutamate metabolism 
Nitrogen metabolism 
1.00 0.19 
3-Phospho-D-glycerate 3 
Carbohydrate 
Metabolism 
Glycolysis / 
Gluconeogenesis 
Glycerolipid metabolism 
1.00 0.18 
Nicotinamide 4 
Metabolism of Cofactors 
and Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
1.00 0.17 
Glutathione disulfide 1 Amino Acid Metabolism 
Glutamate metabolism 
Glutathione metabolism 
1.00 0.17 
ATP 4 Energy Metabolism 
Oxidative 
phosphorylation 
Purine metabolism 
1.00 0.15 
Lys-Lys 1 Peptide(di-) Basic peptide 1.00 0.15 
Asp-Phe-Cys-Tyr 1 Peptide(tetra-) Hydrophobic peptide 1.00 0.13 
Cellohexaose 3 
Carbohydrate 
Metabolism 
Starch and sucrose 
metabolism 
1.00 0.12 
Cellopentaose 4 
Carbohydrate 
Metabolism 
Starch and sucrose 
metabolism 
1.00 0.12 
[PR] (-)-Limonene 39 Lipids: Prenols 
Monoterpenoid 
biosynthesis 
Limonene and pinene 
degradation 
1.00 0.11 
[FA (18:3)] 13S-
hydroperoxy-9Z,11E,14Z-
octadecatrienoic acid 
20 Lipids: Fatty Acyls 
Fatty Acids and 
Conjugates 
1.00 0.10 
Ethanolamine phosphate 2 Lipid Metabolism 
Glycerophospholipid 
metabolism 
Sphingolipid metabolism 
1.00 0.10 
Asp-Lys-Trp-Pro 3 Peptide(tetra-) Basic peptide 1.00 0.09 
[FA (16:0)] N-hexadecanoyl-
glycine 
2 Lipids: Fatty Acyls Fatty amides 1.00 0.08 
[PR] (+)-Longifolene 151 Lipids: Prenols 
Oleoresin turpentine 
biosynthesis 
1.00 0.07 
Sucrose 42 
Carbohydrate 
Metabolism 
Galactose metabolism 
Starch and sucrose 
metabolism 
1.00 0.03 
 
Table V-3. Significantly decreased metabolites in the SILAC-labelled ∆lmgt 
promastigotes. Specified in blue are metabolites involved in amino acid metabolism, in pink, metabolits 
involved in carbohydrate metabolism, in yellow, metabolites involved in metabolism of cofactors and vitamins, in 
green, metabolites involved in lipid metabolism, in brown, peptide, and in violet, metabolites involved in energy 
metabolisms. Specified in yellow are the metabolites matched to authentic standards. 
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   Putative metabolite                               Map                      Pathway                 WT   ∆lmgt 
 
Cholate 82 Lipids: Sterol lipids Bile acid biosynthesis ND 27.55* 
SM(d16:1/18:1) 3 Lipids: Sphingolipids Phosphosphingolipids ND 16.41* 
Docosahexaenoicacid 11 Lipids: Fatty Acyls 
Biosynthesis of unsaturated 
fatty acids 
1.00 9.86 
Leu-Arg 2 Peptide(di-) Basic peptide 1.00 8.48 
Nicotinate 4 
Metabolism of 
Cofactors and 
Vitamins 
Nicotinate and 
nicotinamide metabolism 
Alkaloid biosynthesis II 
1.00 7.63 
[FA (20:4)] 5Z,8Z,11Z,14Z-
eicosatetraenoic acid 
46 Lipids: Fatty Acyls Fatty Acids and Conjugates 1.00 6.31 
Glu-Gln-Gln-Tyr 1 Peptide(tetra-) Hydrophobic peptide 1.00 6.21 
sn-glycero-3-
Phosphocholine 
1 Lipid Metabolism 
Glycerophospholipid 
metabolism 
Ether lipid metabolism 
1.00 6.13 
3-(4-Hydroxyphenyl) 
pyruvate 
11 
Amino Acid 
Metabolism 
Tyrosine metabolism 
Phenylalanine, tyrosine and 
tryptophan  
1.00 3.74 
 
Table V-4. Significantly increased metabolites in the SILAC-labelled ∆lmgt 
promastigote spent media. Specified in yellow are metabolites involved in metabolism of cofactors and 
vitamins, in green, metabolites involved in lipid metabolism, in blue, metabolites involved in amino acid 
metabolism, and in brown, peptides. Specified in yellow are the metabolites matched to authentic standards. 
Metabolites with unassigned function are not included. 
* - Metabolite detected in the ∆lmgt test samples and not detected (ND) in the wild type control samples are 
denoted by the control group having ND as a descriptor. The value in the ∆lmgt column is the average intensity of 
the compound in the ∆lmgt samples. 
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   Putative metabolite                               Map                        Pathway               WT   ∆lmgt 
 
Fumarate 3 
Carbohydrate 
Metabolism 
TCA cycle 
Oxidative 
phosphorylation 
1.00 0.27 
[PR] (+)-Longifolene 151 Lipids: Prenols 
Oleoresin turpentine 
biosynthesis 
1.00 0.25 
 
L-Citrulline 
3 Amino Acid Metabolism 
Arginine and proline 
metabolism 
1.00 0.22 
Malate 4 
Carbohydrate 
Metabolism 
TCA cycle 
Glutamate metabolism 
Alanine and aspartate 
metabolism 
Pyruvate metabolism 
Glyoxylate and 
dicarboxylate 
metabolism 
Carbon fixation 
1.00 0.21 
Asp-Cys-Cys-Ser 2 Peptide(tetra-) Acidic peptide 1.00 0.21 
D-Lysine 8 Amino Acid Metabolism Lysine degradation 1.00 0.21 
Nicotinamide 4 
Metabolism of Cofactors 
and Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
1.00 0.08 
Sucrose 42 
Carbohydrate 
Metabolism  
1.00 0.06 
 
Table V-5. Significantly decreased metabolites in the SILAC-labelled ∆lmgt 
promastigote spent media. Specified in blue are metabolites involved in amino acid metabolism, in pink, 
metabolits involved in carbohydrate metabolism, in green, metabolites involved in lipid metabolism, in yellow, 
metabolites involved in metabolism of cofactors and vitamins, and in brown, peptides. Specified in yellow are the 
metabolites matched to authentic standards. Metabolites with unassigned function are not included. 
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     Putative metabolite               WT    ∆lmgt        Putative metabolite              WT   ∆lmgt 
 
L-Alanine 1.00 0.37 L-Alanine 1.00 0.22 
L-Asparagine 1.00 0.42 L-Asparagine 1.00 0.68 
L-Glutamate 1.00 0.19 L-Glutamate 1.00 0.32 
Malate 1.00 0.28 Malate 1.00 0.51 
Succinate 1.00 0.32 Succinate 1.00 0.11 
 
Table V-6. Metabolic comparison between regular and SILAC-labelled Δlmgt 
promastigotes. Significantly modulated cell metabolites in the SILAC (left side) and regular (right side) global 
metabolomics data sets. 
 
 
To compare the metabolomes of the wild type and ∆lmgt promastigotes grown under 
SILAC conditions and detect possible metabolic changes, we have subjected the 
SILAC-labelled promastigotes to a global metabolomic analysis by 1D LC-MS/MS and 
analysis of the generated data with IDEOM (Creek et al., 2012). 956 metabolites were 
identified in total. 122 metabolites were statistically significant (with p<0.05 and a 
fold-change equal or above 2) in the cells. 16 of the significant cell metabolites were 
identified against authentic standards. 32 metabolites were significant in the spent 
media. 10 of the significant spent medium metabolites were authentically identified. 
The rest of the metabolites were putatively identified. The cell metabolites were 
grouped in the 8 categories: amino acid metabolism, carbohydrate metabolism, 
energy metabolism, lipid metabolism, metabolism of cofactors and vitamins, 
nucleotide metabolism, peptides and metabolites with unassigned function (Figure V-
8). The four large categories of significantly modulated metabolites in the cells were 
amino acids, lipids, peptides and metabolites with unassigned function (Figures V-8, 
A) while amino acids and lipids dominated the metabolites in the spent media (Figure 
V-8, B). A number of lipids were increased in the SILAC ∆lmgt promastigotes (Table V-
2). Significantly (>5- fold) decreased in the ∆lmgt promastigotes were L-citrulline, 
orotate, UDP-glucose, UDP-N-acetyl-D-glucosamine, sedoheptulose 7-phosphate, 
glucose 6-phsophate, 3-phosphoglycerate, phosphoenolpyruvate, succinate, malate, 
fumarate, L-glutamate, L-threonine, L-alanine, L-asparagine, L-ornithine, ovothiol A 
disulfide, trypanothione disulfide, glutathione disulfide, nicotinamide, ATP, 
phosphoethanolamine, cellohexaose and cellopentaose (Table V-3; Supplemental 
                       SILAC                                                               Regular metabolomics                              
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table V-1). Sucrose was 50-fold decreased in the ∆lmgt promastigotes (Table V-3). 
Nicotinate and glycerol-3-phosphocholine were among the increased metabolites in 
the ∆lmgt spent media (Table V-3) whereas fumarate, malate, L-citrulline and D-
lysine were significantly decreased. Highly decreased in the ∆lmgt spent media were 
nicotinamide and sucrose (Table V-4).   
To elucidate any differences in the SILAC ∆lmgt promastigote metabolism, we 
compared the regular metabolomic data described in Chapter III and Chapter IV) with 
the SILAC ones. The analysis revealed that metabolites of the central carbon 
metabolism such as L-alanine, L-asparagine, L-glutamate, malate and succinate had 
similar levels in the regular and SILAC promastigotes (Table V-9). Some metabolites 
that were not observed in the regular ∆lmgt promastigotes were found in the SILAC 
∆lmgt promastigotes (Supplemental tables III-2 and V-1). Their absence in the regular 
promastigotes may indicate changes in the SILAC ∆lmgt promastigotes metabolism. 
Confirmative analysis, however, are needed to deduce anything further.  
V.1.3.   Stable isotope tracing in SILAC-labelled Δlmgt promastigotes 
L-Lysine is an essential amino acid for Leishmania (Opperdoes and Michels, 
2008). The partial incorporation of the heavy lysine by the ∆lmgt promastigotes, 
along with the significant lack of information regarding L-lysine metabolism in 
Lesihmania, drove us to engage novel bioinformatics tools to look in more detail into 
promastigote metabolism. Employing  two sets of metabolomic data, derived from 
SILAC/13C-L-lysine-labelled and 13C-D-glucose-labelled (condition 0, *glc0) wild type 
and ∆lmgt promastigotes, as well as the isotope data analysis software mzMatch-ISO 
(Chokkathukalam et al., 2013), we have performed a comprehensive isotope tracing 
analysis among a number of pathways and L-lysine derivatives that gave a redefined 
overview of L-lysine metabolism in the Leishmania parasites. The SILAC labelling 
data revealed that the fresh light media, light-labelled wild type promastigotes and 
wild type spent media contain unlabelled L-lysine (grey peaks) only (Figure V-9). 13C-
L-Lysine (red peaks) was expectedly present only in the fresh heavy media, labelled 
∆lmgt promastigotes and ∆lmgt spent media (Figure V-9). In consensus with the 
proteomics results, which indicated that only 52% of the heavy L-lysine was 
incorporated into proteins, the labelling trend of the 13C-L-lysine revealed that 
approximately 55% of the total L-lysine inside the ∆lmgt promastigotes was heavy-
labelled (Figure V-10). 
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Figure V-9. Chromatograms of unlabelled (A) and 13C-labelled L-lysine (B) in the fresh 
media, wild type and Δlmgt promastigotes, and wild type and Δlmgt spent media. The 
chromatograms were generated by mzMatch-ISO and illustrate the presence of unlabelled L-lysine in the light 
fresh media, wild type promastigotes, wild type spent media, ∆lmgt promastigotes and ∆lmgt spent media. 13C-L-
lysine was present in the heavy fresh media, ∆lmgt promastigotes and ∆lmgt spent media. Abbreviations: B - 
blank, L - fresh light media, WT – wild type promastigotes, WT* - wild type spent media, H - fresh heavy media, 
Δlmgt - ∆lmgt promastigotes, Δlmgt* - ∆lmgt spent media.. UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 
2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-
labelled carbon. STD - standard, RT - retention time, +ve - positive mode. 
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Figure V-10. Labelling pattern of L-lysine in the wild type and Δlmgt promastigotes. 
(A) Overall labelling trend of L-lysine. (B) Labelling trend of 13C-L-lysine. Abbreviations: B - blank, L - fresh light 
media, WT – wild type promastigotes, WT* - wild type spent media, H - fresh heavy media, Δlmgt - ∆lmgt 
promastigotes, Δlmgt* - ∆lmgt spent media. 
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The labelling trend of the 13C-L-lysine additionally showed that approximately 95% of 
the L-lysine in the fresh medium was heavy-labelled (Figure V-10, B). Possible 
impurity or degradation of the heavy L-lysine could account for the rest 5%, as 
evident from the presence of 5-13C-labelled 1-piperidein in the fresh heavy media 
(Figure V-11). Since 1-piperideine is an intermediate in the L-lysine degradation via 
cadaverin (Supplemental figure V-1), together with the fact that the level of heavy 
lysine in the fresh media is approximately 95% while the level of heavy 1-piperideine 
is nearly 28 % in both the fresh and spent media, the latter is more likely to be a 
result of L-lysine degradation during the process of obtaining 13C-L-lysine than a 
product of L-lysine degradation in the fresh media. Additionally, other than 5-13C-
labelled 1-piperidein, no other 5-13C-labelled compounds were detected in the cells or 
spent media. 
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Figure IV-11. Labelling trend of 5-13C-1-piperidein in the wild type and Δlmgt 
promastigotes. Abbreviations: B - blank, L - fresh light media, WT – wild type promastigotes, WT* - wild 
type spent media, H - fresh heavy media, Δlmgt - ∆lmgt promastigotes, Δlmgt* - ∆lmgt spent media. 
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Figure V-12. Initial steps in L-lysine degradation pathways: 1 - Lysine decarboxylase (EC 
4.1.1.18), 2 - Saccharopine dehydrogenase (NADP+, L-lysine forming) (EC 1.5.1.8) (Lysine-α-ketoglutarate 
reductase), 3 - Lysine:α-ketoglutarate ε-aminotransferase (EC 2.6.1.36), 4 - Lysine 2-monooxygenase (EC 
1.13.12.2), 5 - Lysine α-oxidase (EC 1.4.3.14), 6 - Lysine racemase (EC 5.1.1.5), 7 - Lysine N6-acetyltransferase (EC 
2.3.1.32),  8 - Lysine N6-hydroxylase (EC 1.14.13.59), 9 - Lysine 2,3-aminomutase (EC 5.4.3.2), 10 – Lysine N-
methyltransferase (2.1.1._). 
Credit: Zabriskie and Jackson, 2000 
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L-Lysine degradation 
Nine L-lysine degradation pathways are known to exist in the living organisms 
so far and they occur via cadaverine, 5-aminopentanamide, L-saccharopine, ∆1-
piperideine-6-carboxylate, N6-acetyl-L-lysine, 2-oxo-6-acetamidocaproate, D-lysine, 
L-β-lysine, and N6-hydroxylysin (Figure V-12) (Zabriskie and Jackson, 2000). All nine 
pathways, as well as the protein-lysine degradation pathway (10) (Figure V-13, 
where each pathway is presented as a single vertical line with circles indicating the 
respective metabolites belonging to the pathway, ordered according to their place in 
the pathway) were investigated for isotope labelling. 8 of the 239 authentic standards 
used in our metabolomic experiments belonged to the L-lysine degradation pathways. 
Six of the standards, namely L-lysine, L-carnitine, L-2-aminoadipate, glycine, N2-
acetyl-L-lysine, 4-trimethyl-ammoniobutanoate and acetoacetate, were detected. 
Acetyl-CoA, however, was not. Thus, 37 of the detected metabolites were putatively 
identified. 
The isotope tracing in the ten degradation pathways showed that: 
 there was no isotope labelling in six of the L-lysine degradation pathways, i.e. 
pathway 1, 2, 3, 4, 8, and 9 (Figure V-13), (see Supplemental figures V-1, V-2, 
V-3, V-4, V-5 and V-6 for detailed  representation of each individual pathway, 
including their labelling profile), 
 three metabolites in four different pathways were 13C-labelled and they 
included N6-acetyl-L-lysine, involved in L-lysine degradation via N6-acetyl-L- 
lysine (Figure V-14), L-pipecolate, involved in two L-lysine degradation 
pathways, via 2-oxo-6-aminocaproate and via D-lysine (Figures V-15 and V-
16) and N6, N6, N6-trimethyl-L-lysine, involved in protein lysine degradation 
(Figure V-17). It must be emphasized, however, that the three metabolites 
were putatively identified. 
D-Lysine, L-β-lysine and 3,5-diaminohexanoate have the same mass and therefore the 
same labelling pattern as L-lysine (Figure V-13). Analysis of the raw MS data, 
however, confirmed the presence of L-lysine only.  Investigated were also L-
glutamate, α-ketoglutarate, coenzyme A (CoA), succinate and succinyl-CoA which are 
involved in many reactions of the L-lysine degradation pathways (Figure V-13). L-
Glutamate, α-ketoglutarate and succinate were found unlabelled. 
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Figure V-13. Stable isotope tracing analysis of L-lysine degradation in SILAC-labelled 
Δlmgt promastigotes. Each pathway is presented as a single vertical line with circles indicating the respective 
metabolites belonging to the pathway, ordered according to their place in the pathway. 1- via cadaverin (Cad), 2 - via 5-
aminopentanamide (5-Apm), 3 - via L-saccharopine (L-Sac), 4 - via  ∆1-piperideine-6-carboxylate (∆1-P6), 5 - via N6-acetyl-L-
lysine (N6-A-L-lys), 6 - via 2-oxo-6-acetamido-caproate (2-O-6-aac), 7 - D-lysine (D-Lys), 8 - L-β-Lysine (L-β -Lys), 9 - via N6-
hydroxy-lysine (N6-Hlys), 10 - via protein lysine (Prot lys).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: L-Lys - L-lysine, D-Lys - D-lysine, Cad - cadaverine, 1-P- 1-piperideine, N6-A-L-lys - N6-acetyl-L-lysine, 2-O-6-aac - 
2-oxo-6-acetamidocaproate, 2-O-6-ac - 2-oxo-6-aminocaproate, 5-Apm - 5-aminopentanamide, 5-Aapn - 5-acetamidopentanoate, 
5-Apn - 5-aminopentanoate, Gtr sa - glutarate semialdehyde, Gtr - glutarate, Gyl-CoA - glutaryl-CoA, ∆1-P2 - ∆1-piperideine-2-
carboxylate, L-Pc - L-pipecolate, ∆1-P6 - ∆1-piperideine-6-carboxylate, L-Sac - L-saccharopine, L-2-Aa 6-sa - L-2-aminoadipate 6-
semialdehyde, L-2-Aa - L-2-aminoadipate, 2-Oa - 2-oxoadipate, L-β -Lys - L-β-lysine, 3,5-Dah -  3,5-diaminohexanoate, 5-A-3-oh - 
5-amino-3-oxohexanoate, L-3-Abyl-CoA - L-3-aminobutyryl-CoA, Cyl-CoA - crotonyl-CoA, 3-H-byl-CoA - 3-hydroxy-butanoyl-CoA, 
Aa - acetoacetate, Aa-CoA - acetoacetyl-CoA, Ac-CoA - acetyl-CoA, N6-Hlys - N6-hydroxylysine, N6-A-N6-hlys - N6-acetyl-N6-
hydroxylysine, N2-C-N6-a-N6-hlys - N2-citryl-N6-acetyl-N6-hydroxylysine, Ae - aerobactin, Prot lys - protein lysine, Prot N6-m-L-lys - 
protein N6-methyl-L-lysine, Prot N6,N6-dm-L-lys - protein N6,N6-dimethyl-L-lysine, Prot N6,N6,N6-tm-L-lys - protein N6,N6,N6-
trimethyl-L-lysine, N6,N6,N6-tm-L-lys - N6,N6,N6-trimethyl-L-lysine, N6-h-tmlys - N6-hydroxy-trimethyllysine, Gly - glyvine, 4-tm-
abal - 4-trimethyl-ammoniobutanal, 4-tm-abn - 4-trimethyl-ammoniobutanoate, Car - L-carnitine, Glu - L-glutamate, α-K - α-
ketoglutarate, CoA - coenzyme A, Ac - acetate, Suc - succinate, Suc-CoA - succinyl-CoA. 
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Figure V-14. Labelling profile of L-lysine degradation via N6-acetyl-L-lysine in 
the SILAC-labelled wild type and Δlmgt promastigotes. Abbreviations: WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-
labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-
13C-labelled carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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Figure V-15. Labelling profile of L-lysine degradation via 2-oxo-6-aminocaproate in 
the SILAC-labelled wild type and Δlmgt promastigotes. Abbreviations: WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-labelled 
carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-labelled 
carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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Figure V-16. Labelling profile of L-lysine degradation via D-lysine in the SILAC-
labelled wild type and Δlmgt promastigotes. Abbreviations: WT – wild type promastigotes, ∆lmgt - 
∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-
labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-labelled carbon. Dashed lines 
indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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Figure V-17. Labelling profile of protein-lysine degradation in the SILAC-
labelled wild type and Δlmgt promastigotes. Abbreviations: WT – wild type promastigotes, 
∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-labelled carbon, 
+3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-labelled 
carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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L-Lysine biosynthesis 
Two main pathways for L-lysine biosynthesis are known to exist to date and 
these are the diaminopimelate (DAP) and L-2-aminoadipic acid (AAA) pathways, 
where L-aspartate and α-ketoglutarate are used as precursors for the synthesis, 
respectively (Zabriskie and Jackson, 2000). Key enzymes from the L-lysine synthesis 
are absent in Leishmania and the pathway is believed not to operate in these 
organisms (Opperdoes and Coombs, 2007). The DAP and AAA L-lysine biosynthetic 
pathways, however, were also scrutinized for isotope labelled intermediates. Used for 
that purpose were two metabolomic data sets, the SILAC (13C-L-lysine) and *glc0 
(13C-D-glucose) sets. The SILAC data showed that all metabolites of the four variant 
DAP pathway, except for L,L-2,6-diaminopimelate (L-DAP) and meso-2,6-
diaminopimelate (m-DAP), were unlabelled (Figure V-18). The identification of L-
DAP and m-DAP as 13C-labelled derivatives of L-lysine, however, was accompanied 
with several issues. First, an authentic standard was available for m-DAP only and it 
was detected in the *glc0 data but not in the SILAC data. Analysis of the raw *glc0 
data revealed that the unlabelled peak for m-DAP in both the wild type and ∆lmgt 
promastigotes did not coincide with the authentic standard peak. A peak for 6-13C-m-
DAP was not found either. By contrast, peaks for unlabelled and 6-13C-m-DAP were 
found in the SILAC samples but they had different retention times. Thus, m-DAP was 
only putatively identified, similar to most of the intermediate of the DAP pathway, 
except for L-aspartate and L-homoserine. Second, L-DAP and m-DAP have the same 
mass and are indistinguishable from one another. No other metabolite involved in the 
L-lysine biosynthesis or degradation has the same mass as the two metabolites. 
However, a search in the PubChem Compound, ChemSpider, and ChEBI databases 
revealed that N6-carboxymethyl-L-lysine, methyl L-lysinate, N6-carboxy-L-lysine, the 
Ala-Thre dipeptide, N,N'-Bis(2- hydroxyethyl) malonamide and diethyl methylene-
biscarbamate were among the compounds with the same mass of 190.095 as L-DAP 
and m-DAP. Only the former three compounds, however, are directly related to the L-
lysine metabolism. Finally, 6-13C-L-DAP and/or 6-13C-m-DAP, similar to 1-piperidein, 
could be degradative products of 13C-L-lysine. In condition *glc0 wild type 
promastigotes, except L-aspartate and α-ketoglutarate, none of the detected 
intermediates of the DAP and AAA L-lysine biosynthetic pathways were labelled 
(Figure V-19). 
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Figure V-18. Stable isotope tracing analysis of L-lysine biosynthesis in the SILAC-
labelled Δlmgt promastigotes. Each pathway is presented as a single vertical line with circles indicating 
the respective metabolites belonging to the pathway, ordered according to their place in the pathway. I - 
diaminopimelate pathway (DAP) via N-acetyl-L-2-amino-6-oxopimelate (N-A-L-2-a-6-o), II - DAP via N-succinyl-2-
L-amino-6-oxoheptanedioate (N-S-2-L-a-6-o), III - DAP via L-2-amino-6-oxopimelate (L-2-A-6-o), IV - DAP via L,L-
2,6-diaminopimelate (L,L-2,6-D), V - L-2-amino adipic acid pathway (AAA) via L-saccharopine (L-Sac), VI - AAA via 
LysW-γ-L-lysine (LysW-γ-L-lys).  
 
 
 
 
 
 
 
 
 
 
Asp - L-aspartate, L-4-Ap - L-4-aspartyl phosphate, L-A 4-s - L-aspartate 4-semialdehyde, L-H - L-homoserine, 
(2S,4S)-4-H-2,3,4,5,-t - (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate, L-2,3,4,5-T - L-2,3,4,5-
tetrahydrodipicolinate, N-A-L-2-a-6-o - N-acetyl-L-2-amino-6-oxopimelate, N6-A-L,L-2,6-d - N6-acetyl-L,L-2,6-
diaminoheptanedioate, N-S-2-L-a-6-o - N-succinyl-2-L-amino-6-oxoheptanedioate, N-S-L,L-2,6-d - N-succinyl-L,L-
2,6-diaminoheptanedioate, L-2-A-6-o - L-2-amino-6-oxopimelate, L-D - L,L-2,6-diaminopimelate, m-D - meso-2,6-
diaminopimelate, L-Lys - L-lysine, α-K - α-ketoglutarate, Hc - homocitrate, cis-H - cis-homoaconitate, Hic - 
homoisocitrate, 2-Oa - 2-oxoadipate, L-2-Aa - L-2-aminoadipate, 5-A-2-a - 5-adenyl-2-aminoadipate, α-A-S-a e - α-
aminoadipoyl-S-acyl enzyme, L-2-Aa 6-sa - L-2-aminoadipate 6-semialdehyde, L-Sac - L-saccharopine, LysW-γ-L-α-
aa -   LysW-γ-L-α-aminoadipate, LysW-γ-L-α-a-6-p - LysW-γ-L-α-aminoadipyl-6-phosphate, LysW-γ-L-α-aa 6-sa - 
LysW-γ-L-α-aminoadipate 6-semialdehyde,  LysW-γ-L-lys - LysW-γ-L-lysine. 
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Figure V-19. Stable isotope tracing analysis of L-lysine biosynthesis in condition *glc0 
wild type promastigotes. Each pathway is presented as a single vertical line with circles indicating the 
respective metabolites belonging to the pathway, ordered according to their place in the pathway. I - 
diaminopimelate pathway (DAP) via N-acetyl-L-2-amino-6-oxopimelate (N-A-L-2-a-6-o), II - DAP via N-succinyl-2-
L-amino-6-oxoheptanedioate (N-S-2-L-a-6-o), III - DAP via L-2-amino-6-oxopimelate (L-2-A-6-o), IV - DAP via L,L-
2,6-diaminopimelate (L,L-2,6-D), V - L-2-amino adipic acid pathway (AAA) via L-saccharopine (L-Sac), VI - AAA via 
LysW-γ-L-lysine (LysW-γ-L-lys). 
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A number of pathways directly linked to L-lysine metabolism were also investigated 
with mzMatch-ISO. These included alkaloid biosynthesis, L-pyrrolysine synthesis, 
peptidoglycan synthesis, penicillin and cephalosporin biosynthesis and fructoselysine 
and psicoselysine degradation. L-lysine, similar to its homologue L-ornithine, is 
involved in the synthesis of several groups of alkaloids, namely piperidine, 
quinolizidin, and indolizidine alkaloids. None of the following alkaloids: slaframine, 
13 α-tigloyloxylupanine, (+)-cystine, anatalline, anapheline, piperine, sedamine and 
lobeline, were detected. Swainsonine, lupinine, pelletierine and pseudopelletierine 
were detected but they were unlabelled. All alkaloids were putatively identified. L- 
Lysine also serves as a precursor for the synthesis of L-pyrrolysine, an unusual 
proteinogenic amino acid in some methanogenic archae (Gaston et al., 2011). The 
first step of the L-pyrrolysine synthesis is the conversion of L-lysine to 3-methyl- 
ornithine, a compound that has the same mass as L-lysine and is thus 
indistinguishable from it. Two of the next three metabolites were found unlabelled, 
i.e. 3-methylornithine-N6-L-lysine and L-pyrrolysine, while 3-methylglutamyl-5-
semialdehyde-N6-lysine was not detected. The metabolites were again putatively 
identified. L-lysine, together with meso-2,6-diaminopimelate, are also important 
precursors in bacterial cell wall peptidoglycan synthesis (Zabriskie and Jackson, 
2000). A search among the muramoyl derivatives of m-DAP in the SILAC and *glc0 
data sets was fruitless. Similarly, an analysis of the fructoselysine and psicoselysine 
degradation revealed that none of the metabolites were labelling.  
Furthermore, a group of 61 L-lysine derivatives, obtained from the ChEBI database 
(http://www.ebi.ac.uk/chebi/) were also inspected for isotope labelling (Figure V-
20). 6 of the metabolites were already investigated as part of the pathways described 
above, 19 were preliminary entries, 5 were manually annotated, 1 had the same mass 
as L-lysine and 1 was a reference compound for 3'-O-L-lysyl derivatives of any 1,2-
diacyl-sn-glycero-3-phospho-1ʼ-sn-glycerol (Supplemental tables V-3 and V-4). That 
left 29 metabolites for analysis. Included in the search was also the dipeptide β-
alanyl-L-lysine. 11 of the 30 metabolites were detected: D-lysopine, L-homocitrulline, 
L-homoarginine, N2-methyl-L-lysine, N6-carboxymethyl-L-lysine, methyl L-lysinate, 
N6-carboxy-L-lysine, psicosyl-lysine (or psicoselysine), β-alanyl-L-lysine, L-2-
aminohexano-6-lactam (or L-lysine 1,6-lactam) and N6-methyl-L-lysine, the former 
nine of which were unlabelled while the latter two were 13C-labelled.  
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Figure V-20. List of L-lysine derivatives subjected to stable isotope tracing analysis.  
Credits: ChEBI 
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Figure V-21. Derivatives of 13C-L-lysine found in the Δlmgt promastigotes. The 
metabolites are grouped based on elemental composition specified at the bottom of the rectangles.  
 
N2-Methyl-L-lysine has the same mass as N6-methyl-L-lysine and was available as an 
authentic standard. However, the unlabelled and 6-13C-lablled peaks for N2-methyl-L-
lysine did not correspond to those of the authentic standard and that indicated that 
the metabolite was most probably N6-methyl-L-lysine. Additionally, N6-methyl-L-
lysine has the same mass as L-DAP and m-DAP. However, the unconvincing results 
regarding the L-D and m-D identification do not exclude N6-methyl-L-lysine as also 
being labelled. The mass of L-lysine 1,6-lactam was different from that of any relevant 
to L-lysine metabolism compounds investigated here. 
Finally, an analysis of L-alanine, L-arginine, L-asparagine, L-aspartate, L-citrulline, L- 
cysteine, L-cystine, L-glutamate, L-glutamine, L-histidine, L- leucine, L-methionine, L- 
ornithine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine 
and L-valine, showed that none of the amino acids were heavy-labelled. Thus, the 
following isotopomers of 13C-L-lysine were detected: L-pipecolate, N6-acetyl-L-lysine, 
N
6
,N
6
,N
6
-trimethyl-L-lysine, N6-methyl-L-lysine and L-lysine 1,6- lactam (Figure V-21). 
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V.2.   Discussion  
V.2.1.   Global quantitative proteomic characterization of ∆lmgt 
promastigotes  
The initial phenotypic characterization of the ∆lmgt promastigotes by 
Landfear and colleagues revealed that the ∆lmgt promastigotes grow considerably 
more slowly and reach lower cell density compared to the wild type promastigotes 
(Burchmore et al., 2003). The growth profile of the ∆lmgt promastigotes observed in 
this project was similar. Specifically, the growth rate of the ∆lmgt promastigotes is 
approximately half that of the wild type promastigotes when cultured in the defined 
medium HOMEM supplemented with 10% serum (Figure V-2). The reduced growth 
rate of the ∆lmgt promastigotes was one of the biggest issues with regard to one of 
our main aims, namely, to perform a global quantitative characterization of the ∆lmgt 
promastigotes via SILAC. To apply SILAC to the wild type and ∆lmgt promastigotes, 
we had to adapt the two cell lines, initially grown in media with regular serum, to 
media with dialyzed serum. Growing the ∆lmgt promastigotes in media with dialyzed 
serum, however, proved to be problematic. While the defined media with added 
serum contain all necessary nutrients for the proliferation of the Leishmania 
promastigotes, media with dialyzed serum lacks low molecular weight components, 
some of which appear to be important for parasite growth. These may include 
nutrients such as sugars, other than D-glucose, amino acids, which appear to be major 
energy and carbon sources for the ∆lmgt promastigotes (see Chapter IV), and other 
nutrients such as lipids, nucleotides, cofactors and vitamins, for many of which 
Leishmania are likely auxotrophic. Removing these components from the culture 
media resulted in poor growth of both the wild type and ∆lmgt promastigotes 
(Figures V-3 and V-4). Concisely, the adaptation of the wild type and ∆lmgt 
promastigotes was hampered, first, by the lack of important nutrients in the culturing 
media, second, by the period of time provided for adaptation (two passages only), 
and, third, by the low starting cell density. Nothing could have been changed with 
regard to the first problem since it is a necessity of SILAC required for the full 
incorporation of the isotope amino acids only. The second and third problems, 
however, were dealt with by extending the adaptation time to two passages with four 
changes of the fresh medium, which took nearly a month and a half, and increasing of 
the initial cell density from 1.0 x 105 cells ml-1 to 1.0 x 106 cells ml-1, respectively.  
Resolving the second and third problems was based on the observation, made on 
multiple occasions, that the time necessary for the cell cultures to reach log phase 
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was longer when they were started at lower initial cell density. As a result of the 
prolonged time for adaptation and increased number of cells sub-passaged in fresh 
media, the growth of the wild type and ∆lmgt promastigotes in the SILAC media 
improved which facilitated the generation of enough SILAC-labelled protein from the 
two cell lines. Two interesting facts became obvious from the SILAC data analysis. 
First, since the digestion of the labelled proteins was performed with trypsin, the 
resulting peptides were cut after L-arginine or L-lysine. It was observed that many 
peptides ending with L-arginine did not contain L-lysine and were thus not 
considered in the quantitation. The first important conclusion of this study, therefore, 
corroborates with the well known concept that more accurate quantitative 
information would be obtained if both L-arginine and L-lysine are used as isotope 
amino acids when trypsin is used as a protease. Second, the Mascot search revealed 
that many peptides in the heavy-labelled protein samples were actually not heavy-
labelled. That led to further investigation of the labelling efficiency. It was revealed 
that only half (52%) of the heavy-labelled L-lysine was incorporated into proteins by 
both the wild type and ∆lmgt promastigotes. With regard to L-lysine, that revealed 
that the amino acid, as shown before (Simon et al., 1983), was maintained in a free 
form in the amino acid pool and suggested that the L-lysine might have other role(s) 
in promastigote metabolism than just protein synthesis. With regard to the SILAC 
results, the partial incorporation of the heavy-lysine meant that the generated 
quantitative data were inaccurate because all proteins but one were found down-
regulated in the ∆lmgt promastigotes. Altogether, the proteomic data revealed that 
SILAC with L-lysine as a single amino acid of choice is not applicable for investigation 
of the L. mexicana proteome. Two separate analyses, with L-arginine and with both L-
lysine and L-arginine, have to be performed to be clarified if the method is useful for 
accurate quantitative probing of the L. mexicana or Leishmania proteome in general. 
 V.2.2.   Global metabolomic characterization of SILAC-labelled ∆lmgt 
promastigotes  
L-Lysine is a 6-carbon polar amino acids with a highly reactive (pKa = 10.5), 
positively charged ε-amino group at the end of the side chain and three methylene 
groups (CH2) close to the α-amino group rendering it considerably hydrophobic. As a 
consequence of their high hydrophobicity, L-lysines are usually, but not exclusively, 
buried within the proteins with only the charged part of the side chain and the ε-
amino group exposed on the outside. L-Lysines are often in the protein active or 
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binding sites where the ε-amino group participates in hydrogen bonding with 
negatively charged amino acids which is involved in protein structure stabilization 
and enzyme catalysis.  
Among the 20 canonical amino acids, L-lysine is unusual in that it has two distinct 
biosynthetic pathways. In most bacteria, lower fungi and higher plants, L-lysine is 
synthesised from L-aspartate via the diaminopimelate pathway (DAP) (Figure V-25), 
while in some bacteria, yeasts and higher fungi the amino acid is synthesised via the 
L-2-amino adipic acid (AAA) pathway, with α-ketoglutarate serving as a precursor 
(Figure V-26) (Zabriskie and Jackson, 2000; Xu et al., 2006). 
Diaminopimelate pathway. The DAP pathway is a source for L-lysine for protein 
synthesis in Gram-negative bacteria and for L-lysine and meso-diaminopimelate for 
cell wall peptidoglycan biosynthesis in Gram positive bacteria. Four variants of the 
pathway have been identified so far: two acyl pathways going via succinyl (Figure V-
25) or acetyl (Figure V-26) intermediates, one meso-diaminopimelate dehydrogenase 
pathway (Figure V-27) and one L,L-diaminopimelate aminotransferase pathway 
(Figure V-28) (Nachar et al., 2012). The first half of all four pathways results in the 
synthesis of L-2,3,4,5-tetrahydrodipicolinate from L-aspartate in four consequent 
reactions catalysed by aspartate kinase, aspartate semialdehyde dehydrogenase, 4-
hydroxy-tetrahydrodipicolinate synthase, and 4-hydroxy-tetrahydrodipicolinate 
reductase, respectively (Figures V-25 and V-26).  The second half of the pathway 
leads to the conversion of L-2,3,4,5-tetrahydrodipicolinate to meso-diaminopimelate 
and is carried out in four different ways. The two acyl pathways involve four 
reactions once again and the enzymes 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate 
N-acyl-transferase, N-acyl-diaminopimelate aminotransferase, acyl-diaminopimelate 
deacylase and acyl-diaminopimelate epimerase, respectively (Figure V-25).  The 
other two pathways involve either oxidation or transamination of L-2,3,4,5-
tetrahydrodipicolinate to meso-diaminopimelate in a single reaction cataslyzed by 
meso-diaminopimelate dehydrogenase and L,L-diaminopimelate aminotransferase, 
respectively (Figure V-26). The last half of the pathway is common to all variants 
again and concludes with the synthesis of L-lysine (Figures V-25 and V-26) (Nachar et 
al., 2012).   
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Figure V-22. Acyl diaminopimelate pathway biosynthetic pathways via succinyl 
(black) and acetyl (blue) intermediates. EC 2.7.2.4  - Aspartate kinase, EC 1.2.1.11 - Aspartate semialdehyde 
dehydrogenase, EC 4.3.3.7 -  4-hydroxy-tetrahydrodipicolinate synthase (DapA), EC 1.17.1.8 - 4-hydroxy-tetrahydrodipicolinate 
reductase (DapB), EC 2.3.1.117  -  2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (DapD), EC 2.6.1.17 - 
Succinyldiaminopimelate amino-transferase (DapC), EC 3.5.1.18 - Succinyl-diaminopimelate desuccinylase (DapE), EC 5.1.1.7 - 
Diaminopimelate epimerase (DapF), EC 4.1.1.20 - Diaminopimelate decarboxylase, EC 2.3.1.89 - Tetrahydrodipicolinate N-
acetyltransferase (DapH, DapD), EC 2.6.1.- - Aminotransferase, EC 3.5.1.47 - N-acetyldiaminopimelate deacetylase. Adapted from 
KEGG and MetaCyc. 
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Figure V-23. meso-Diaminopimelate dehydrogenase (green) and LL-diaminopimelate 
aminotransferase (red) diaminopimelate pathway biosynthetic pathways. EC 2.7.2.4 - 
Aspartate kinase, EC 1.2.1.11 - Aspartate semialdehyde dehydrogenase, EC 4.3.3.7 -  4--hydroxy-tetrahydrodipicolinate synthase 
(DapA), EC 1.17.1.8 - 4-hydroxy-tetrahydrodipicolinate reductase (DapB), EC 2.6.1.83 - LL-diaminopimelate aminotransferase, 
EC 5.1.1.7 - DAP epimerase (DapF), EC 4.1.1.20 - Diaminopimelate decarboxylase. EC 2.6.1.83 - LL-diaminopimelate 
aminotransferase, EC 1.4.1.16 - meso-diamiinopimelate dehydrogenase. 
Adapted from KEGG and MetaCyc. 
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L-2-amino adipic acid pathway. L-Lysine biosynthesis via L-2-aminoadipate is an 
eight-step process involving three cell compartments: nucleus, mitochondria and 
cytosol (Zabriskie and Jackson, 2000). The first half of the synthesis results in the 
generation of L-2-aminoadipate from α-ketoglutarate through several one-carbon 
higher homologues of the initial three tricarboxylic acids of the TCA cycle, that is, 
homocitrate, cis-homoaconitate and homoisocitrate (Figures V-27 and V-28). It starts 
with the condensation of α-ketoglutarate and acetyl-CoA into homocitrate by 
homocitrate synthase, localized to the nucleus, followed by the consequent 
dehydration of homocitrate to cis-homoaconitate and homoisocitrate by 
homoaconitase in the mitochondria. Homoisocitrate dehydrogenase oxidises the 
homoisocitrate to α-ketoadipate which then undergoes L-glutamate-dependent 
transamination carried out by L-2-aminoadipate transaminase to form L-2- 
aminoadipate (Figures V-27 and V-28). In the second half of the pathway, L-2-
aminoadipate is consequently reduced to L-2-aminoadipate 6-semialdehyde and L-
saccharopine by L-2-aminoadipate reductase and L-saccharopine dehydrogenase (L-
glutamate-forming), respectively, before being converted to L-lysine by L-
saccharopine dehydrogenase (L-lysine-forming). The second half of the pathway can 
occur via a protein carrier-independent or carrier-dependent way (Figures V-27 and 
V-28). 
L. major lacks the enzymes for de novo synthesis of L-lysine (Opperdoes and Michels, 
2008). A BLASTP search against the L. mexicana genome was performed to 
investigate whether L-lysine biosynthesis is present or absent in L. mexicana. The 
genome of Leishmania mexicana MHOMGT2001U1103 was derived from the TriTryp 
database which contains 8,500 sequences while the protein sequences of the enzymes 
of the L-lysine biosynthesis from five organisms, Chlorella variabilis, Aspergillus 
fumigatus, Escherichia coli, Thermovirga lienii and Bacillus subtilis, where one or two 
of the many variants of the DAP and the AAA pathways are present, were derived 
from the Kyoto encyclopedia of genes and genomes (KEGG) pathway database 
(http://www.kegg.jp/kegg/pathway.html). The search revealed that L. mexicana has 
a homoserine dehydrogenase, which interconvers L-aspartate 4-semialdehyde to 
homoserine, and a succinyl-diaminopimelate desuccinylase, involved in the 
interconversion of N-succinyl-LL-2,6-diaminopimelate to succinate and LL-2,6-
diaminopimelate. Succinyl-diaminopimelate desuccinylase-like protein was the only 
enzyme of the L-lysine metabolism found differentially regulated in the ∆lmgt 
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promastigotes (Supplemental table III-1). The function of the homoserine 
dehydrogenase and succinyl-diaminopimelate desuccinylase-like protein in 
Leishmania, however, may not be the same as the one they execute in the L-lysine 
biosynthesis. Thus, the proteomic data did not provide any significant information 
regarding the L-lysine metabolism in the L. mexicana promastigotes. Our 
metabolomic data, on the other hand, shed some light on this matter. The untargeted 
metabolomic profile of the ∆lmgt promastigotes grown under SILAC conditions 
(SILAC ∆lmgt promastigotes) was similar to that of the ∆lmgt promastigotes grown 
under regular conditions (regular ∆lmgt promastigotes). For instance, the levels of 
the glucogenic amino acids L-alanine and L-glutamate and the TCA cycle 
intermediates succinate and malate were decreased in the ∆lmgt promastigotes 
(Table V-9). Amino acids such as L-alanine, L-glutamate and L-proline appear to be 
major carbon sources for the ∆lmgt promastigotes (see chapter IV). The lack of 
external amino acids in the SILAC media would impair the supply of carbon and 
energy for the ∆lmgt promastigotes and result in a number of defficiency which 
would eventually undermine the cell viability. The inability of the ∆lmgt 
promastigotes to use amino acids as carbon and energy sources was probably one of 
the main reasons behind the poor adaptation of these cells to the media with dialyzed 
serum. The prolonged adaption of the ∆lmgt promastigotes, along with the more or 
less similar central carbon metabolism of the SILAC ∆lmgt promastigotes to that of 
the regular ∆lmgt promastigotes, on the other hand, indicates that the cells possibly 
adapted to using other alternative carbon sources. For instance, fatty acids and other 
types of lipids are present in the serum. The absence of a glyoxylate cycle in the 
Leishmania, however, renders the parasites unable to use fatty acids as sole carbon 
sources for the synthesis of sugars (Opperdoes and Michels, 2008). Additionally, β-
oxidation of fatty acids was down-regulated in the ∆lmgt promastigotes (see Chapter 
IV). Further to that, it was demonstrated that incubation of the ∆lmgt promastigotes 
in RPMI 1640 for 6 months resulted in the generation of a suppressor cell line which 
over-expressed the alternative hexose transporter GT4 (Feng et al., 2011). The 
spontaneous suppression resulted in partial restoration of the hexose transport. 
Thus, it could be hypothesized that the shorter-term incubation of the ∆lmgt 
promastigotes in the SILAC media could result in over-expression of some 
transporters, including GT4.  
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Figure V-24. Carrier-independent L-2-amino adipic acid biosynthetic pathway. EC 
2.3.3.14 - Homocitrate synthase, EC 4.2.1.- - Homoaconitase, EC 4.2.1.114 -  Methanogen homoaconitase, EC 4.2.1.36 - 
Homoaconitase, EC 1.1.1.87 - Homoisocitrate dehydrogenase, EC 1.1.1.286 - Isocitrate--homoisocitrate dehydrogenase, EC 
2.6.1.39 - L-2-aminoadipate transaminase, EC 2.6.1.57 - Aromatic-amino-acid transaminase, EC 1.2.1.31 - L-2-aminoadipate-
semialdehyde dehydrogenase, EC 1.5.1.10 - L-saccharopine dehydrogenase (NADP+, L-glutamate-forming), EC 1.5.1.7 - L-
saccharopine dehydrogenase (NAD+, L-lysine-forming). 
Adapted from KEGG and MetaCyc. 
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Figure V-25. Carrier-dependent L-2-amino adipic acid biosynthetic pathway. EC 2.3.3.14 - 
Homocitrate synthase, EC 4.2.1.- - Homoaconitase, EC 4.2.1.114 -  Methanogen homoaconitase, EC 4.2.1.36 - Homoaconitase, EC 
1.1.1.87 - Homoisocitrate dehydrogenase, EC 1.1.1.286 - Isocitrate--homoisocitrate dehydrogenase, EC 2.6.1.39 - L-2-
aminoadipate transaminase, EC 2.6.1.57 - Aromatic-amino-acid transaminase, EC 1.2.1.31 - L-2-aminoadipate-semialdehyde 
dehydrogenase, EC 1.5.1.10 - L-saccharopine dehydrogenase (NADP+, L-glutamate-forming), EC 1.5.1.7 - L-saccharopine 
dehydrogenase (NAD+, L-lysine-forming). 
Adapted from KEGG and MetaCyc. 
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This assumption is backed up by the observation that some of the 
glycolytic/gluconeogenic intermediates were negligibly labelled in condition *glc and 
pro+*glc ∆lmgt promastigotes where 13C-D-glucose was provided as a carbon source 
(see Chapter III). No labelling was observed in the ∆lmgt promastigotes grown in the 
defined media supplemented with serum, condition *glc0 ∆lmgt promastigotes. 
In addition to protein synthesis, L-Lysine can be used as an energy source. The amino 
acid is a ketogenic amino acid which can be converted to acetyl-CoA, fueled into the 
TCA cycle and catabolized for energy. Unfortunately, acetyl-CoA was not detected as a 
standard. No putative metabolite with the same mass was found in the ∆lmgt 
promastigotes either. In addition to oxidation via the TCA cycle, we also investigated 
several alternative pathways for catabolism of L-lysine in the ∆lmgt promastigotes. 
Up to date, known to exist in the living organisms are nine L-lysine catabolic 
pathways (Figure V-15) (Zabriskie and Jackson, 2000). In mammals and plants, the 
majority of L-lysine is catabolised via L-saccharopine (Supplemental figure V-3) 
(Galili et al., 2001). The initial steps of the saccharopine L-lysine degradation pathway 
are essentially reversed analogues of the last reactions of the AAA biosynthetic 
pathway in fungi. Shortly, under the action of the bifunctional L-lysine:α-
ketoglutarate reductase/saccharopine dehydrogenase (L-glutamate forming) L-lysine 
is transaminated through saccharopine to L-2-aminoadipate 6-semialdehyde and L-
glutamate by transferring the lysine ε-group to α-ketoglutarate. L-2-Aminoadipate 6-
semialdehyde is then converted to L-2-amino adipate by L-2-aminoadipate 6-
semialdehyde dehydrogenase. In mammal, L-lysine can also be metabolised through 
other pathways. In rat, monkey and human brain, L-lysine is converted to L-
pipecolate while in the liver and kidney, where the AAA pathways operates, L-
pipecolate is a by-product formed most likely from D-lysine (Supplemental figure V-
7) (Zabriskie and Jackson, 2000).  
Considering all catabolic pathways described above, as well as our stable isotope 
tracing data, we could hypothesize that, except for protein-lysine degradation, no L-
lysine biosynthesis or degradation pathways are fully functional in Leishmania. Some 
of the intermediates in the mentioned degradative pathways were not detected at all 
while others were putatively identified. Heavy-labelled were N6N6N6-trimethyl-L-
lysine, N6-methyl-L-lysine, N6-acetyl-L-lysine, L-pipecolate and L-lysine 1,6-lactam 
(Figures V-14, V-15, V-16 and V-17). 
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Figure V-26. Protein-lysine degradation in the SILAC-labelled Δlmgt promastigotes. 
Indicated with red dots are the heavy carbons. Indicated with red arrows are the possible routes of heavy 
labelling. Indicated with blue dashed line is the occurance of proteolytic digestion. Indicated with dashed black 
arrow is an indirect reaction. 
Adapted from KEGG and MetaCyc. 
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The first two metabolites are involved in protein-lysine degradation, the third is 
involved in L-lysine degradation via N6-acetyl-L-lysine and the forth is involved in L-
lysine degradation via 2-oxo-6-aminocaproate and D-lysine. The last metabolite is an 
L-lysine derivative involved in a pathway-independent reaction. Protein-lysine 
degradation starts with triple methylation of L-lysine residues by protein-lysine 
methyltransferases which transfer methyl groups from S-adenosyl-L-methionine to 
the residues to form protein N6-methyl-L-lysine, protein N6,N6-dimethyl-L-lysine and 
protein N6,N6,N6-methyl-L-lysine, respectively (Figure V-26) (Rebouche, 1991). 
N6,N6,N6-trimethyl-L-lysine is then released after proteolytic digestion, hydroxylated 
to N6-hydroxy-L-lysine which is cleaved to 4-trimethylammoniobutanal and glycine. 
The aldehyde is then oxidized by an aldehyde dehydrogenase (ALDH) to 4-
trimethylammoniobutanoate. The latter is hydroxylated again to L-carnitine 
(Rebouche, 1991). L-Carnitine, however, was not found heavy-labelled in the ∆lmgt 
promastigotes. The second heavy-labelled metabolite, N6-Methyl-L-lysine, similar to 
N6,N6,N6-trimethyl-L-lysine, could be a product of a single methylation and 
proteolytic digestion or a spontaneous methylation reaction (Figure V-26). The third 
labelled metabolite was N6-acetyl-L-lysine. Although it is the first compound in lysine 
degradation via N6-acetyl-L-lysine, none of the other intermediates were found 
labelled (Supplemental figure V-5). On the other hand, acetylation is one of the most 
often posttranslational modifications (PTMs) of L-lysine residues. Acetylated residues 
could later be cleaved as a result of proteolytic digestion and released as separate 
compounds (Figure V-27). Genomic analysis in L. major revealed that Leishmania 
have methyltransferases, demethylases, acetyltransferases and deacetylases which 
are possibly involved in histone modifications (Ivens et al., 2006; Renauld et al., 
2007). Modified, however, can also be nonhistone proteins such as α-tubulin for 
example which can be acetylated (Alonso and Serra, 2012) or p53, estrogen receptor 
α, nuclear factor kappa-light chain-enhancer of activated B cells, transcription factor 
E2F1, retinoblastoma protein and signaling transducer and activator of transcription 
3 which can be methylated (Zhang et al., 2012). Thus, lysine acetylation and 
methylation are involved in a number of cellular processes including transcription, 
DNA repair, splicing, chromatin remodeling, cytoskeletal dynamics, cell signalling, 
apoptosis, protein folding, metabolism and others (Alonso and Serra, 2012; Zhang et 
al., 2012). It could be said that lysine acetylome and methylome are as substantial and 
important as the phosphoproteome. 
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Figure V-27. L-Lysine degradation via N6-acetyl-L-lysine and 2-oxo-6-aminocaproate 
in SILAC-labelled Δlmgt promastigotes. Indicated with red dots are the places of the heavy carbons. 
Indicated with red arrows are the possible routes of heavy labelling. Indicated with blue dashed line is the 
occurance of proteolytic digestion. Indicated with dashed black arrow is an indirect reaction. 
Adapted from KEGG and MetaCyc. 
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Next, L-lysine 1,6-lactam is a product of L-lysine lactamase which reversibly 
hydrolyses L-lysine 1,6-lactam to L-lysine. Since no information about L-lysine 1,6-
lactam metabolism is available, it could be hypothesized that, similar to other 
lactamases in bacteria, L-lysine lactamase plays a role in resistance to anti-bacterial 
and/or anti-leishmanial drugs. Finally, L-pipecolate is generated during L-lysine 
degradation via D-lysine or directly via 2-oxo-6-aminocaproate (Supplementary 
figures V-15 and V-16) (Zabriskie and Jackson, 2000). In addition to degradative 
pathways, L-pipecolate is involved in biosynthetic reactions as well. For instance, 
Rhodotorula glutinis is capable of growing on a minimal media supplemented with L-
pipecolate which the aerobic red yeast uses as a nitrogen source in the synthesis of L-
lysine (Zabriskie and Jackson, 2000). Since none of the other intermediates of the L-
lysine degradation via 2-oxo-6-aminocaproate were heavy-labelled in the Δlmgt 
promastigotes, L-pipecolate could also be used as a nitrogen donor which possibly 
transfers the amine group to a more universal donor such as L-glutamate.  
V.3.   Summary  
L-Lysine is an important proteinogenic amino acid for the Leishmania 
parasites. Our sequence similarity search confirmed that L. mexicana lack the 
enzymatic capacity to synthesize L-lysine via the diaminopimelate or L-2-amino 
adipic acid pathway and thus have to scavange the amino acid from the environment. 
Comparative information regarding the rate at which the wild type and Δlmgt 
promastigotes take up L-lysine is not available. Our metabolomic analysis, however, 
showed that the level of L-lysine in the two cell lines is more or less the same. These 
data thus show that the glucose transporter null-mutation does not affect L-lysine 
transport. Furthermore, the stable isotope tracing revealed that approximately 55% 
of the intracellular L-lysine is heavy labelled while the incorporation efficiency 
analysis showed that 52% of that L-lysine is used in protein synthesis in both wild 
type and Δlmgt promastigotes. Three main conclusions were made from these results: 
i/ 55% of the intracellular L-lysine in Leishmania has an exogenous origin, ii/ the 
majority of the exogenous L-lysine is used in protein synthesis while a small portion 
is used in derivative synthesis, and iii/ a source of unlabelled L-lysine provides 48% 
of the L-lysine for protein synthesis (and possibly the portion of L-lysine present in 
the free amino acid pool). Altogether, our study showed that two sources of L-lysine 
are present in Leishmania, exogenous and possibly endogenous, and that the 
existence of endogenous source results in ineffective labelling of the Δlmgt proteins 
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by exogenous L-lysine. The tracing study suggested that protein-lysine degradation is 
most probably (one of) the source(s) for endogenous L-lysine. Protein-lysine is 
degraded under the action of methyltransferases, then demethylated to L-lysine by 
demethylases, and possibly recycled back for protein synthesis and/or directed 
toward the free amino acid pool. Alternatively, acetyltransferases and deacetylases 
may also contribute toward recycling of L-lysine. Thus, degradation of protein-lysine 
originating from the serum supplementing the culture media or intracellular protein-
lysine may be involved in maintaining the intracellular level of L-lysine and thus be a 
source of the remaining 48% of unlabelled L-lysine in the promastigotes. The results, 
additionally, implicate L-lysine in post-translational modifications. However, almost 
no information is available about L-lysine methylation in Leishmania. And finally, L-
lysine is involved in derivative biosynthesis. Pathways where L-lysine is used as a 
precursor in other organisms, such as peptidoglycan synthesis, penicillin and 
cephalosporin biosynthesis, and fructoselysine and psicoselysine degradation, as well 
as L-lysine degradation, do not operate in Leishmania. Few L-lysine derivatives were 
found heavy labelled in the SILAC-labelled Δlmgt promastigotes, including L,L-2,6-
diaminopimelate/meso-2,6-diaminopimelate, L-pipecolate, and L-lysine 1,6-lactam. 
Although their function in Leishmania is unknown, it could be hypothesized that they 
have roles in secondary metabolism. 
The partial incorporation of exogenous L-lysine into proteins thus appears to be due 
to the specific metabolism of Leishmania and not the SILAC methodology. The latter 
requires the use of dialyzed serum and, contrary to the experiments with L. infantum 
and L. donovani, we observed that both the wild type and Δlmgt L. mexicana 
promastigotes struggled to adapt to dialyzed serum. In the Δlmgt promastigotes, the 
lack of amino acids and other essential nutrients in the dialyzed serum was adding to 
the stress resulting from the glucose transport deficiency. The Δlmgt promastigote 
adaptation to the dialyzed serum must have occurred through certain alterations, the 
nature of which was outside the scope of our investigation. Nevertheless, we could 
speculate that some of the alteration in terms of metabolism most probably involved 
over-expression of some transporters, including the glucose transporter GT4, and/or 
the use of alternative carbon and energy sources (other than carbohydrates and 
amino acids). The successful adaptation of the Δlmgt promastigotes was evident from 
the similar metabolic profile and rate of protein synthesis of these organisms to those 
of the wild type promastigotes. Concisely, these observations show that Leishmania 
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mexicana adapt to SILAC conditions but that the species’ metabolism prevent them 
from being efficiently labelled by SILAC. Further investigation of this feature could 
lead to the development of species-specific antileishmanial compounds. 
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CHAPTER VI.   Concluding remarks - drug targeting the Δlmgt 
promastigote metabolism 
Sequencing of the genomes of several Trypanosoma and Leishmania species 
has allowed global comparative genomic, proteomic, and metabolomic investigations 
of trypanosomatid metabolism. Genomic approaches have provided information 
about the metabolic repertoire of trypanosomatids and have revealed that 
Leishmania contain a considerable number of genes, some of which encoding putative 
proteins involved in metabolism, with no homologues in other eukaryotes (Ivens et 
al., 2005; Berriman et al., 2005). Additionally, proteomic and metabolomic 
approaches have enhanced knowledge of Leishmania metabolism by comprehensive 
studies on promastigote and amastigote development and parasite-host relationship 
and have yielded a considerable amount of data that show that Leishmania 
metabolism differs from that of their hosts (Berriman et al., 2005). These differences 
between Leishmania and their hosts are particularly important with respect to 
identifying potential drug targets and investigating the impact of antiparasitic drugs 
on Leishmania metabolism.  
Promastigote metabolism is characterized with active metabolization of sugars such 
as D-glucose for biosynthetic and energy needs. L. mexicana promastigotes transport 
D-glucose via three high-affinity and one low-affinity transporters, namely GT1-3 and 
GT4, respectively (Burchmore et al., 2003; Feng et al., 2013). L. mexicana glucose 
transporter null mutant promastigotes, Δlmgt promastigotes, in which the gene locus 
encoding the GT1-3 transporters was deleted by targeted gene replacement, are 
viable which showed that D-glucose is a major but not exclusive energy and carbon 
source for the Leishmania promastigotes (Burchmore et al., 2003). Phenotypic 
characterization of the medically relevant amastigote forms of this cell line, Δlmgt 
amastigotes, on the other hand, showed that the null mutant amastigotes cannot 
survive in macrophages which illustrated the central role of D-glucose in the 
Leishmania amastigotes (Burchmore et al., 2003). Gene complementation of the Δlmgt 
amastigotes, furthermore, showed that GT3 alone is able to rescue Δlmgt amastigote 
growth to levels comparable with those of the wild type amastigotes which indicated 
that GT3 is important for amastigote survival (Burchmore et al., 2003). These studies, 
altogether, showed that suppression of the expression of the GT gene locus, or 
possibly of the GT3 alone, although further confirmation is needed, has parasitocidal 
effect on Leishmania which validated GT1-3/GT3 as new drug targets.    
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The molecular events behind the inability of the Δlmgt amastigotes to proliferate in 
mammalian macrophages could obviously not be investigated in the non-growing 
Δlmgt amastigotes. The Δlmgt promastigotes, however, remain viable in axenic 
cultures and have been used to gain insight into the metabolic machinery of these 
mutants and elucidate which aspects of metabolism are affected by deletion of the 
GT1-3 transporters. The initial characterization revealed that the Δlmgt promastigote 
growth and biosynthetic capabilities are impaired (Burchmore et al., 2003; 
Rodriguez-Contreras and Landfear, 2006; Rodriguez-Contreras et al., 2007; Feng et 
al., 2011). To gain more specific information, we aimed to investigate the central 
carbon metabolism of the Δlmgt promastigotes, with particular emphasis on 
alternative carbon source utilization. The complexity and scale of the information we 
were after imposed the necessity to use global quantitative proteomic and 
metabolomic techniques. The proteomic techniques used were SILAC and stable 
isotope dimethyl labelling, none of which had been applied to L. mexicana before. 
Using two stable isotope-based labelling techniques stemmed from the desire to 
compare quantitative proteomic data from metabolic (SILAC) and chemical 
(dimethyl) protein labelling. Dimethyl labelling methodology proved to be 
straightforward and efficient as virtually all peptides were dimethyl labelled. 
Dimethyl labelling, combined with digitonin prefractionation, led to quantification of 
a large number of enzymes of the central carbon metabolism, which was one of the 
main aims of this study. SILAC, on the other hand, proved time-consuming, expensive, 
difficult to implement to L. mexicana, and inefficient in isotope labelling of all 
proteins. As a result of the latter, no quantitative data were generated from the SILAC 
experiment and only the dimethyl labelling data were considered. Dimethyl labelling 
data helped us map the enzymatic activities in the central carbon metabolism of the 
Δlmgt promastigotes. To link enzyme activities and metabolite levels, and thus get a 
general overview of the changes in pathways of central carbon metabolism, we 
complemented quantitative proteomic with quantitative metabolomic analysis. The 
metabolomic techniques used were untargeted LC-MS, targeted GC-MS, and NMR 
analysis, each chosen for their specific advantages. The pHILIC LC-MS platform was 
used as a mean to quantify polar and charged metabolites such as amino and organic 
acids. The GC-MS platform was used to separate and quantify sugars and sugars 
phosphates. The NMR analysis focused on the carbon preferences of the investigated 
null mutant promastigotes. Lipidomic analysis of the Δlmgt promastigotes was also 
performed but it showed minimal changes in lipid metabolism in these organisms.  
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Figure VI-1. Regulated enzymes in the Δlmgt promastigotes. Abbreviations:, HXK - hexokinase, 
GAPDH - glyceraldehyde 3-phosphate dehydrogenase, PGK - phosphoglycerate kinase, G3PDH - glycerol 3-
phosphate dehydrogenase, ENO - enolase, PYK - pyruvate kinase, PPDK - pyruvate phosphate dikinase, GK - 
glycerol kinase, LDH - lactate dehydrogenase, PEPCK - phosphoenolpyruvate carboxikinase, GALE - uridine 
diphopshate glucose 4’-epimerase, PMI - phosphomannose isomerase, PMM - phosphomannomutase, GDPMP - 
guanosine diphosphate pyrophosphorylase, G6PDH - glucose 6-phophate dehydrogenase, 6PDH - 6-
phosphogluconate dehydrogenase, RK - ribokinase, I1PS - inositol 1-phosphate synthase, DA - dihydrolipoamide 
acetyltransferase, DD - dihydrolipoamide dehydrogenase, CS - citrate synthase, ODH2 - 2-oxoglutarate 
dehydrogenase E2 component, SCL - succinyl-CoA ligase, SCS - succinyl-CoA synthetase, SDF - succinate 
dehydrogenase flavoprotein, FH - fumarate hydratase, FRD - fumarate reductase, MDH - malate dehydrogenase, 
gMDH - glycosomal malate dehydrogenase, ME -  malic enzyme AS - acetyl-CoA synthetase, 3’-NT/NU - 3’-
nucleotidase/nuclease, AK - adenosine kinase, APRT - adenine phosphoribosyl-transferase, XPRT - xanthine 
phosphoribosyltransferase, GD - guanine deaminases, NNH - nonspecific nucleoside hydrolase, ADHAPS - alkyl 
dihydroxyacetone phosphate synthase, FPPS - farnesyl pyrophosphate synthase, β-KCR - β-ketoacyl-CoA 
reductase, ETF - electron-transfer flavoprotein, α polypeptide, TXN - tryparedoxin, GPx-II - glutathione 
peroxidase-like tryparedoxin peroxidases II, TXNPx - TXN-dependent peroxidase, ALT - alanine aminotransferase, 
ARG - arginase, GDH - glutamate dehydrogenase, MetE - 5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase, CSE - cystathionine γ-lyase, MTAP - methylthioadenosine phosphorylase, mALDH - 
mitochondrial aldehyde dehydrogenase, TCA - tricarboxylic acid cycle, ETC - electron transport chain. 
 
 
The proteomic and metabolomic data were integrated, and elucidated a number of 
important, and in some cases surprising, aspects of the Δlmgt promastigote 
metabolism. The data revealed profound metabolic changes in carbohydrate, amino 
acid, energy, and nucleotide metabolism. First, it was determined that the inability of 
Leishmania to utilize D-glucose leads to i/ acquisition of alternative exogenous 
sugars, such as sucrose, for the production of D-glucose and ii/ activation of 
gluconeogenesis. Regarding the first observation, it could be speculated that 
simultaneous inhibition of D-glucose and alternative sugar transport may represent a 
promising antileishmanial strategy. Regarding the second observation, we concluded 
that D-glucose, under the action of HXK, and gluconeogenesis serve to generate G6P, a 
central precursor in many biosynthetic pathways. HXK, which is up-regulated in the 
Δlmgt promastigotes (Figure VI-1) (Feng et al., 2011) and a validated drug target in 
Leishmania (Pabon et al., 2007), thus appears to be crucial for carbohydrate 
anabolism in Leishmania and must be, respectively, a center for further inhibition 
investigations. Other glycolytic/gluconeogenic enzymes such as GAPDH, PPDK, and 
PEPCK, which exercise a considerable amount of control over the influx of 
intermediates in glycolysis/gluconeogenesis, are also of particular interest for the 
development of competitive inhibitors. GAPDH facilitates the entry of glycerol while 
PPDK and PEPCK participate in the entry of amino acids in gluconeogenesis 
(Rodriguez-Contreras and Hamilton, 2014). Indeed, the Δlmgt promastigotes increase 
the uptake of amino acids (Thesis: Lamasudin, 2012), and possibly of other 
glucogenic precursor such as glycerol and acetate. The gluconeogenic capacity of the 
Δlmgt promastigotes, however, is reduced and insufficient in meeting the 
requirements for hexose phosphates and other gluconeogenic intermediates. The 
   
                                                                                                                                                                                                CHAPTER VI 
 221 
 
influx of G6P in the PPP is reduced and the oxidative reactions involved in 
regenerating NADPH, catalyzed by G6PDH and 6PDH (Figure VI-1), are down-
regulated which we speculate lead to production of less NADPH in the Δlmgt 
promastigotes. Furthermore, enzymes such as ARG, TXN, TXNPx, and GPx-II, which 
are involved in trypanothione synthesis and metabolism, are also significantly down-
regulated in the Δlmgt promastigotes (Figure VI-1). The cytosolic TXN1 and the 
mitochondrial 2-Cys peroxiredoxin (mTXNPx) of L. infantum have recently been 
validated as drug targets and the elimination of hydroperoxides by TXN/TXNPx 
associated with survival of Leishmania within macrophages and virulence (Romao et 
al., 2009; Castro et al., 2011). Taking these together, it can be postulated that i/ the 
high sensitivity of the glucose transporter null mutant promastigotes to oxidative 
stress is due to decreased ability to reduce hydroperoxides and other reactive 
species, and ii/ enzymes of NADPH and trypanothione synthesis, including the PPP 
pathway and glutathione and polyamine metabolism, represent strong candidate 
drug targets for antileishmanial therapy. 
Two other important conclusions were drawn from our data. First, ablation of the D-
glucose transport leads to down-regulation of all enzymes of glycosomal succinate 
fermentation and the mannose activation pathway (Figure VI-1). Considering the 
essential role of glycosomal succinate fermentation in maintaining the glycosomal 
redox and energy balance, the enzymes of the pathway, as well as proteins involved in 
translocation of metabolites across the glycosomal membrane and glycosomal 
biogenesis (peroxins, PEXs), have long been considered targets for the development 
of selective inhibitors (Gualdron-Lopez et al., 2013 and the references therein). 
Similar to glycosomal succinate fermentation, our study confirmed that enzymes of 
glycoconjugate synthesis, in particular PMM and GDP-MP of mannose activation 
pathway, GALE of galactose metabolism (Figure VI-1), and arabinose metabolism, are 
valuable drug targets (Garami and Ilg, 2001a; Garami and Ilg, 2001b; Garami et al., 
2001; Stewart et al., 2005; Chawla and Madhubala, 2010). Second, inhibition of D-
glucose transport further interferes with the purine salvage pathway. It is known that 
more than one enzyme of the pathway have to be targeted for successful therapy due 
to the existence of several alternative purine salvage pathways in Leishmania (Chawla 
and Madhubala, 2010). One such enzyme could be ribokinase which appears to 
salvage ribose from nucleotide degradation for reuse in nucleotide synthesis.  
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Finally, our study showed that the TCA cycle has a central role in carbon and energy 
metabolism in Leishmania. When D-glucose is not available as a nutrient, amino acids 
such as L-proline, L-glutamate, L-glutamine, L-alanine, L-aspartate, and L-threonine 
are used as biosynthetic precursors in TCA cycle anaplerosis and gluconeogenesis, 
and as energy sources through catabolism via the TCA cycle. Lipids, most surprising, 
do not represent energy sources for the Δlmgt promastigotes. Leishmania rely on 
oxidative phosphorylation for the generation of energy in the promastigote stages 
and every perturbation of the electron transport chain can possibly be lethal and 
hence, of interest in drug development. It was recently shown, however, that L. 
donovani amastigotes are oxidative phosphorylation-independent and rely on 
substrate level phosphorylation for the generation of energy (Mondal et al., 2014). 
Thus, enzymes such as PGK, PYK, PEPCK, SCS, and ASCT represent valuable drug 
targets.     
Concisely, ablation of D-glucose transport leads to i/ import of alternative sugars for 
the production of D-glucose, ii/ use of amino acids as main carbon and energy 
sources, iii/ synthesis of hexose phosphates through gluconeogenesis, iv/ generation 
of energy through the TCA cycle and linked ETC and oxidative phosphorylation, v/ 
impaired redox balance, and vi/ overall reduction of biosynthetic capacity of 
Leishmania promastigotes. 
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Appendix 1 
Accession 
number 
Protein name 
Fraction 
I II III IV V 
 
 
L/H L/H L/H L/H L/H 
LmxM.26.0620 10 kDa Heat shock protein, putative 
  
3.42 
  
LmxM.11.0350 14-3-3 protein, putative 
  
4.07 
  
LmxM.36.3210 14-3-3 protein-like protein 
  
3.91 
  
LmxM.03.0540 
26S protease regulatory subunit, putative, 
serine peptidase, Clan SJ, family S16, putative   
2.40 
  
LmxM.28.2420 
2-Oxoglutarate dehydrogenase, E2 component, 
dihydrolipoamide succinyltransferase, putative     
0.41 
LmxM.32.1590 3-ketoacyl-CoA reductase, putative 
    
0.19 
LmxM.30.2310 3'-Nucleotidase/nuclease precursor, putative 
    
2.20 
LmxM.36.5010 40S ribosomal protein SA, putative 
  
2.00 
  
LmxM.13.0570 40S ribosomal protein S12, putative 
  
2.61 
  
LmxM.30.0010 
5-Methyltetrahydropteroyltriglutamate—
homocysteine methyltransferase, putative   
3.33 
  
LmxM.15.1203 60S acidic ribosomal protein P2 
  
2.67 
  
LmxM.29.3730 60S acidic ribosomal protein P2, putative 
  
2.60 
  
LmxM.27.1380 60S acidic ribosomal subunit protein, putative 
  
3.18 
  
LmxM.21.1050 60S ribosomal protein L9, putative 
    
2.54 
LmxM.04.0750 60S ribosomal protein L10, putative 
  
2.11 
  
LmxM.08_29.2460 60S ribosomal protein L13, putative 
  
6.50 
  
LmxM.34.3340 
6-Phosphogluconate dehydrogenase, 
decarboxylating, putative   
4.19 
  
LmxM.23.0710 Acetyl-CoA synthetase, putative 
  
2.26 
  
LmxM.04.1230 Actin 5.5 3.48 3.83 
 
2.05 
LmxM.26.0140 Adenine phosphoribosyltransferase 
    
6.29 
LmxM.29.0880 Adenosine kinase, putative 
  
5.00 
  
LmxM.12.0630 Alanine aminotransferase, putative 
  
5.01 
  
LmxM.29.0120 Alkyl dihydroxyacetonephosphate synthase 
    
0.25 
LmxM.20.1550 
Aminoacylase, putative,  
N-acyl-L-amino acid amidohydrolase, putative   
3.18 
  
LmxM.20.1560 
Aminoacylase, putative,  
N-acyl-L-amino acid amidohydrolase, putative   
3.18 
  
LmxM.34.2350 Aminopeptidase P, putative 
  
2.79 
  
LmxM.08_29.2240 
Aminopeptidase, putative,  
metallo-peptidase, Clan MA(E), Family M1   
2.39 
  
LmxM.34.1480 Arginase 
  
2.29 
  
LmxM.16.0540 Aspartate carbamoyltransferase, putative 
  
2.87 
  
LmxM.29.0460 Aspartyl-tRNA synthetase, putative 
  
2.65 
  
LmxM.21.1770 ATP synthase F1 subunit γ protein, putative 
   
0.32 
 
LmxM.29.3600 ATP synthase, ε chain, putative 
    
0.50 
LmxM.05.0510 ATPase α subunit, putative 
    
0.39 
LmxM.25.1170 ATPase β subunit, putative 
   
0.29 0.43 
LmxM.08_29.1270 
ATP-dependent Clp protease subunit,  
heat shock protein 100 (HSP100), putative,  
serine peptidase, putative  
  
26.9 
  
LmxM.34.0370 
ATP-dependent DEAD-box RNA helicase, 
putative   
4.51 
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LmxM.34.3100 ATP-dependent RNA helicase, putative 2.3 
 
4.91 
 
0.40 
LmxM.30.1070 Biotin/lipoate protein ligase-like protein 
  
2.69 
  
LmxM.04.0010 
Calcium-translocating P-type ATPase, organelle-
type calcium ATPase     
0.40 
LmxM.20.1180 Calpain-like cysteine peptidase 
  
3.06 
 
0.09 
LmxM.20.1185 Calpain-like cysteine peptidase, putative  
  
3.02 
 
0.09 
LmxM.20.1310 
Calpain-like cysteine peptidase, putative, 
calpain-like cysteine peptidase, Clan CA,  
family C2 
3.3 
    
LmxM.27.0490 
Calpain-like cysteine peptidase, putative, 
cysteine peptidase, Clan CA, family C2, putative     
0.39 
LmxM.13.0090 
Carboxypeptidase, putative, 
metallo-peptidase, Clan MA(E), family 32   
2.48 
  
LmxM.31.3270 Chaperonin α subunit, putative 
  
3.01 
  
LmxM.36.2030 Chaperonin HSP60, mitochondrial precursor 
 
0.47 2.17 
  
LmxM.36.2020 Chaperonin HSP60, mitochondrial precursor 
 
0.43 
   
LmxM.13.1660 Chaperonin TCP20, putative 
  
4.00 
  
LmxM.18.0680 Citrate synthase, putative 
 
0.28 
   
LmxM.18.0670 Citrate synthase, putative 
 
0.29 
   
LmxM.25.0910 Cyclophilin A 
  
3.32 
  
LmxM.34.3230 Cystathione γ lyase, putative 
  
2.13 
 
0.17 
LmxM.32.1330 
Cysteine conjugate β-lyase, aminotransferase- 
like protein   
4.33 
  
LmxM.19.1420 Cysteine peptidase A (CBA) 
  
2.32 
  
LmxM.08_29.0820 
Cysteine peptidase C (CPC), CPC cysteine 
peptidase, Clan CA, family C1, Cathepsin B-like   
2.34 
  
LmxM.12.0250 Cysteinyl-tRNA synthetase, putative 
  
4.16 
  
LmxM.26.1710 Cytochrome c oxidase subunit V, putative 
   
0.38 
 
LmxM.36.2660 
Dihydrolipoamide acetyltransferase precursor, 
putative     
0.22 
LmxM.31.3310 Dihydrolipoamide dehydrogenase, putative 
 
0.33 
   
LmxM.27.2020 D-lactate dehydrogenase-like protein 0.31 0.23 
  
0.21 
LmxM.25.0980 Dynein heavy chain, putative 
    
0.34 
LmxM.28.1140 
Electron-transfer-flavoprotein, α polypeptide, 
putative   
3.56 
  
LmxM.17.0080 Elongation factor 1-α 2.91 2.89 8.02 
  
LmxM.33.0820 Elongation factor 1-β 
 
2.35 5.06 
  
LmxM.09.0970 Elongation factor-1 γ 
  
2.68 
  
LmxM.03.0980 Elongation initiation factor 2 α subunit, putative 
    
0.42 
LmxM.28.2310 Eukaryotic translation initiation factor, putative 
  
2.48 
  
LmxM.22.1360 Farnesyl pyrophosphate synthase, putative 
  
2.75 
  
LmxM.10.1190 
Flagellar protofilament ribbon protein-like 
protein     
0.23 
LmxM.13.0430 Flagellar radial spoke protein, putative 
    
0.29 
LmxM.08_29.1960 Fumarate hydratase, putative 
  
5.85 
  
LmxM.33.2290 
G-Actin binding protein, putative,  
twinfilin, putative   
10.40 
  
LmxM.33.0080 Glucose-6-phosphate dehydrogenase 
  
4.08 
  
LmxM.28.2910 Glutamate dehydrogenase, putative 6.56 5.37 12.35 
  
LmxM.29.2980 
Glyceraldehyde 3-phosphate dehydrogenase, 
glycosomal   
3.83 
 
0.43 
LmxM.10.0510 
Glycerol-3-phosphate dehydrogenase [NAD+], 
glycosomal/mitochondrial   
17.06 
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LmxM.34.4720 Glycine cleavage system H protein, putative 
  
2.49 
  
LmxM.33.0990 p-Glycoprotein 4.10 
   
4.05 
LmxM.19.0710 Glycosomal malate dehydrogenase 
  
8.95 
  
LmxM.27.1805 
Glycosomal phosphoenolpyruvate 
carboxykinase, putative   
4.72 
  
LmxM.10.0470 GP63, leishmanolysin 0.10 
    
LmxM.10.0405 GP63, leishmanolysin 0.09 
   
0.03 
LmxM.10.0390 GP63, leishmanolysin 0.08 0.06 
  
0.02 
LmxM.10.0460 GP63, leishmanolysin 0.08 
    
LmxM.25.1420 GTP-binding protein, putative 
  
2.71 
  
LmxM.08_29.0867 Guanine deaminase, putative 
  
4.17 
  
LmxM.29.2460 
Heat shock 70-related protein 1, mitochondrial 
precursor, putative  
0.44 2.28 
  
LmxM.29.2490 
Heat shock 70-related protein 1, mitochondrial 
precursor, putative   
2.17 
  
LmxM.29.2550 
Heat shock 70-related protein 1, mitochondrial 
precursor, putative   
2.39 
  
LmxM.32.0312 Heat shock protein 83-1 
  
2.84 
  
LmxM.27.2400 Heat shock protein DNAJ, putative 2.95 
 
3.92 
  
LmxM.18.1370 Heat shock protein, putative 
  
3.29 
  
LmxM.28.2770 Heat-shock protein hsp70, putative 
   
2.62 
 
LmxM.08_29.0850 
High mobility group protein homolog tdp-1, 
putative   
6.94 
  
LmxM.36.6480 Histidine secretory acid phosphatase, putative 2.34 
    
LmxM.08_29.1720 Histone H2A, putative 
    
0.17 
LmxM.17.1220 Histone H2B 
    
0.22 
LmxM.09.1340 Histone H2B 
    
0.25 
LmxM.15.0010 Histone H4 
    
0.26 
LmxM.06.0010 Histone H4 
    
0.25 
LmxM.25.2450 Histone H4 
    
0.24 
LmxM.08_29.0320 Hypothetical protein, conserved 
  
4.19 
  
LmxM.08_29.1240 Hypothetical protein, unknown function 
  
3.17 
  
LmxM.08_29.1470 Hypothetical protein, conserved 
  
3.02 
  
LmxM.11.1030 Hypothetical protein, conserved 
   
0.24 
 
LmxM.13.0450 Hypothetical protein, conserved 
  
6.52 
  
LmxM.17.0870 Hypothetical protein, conserved  3.13 
    
LmxM.18.0210 Hypothetical protein, conserved 
  
2.94 
  
LmxM.21.0980 Hypothetical protein, conserved  
  
2.91 
  
LmxM.22.0730 Hypothetical protein, conserved 
   
0.22 
 
LmxM.23.1020 Hypothetical protein, unknown function 
   
0.50 
 
LmxM.23.1480 Hypothetical protein, conserved  
  
2.08 
  
LmxM.23.1580 Hypothetical protein, conserved  
  
2.55 
  
LmxM.25.2010 Hypothetical protein, conserved 
  
2.31 
  
LmxM.27.1730 Hypothetical protein, conserved 3.05 
    
LmxM.27.2000 Hypothetical protein, conserved 
  
3.07 
  
LmxM.29.2850 Hypothetical protein, conserved 
 
0.49 
   
LmxM.29.3430 Hypothetical protein, conserved 
  
3.63 
  
LmxM.31.0630 Hypothetical protein, conserved 
  
8.50 
  
LmxM.31.0950 Hypothetical protein, conserved 
  
3.62 
  
LmxM.33.0190 Hypothetical protein, conserved 
  
22.70 
  
LmxM.33.1520 Hypothetical protein, conserved 3.47 3.83 7.26 
  
LmxM.33.2580 Hypothetical protein, conserved 
  
3.27 
  
LmxM.34.4470 Hypothetical protein, conserved  
 
2.00 
   
LmxM.36.0740 Hypothetical protein, conserved  
  
16.95 
  
LmxM.36.1520 
Hypothetical protein, conserved, nima-related 
protein kinase, putative    
4.66 
  
LmxM.36.5100 Hypothetical protein, conserved 
  
2.61 
  
LmxM.36.5910 Hypothetical protein, conserved 
  
2.87 
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LmxM.36.6060 Hypothetical protein, conserved 
  
3.18 
  
LmxM.36.1520 
Hypothetical protein, conserved, nima-related  
protein kinase, putative   
4.66 
  
LmxM.31.1820 Iron superoxide dismutase, putative 
  
2.77 
  
LmxM.36.5620 Isoleucyl-tRNA synthetase, putative 
  
2.96 
  
LmxM.16.1460 Kinesin, putative 
   
0.46 
 
LmxM.16.1470 Kinesin, putative 
   
0.46 
 
LmxM.27.0240 Kinetoplast-associated protein-like protein 
  
2.17 
  
LmxM.33.0140 Malate dehydrogenase 
 
0.39 2.57 
  
LmxM.24.0770 Malic enzyme, putative 
  
5.18 
  
LmxM.05.0830 Methylthioadenosine phosphorylase, putative 
  
2.22 
  
LmxM.05.0380 Microtubule-associated protein, putative 
   
0.16 
 
LmxM.34.1380 
Mitochondrial processing peptidase, β subunit, 
putative, metallo-peptidase, Clan ME, Family 
M16 
   
0.31 
 
LmxM.32.1380 
Mitogen activated protein kinase, putative, 
map kinase, putative  
2.39 7.54 
  
LmxM.14.1360 myo-Inositol-1-phosphate synthase 
  
2.59 
  
LmxM.34.1180 NADH-dependent fumarate reductase, putative 
  
6.61 
  
LmxM.10.0210 Nucleolar protein 56, putative 
  
2.26 
  
LmxM.14.0130 Nucleoside hydrolase-like protein 
  
3.15 
  
LmxM.19.0440 Nucleosome assembly protein, putative 
  
4.73 
  
LmxM.30.1750 Nucleosome assembly protein-like protein 
  
5.46 
  
LmxM.36.4170 Oxidoreductase, putative 
  
5.40 
  
LmxM.16.1430 Paraflagellar rod protein 2C 0.29 0.26 
   
LmxM.30.3090 
Peptidase, putative, metallo-peptidase, Clan ME, 
Family M16   
4.42 
  
LmxM.23.0040 Peroxidoxin,tryparedoxin peroxidase 
  
2.22 
  
LmxM.20.0110 Phosphoglycerate kinase B, cytosolic 
  
3.41 
  
LmxM.20.0100 Phosphoglycerate kinase C, glycosomal 
  
3.30 
  
LmxM.36.1960 Phosphomannomutase, putative 
  
3.50 
  
LmxM.09.0891 Polyubiquitin, putative 
  
4.95 
  
LmxM.36.1600 Proteasome α 1 subunit, putative 
  
3.18 
  
LmxM.34.4850 Proteasome α 1 subunit, putative 
  
2.19 
  
LmxM.21.1830 
Proteasome α 5 subunit, putative,20S 
proteasome subunit α 5, (putative)   
2.35 
  
LmxM.31.0390 
Proteasome regulatory non-ATP-ase subunit 8, 
putative, 26S proteasome regulatory subunit, 
putative 
  
2.01 
  
LmxM.08_29.0120 
Proteasome regulatory non-ATPase subunit, 
putative   
3.64 
  
LmxM.36.6940 Protein disulfide isomerase 0.28 0.31 
   
LmxM.26.0660 Protein disulfide isomerase, putative 
  
5.08 
  
LmxM.19.0150 
Protein kinase, putative, 
mitogen-activated protein kinase, putative   
7.73 
  
LmxM.07.0190 
Protein phosphatase 2A, regulatory subunit B, 
putative,phosphotyrosyl phosphate activator 
protein, putative 
  
5.25 
  
LmxM.29.1250 Pyridoxal kinase, putative 
  
4.04 
  
LmxM.34.0020 Pyruvate kinase 
  
2.51 
  
LmxM.34.0030 Pyruvate kinase, putative 
  
2.51 
  
LmxM.11.1000 Pyruvate phosphate dikinase, putative 
  
2.69 
  
LmxM.08_29.2160 rab-GDP dissociation inhibitor, putative 2.01 
 
4.68 
  
LmxM.33.2820 
Regulatory subunit of protein kinase a-like 
protein   
2.00 
  
LmxM.15.0270 Replication factor A 28 kDa subunit, putative 
 
2.92 
   
LmxM.15.0275 
Ribonucleoprotein p18, mitochondrial 
precursor, putative    
0.32 
 
LmxM.08_29.1070 Ribosomal protein L1a, putative 
 
0.47 2.47 
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LmxM.21.1552 RNA helicase, putative 
  
2.74 
  
LmxM.31.0750 RNA-binding protein, putative 
 
7.97 9.84 
  
LmxM.25.0490 RNA-binding protein, putative, UPB1 
  
40.00 
  
LmxM.11.0100 Seryl-tRNA synthetase, putative 2.31 3.23 7.77 
  
LmxM.14.0850 Small myristoylated protein-3, putative 
  
4.08 
  
LmxM.07.0870 Splicing factor ptsr1-like protein 
  
5.18 
  
LmxM.36.0070 Stress-inducible protein STI1 homolog 
 
5.62 
   
LmxM.24.1630 Succinate dehydrogenase flavoprotein, putative 
   
0.49 
 
LmxM.36.2950 
Succinyl-CoA ligase [GDP-forming] β-chain, 
putative   
3.94 
  
LmxM.25.2130 Succinyl-CoA synthetase α subunit, putative 
  
2.96 
  
LmxM.32.2340 
Succinyl-CoA:3-ketoacid-CoA transferase, 
mitochondrial precursor, putative   
7.62 
  
LmxM.30.2020 
Succinyl-diaminopimelate desuccinylase-like 
protein 
0.22 
 
2.53 
  
LmxM.04.0190 Surface antigen-like protein 0.16 
  
0.09 
 
LmxM.05.1215 Surface antigen-like protein 0.07 
  
0.05 
 
LmxM.21.1090 T-complex protein 1, Δ subunit, putative 
  
3.38 
  
LmxM.34.3860 T-complex protein 1, η subunit, putative 
  
2.57 
  
LmxM.23.1220 T-complex protein 1, γ subunit, putative 
  
3.17 
  
LmxM.26.1570 
Thimet oligopeptidase, putative, 
metallo-peptidase, Clan MA(E), Family M3   
3.98 
  
LmxM.32.0240 Thiol-dependent reductase 1 
 
2.29 5.66 
  
LmxM.29.2740 TPR domain protein, conserved 
  
3.12 
  
LmxM.36.1430 Translation elongation factor 1-β, putative 
  
5.43 
  
LmxM.17.1290 Translation initiation factor, putative 
  
2.45 
  
LmxM.13.0280 α-Tubulin    0.20  
LmxM.08_29.1160 Tryparedoxin 
  
2.78 
  
LmxM.26.0800 
Type II (glutathione peroxidase-like) 
tryparedoxin peroxidase   
16.86 
  
LmxM.34.3060 Ubiquitin-activating enzyme e1, putative 
  
4.45 
  
LmxM.23.0550 Ubiquitin-activating enzyme e1, putative 
  
2.49 
  
LmxM.32.2300 UDP-glc 4'-epimerase, putative 
 
5.25 6.46 
  
LmxM.33.3670 
Vacuolar ATP synthase catalytic subunit A, 
putative   
2.66 
  
LmxM.23.1510 
Vacuolar proton translocating ATPase subunit A, 
putative    
0.36 
 
LmxM.30.1220 
Vacuolar-type proton translocating 
pyrophosphatase 1, putative    
0.39 
 
LmxM.29.3130 Valyl-tRNA synthetase, putative 
  
3.11 
  
LmxM.21.0850 Xanthine phosphoribosyltransferase 
 
4.50 5.47 
  
LmxM.01.0770 Unspecified product  
  
2.73 
  
LmxM.04.0800 Unspecified product 
    
0.20 
LmxM.08.1171 
Unspecified product  
    
0.35 
 
LmxM.31.3650 Unspecified product  
  
9.09 
  
 
Supplemental table III-1. Significantly modulated proteins in the ∆lmgt promastigotes 
pre-fractionated with digitonin.  Wild type and ∆lmgt promastigotes was consecutively treated with 20 
µM, 200 µM, 1mM, and 10 mM of digitonin to generate five sub-cellular fractions: two cytosolic, two organellar and 
one containing digitonin-insoluble material. The fraction proteins were extracted, digested with trypsin, stable 
isotope dimethyl labelled, combined and analyzed by 1D HPLC-ESI-MS/MS. The data were analyzed with Mascot 
Distiller. L/H - light/heavy ratio. 
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  Mass        RT            Formula                           Putative metabolite                              Map                  Pathway                
 
136.04 11.44 C4H8O5 3 
[FA trihydroxy(4:0)]  
2,2,4-trihydroxy- 
butanoic acid 
5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 0.00 50.03 0.03 
169.05 16.43 C4H12NO4P 1 
Phosphodime 
thylethanolamine 
8 Lipid Metabolism 
Glycero 
phospholipid 
metabolism 
0.00 19.87 0.01 
298.08 7.974 C16H14N2O2S 1 Mefenacet 7 0  0 0.00 18.15 0.04 
164.05 4.787 C9H8O3 13 Phenylpyruvate 8 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
1.00 17.32 0.01 
92.047 11.46 C3H8O3 1 Glycerol 8 
Carbohydrate 
Metabolism  
Galactose 
metabolism 
Glycerolipid 
metabolism 
1.00 14.38 0.02 
185.03 17.44 C7H7NO5 1 
2-Amino- 
3-carboxymuconate  
semialdehyde 
8 
Amino Acid 
Metabolism  
Tryptophan 
metabolism 1.00 13.55 0.00 
123.03 7.818 C6H5NO2 4 Nicotinate 10 
Metabolism of 
Cofactors and 
Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
1.00 9.21 0.01 
141.02 18.37 C2H8NO4P 2 Phosphoethanolamine  10 
Amino Acid 
Metabolism  
Glycero 
phospholipid 
metabolism 
Sphingolipid 
metabolism 
1.00 9.14 0.03 
180.04 8.192 C9H8O4 11 
3-(4-Hydroxyphenyl) 
pyruvate 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
1.00 7.87 0.01 
260.2 4.032 C14H28O4 1 
[FA hydroxy(14:0)] 3,11-
dihydroxy- 
tetradecanoic acid 
7 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 0.00 7.84 0.00 
102.07 7.535 C5H10O2 9 Pentanoate 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 7.41 0.00 
254.04 18.29 C7H14N2O4S2 1 L-Djenkolic acid 7 0  0 1.00 6.72 0.01 
88.052 7.57 C4H8O2 8 Butanoic acid 8 
Carbohydrate 
Metabolism  
Butanoate 
metabolism 1.00 5.49 0.01 
102.07 5.118 C5H10O2 9 Ethyl propionate 7 
Lipids: Fatty 
Acyls 
Fatty esters 1.00 4.65 0.00 
130.06 4.783 C6H10O3 18 Ethyl 3-oxobutanoate 7 0  0 1.00 4.39 0.01 
271.25 7.632 C16H33NO2 6 
[FA amino(16:0)]  
2R-aminohexadecanoic 
acid 
7 
Lipids: Fatty 
Acyls 
Amino Fatty Acids 1.00 4.05 0.04 
100.05 7.537 C5H8O2 18 Tiglic acid 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 3.70 0.00 
131.06 16.55 C5H9NO3 14 
L-Glutamate  
5-semialdehyde 
8 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 3.41 0.02 
400.1 17.56 C14H20N6O4S2 1 Ovothiol A disulfide 5 0  0 1.00 3.31 0.01 
111.04 12.67 C4H5N3O 1 Cytosine 10 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 3.13 0.00 
205.07 8.079 C11H11NO3 5 Indolelactate 8 
Amino Acid 
Metabolism  
Tryptophan 
metabolism 1.00 3.03 0.01 
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200.98 19.6 C3H7NO5S2 1 S-Sulfo-L-cysteine 8 
Amino Acid 
Metabolism  
Cysteine  
metabolism 1.00 2.93 0.02 
815.55 3.961 C47H78NO8P 17 PE(42:8) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 2.89 0.04 
189.04 7.647 C10H7NO3 6 Kynurenate 6 
Amino Acid 
Metabolism  
Tryptophan 
metabolism 1.00 2.84 0.01 
132.08 5.055 C6H12O3 15 
[FA hydroxy(6:0)]  
4-hydroxy-hexanoic acid 
5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 2.76 0.00 
129.08 14.17 C6H11NO2 9 L-Pipecolate 8 
Amino Acid 
Metabolism  
Lysine degradation 1.00 2.41 0.02 
183.07 17.23 C5H14NO4P 1 Choline phosphate 10 Lipid Metabolism 
Glycero 
phospholipid 
metabolism  
Glycine, serine and 
threonine 
metabolism 
1.00 2.35 0.03 
825.53 3.93 C48H76NO8P 3 
PC(18:4(6Z,9Z,12Z,15Z)/ 
22:6(4Z,7Z,10Z,13Z, 
16Z,19Z)) 
7 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 2.34 0.05 
117.08 12.8 C5H11NO2 17 Betaine 10 
Amino Acid 
Metabolism  
Glycine, serine and 
threonine 
metabolism 
1.00 2.26 0.01 
118.06 7.528 C5H10O3 13 5-Hydroxypentanoate 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 2.24 0.01 
126.04 13.4 C5H6N2O2 2 Thymine 6 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 2.20 0.02 
330.26 3.722 C22H34O2 13 
[FA (22:5)] 7Z,10Z,13Z, 
16Z,19Z-docosapenta 
enoic acid 
6 
Lipids: Fatty 
Acyls 
Biosynthesis of 
unsaturated fatty 
acids 
1.00 2.17 0.03 
328.24 3.708 C22H32O2 11 Docosahexaenoicacid 8 
Lipids: Fatty 
Acyls 
Biosynthesis of 
unsaturated fatty 
acids 
1.00 2.17 0.01 
145.04 12.35 C5H7NO4 2 2-Oxoglutaramate 8 
Amino Acid 
Metabolism  
Glutamate 
metabolism 1.00 2.16 0.00 
787.61 3.881 C44H86NO8P 44 PC(36:1) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 2.14 0.01 
161.07 10.74 C6H11NO4 10 O-Acetyl-L-homoserine 6 
Amino Acid 
Metabolism  
Methionine 
metabolism Sulfur 
metabolism 
1.00 2.13 0.02 
134.02 18.58 C4H6O5 4 (S)-Malate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
Pyruvate 
metabolism 
1.00 0.51 0.00 
771.61 3.873 C44H86NO7P 15 
[PC (18:1/18:0)]  
1-(1Z-octadecenyl)- 
2-(9Z-octadecenoyl)- 
sn-glycero-3-phospho 
choline 
5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.49 0.01 
252.11 14.7 C19H32N6O10 3 Asp-Lys-Asp-Gln 7 Peptide(tetra-)  Basic peptide 1.00 0.48 0.03 
133.04 14.31 C4H7NO4 4 Iminodiacetate 7 0  
Nitrilotriacetate 
degradation 1.00 0.48 0.00 
715.52 3.977 C39H74NO8P 27 PE(34:2) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 0.47 0.00 
755.55 3.977 C42H78NO8P 34 PC(34:3) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.47 0.00 
739.52 3.865 C41H74NO8P 35 PE(36:4) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 0.46 0.00 
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781.56 3.906 C44H80NO8P 52 PC(36:4) 7 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.46 0.01 
750.59 3.522 C52H78O3 2 
Nonaprenyl- 
4-hydroxybenzoate 
7 
Metabolism of 
Cofactors and 
Vitamins 
Ubiquinone-9 
biosynthesis  1.00 0.46 0.01 
523.36 4.581 C26H54NO7P 11 
[PC (18:0)]  
1-octadecanoyl- 
sn-glycero-3- 
phosphocholine 
5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.45 0.01 
729.53 4.018 C40H76NO8P 33 PC(32:2) 7 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.45 0.00 
521.35 4.679 C26H52NO7P 12 
1-Oleoylglycero 
phosphocholine 
5 0  0 1.00 0.44 0.01 
837.55 3.58 C46H80NO10P 16 PS(40:5) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho- 
serines 1.00 0.43 0.01 
753.53 3.977 C42H76NO8P 41 PC(34:4) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.43 0.00 
757.56 3.918 C42H80NO8P 53 PC(34:2) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.41 0.00 
158.03 13.08 C5H6N2O4 3 (S)-Dihydroorotate 8 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 0.41 0.01 
836.54 3.625 C43H81O13P 21 PI(34:1) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
inositols 1.00 0.41 0.01 
808.51 3.693 C41H77O13P 15 PI(32:1) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
inositols 1.00 0.38 0.03 
134.06 9.917 C5H10O4 8 Deoxyribose 8 
Carbohydrate 
Metabolism  
Pentose phosphate 
pathway 1.00 0.37 0.01 
426.09 19.48 C13H22N4O8S2 2 Asp-Cys-Cys-Ser 5 Peptide(tetra-)  Acidic peptide 1.00 0.36 0.01 
646.46 3.595 C35H67O8P 15 PA(32:1) 7 
Lipids: 
Glycerophospho 
lipids 
Glycero 
phosphates 1.00 0.36 0.01 
687.48 3.925 C37H70NO8P 20 PE(32:2) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 0.35 0.00 
476.16 17.49 C18H28N4O9S 2 Asp-Met-Asp-Pro 5 Peptide(tetra-)  
Hydrophobic 
peptide 1.00 0.34 0.00 
147.05 17.04 C5H9NO4 14 L-Glutamate 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
Glutamate 
metabolism D-
Glutamine and D-
glutamate 
metabolism 
Glutathione 
metabolism 
1.00 0.32 0.00 
133.04 17.35 C4H7NO4 4 L-Aspartate 10 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
Arginine and 
proline 
metabolism  
1.00 0.31 0.00 
674.49 3.592 C37H71O8P 19 PA(34:1) 5 
Lipids: 
Glycerophospho 
lipids 
Glycero 
phosphates 1.00 0.30 0.00 
703.52 4.047 C38H74NO8P 29 PC(30:1) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.28 0.00 
834.53 3.659 C43H79O13P 21 PI(34:2) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
inositols 1.00 0.27 0.00 
663.48 3.607 C35H70NO8P 30 PE(30:0) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 0.25 0.00 
   
                                                                                                                                                                                               APPENDICES 
 252 
 
691.51 3.566 C37H74NO8P 29 PE(32:0) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 0.25 0.00 
644.44 3.705 C35H65O8P 12 PA(32:2) 7 
Lipids: 
Glycerophospho 
lipids 
Glycero 
phosphates 1.00 0.25 0.01 
458.25 7.586 C43H82O16P2 5 
[GP (16:0/18:0)]  
1-hexadecanoyl-2- 
(9Z-octadecenoyl)- 
sn-glycero-3-phospho 
-(1'-myo-inositol- 
3'-phosphate) 
7 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho- 
inositol 
monophosphates 
1.00 0.25 0.01 
467.3 4.932 C22H46NO7P 4 
[PC (14:0)]  
1-tetradecanoyl- 
sn-glycero-3-phospho 
choline 
5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.24 0.00 
89.048 16.81 C3H7NO2 9 L-Alanine 10 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
1.00 0.22 0.00 
705.53 4.029 C38H76NO8P 32 PC(30:0) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.22 0.00 
422.08 18.44 C12H23O14P 5 Lactose 6-phosphate 8 
Carbohydrate 
Metabolism  
Galactose 
metabolism 1.00 0.22 0.01 
699.48 4.063 C38H70NO8P 14 
PE(15:0/18:3(6Z, 
9Z,12Z)) 
5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
ethanolamines 1.00 0.21 0.02 
701.5 4.031 C38H72NO8P 20 PC(30:2) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.19 0.01 
307.08 16.85 C10H17N3O6S 3 Glutathione 10 
Amino Acid 
Metabolism  
Glutamate 
metabolism 
Cysteine 
metabolism 
Glutathione 
metabolism 
1.00 0.15 0.04 
677.5 4.06 C36H72NO8P 31 PC(28:0) 5 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho-
cholines 1.00 0.14 0.00 
118.03 17.64 C4H6O4 7 Succinate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Oxidative 
phosphorylation 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
1.00 0.11 0.02 
313.33 8.431 C20H43NO 1 
[SP amino,dimethyl 
(18:0)] 2-amino-14, 
16-dimethylocta 
decan-3-ol 
7 
Lipids: 
Sphingolipids 
Sphingoid bases 1.00 0.07 0.00 
285.3 9.181 C18H39NO 1 
[SP] 1-deoxy- 
sphinganine 
7 
Lipids: 
Sphingolipids 
Sphingoid bases 1.00 0.05 0.00 
 
Supplemental table III-2. Significantly modulated metabolites in the ∆lmgt 
promastigotes. Wild type and ∆lmgt promastigotes, wild type and ∆lmgt promastigote spend media and fresh 
media (biological replicates, n=3) were subjected to quick quenching to 4°C, metabolite extraction with 
chloroform/methanol/wate (1:3:1), analysis of the extracts by 1D-pHILIC-HPLS-ESI-MS, and data analysis by 
IDEOM. Specified in yellow are the metabolites matched to authentic standards. Specified in red are the 
metabolites with more than one isomeric peak. 
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           Mass          RT          Formula                            Putative metabolite                           Map                  Pathway     
       
727.55 3.808 C41H78NO7P 16 
PE(18:1(11Z)/ P-
18:1(11Z)) 
7 
Lipids: 
Glycerophospho 
lipids 
Glycerophospho 
ethanolamines 0.00 15.53 0.00 
164.05 4.787 C9H8O3 13 Phenylpyruvate 8 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
1.00 15.07 0.01 
222.09 4.135 C12H14O4 8 Apiole 5 0  0 1.00 13.30 0.00 
123.03 7.818 C6H5NO2 4 Nicotinate 10 
Metabolism of 
Cofactors and 
Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
Alkaloid 
biosynthesis 
1.00 9.73 0.00 
180.04 8.192 C9H8O4 11 
3-(4-Hydroxyphenyl) 
pyruvate 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
Alkaloid 
biosynthesis 
1.00 7.47 0.00 
170.09 4.301 C9H14O3 2 Furfural diethyl acetal 5 0  0 1.00 7.21 0.01 
180.11 4.221 C11H16O2 6 Olivetol 5 0  0 1.00 6.83 0.02 
226.1 7.719 C10H14N2O4 2 Carbidopa 5 0  0 1.00 6.70 0.04 
341.16 5.073 C20H23NO4 6 
5,8,13,13a-Tetrahydro-
columbamine 
5 
Biosynthesis of 
Secondary 
Metabolites  
Alkaloid 
biosynthesis I 1.00 6.29 0.02 
264.1 4.148 C14H16O5 1 
1'-Acetoxyeugenol 
acetate 
5 0  0 1.00 6.20 0.02 
187.12 5.135 C9H17NO3 3 N-Heptanoylglycine 7 0  0 1.00 6.11 0.02 
224.14 4.25 C13H20O3 6 [FA] Methyl jasmonate 6 
Lipids: Fatty 
Acyls 
Octadecanoids 1.00 5.85 0.02 
98.073 4.271 C6H10O 8 3-Hexenal 6 
Lipids: Fatty 
Acyls 
α-Linolenic acid 
metabolism 1.00 5.62 0.04 
210.13 4.309 C12H18O3 6 (3S,7S)-Jasmonic acid 5 
Lipids: Fatty 
Acyls 
Octadecanoids 1.00 5.56 0.03 
133.07 15.29 C5H11NO3 4 1-deoxyxylono jirimycin 7 0  0 1.00 5.50 0.01 
168.08 4.448 C9H12O3 3 
1,3,5-trimethoxy 
benzene 
5 
Biosynthesis of 
Secondary 
Metabolites  
1,3,5-trimethoxy-
benzene 
biosynthesis 
1.00 4.94 0.05 
133.07 7.603 C5H11NO3 4 3-nitro-2-pentanol 5 0  0 0.00 4.33 0.02 
88.052 7.57 C4H8O2 8 Butanoic acid 8 
Carbohydrate 
Metabolism  
Butanoate 
metabolism 1.00 4.26 0.01 
130.06 4.783 C6H10O3 18 Ethyl 3-oxobutanoate 7 0  0 1.00 4.07 0.00 
102.07 7.535 C5H10O2 9 Pentanoate 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 3.84 0.03 
216.15 7.56 C10H20N2O3 1 Val-Val 5 Peptide(di-) 
Hydrophobic 
peptide 1.00 3.54 0.02 
205.07 8.079 C11H11NO3 5 Indolelactate 8 
Amino Acid 
Metabolism  
Tryptophan 
metabolism 1.00 3.52 0.00 
166.06 5.072 C9H10O3 17 
3-Methoxy-4-hydroxy 
phenylacetaldehyde 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 1.00 3.26 0.00 
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200.98 19.6 C3H7NO5S2 1 S-Sulfo-L-cysteine 8 
Amino Acid 
Metabolism  
Cysteine 
metabolism 1.00 3.26 0.00 
244.09 7.563 C10H16N2O3S 1 Biotin 6 
Metabolism of 
Cofactors and 
Vitamins 
Biotin metabolism 1.00 3.22 0.04 
100.05 7.537 C5H8O2 18 Tiglic acid 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 2.69 0.00 
156.05 12.87 C6H8N2O3 4 
4-Imidazolone-5-
propanoate 
6 
Amino Acid 
Metabolism  
Histidine 
metabolism 1.00 2.67 0.00 
238.13 7.532 C24H36N4O6 3 Ile-Phe-Thr-Pro 7 Peptide(tetra-)  
Hydrophobic 
peptide 1.00 2.55 0.02 
102.07 5.118 C5H10O2 9 Ethyl propionate 7 
Lipids: Fatty 
Acyls 
Fatty esters 1.00 2.49 0.01 
132.08 5.055 C6H12O3 15 
[FA hydroxy(6:0)] 4-
hydroxy-hexanoic acid 
5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 2.49 0.00 
120.06 4.147 C8H8O 8 Phenylacetaldehyde 6 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 1.00 2.32 0.01 
134.06 9.917 C5H10O4 8 Deoxyribose 8 
Carbohydrate 
Metabolism  
Pentose phosphate 
pathway 1.00 2.29 0.00 
228.15 7.555 C11H20N2O3 3 Leu-Pro 5 Peptide(di-) 
Hydrophobic 
peptide 1.00 2.27 0.04 
182.06 9.909 C9H10O4 13 
3-(4-Hydroxyphenyl) 
lactate 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 1.00 2.15 0.00 
161.07 10.74 C6H11NO4 10 O-Acetyl-L-homoserine 6 
Amino Acid 
Metabolism  
Methionine 
metabolism Sulfur 
metabolism 
1.00 2.01 0.01 
156.02 11.52 C5H4N2O4 2 Orotate 10 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 0.48 0.02 
298.29 3.691 C19H38O2 25 Nonadecanoicacid 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.47 0.01 
270.26 3.733 C17H34O2 30 
[FA (17:0)] 
heptadecanoic acid 
5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.44 0.04 
115.06 14.63 C5H9NO2 4 L-Proline 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.37 0.03 
282.26 3.735 C18H34O2 57 
[FA (18:1)] 9Z-
octadecenoic acid 
8 
Lipids: Fatty 
Acyls 
Fatty acid 
biosynthesis 
Biosynthesis of 
unsaturated fatty 
acids 
1.00 0.34 0.00 
89.048 16.81 C3H7NO2 9 L-Alanine 10 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
Cysteine 
metabolism D-
Alanine 
metabolism 
1.00 0.30 0.02 
81.982 17.37 H3O3P 1 Phosphonate 7 0  0 1.00 0.22 0.03 
118.03 17.64 C4H6O4 7 Succinate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Oxidative 
phosphorylation 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
1.00 0.12 0.02 
 
Supplemental table III-3. Significantly modulated metabolites in the ∆lmgt 
promastigote spent media. Specified in yellow are the metabolites matched to authentic standards. 
Specified in red are the metabolites with more than one isomeric peak. 
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Condition 1 – Wild type and Δlmgt promastigotes incubated in PBS without carbon 
sources 
 
                      
 
                      
Supplemental figure III-1. 1H NMR spectra of acetate nand succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS 
without carbon sources. Wild type and Δlmgt promastigotes (biological replicates, n=3) were incubated 
for 6 hours in PBS without carbon sources and analyzed by 1H-NMR. The spectra are within the 1.5 – 3.0 ppm 
range and include the peaks of 12C-acetate and 12C-succinate in the wild type promastigotes (top spectrum) and of 
12C-acetate in the Δlmgt promastigotes (bottom spectrum). WT - wild type promastigotes, ∆lmgt - ∆lmgt 
promastigotes. 
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Condition 2 – Wild type and Δlmgt promastigotes incubated with 13C-D-glucose 
 
 
 
                      
 
          
     
                       
Supplemental figure III-2. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
13C-D-glucose as a carbon source. Wild type and Δlmgt promastigotes (biological replicates, n=3) were 
incubated for 6 hours in PBS with 13C-D-glucose as a carbon source and analyzed by 1H-NMR. The spectra are 
within the 1.5 – 3.0 ppm range and include the peaks of 12C-acetate, 13C-acetate, 12C-succinate and 13C-succinate in 
the wild type promastigotes (top spectrum) and of 12C-acetate in the Δlmgt promastigotes (bottom spectrum). WT 
- wild type promastigotes, ∆lmgt - ∆lmgt promastigotes. 
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Condition 3 – Wild type and Δlmgt promastigotes incubated in 12C-L-proline and 13C-
D-glucose 
 
 
                      
 
 
                         
Supplemental figure III-3. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
12C-L-proline and 13C-D-glucose as carbon sources. Wild type and Δlmgt promastigotes (biological 
replicates, n=3) were incubated for 6 hours in PBS with 12C-L-proline and 13C-D-glucose as carbon sources and 
analyzed by 1H-NMR. The spectra are within the 1.5 – 3.0 ppm range and include the peaks of 12C-acetate, 13C-
acetate, 12C-succinate and 13C-succinate in the wild type promastigotes (top spectrum) and of 12C-acetate in the 
Δlmgt promastigotes (bottom spectrum). WT - wild type promastigotes, ∆lmgt - ∆lmgt promastigotes. 
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Condition 4 – Wild type and Δlmgt promastigotes incubated with 12C-D-glucose and 
13C-L-proline 
 
 
 
                         
 
 
              
                          
Supplemental figure III-4. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
12C-D-glucose and 13C-L-proline as carbon sources. Wild type and Δlmgt promastigotes (biological 
replicates, n=3) were incubated for 6 hours in PBS with 12C-D-glucose and 13C-L-proline as carbon sources and 
analyzed by 1H-NMR. The spectra are within the 1.5 – 3.0 ppm range and include the peaks of 12C-acetate and 12C-
succinate in the wild type promastigotes (top spectrum) and of 12C-acetate in the Δlmgt promastigotes (bottom 
spectrum). WT - wild type promastigotes, ∆lmgt - ∆lmgt promastigotes. 
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Condition 5 – Wild type and Δlmgt promastigotes incubated with 13C-L-proline 
 
 
 
 
                         
 
 
 
              
                         
Supplemental figure III-5. 1H NMR spectra of acetatate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
13C-L-proline as a carbon source. Wild type and Δlmgt promastigotes (biological replicates, n=3) were 
incubated for 6 hours in PBS with 13C-L-proline as a carbon source and analyzed by 1H-NMR. The spectra are 
within the 1.5 – 3.0 ppm range and include the peaks of 12C-acetate and 12C-succinate in the wild type 
promastigotes (top spectrum) and of 12C-acetate in the Δlmgt promastigotes (bottom spectrum). WT - wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes. 
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Condition 6 – Wild type and Δlmgt promastigotes incubated with 12C-L-threonine and 
13C-D-glucose 
 
 
                         
              
                       
                         
 
Supplemental figure III-6. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
12C-L-threonine and 13C-D-glucose carbon sources. Wild type and Δlmgt promastigotes (biological 
replicates, n=3) were incubated for 6 hours in PBS with 12C-L-threonine and 13C-D-glucose as carbon sources and 
analyzed by 1H-NMR. The spectra are within the 1.6 – 2.4 ppm range and include the peaks of 12C-acetate and 13C-
acetate in the wild type promastigotes (top spectrum) and of 12C-acetate in the Δlmgt promastigotes (bottom 
spectrum). WT - wild type promastigotes, ∆lmgt - ∆lmgt promastigotes, Ct - contaminant.  
 
 
 
WT 
Δlmgt 
12C-Acetate 
13C-Acetate 
 
13C-Acetate 
 
Ct 
12C-Acetate 
Ct 
   
                                                                                                                                                                                               APPENDICES 
 261 
 
Condition 7 – Wild type and Δlmgt promastigotes incubated with 12C-D-glucose and 
13C-L-threonine 
 
                        
                
 
                         
 
                    
Supplemental figure III-7. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
12C-D-glucose and 13C-L-threonine as carbon sources. Wild type and Δlmgt promastigotes 
(biological replicates, n=3) were incubated for 6 hours in PBS with 12C-D-glucose and 13C-L-threonine as carbon 
sources and analyzed by 1H-NMR. The spectra are within the 1.6 – 2.4 ppm range and include the peaks of 12C-
acetate, 13C-acetate and 12C-succinate in the wild type promastigotes (top spectrum) and of 12C-acetate and 13C-
acetate in the Δlmgt promastigotes (bottom spectrum). WT - wild type promastigotes, ∆lmgt - ∆lmgt 
promastigotes, Ct - contaminant. 
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Condition 8 – Wild type and Δlmgt promastigotes incubated with 13C-L-threonine 
 
 
 
                         
                     
              
                       
 
                         
 
Supplemental figure III-8. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
13C-L-threonine as a carbon source. Wild type and Δlmgt promastigotes (biological replicates, n=3) 
were incubated for 6 hours in PBS with 13C-L-threonine as a carbon source and analyzed by 1H-NMR. The spectra 
are within the 1.6 – 2.4 ppm range and include the peaks of 12C-acetate and 13C-acetate in the wild type 
promastigotes (top spectrum) and of 12C-acetate and 13C-acetate in the Δlmgt promastigotes (bottom spectra). WT 
- wild type promastigotes, ∆lmgt - ∆lmgt promastigotes, Ct - contaminant. 
 
 
 
WT 
Δlmgt 
13C-A 
 
Ct 
12C-Acetate 
 
Ct 
 
12C-Acetate 
 13C-A 
 
13C-A - 13C-acetate 
 
 
 
 
 
13C-A 
 
13C-A 
 
   
                                                                                                                                                                                               APPENDICES 
 263 
 
Condition 9 – Wild type and Δlmgt promastigotes incubated with 12C-glycerol 
 
 
 
                        
 
 
                                     
 
Supplemental figure III-9. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
12C-glycerol. Wild type and Δlmgt promastigotes (biological replicates, n=3) were incubated for 6 hours in PBS 
with 12C-glycerol as a carbon source and analyzed by 1H-NMR. The spectra are within the 1.6 – 2.4 ppm range and 
include the peaks of 12C-acetate in the wild type promastigotes (top spectrum) and of 12C-acetate in Δlmgt 
promastigotes (bottom spectrum). WT - wild type promastigotes, ∆lmgt - ∆lmgt promastigotes, Ct - contaminant. 
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Condition 10 – Wild type and Δlmgt promastigotes incubated with 12C-glycerol and 
13C-D-glucose 
                        
                         
Supplemental figure III-10. 1H NMR spectra of acetate and succinate in the wild type 
(top spectrum) and Δlmgt promastigotes (bottom spectrum) incubated in PBS with 
12C-glycerol and 13C-D-glucose. Wild type and Δlmgt promastigotes (biological replicates, n=3) were 
incubated for 6 hours in PBS with 12C-glycerol and 13C-D-glucose as carbon sources and analyzed by 1H-NMR. The 
spectra are within the 1.6 – 2.4 ppm range and include the peaks of 12C-acetate and 13C-acetate in the wild type 
promastigotes (top spectrum) and of 12C-acetate in the Δlmgt promastigotes (bottom spectrum). WT - wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, Ct - contaminant. 
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Appendix 2 
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Supplemental table IV-1. Amino acids subjected to stable isotope tracing analysis. 
Presented here is a list of the amino acids investigated for stable isotope labelling in the wild type and Δlmgt 
promastigotes grown with 13C-D-glucose for 48 hours (condition 0, C0) and the promastigotes grown under the 10 
NMR conditions (C1 – C10). + - heavy-labelled, - -unlabelled. 
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Supplemental table IV-2. Stable isotope tracing analysis of purine metabolism. 
Presented here is a list of the labelled purines in the wild type and Δlmgt promastigotes grown with 13C-D-glucose 
for 48 hours (condition 0, C0) and the promastigotes grown under the 10 NMR conditions (C1 – C10). + - heavy-
labelled, - -unlabelled, N - not detected. 
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The figure continues on page 268. 
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Supplemental figure IV-1. Labelling pattern of sphinganine and phytosphingosine in 
condition 6 (A), condition 7 (B), condition 8 (C), condition 9 (D) and condition 10 (E) 
wild type and Δlmgt promastigotes. UL- Unlabelled, +1 - 1-13C-labelled, +2 - 2-13C-labelled, +3 - 3-13C-
labelled, +4 - 4-13C-labelled, +5 - 5-13C-labelled, +6 - 6-13C-labelled, +7 - 7-13C-labelled, +8 - 8-13C-labelled, +9 - 9-
13C-labelled, +10 - 10-13C-labelled, +11 - 11-13C-labelled, +12 - 12-13C-labelled, +13 - 13-13C-labelled, +14 - 14-13C-
labelled, WT – wild type promastigotes, ∆lmgt - ∆lmgt promastigotes. * - the colours corresponding to the type of 
labelling above +14 are not presented. 
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Appendix 3 
 
                                                                                                                                                                                                                                                      
      Mass          RT          Formula                            Putative metabolite                              Map                  Pathway                
  
149.11 8.9 C21H30O 1 
3-Methyl-19-nor-
17alpha-pregna-
1,3,5(10)-trien-17-ol 
7 0  0 0.00 103.69 0.04 
750.6 3.43 C52H78O3 2 
Nonaprenyl-4-
hydroxybenzoate 
7 
Metabolism of 
Cofactors and 
Vitamins 
Ubiquinone-9 
biosynthesis  1.00 20.28 0.01 
773.5 3.993 C44H72NO8P 8 
PC(18:4(6Z,9Z,12Z,15Z)
/18:4(6Z,9Z,12Z,15Z)) 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 5.99 0.02 
283.95 4.134 C6H12O4PCl3 1 
Tris(2-chloroethyl) 
phosphate 
5 0  0 1.00 5.30 0.04 
555.52 3.83 C34H69NO4 1 
[SP hydroxy(16:0)] N-
(hexadecanoyl)-4S-
hydroxysphinganine 
5 
Lipids: 
Sphingolipids 
Ceramides 1.00 3.53 0.00 
877.56 3.874 C52H80NO8P 3 
[PC (22:6/22:6)] 1,2-di-
(4Z,7Z,10Z,13Z,16Z,19Z
-docosahexaenoyl)-sn-
glycero-3-
phosphocholine 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 3.42 0.00 
148.07 7.284 C6H12O4 14 
[FA methyl, 
hydroxy(5:0)] 3R-
methyl-3,5-dihydroxy-
pentanoic acid 
8 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 3.34 0.05 
775.52 3.964 C44H74NO8P 8 
PC(14:1(9Z)/22:6(4Z,7
Z,10Z,13Z,16Z,19Z)) 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 3.32 0.01 
112.05 7.477 C6H8O2 19 Sorbate 7 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 3.24 0.02 
723.52 3.79 C41H74NO7P 15 
PE(18:3(6Z,9Z,12Z)/P-
18:1(11Z)) 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoet
hanolamines 1.00 3.18 0.04 
825.53 3.901 C48H76NO8P 3 
PC(18:4(6Z,9Z,12Z,15Z)
/22:6(4Z,7Z,10Z,13Z,16
Z,19Z)) 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 2.96 0.03 
139.99 10.15 C2H5O5P 2 Acetyl phosphate 6 
Amino Acid 
Metabolism  
Taurine and 
hypotaurine 
metabolism 
Pyruvate 
metabolism 
1.00 2.72 0.02 
96.969 10.14 [H2PO4]- 1 Dihydrogenphosphate 5 0  0 1.00 2.63 0.04 
537.51 3.769 C34H67NO3 4 
[SP (16:0)] N-
(hexadecanoyl)-sphing-
4-enine 
5 
Lipids: 
Sphingolipids 
Ceramides 1.00 2.52 0.03 
346.16 11.55 C12H22N6O6 1 Asp-Gly-Arg 7 Peptide(tri-) Basic peptide 1.00 2.42 0.04 
172.08 9.136 C7H12N2O3 2 Glycylproline 5 Peptide(di-) Polar peptide 1.00 0.50 0.02 
296.24 3.686 C18H32O3 40 
[FA (18:1)] 9R,10S-
epoxy-12Z-
octadecenoic acid 
6 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.49 0.03 
256.24 3.612 C16H32O2 27 Hexadecanoic acid 6 
Lipid 
Metabolism  
Fatty acid 
biosynthesis 
Fatty acid 
elongation in 
mitochondria 
Fatty acid 
metabolism 
Biosynthesis of 
unsaturated fatty 
acids 
1.00 0.49 0.03 
175.1 11.1 C6H13N3O3 3 L-Citrulline 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.49 0.00 
332.24 3.987 C21H32O3 19 
17α-
Hydroxypregnenolone 
6 
Lipids: Sterol 
lipids 
C21-Steroid 
hormone 
metabolism 
1.00 0.49 0.03 
Is
o
m
er
s 
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301.06 10.21 C8H16NO9P 9 
N-Acetyl-D-glucosamine 
6-phosphate 
6 
Amino Acid 
Metabolism  
Glutamate 
metabolism 
Aminosugars 
metabolism 
1.00 0.48 0.04 
246.09 8.652 C9H14N2O6 2 5-6-Dihydrouridine 5 0  0 1.00 0.48 0.03 
781.56 3.941 C44H80NO8P 52 PC(36:4) 7 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 0.48 0.05 
298.25 3.782 C18H34O3 63 2-Oxooctadecanoic acid 5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.48 0.04 
174.1 10.75 C7H14N2O3 5 N-Acetylornithine 8 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.47 0.04 
142.07 9.921 C6H10N2O2 1 Ectoine 8 
Amino Acid 
Metabolism  
Glycine, serine 
and threonine 
metabolism 
1.00 0.47 0.05 
566.05 10.84 
C15H24N2O17
P2 
3 UDP-glucose 6 
Carbohydrate 
Metabolism  
Pentose and 
glucuronate 
interconversions 
Galactose 
metabolism 
Ascorbate and 
aldarate 
metabolism 
Pyrimidine 
metabolism 
Starch and sucrose 
metabolism 
Nucleotide sugars 
metabolism 
Glycerolipid 
metabolism 
1.00 0.47 0.02 
234.2 4.173 C16H26O 6 
[FA (16:3)] 4,6,11-
hexadecatrienal 
5 
Lipids: Fatty 
Acyls 
Fatty aldehydes 1.00 0.47 0.04 
97.016 7.054 C4H3NO2 1 Maleimide 5 0  0 1.00 0.46 0.01 
130.03 10.5 C5H6O4 7 Mesaconate 6 
Carbohydrate 
Metabolism  
C5-Branched 
dibasic acid 
metabolism 
1.00 0.46 0.03 
275.15 10.89 C11H21N3O5 6 L-a-glutamyl-L-Lysine 5 Peptide(di-) Basic peptide 1.00 0.45 0.03 
607.08 10.17 
C17H27N3O17
P2 
3 
UDP-N-acetyl-D-
glucosamine 
6 
Carbohydrate 
Metabolism  
Aminosugars 
metabolism 
Lipopolysaccharid
e biosynthesis 
Peptidoglycan 
biosynthesis 
1.00 0.45 0.02 
458.34 4.19 C29H46O4 7 
[ST (2:0)] (5Z,7E)-
(1S,3R)-18-acetoxy-
9,10-seco-5,7,10(19)-
cholestatriene-1,3-diol 
5 
Lipids: Sterol 
lipids 
Secosteroids 1.00 0.45 0.02 
426.31 4.272 C28H42O3 9 
[ST (5:0/3:0)] 
(5Z,7E,22E,24E)-
(1S,3R)-24a-homo-
9,10-seco-
5,7,10(19),22,24-
cholestapentaene-
1,3,25-triol 
5 
Lipids: Sterol 
lipids 
Secosteroids 1.00 0.45 0.04 
408.3 4.153 C28H40O2 1 
4Z,7Z,10Z,13Z,16Z,19Z,
22Z,25Z-
octacosaoctaenoic acid 
7 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.44 0.03 
133.07 11.11 C5H11NO3 4 N-hydroxyvaline 5 0  
Superpathway of 
linamarin and 
lotaustralin 
biosynthesis 
1.00 0.44 0.01 
130.07 15.06 C5H10N2O2 4 Casein K 5 0  0 1.00 0.44 0.02 
440.33 4.269 C29H44O3 11 
[ST (3:0)] (5Z,7E)-
(1S,3R,11S)-11-ethynyl-
9,10-seco-5,7,10(19)-
cholestatriene-1,3,25-
triol 
5 
Lipids: Sterol 
lipids 
Secosteroids 1.00 0.44 0.02 
300.27 3.647 C18H36O3 27 
[FA hydroxy(18:0)] 2S-
hydroxy-octadecanoic 
acid 
5 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.43 0.03 
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173.12 15.19 C7H15N3O2 2 L-Indospicine 7 0  0 1.00 0.43 0.01 
245.15 11.17 C9H19N5O3 2 β-Alanyl-L-arginine 6 
Amino Acid 
Metabolism  
β-Alanine 
metabolism 1.00 0.43 0.02 
113.94 14.08 H2O3S2 1 H2S2O3 5 0  Sulfur metabolism 1.00 0.42 0.03 
480.32 4.287 C24H49O7P 1 PA(21:0/0:0) 5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphate
s 1.00 0.42 0.02 
207.14 13.94 C20H38N4O5 8 Ala-Leu-Leu-Val 7 Peptide(tetra-)  
Hydrophobic 
peptide 1.00 0.42 0.05 
290.04 10.78 C7H15O10P 6 
D-Sedoheptulose 7-
phosphate 
6 
Carbohydrate 
Metabolism  
Pentose phosphate 
pathway 
Carbon fixation 
1.00 0.42 0.01 
132.05 10.79 C4H8N2O3 6 L-Asparagine 8 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
1.00 0.42 0.01 
132.09 15.04 C5H12N2O2 6 L-Ornithine 8 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
D-Arginine and D-
ornithine 
metabolism 
Glutathione 
metabolism 
1.00 0.42 0.02 
148.04 10.37 C5H8O5 18 D-Xylonolactone 6 
Carbohydrate 
Metabolism  
Pentose and 
glucuronate 
interconversions 
1.00 0.41 0.03 
360.64 12.7 
C27H47N9O10
S2 
1 
Trypanothione 
disulfide 
8 
Amino Acid 
Metabolism  
Glutathione 
metabolism 1.00 0.41 0.01 
404 11.15 
C9H14N2O12P
2 
1 UDP 6 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 
Peptidoglycan 
biosynthesis 
Zeatin 
biosynthesis 
1.00 0.40 0.04 
159.1 15.96 C6H13N3O2 1 ∆-Guanidinovaleric acid 7 0  0 1.00 0.40 0.01 
182.06 7.507 C9H10O4 13 
3-(4-Hydroxyphenyl) 
lactate 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 1.00 0.40 0.01 
226.19 4.104 C14H26O2 35 
(9Z)-Tetradecenoic 
acid 
7 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.40 0.04 
217.11 8.961 C8H15N3O4 3 N-Acetyl-L-citrulline 6 
Amino Acid 
Metabolism  
Arginine 
biosynthesis III 1.00 0.40 0.04 
119.06 10.49 C4H9NO3 11 L-Threonine 10 
Amino Acid 
Metabolism  
Glycine, serine 
and threonine 
metabolism 
Valine, leucine 
and isoleucine 
biosynthesis 
1.00 0.39 0.02 
757.56 3.956 C42H80NO8P 53 PC(34:2) 5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 0.39 0.05 
183.05 7.151 C8H9NO4 6 4-Pyridoxate 6 
Metabolism of 
Cofactors and 
Vitamins 
Vitamin B6 
metabolism 1.00 0.39 0.01 
161.07 7.509 C6H11NO4 10 O-Acetyl-L-homoserine 8 
Amino Acid 
Metabolism  
Methionine 
metabolism 
Sulfur metabolism 
1.00 0.38 0.04 
166.06 4.769 C9H10O3 17 
3-(3-Hydroxy-phenyl)-
propanoic acid 
6 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 1.00 0.38 0.04 
244.11 10.17 C10H16N2O5 2 Glu-Pro 5 Peptide(di-) Acidic peptide 1.00 0.38 0.00 
192.07 9.453 C6H12N2O5 1 Ser-Ser 5 Peptide(di-) Polar peptide 1.00 0.38 0.04 
176.08 15.02 C6H12N2O4 4 Ala-Ser 5 Peptide(di-) Polar peptide 1.00 0.38 0.01 
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405.14 11.36 C15H23N3O10 1 Glu-Glu-Glu 5 Peptide(tri-) Acidic peptide 1.00 0.37 0.01 
231.16 15.56 C10H21N3O3 1 
Gamma-Aminobutyryl-
lysine 
7 0  0 1.00 0.37 0.04 
89.048 10.77 C3H7NO2 9 L-Alanine 10 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
1.00 0.37 0.00 
434.24 4.589 C21H39O7P 3 LPA(0:0/18:2(9Z,12Z)) 5 
Lipid 
Metabolism  
Glycerolipid 
metabolism 
Glycerophospholi
pid metabolism 
1.00 0.37 0.01 
189.06 9.716 C7H11NO5 4 N-Acetyl-L-glutamate 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.36 0.03 
327.22 4.733 C16H29N3O4 2 Leu-Val-Pro 5 Peptide(tri-) 
Hydrophobic 
peptide 1.00 0.36 0.03 
303.15 10.88 C11H21N5O5 1 Glu-Arg 5 Peptide(di-) Basic peptide 1.00 0.35 0.04 
156.02 8.203 C5H4N2O4 2 Orotate 8 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 0.35 0.02 
260.03 11.06 C6H13O9P 46 D-Glucose 6-phosphate 10 
Carbohydrate 
Metabolism  
Starch and sucrose 
metabolism 
Inositol phosphate 
metabolism 
1.00 0.35 0.01 
145.09 10.95 C5H11N3O2 3 4-Guanidinobutanoate 8 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.35 0.00 
353.23 4.639 C20H33O5 2 
13,14-Dihydro- lipoxin 
A4 
7 0  0 1.00 0.34 0.04 
126.12 12.41 C7H14N2 2 1-5-diazabicyclononane 7 
Amino Acid 
Metabolism  
β-Alanine 
biosynthesis I 1.00 0.34 0.02 
519.33 4.596 C26H50NO7P 3 
[PC (18:2)] 1-(9Z,12Z-
octadecadienoyl)-sn-
glycero-3-
phosphocholine 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoch
olines 1.00 0.34 0.03 
205.07 7.161 C11H11NO3 5 Indolelactate 6 
Amino Acid 
Metabolism  
Tryptophan 
metabolism 1.00 0.32 0.02 
244.07 9.627 C9H12N2O6 3 Pseudouridine 6 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 0.32 0.03 
118.03 10.41 C4H6O4 7 Succinate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Oxidative 
phosphorylation 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
1.00 0.32 0.02 
358.2 10.71 C14H26N6O5 1 Pro-Ser-Arg 5 Peptide(tri-) Basic peptide 1.00 0.32 0.03 
167.98 11.51 C3H5O6P 3 Phosphoenolpyruvate 8 
Carbohydrate 
Metabolism  
Glycolysis / 
Gluconeogenesi 
TCA cycle 
Pyruvate 
metabolism 
1.00 0.31 0.01 
210.06 7.318 C9H10N2O4 1 
N-carbamoyl-p-
hydroxy-D-
phenylglycine 
5 0  0 1.00 0.31 0.00 
179.08 12.38 C7H9N5O 2 
7-Aminomethyl-7-
carbaguanine 
5 0  0 1.00 0.31 0.01 
264.15 4.519 C14H20N2O3 2 Phe-Val 5 Peptide(di-) 
Hydrophobic 
peptide 1.00 0.31 0.01 
320.2 3.931 C19H28O4 4 Ubiquinol-2 5 
Metabolism of 
Cofactors and 
Vitamins 
Oxidative 
phosphorylation 1.00 0.31 0.04 
155.03 10.18 C3H10NO4P 3 
N-Methylethanolamine 
phosphate 
6 
Lipid 
Metabolism  
Glycerophospholi
pid metabolism 1.00 0.31 0.01 
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341.13 11.82 C12H23NO10 2 Lactosamine 8 
Carbohydrate 
Metabolism  
Aminosugars 
metabolism 1.00 0.30 0.00 
250.03 4.186 C12H10O4S 1 4,4'-Sulfonyldiphenol 5 0  0 1.00 0.30 0.00 
479.3 4.447 C23H46NO7P 6 
[PE (18:1)] 1-(9Z-
octadecenoyl)-sn-
glycero-3-
phosphoethanolamine 
5 
Lipids: 
Glycerophospho
lipids 
Glycerophosphoet
hanolamines 1.00 0.30 0.03 
226.11 10.9 C9H14N4O3 3 Ala-His 5 Peptide(di-) Basic peptide 1.00 0.30 0.03 
427.03 10.55 
C10H15N5O10
P2 
6 dGDP 6 
Nucleotide 
Metabolism  
Purine metabolism 1.00 0.30 0.03 
164.01 7.492 C5H8O4S 1 2-mercaptoglutarate 5 0  0 1.00 0.30 0.03 
208.05 11.04 C6H12N2O4S 2 Cys-Ser 7 Peptide(di-) Polar peptide 1.00 0.30 0.04 
384.13 11.59 C14H24O12 1 Acetyl-maltose 5 0  0 1.00 0.29 0.01 
573.09 9.021 
C16H25N5O14
P2 
1 
GDP-3,6-dideoxy-D-
galactose 
7 0  
GDP-L-colitose 
biosynthesis 1.00 0.28 0.04 
134.02 10.95 C4H6O5 4 (S)-Malate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
Pyruvate 
metabolism 
Carbon fixation 
1.00 0.28 0.03 
201.12 11.72 C18H34N4O6 9 Ala-Leu-Leu-Ser 7 Peptide(tetra-)  
Hydrophobic 
peptide 1.00 0.27 0.02 
116.01 10.81 C4H4O4 3 Fumarate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Oxidative 
phosphorylation 
Arginine and 
proline 
metabolism 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
1.00 0.27 0.01 
487.68 12.03 
C40H53N11 
O18 
1 
5-Methyltetrahydro 
pteroylpentaglutamate 
7 0  0 1.00 0.27 0.01 
174.06 8.671 C6H10N2O4 4 
N-Formimino-L-
glutamate 
6 
Amino Acid 
Metabolism  
Histidine 
metabolism 1.00 0.26 0.02 
252.09 7.559 C10H12N4O4 2 Deoxyinosine 6 
Nucleotide 
Metabolism  
Purine metabolism 1.00 0.26 0.02 
326.16 10.9 C14H22N4O5 2 Asn-Pro-Pro 5 Peptide(tri-) Polar peptide 1.00 0.25 0.03 
400.1 10.24 
C14H20N6O4 
S2 
1 Ovothiol A disulfide 5 0  0 1.00 0.23 7.05E 
166.06 7.023 C9H10O3 17 Phenyllactate 8 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 1.00 0.23 0.02 
248.06 11.26 C8H12N2O7 2 Asp-Asp 5 Peptide(di-) Acidic peptide 1.00 0.22 0.01 
228.21 3.694 C14H28O2 23 Tetradecanoic acid 8 
Lipid 
Metabolism  
Fatty acid 
biosynthesis 1.00 0.20 0.04 
147.05 10.15 C5H9NO4 14 L-Glutamate 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
Glutamate 
metabolism 
D-Glutamine and 
D-glutamate 
1.00 0.19 0.01 
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metabolism 
Glutathione 
metabolism 
Nitrogen 
metabolism 
185.99 11.34 C3H7O7P 3 3-Phospho-D-glycerate 6 
Carbohydrate 
Metabolism  
Glycolysis / 
Gluconeogenesis 
Glycine, serine 
and threonine 
metabolism 
1.00 0.18 0.03 
122.05 7.183 C6H6N2O 4 Nicotinamide 10 
Metabolism of 
Cofactors and 
Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
1.00 0.17 0.01 
306.08 10.98 
C20H32N6O12
S2 
1 Glutathione disulfide 8 
Amino Acid 
Metabolism  
Glutamate 
metabolism 
Glutathione 
metabolism 
1.00 0.17 0.00 
120.09 4.116 C9H12 6 
1,2,4-
Trimethylbenzene 
5 0  0 1.00 0.16 0.01 
507 11.12 
C10H16N5O13
P3 
4 ATP 6 
Energy 
Metabolism  
Oxidative 
phosphorylation 
Photosynthesis 
Purine metabolism 
1.00 0.15 0.01 
274.2 13.17 C12H26N4O3 1 Lys-Lys 7 Peptide(di-) Basic peptide 1.00 0.15 0.03 
546.18 11.38 C25H30N4O8S 1 Asp-Phe-Cys-Tyr 7 Peptide(tetra-)  
Hydrophobic 
peptide 1.00 0.13 0.01 
990.33 11.59 C36H62O31 3 Cellohexaose 8 
Carbohydrate 
Metabolism  
Starch and sucrose 
metabolism 1.00 0.12 0.00 
828.28 11.48 C30H52O26 4 Cellopentaose 8 
Carbohydrate 
Metabolism  
Starch and sucrose 
metabolism 1.00 0.12 0.00 
136.13 4.072 C10H16 39 [PR] (-)-Limonene 6 Lipids: Prenols 
Monoterpenoid 
biosynthesis 
Limonene and 
pinene degradation 
1.00 0.11 0.00 
310.21 3.629 C18H30O4 20 
[FA (18:3)] 13S-
hydroperoxy-
9Z,11E,14Z-
octadecatrienoic acid 
6 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.10 2.99E 
141.02 10.75 C2H8NO4P 2 
Ethanolamine 
phosphate 
8 
Amino Acid 
Metabolism  
Glycine, serine 
and threonine 
metabolism 
Glycerophospholi
pid metabolism 
Sphingolipid 
metabolism 
1.00 0.10 0.04 
544.26 11.27 C26H36N6O7 3 Asp-Lys-Trp-Pro 5 Peptide(tetra-)  Basic peptide 1.00 0.09 0.01 
313.26 4.032 C18H35NO3 2 
[FA (16:0)] N-
hexadecanoyl-glycine 
5 
Lipids: Fatty 
Acyls 
Fatty amides 1.00 0.08 0.01 
204.19 4.102 C15H24 151 [PR] (+)-Longifolene 8 Lipids: Prenols 
Superpathway of 
oleoresin 
turpentine 
biosynthesis 
Oleoresin 
sesquiterpene 
volatiles 
biosynthesis 
1.00 0.07 0.01 
342.12 10.86 C12H22O11 42 Sucrose 10 
Carbohydrate 
Metabolism  
Galactose 
metabolism 
Starch and sucrose 
metabolism 
1.00 0.03 0.01 
 
Supplemental table V-1. Significantly modulated metabolites in the SILAC-labelled 
∆lmgt promastigotes. Specified in yellow are the metabolites matched to authentic standards. Specified in 
red are the metabolites with more than one isomeric peak. 
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       Mass          RT          Formula                            Putative metabolite                              Map                  Pathway     
            
135.1 9.703 C19H26O 2 
17beta-Methylestra-
1,3,5(10)-trien-3-ol 
7 0  0 0.00 95.21 0.01 
384.13 11.59 C14H24O12 1 Acetyl-maltose 5 0  0 0.00 31.40 0.01 
408.29 4.754 C24H40O5 82 Cholate 6 
Lipids: Sterol 
lipids 
Bile acid 
biosynthesis 0.00 27.55 0.00 
342.15 10.54 C20H22O5 2 Phaseollidin hydrate 5 0  0 0.00 18.66 0.04 
700.55 4.178 C39H77N2O6P 3 SM(d16:1/18:1) 5 
Lipids: 
Sphingolipids 
Phosphosphingol
ipids 0.00 16.41 0.05 
328.24 3.548 C22H32O2 11 Docosahexaenoicacid 8 
Lipids: Fatty 
Acyls 
Biosynthesis of 
unsaturated fatty 
acids 
1.00 9.86 0.01 
287.2 9.503 C12H25N5O3 2 Leu-Arg 5 Peptide(di-) Basic peptide 1.00 8.48 0.01 
123.03 7.185 C6H5NO2 4 Nicotinate 10 
Metabolism of 
Cofactors and 
Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
Alkaloid 
biosynthesis II 
1.00 7.63 0.00 
304.24 3.596 C20H32O2 46 
[FA (20:4)] 
5Z,8Z,11Z,14Z-
eicosatetraenoic acid 
6 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 6.31 0.00 
283.12 7.834 C24H34N6O10 1 Glu-Gln-Gln-Tyr 7 Peptide(tetra-)  
Hydrophobic 
peptide 1.00 6.21 0.03 
257.1 10.31 C8H20NO6P 1 
sn-glycero-3-
Phosphocholine 
8 
Lipid 
Metabolism  
Glycerophospholi
pid metabolism 
Ether lipid 
metabolism 
1.00 6.13 0.02 
180.04 7.178 C9H8O4 11 
3-(4-Hydroxyphenyl) 
pyruvate 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
Alkaloid 
biosynthesis I 
1.00 3.74 0.05 
216.04 10.34 C5H13O7P 1 
2-C-Methyl-D-erythritol 
4-phosphate 
8 
Lipid 
Metabolism  
Biosynthesis of 
steroids 1.00 2.51 0.02 
129.09 17.53 C5H11N3O 3 4-Guanidinobutanal 8 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 2.43 0.02 
204.09 9.458 C11H12N2O2 6 L-Tryptophan 10 
Amino Acid 
Metabolism  
Tryptophan 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
Indole and ipecac 
alkaloid 
biosynthesis 
1.00 2.10 0.02 
245.15 11.17 C9H19N5O3 2 β-Alanyl-L-arginine 6 
Amino Acid 
Metabolism  
β-Alanine 
metabolism 1.00 1.95 0.04 
174.11 17.41 C6H14N4O2 2 L-Arginine 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
D-Arginine and 
D-ornithine 
metabolism 
1.00 1.93 0.04 
133.04 10.4 C4H7NO4 4 L-Aspartate 8 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
lycine, serine and 
threonine 
metabolism 
Lysine 
biosynthesis 
Arginine and 
proline 
metabolism 
Carbon fixation 
1.00 1.88 0.04 
Is
o
m
er
s 
C
o
n
fi
d
en
ce
 
WT ∆lmgt          ∆l
m
g
t 
  t
 t
es
t 
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165.08 8.48 C9H11NO2 7 L-Phenylalanine 10 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 
Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
Phenylpropanoid 
biosynthesis 
Alkaloid 
biosynthesis II 
1.00 1.72 0.05 
309.13 8.029 C14H19N3O5 3 Ala-Gly-Tyr 5 Peptide(tri-) 
Hydrophobic 
peptide 1.00 1.59 0.03 
203.13 11.53 C8H17N3O3 1 Lys-Gly 5 Peptide(di-) Basic peptide 1.00 1.58 0.04 
114.03 10.86 C5H6O3 6 
2-Hydroxy-2,4-
pentadienoate 
6 
Amino Acid 
Metabolism  
Phenylalanine 
metabolism 1.00 1.43 0.05 
231.11 7.107 C10H17NO5 3 Suberylglycine 7 0  0 1.00 1.43 0.04 
261.14 11.38 C9H19N5O4 1 Ser-Arg 5 Peptide(di-) Basic peptide 1.00 1.40 0.04 
187.12 7.121 C9H17NO3 3 
8-Amino-7-
oxononanoate 
6 
Metabolism of 
Cofactors and 
Vitamins 
Biotin 
metabolism 1.00 1.37 0.02 
258.09 9.559 C10H14N2O6 3 
(1-Ribosylimidazole)-4-
acetate 
8 
Amino Acid 
Metabolism  
Histidine 
metabolism 1.00 1.37 0.04 
145.09 17.47 C5H11N3O2 3 Fibrin 5 0  0 1.00 1.34 0.03 
239.9 14.08 H3O9P3 1 Trimetaphosphate 7 
Nucleotide 
Metabolism  
Pyrimidine 
metabolism 1.00 0.94 0.02 
104.02 9.291 C2H4N2O3 1 Urea-1-carboxylate 6 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.76 0.01 
182.08 10.42 C6H14O6 6 D-Sorbitol 6 
Carbohydrate 
Metabolism  
Fructose and 
mannose 
metabolism 
Galactose 
metabolism 
1.00 0.75 0.03 
504.17 11.55 C18H32O16 22 Raffinose 8 
Carbohydrate 
Metabolism  
Galactose 
metabolism 1.00 0.71 0.03 
142.06 4.804 C7H10O3 6 
methoxyfuraneol (keto 
form) 
7 0  
Furaneol 
biosynthesis 1.00 0.71 0.04 
106.06 7.214 C4H10O3 1 Diethylene glycol 5 0  0 1.00 0.69 0.04 
666.22 11.72 C24H42O21 14 Stachyose 6 
Carbohydrate 
Metabolism  
Galactose 
metabolism 1.00 0.69 0.02 
294.16 4.746 C15H22N2O4 2 Leu-Tyr 5 Peptide(di-) 
Hydrophobic 
peptide 1.00 0.62 0.04 
188.15 14.96 C9H20N2O2 2 
N6,N6,N6-Trimethyl-L-
lysine 
6 
Amino Acid 
Metabolism  
Lysine 
degradation 1.00 0.60 0.02 
218.09 9.945 C8H14N2O5 3 L-Ala-L-Glu 5 Peptide(di-) Acidic peptide 1.00 0.59 0.05 
264.15 4.519 C14H20N2O3 2 Phe-Val 5 Peptide(di-) 
Hydrophobic 
peptide 1.00 0.58 0.02 
70.042 11.07 C4H6O 3 3-Butyn-1-ol 6 
Carbohydrate 
Metabolism  
Butanoate 
metabolism 1.00 0.54 0.02 
182.06 7.507 C9H10O4 13 
3-(4-
Hydroxyphenyl)lactate 
8 
Amino Acid 
Metabolism  
Tyrosine 
metabolism 1.00 0.50 0.02 
297.05 10.13 C8H15N3O5S2 1 
L-Cysteinylglycine 
disulfide 
7 Peptide  0 1.00 0.47 0.02 
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126.03 5.065 C6H6O3 8 Benzene-1,2,4-triol 5.5 
Xenobiotics 
Biodegradation 
and Metabolism  
γ-Hexachloro-
cyclohexane 
degradation 
Benzoate 
degradation via 
hydroxylation 
1.00 0.46 0.03 
130.06 4.667 C6H10O3 18 
(S)-3-Methyl-2-
oxopentanoic acid 
8 
Amino Acid 
Metabolism  
Valine, leucine 
and isoleucine 
degradation and 
biosynthesis 
1.00 0.39 0.00 
89.048 10.77 C3H7NO2 9 L-Alanine 10 
Amino Acid 
Metabolism  
Alanine and 
aspartate 
metabolism 
D-Alanine 
metabolism 
Carbon fixation 
1.00 0.38 0.03 
310.21 3.629 C18H30O4 20 
[FA (18:3)] 13S-
hydroperoxy-
9Z,11E,14Z-
octadecatrienoic acid 
6 
Lipids: Fatty 
Acyls 
Fatty Acids and 
Conjugates 1.00 0.38 0.02 
222.07 11.29 C7H14N2O4S 4 L-Cystathionine 10 
Amino Acid 
Metabolism  
Glycine, serine 
and threonine 
metabolism 
Methionine 
metabolism 
1.00 0.37 0.00 
313.26 4.032 C18H35NO3 2 
[FA (16:0)] N-
hexadecanoyl-glycine 
5 
Lipids: Fatty 
Acyls 
Fatty amides 1.00 0.33 0.01 
116.01 10.81 C4H4O4 3 Fumarate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Oxidative 
phosphorylation
Arginine and 
proline 
metabolism 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
Arginine and 
proline 
metabolism 
1.00 0.27 0.01 
204.19 4.102 C15H24 
15
1 [PR] (+)-Longifolene 8 Lipids: Prenols 
Oleoresin 
turpentine 
biosynthesis  
1.00 0.25 0.03 
175.1 11.1 C6H13N3O3 3 L-Citrulline 10 
Amino Acid 
Metabolism  
Arginine and 
proline 
metabolism 
1.00 0.22 0.02 
134.02 10.95 C4H6O5 4 (S)-Malate 10 
Carbohydrate 
Metabolism  
TCA cycle 
Glutamate 
metabolism 
Alanine and 
aspartate 
metabolism 
Pyruvate 
metabolism 
Glyoxylate and 
dicarboxylate 
metabolism 
1.00 0.21 0.01 
426.09 10.94 
C13H22N4O8S
2 
2 Asp-Cys-Cys-Ser 5 Peptide(tetra-)  Acidic peptide 1.00 0.21 0.01 
146.11 16.16 C6H14N2O2 8 D-Lysine 8 
Amino Acid 
Metabolism  
Lysine 
degradation 1.00 0.21 0.01 
89.084 14.45 C4H11NO 1 
N-dimethyl 
ethanolamine 
7 0  
Choline 
biosynthesis  1.00 0.19 0.02 
122.05 7.183 C6H6N2O 4 Nicotinamide 10 
Metabolism of 
Cofactors and 
Vitamins 
Nicotinate and 
nicotinamide 
metabolism 
1.00 0.08 0.01 
342.12 10.86 C12H22O11 42 Sucrose 10 
Carbohydrate 
Metabolism  
Galactose 
metabolism 
Starch and 
sucrose 
metabolism 
1.00 0.06 0.03 
 
Supplemental table V-2. Significantly modulated metabolites in the SILAC-labelled 
∆lmgt spent medium. Specified in yellow are the metabolites matched to authentic standards. Specified in 
red are the metabolites with more than one isomeric peak. 
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# Name Formula Infomation 
1 (3S)-3,6-Diaminohexanoic acid C6H14N2O2 
A chiral diamino acid consisting of 
hexanoic acid having amino substituents 
at the 3- and 6-positions and (S)-
configuration. 
2 
(Z)-N6-[(4R,5S)-5-(2-
Carboxyethyl)-4-
(carboxymethyl)piperidin-3-
ylidene]-L-lysine 
Preliminary entry 
 
- 
3 
1,2-Diacyl-sn-glycero-3-
phospho-1ʼ-(3ʼ-O-L-lysyl)-sn-
glycerol 
C14H25N2O11PR2 
A phosphatidylglycerol that is the 3'-O-L-
lysyl of any 1,2-diacyl-sn-glycero-3-
phospho-1ʼ-sn-glycerol. 
4 1-(L-Norleucin-6-yl)pyrraline C12H18N2O4 
A pyrrole formed via Maillard reaction 
of L-lysine with glucose. 
5 1-(L-Norvalin-5-yl)pyrraline C11H16N2O4 
A pyrrole formed via Maillard reaction 
of L-ornithine with glucose 
6 
5'-(N6-L-Lysine)-L-
tyrosylquinone 
C15H21N3O6 
An L-lysine derivative in which one of the 
amino hydrogens at N6-amino is 
substituted by a 6-[(2S)-2-amino-2-
carboxyethyl]-3,4-dioxocyclohexa-1,5-
dien-1-yl group. 
7 5-Glycosyloxy-L-lysine - Manually annotated 
8 
erythro-5-Phosphonooxy-L-
lysine 
C6H15N2O6P 
The 5-phosphonooxy derivative of L-
lysine having erythro-stereochemistry. 
9 
N-Hippuryl-N6-
(carboxymethyl)lysine 
C17H23N3O6 
A lysine derivative in which the α-amino 
nitrogen of the amino acid has entered 
into amide formation with hippuric acid. 
11 
Nε-(5'-Guanylyl)-Nα-acetyl-L-
lysine methyl ester(1−) 
C19H29N7O10P 
An organic phosphoramidate anion 
obtained by removal of the proton from 
the phosphoramidate OH group of Nε-(5'-
guanylyl)-Nα-acetyl-L-lysine methyl ester; 
major species at pH 7.3. 
12 
Nε-GMP-Nα-Acetyl-L-lysine 
methyl ester 
C19H30N7O10P 
A organic phosphoramidate that is 
guanosine 5'-monophosphate in which 
one of the hydroxy groups of the 
phosphate has been condensed with the 
side chain amino group of Nα-acetyl-L-
lysine methyl ester. 
13 
N2-(5'-Phosphopyridoxyl)-L-
lysine 
C14H24N3O7P 
An L-lysine derivative arising from 
reductive alkylation of the N2-position 
of L-lysine by pyridoxal-5-phosphate. 
14 N2-Methyl-L-lysine C7H16N2O2 
A N-methyl-L-amino acid that is 
the Nα-methyl derivative of L-lysine. 
16 N6-(5'-Adenylyl)-L-lysine 
Preliminary entry 
 
- 
17 N6-(5'-Guanylyl)-L-lysine 
Preliminary entry 
 
- 
18 
N6-(Pyridoxal phosphate)-L-
lysine 
Preliminary entry 
 
- 
19 N6-[(Indol-3-yl)acetyl]-L-lysine C16H21N3O3 
A N-methyl-L-amino acid that is the Nα-
methyl derivative of L-lysine. 
 
20 N6-Acetimidoyl-L-lysine C8H17N3O2 
An L-lysine derivative that is L-lysine in 
which one of the hydrogens attached 
to N6 is substituted by an acetimidoyl 
group. 
21 
N6-Acetyl-N2-(5'-
phosphopyridoxyl)-L-lysine 
C16H26N3O8P 
An L-lysine derivative arising from 
reductive N-alkylation of N6-acetyl-L-
lysine by pyridoxal-5-phosphate. 
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23 N6-Carboxy-L-lysine C7H14N2O4 
 
An L-lysine derivative consisting of L-
lysine carrying a carboxy substituent at 
the N6-position. 
24 N6-Carboxymethyl-L-lysine C8H16N2O4 
An L-lysine derivative with a 
carboxymethyl substituent at the N6-
position. 
25 N6-Dansyl-L-lysine C18H25N3O4S 
An L-lysine derivative with a dansyl 
group at the N6-position. 
26 N6-Glycyl-L-lysine C8H17N3O3 Manually annotated 
27 N6-Methyl-L-lysine C7H16N2O2 
An L-lysine derivative that is L-lysine in 
which one of the hydrogens attached 
to N6 is substituted by a methyl group. 
28 D-Lysopine C9H18N2O4 
The N2-(R)-1-carboxyethyl derivative 
of L-lysine 
29 L-2-Aminohexano-6-lactam C6H12N2O Manually annotated 
30 β-Alanyl-L-lysine C9H19N3O3 Dipeptide 
 
Supplemental table V-3. List of outgoing* L-lysine derivatives. * - the relationship 
between the ChEBI entry and its immediate related entities. 
          Credits: ChEBI 
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# Name Formula Infomation 
31 L-Homoarginine 
 
C7H16N4O2 An L-lysine derivative that is the L-
enantiomer of homoarginine. 
32 L-Homocitrulline  
 
C7H15N3O3 A L-lysine derivative that is L-lysine 
having a carbamoyl group at the N6-
position. 
33 L-Lysine thiazolecarboxylic acid Preliminary entry 
 
- 
36 Acetyl-L-lysine - Manually annotated 
38 Biocytin  
 
C16H28N4O4S A monocarboxylic acid amide that 
results from the formal condensation 
of the carboxylic acid group of biotin 
with the N6-amino group ofL-lysine. 
39 Deoxyhypusine C10H23N3O2 An L-lysine derivative in which the 
N6 of the lysine is substituted with a 
4-aminobutyl group.  
 
40 Fructoselysine 6-phosphate C12H25N2O10P An L-lysine derivative having a 6-
phosphofructosyl group attached to 
the side-chain amino group. 
41 Glyoxal-lysine dimer C15H27N4O4 An imidazolium ion formed via cyclo-
dimerisation of L-lysine and glyoxal.  
 
42 Heme P460-bis-L-cysteine-L-
lysine 
Preliminary entry 
 
- 
43 Hydroxy-L-lysine Preliminary entry 
 
- 
44 Hypusine C10H23N3O3 An L-lysine derivative that is L-lysine 
bearing A (2R)-4-amino-2-
hydroxybutyl substituent at position 
N6.  
 
45 Indole-lysine conjugate - Manually annotated 
46 L-lysine amide Preliminary entry 
 
- 
47 Lysidine C15H25N5O6 Cytidine in which the 2-keto group 
on the cytosine ring is substituted by 
an ε-Llysyl residue. 
48 Methyl L-lysinate C7H16N2O2 The ester formed by conjugating L-
lysine with methanol. 
49 Methylglyoxal-lysine dimer C16H29N4O4 An imidazolium ion formed via cyclo-
dimerisation of L-lysine and 
methylglyoxal. 
50 N6-1-Carboxyethyl-L-lysine Preliminary entry 
 
- 
51 N6-3,4-Didehydroretinylidene-
L-lysine 
Preliminary entry 
 
- 
52 N6-Formyl-L-lysine Preliminary entry 
 
- 
53 N6-Methyl-N6-poly(N-methyl-
propylamine)-L-lysine 
Preliminary entry 
 
- 
54 N6-Mureinyl-L-lysine Preliminary entry 
 
- 
56 N6-Myristoyl-L-lysine Preliminary entry 
 
- 
57 N6-Palmitoyl-L-lysine Preliminary entry 
 
- 
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57 N6-Pyruvic acid 2-iminyl-L-
lysine 
Preliminary entry 
 
- 
58 N6-Retinylidene-L-lysine Preliminary entry 
 
- 
59 Nα-Acetyl-L-lysine methyl ester  Preliminary entry 
 
- 
60 Peptidyl-L-lysine Preliminary entry 
 
- 
61 Psicosyllysine C12H24N2O7 An L-lysine derivative having a 
psicosyl group attached to the side-
chain amino group. 
 
Supplemental table V-4. List of incoming* L-lysine derivatives. * - the relationship 
between the ChEBI entry and its immediate related entities. 
         Credits: ChEBI 
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Not detected 
1-Piperideine 
Cadaverine 
1 
Crotonyl-CoA 
Glutaryl-CoA 
Glutarate semialdehyde 
5-Aminopentanoate 
Tricarboxylic acid cycle 
Acetyl-CoA 
Acetoacetyl-CoA 
3-Hydroxy-butanoyl-CoA 
Supplemental figure V-1. Labelling profile of L-lysine degradation via cadaverine in 
the SILAC-labelled wild type and Δlmgt promastigotes. Abbreviations: WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-
labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-
labelled carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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Not detected 
1-Piperideine 
Cadaverine 
1 
Glutaryl-CoA 
Glutarate 
Glutarate semialdehyde 
5-Aminopentanoate 
Tricarboxylic acid cycle 
Acetyl-CoA 
Supplemental figure V-2. Labelling profile of L-lysine degradation via 5-
aminopentamide in the SILAC-labelled wild type and Δlmgt promastigotes. 
Abbreviations: WT – wild type promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-
labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-
labelled carbon, +6 - 6-13C-labelled carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
 
 
 
Not detected 
Not detected 
Product of 6-13C-L-lysine 
degradation 
Not detected 
5-Aminopentanamide 
WT     ∆lmgt 
 
1.2E+08 
 
8.0E+07 
 
4.0E+07 
 
0.0E+00 
M
ea
n
 p
ea
k
 a
re
a 
2 
Not detected 
1.2E+07 
 
8.0E+06 
 
4.0E+06 
 
0.0E+00 
M
ea
n
 p
ea
k
 a
re
a 
 
WT     ∆lmgt 
 
 
L-Lysine 
WT     ∆lmgt 
 
3.0E+07 
 
2.0E+07 
 
1.0E+07 
 
0.0E+00 
M
ea
n
 p
ea
k
 a
re
a 
 
 
   
                                                                                                                                                                                               APPENDICES 
 284 
 
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L-Saccharopine 
3 
Supplemental figure V-3. Labelling profile of L-lysine degradation via L-
saccharopine in the SILAC-labelled wild type and Δlmgt promastigotes. Abbreviations: 
WT – wild type promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, 
+2 - 2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 
6-13C-labelled carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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Tricarboxylic acid cycle 
Acetyl-CoA 
 
Supplemental figure V-4. Labelling profile of L-lysine degradation via L-2-
aminoadipate 6-semialdehyde in the SILAC-labelled wild type and Δlmgt 
promastigotes. Abbreviations: WT – wild type promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled 
carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled 
carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-labelled carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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Same mass as L-lysine 
L-β-Lysine 3,5-Diaminohexanoate 
5-Amino-3-oxohexanoate 
Acetoacetate 
L-3-Aminobutyryl-CoA 
Butanoyl-CoA 
3 
Crotonyl-CoA 
Acetoacetyl-CoA 
8 
Supplemental figure V-5. Labelling profile of L-lysine degradation via L-β-lysine in 
the SILAC-labelled wild type and Δlmgt promastigotes. Abbreviations: WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-
labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-
labelled carbon. Dashed lines indicate indirect enzymatic reaction. 
Adapted from KEGG and MetaCyc. 
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N6-Hydroxy-L-lysine 
N6-Acetyl-N6-hydroxy-L-lysine 
N2-Citryl-N6-acetyl-N6-hydroxylysine 
Aerobactin 
Supplemental figure V-6. Labelling pattern of L-lysine degradation via N6-hydroxy-
L-lysine in the wild type and Δlmgt promastigotes. Abbreviations: WT – wild type 
promastigotes, ∆lmgt - ∆lmgt promastigotes, UL- unlabelled carbon, +1 - 1-13C-labelled carbon, +2 - 2-13C-
labelled carbon, +3 - 3-13C-labelled carbon, +4 - 4-13C-labelled carbon, +5 - 5-13C-labelled carbon, +6 - 6-13C-
labelled carbon. 
Adapted from KEGG and MetaCyc. 
9
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